UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

 

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2024

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to               

 

Commission file number: 000-21467

 

ALTO INGREDIENTS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   41-2170618
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

1300 South Second Street, Pekin, Illinois   61554
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (833) 710-2586

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of Exchange on Which
Registered
Common Stock, $0.001 par value   ALTO  

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐  No  ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No  ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No  ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒  No  ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer ☒ 
Non-accelerated filer Smaller reporting company  
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No  

 

The aggregate market value of the voting and non-voting common equity held by nonaffiliates of the registrant computed by reference to the closing sale price of such stock, was approximately $105 million as of June 28, 2024, the last business day of the registrant’s most recently completed second fiscal quarter.

 

As of March 12, 2025, there were 76,611,090 shares of the registrant’s common stock, $0.001 par value per share, and 896 shares of the registrant’s non-voting common stock, $0.001 par value per share, outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE:

 

The information required by Part III of this Report, to the extent not set forth herein, is incorporated herein by reference from the registrant’s definitive Proxy Statement relating to the 2025 Annual Meeting of Stockholders (“Proxy Statement”), which definitive Proxy Statement shall be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this Report relates.

 

 

 

 

 

 

TABLE OF CONTENTS

 

      Page
PART I
       
Item 1. Business   1
Item 1A. Risk Factors   15
Item 1B. Unresolved Staff Comments   28
Item 1C. Cybersecurity   28
Item 2. Properties   30
Item 3. Legal Proceedings   30
Item 4. Mine Safety Disclosures   30
       
PART II
       
Item 5. Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities   31
Item 6. [Reserved]   32
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations   32
Item 7A. Quantitative and Qualitative Disclosures About Market Risk   50
Item 8. Financial Statements and Supplementary Data   51
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure   51
Item 9A. Controls and Procedures   51
Item 9B. Other Information   53
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections   53
       
PART III
       
Item 10. Directors, Executive Officers and Corporate Governance   54
Item 11. Executive Compensation   54
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters   54
Item 13. Certain Relationships and Related Transactions, and Director Independence   54
Item 14. Principal Accountant Fees and Services   54
       
PART IV
       
Item 15. Exhibits and Financial Statement Schedules   55
Item 16. Form 10-K Summary   55
Index to Consolidated Financial Statements   F-1

 

i

 

 

CAUTIONARY STATEMENT

 

All statements included or incorporated by reference in this Annual Report on Form 10-K, other than statements or characterizations of historical fact, are forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements concerning projected net sales, costs and expenses, and margins; the expected timing, cost and effects of our capital improvement projects, including our carbon capture and storage project, and other strategic and business initiatives; expectations surrounding our repairs and maintenance activities and their timing, costs and effects; our business outlook and expected performance in future periods; the sufficiency of our liquidity and capital resources; our ability to continue as a going concern; our accounting estimates, assumptions and judgments; the demand for specialty alcohols and essential ingredients; the competitive nature of and anticipated growth in our industry; production capacity and goals; our ability to consummate acquisitions, if any, and integrate their operations successfully; and our prospective needs for additional capital. These forward-looking statements are based on our current expectations, estimates, approximations and projections about our industry and business, management’s beliefs, and certain assumptions made by us, all of which are subject to change. Forward-looking statements can often be identified by words such as “anticipates,” “expects,” “intends,” “plans,” “predicts,” “believes,” “seeks,” “estimates,” “may,” “will,” “should,” “would,” “could,” “potential,” “continue,” “ongoing,” similar expressions and variations or negatives of these words. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors, some of which are listed under “Risk Factors” in Item 1A of this report. These forward-looking statements speak only as of the date of this report. We undertake no obligation to revise or update publicly any forward-looking statement for any reason, except as otherwise required by law.

 

ii

 

 

PART I

 

Item 1. Business.

 

Business Overview

 

We are a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States.

 

We operate five alcohol production facilities. Three of our production facilities are located in Illinois, one is located in Oregon and another is located in Idaho. We have an annual alcohol production capacity of 350 million gallons, including both renewable fuels and specialty alcohols ranging from industrial-, pharmaceutical-, and high-quality food- and beverage-grade alcohols. Of this amount, we can produce up to 110 million gallons annually of specialty alcohols, depending on our product mix among high-quality beverage-grade alcohol and other quality specification alcohols. We market and distribute all of the alcohols produced at our facilities as well as alcohols produced by third parties. In 2024, we marketed and distributed approximately 386 million gallons combined of our own produced alcohols as well as fuel-grade ethanol produced by third parties, and over 1.4 million tons of essential ingredients on a dry matter basis.

 

We also own and operate a liquid carbon dioxide, or CO2, production facility adjacent to our plant in Oregon for the offtake of CO2 gas from the plant for conversion to liquid CO2 and subsequent sale. We acquired this facility on January 1, 2025.

 

In addition, we break bulk and distribute specialty alcohols, produced by us and third parties, through our Eagle Alcohol business.

 

We report our financial and operating performance in three distinct segments:

 

Pekin production, which includes the production and sale of alcohols and essential ingredients produced at our three production facilities located in Pekin, Illinois, which we refer to as our Pekin Campus;

 

Marketing and distribution, which includes marketing and merchant trading for company-produced alcohols and essential ingredients on an aggregated basis, and sales of fuel-grade ethanol sourced from third parties; and

 

Western production, which includes the production and sale of renewable fuels and essential ingredients and, beginning in 2025, liquid CO2, produced at our western production facilities, including our liquid CO2 plant, on an aggregated basis, none of which are individually so significant as to be considered a separately reportable segment.

 

Our mission is to produce the highest quality, sustainable ingredients that make everyday products better. We intend to accomplish this goal in part by investing in our specialized and higher value specialty alcohol production and distribution infrastructure, expanding production in high-demand essential ingredients, expanding and extending the sale of our products into new regional and international markets, building efficiencies and economies of scale and by capturing a greater portion of the value stream.

 

-1-

 

Production Segments

 

We produce specialty alcohols, renewable fuels and essential ingredients, focusing on five key markets: Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels. Products for Health, Home & Beauty markets include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. Products for Food & Beverage markets include grain neutral spirits used in alcoholic beverages and vinegar and corn germ used for corn oils. Products for Industry & Agriculture markets include alcohols and other products for paint applications, vehicle fluids and fertilizers. Products for Essential Ingredients markets include dried yeast, corn protein meal, corn protein feed, corn germ, distillers grains, liquid CO2 and liquid feed used in commercial animal feed and pet foods. We also sell yeast and liquid CO2 for human consumption. Our products for the Renewable Fuels markets include fuel-grade ethanol and distillers corn oil used as a feedstock for renewable diesel and biodiesel fuels. Our specialty alcohols for the Industry & Agriculture, Food & Beverage and Health, Home & Beauty markets represented approximately 12%, 7% and 3%, respectively, of our sales in 2024 from these three markets.

 

We produce our alcohols and essential ingredients at our facilities described below. Our production facilities located in Illinois are in the heart of the Corn Belt, benefit from relatively low-cost and abundant feedstock and enjoy logistical advantages that enable us to provide our products to both domestic and international markets via truck, rail or barge. Our production facilities located in Oregon and Idaho are near their respective fuel and feed customers, offering significant timing, product transportation cost and logistical advantages.

 

All of our production facilities, other than our Magic Valley plant, were operating for all of 2024, subject to scheduled and unscheduled downtimes to address facility repair and maintenance.

 

In January 2024, we temporarily hot-idled our Magic Valley facility to minimize losses from negative regional crush margins and to expedite the installation of additional equipment to achieve the intended production rate, quality and consistency from our corn oil and high protein system at the facility. We restarted our Magic Valley facility in July 2024 and by October 2024, the facility consistently achieved average ethanol production rates at full capacity, the protein content yield from the plant reached 50% or greater, and we were able to expand our corn oil yields. Increases in regional corn basis and declining market prices for protein and corn oil resulted in overall margin compression, outweighing the economic benefits of our plant improvements. As a consequence, we cold-idled our Magic Valley facility on December 31, 2024 to minimize financial losses. We continue to provide terminal services at the plant and intend to resume operations at the facility when the economic environment in the region sustainably improves. We believe that the cold-idling of our Magic Valley facility will have a positive impact on our overall financial results in 2025 compared to 2024.

 

As market conditions change, we may increase, decrease or idle production at one or more operating facilities or resume operations at any idled facility.

 

Marketing and Distribution Segment

 

We market and distribute all the alcohols and essential ingredients we produce at our facilities. We also market and distribute alcohols produced by third parties.

 

We have extensive and long-standing customer relationships, both domestic and international, for our specialty alcohols and essential ingredients. These customers include producers and distributors of ingredients for cosmetics, sanitizers and related products, distilled spirits producers, food products manufacturers, producers of personal health/consumer health and personal care hygiene products, and global trading firms.

 

Our renewable fuel customers are located throughout the Western and Midwestern United States and consist of integrated oil companies and gasoline marketers who blend fuel-grade ethanol into gasoline. Our customers depend on us to provide a reliable supply of fuel-grade ethanol and manage the logistics and timing of delivery. Our customers collectively require fuel-grade ethanol volumes in excess of the supplies we produce at our facilities. We secure additional fuel-grade ethanol supplies from third-party ethanol producers. We arrange for transportation, storage and delivery of fuel-grade ethanol purchased by our customers through our agreements with third-party service providers in the Western United States as well as in the Midwest from a variety of sources.

 

-2-

 

We market food-grade essential ingredients to human and pet food markets, our feed products (such as distillers grains) primarily to export markets from our Pekin Campus, and other feed products to dairies and feedlots, in many cases located near our production facilities. These customers use our feed products for livestock as a substitute for corn and other sources of starch and protein. We sell our corn oil to poultry, renewable diesel and biodiesel customers.

 

See “Note 4 – Segments” to our Notes to Consolidated Financial Statements included elsewhere in this report for financial information about our business segments.

 

Company History

 

We are a Delaware corporation formed in 2005. Our common stock trades on The Nasdaq Capital Market under the symbol “ALTO.” Our Internet website address is http://www.altoingredients.com. Information contained on our website is not part of this Annual Report on Form 10-K. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to such reports filed with or furnished to the Securities and Exchange Commission and other Securities and Exchange Commission filings are available free of charge through our website as soon as reasonably practicable after the reports are electronically filed with, or furnished to, the Securities and Exchange Commission.

 

Business Strategy

 

The key elements of our business and growth strategy include:

 

Focus on our customer relationships. Our primary business focus is to expand the production and sale of specialty alcohols and essential ingredients. Our business is now more service-oriented and focused on specialty products that yield premium prices compared to commodity products that yield predominantly passive, market-driven prices. We strive to make our business ever more customer-centric to enable our premium services to support premium prices and new differentiated and higher-margin products.

 

Implement carbon capture and storage at our Pekin Campus, lowering our carbon footprint. The Inflation Reduction Act of 2022 raised the carbon capture tax credit to $85 per metric ton, reflecting the section 45Q tax incentive benefits established under the Act. Section 45Z low carbon fuel tax credits are also available under the Act. We produce over 600,000 metric tons of CO2 per year at our Pekin Campus, which sits atop the Mount Simon formation, identified as one of the best and largest carbon storage locations in the country. We are prioritizing our carbon capture and storage, or CCS, project over other long-term capital projects. We believe the financial benefits under the Inflation Reduction Act and the substantial additional economic benefits of the environmental attributes associated with low carbon ethanol will result in excellent returns on investment. In furtherance of this project, in November 2024, we entered into a CO2 Transportation and Sequestration Agreement with Vault 44.01, or Vault, to provide transportation, injection and sequestration into the Mount Simon sandstone formation in Illinois of CO2 produced at our Pekin Campus. In December, Vault submitted the formal application to the EPA for our CCS project to obtain the Class VI permit required to begin construction of the CCS pipeline and for long-term CO2 storage in deep geological formations.

 

-3-

 

Expand product offerings. We are pursuing initiatives to broaden our product offerings to appeal to a wider range of customers and uses in our key markets. For example, on January 1, 2025, we acquired a liquid CO2 production facility located adjacent to our Oregon plant and now offer liquid CO2 for sale. Our liquid CO2 facility and our food-grade yeast plant are both FSSC 22000 certified, meeting the Global Food Safety Initiative (GFSI) benchmarking requirements. In addition, we maintain ISO 9001, ICH Q7 and EXCiPACT certifications for all United States Pharmacopia, or USP, grade alcohol products. These certifications appeal to customers with stringent quality demands and enable us to offer alcohol certified for use as an active pharmaceutical ingredient, or API, and as an excipient—an inactive component of a drug or medication, such as solvents, carriers or tinctures—in the pharmaceutical industry. All ingredients we produce for use in beverages, human and pet foods are third-party certified for ISO 9001 and hazard analysis and critical control points (HACCP). In addition, all of our animal feed production, including at our Oregon and Idaho facilities, has undergone third-party Food Safety Modernization Act (FSMA) auditing. We are reviewing additional certifications and product positioning within our key markets to expand the range of customers we serve and the uses our products support.

 

Implement new equipment and technologies. We are evaluating and plan to implement new equipment and technologies to increase our production yields, improve our operating efficiencies and reliability, reduce our overall carbon footprint, diversify our products and revenues, and increase our profitability as financial resources and market conditions Left these investments.

 

Evaluate and pursue strategic opportunities. We are exploring opportunities to expand our business. For example, when the opportunity arose, we moved quickly to acquire the liquid CO2 production facility adjacent to our Oregon plant and establish an improved, long-term liquid CO2 sales agreement with a leading reseller of liquid CO2. We intend to pursue these and other strategic opportunities as financial resources and business prospects make these opportunities desirable. We are also exploring divestiture opportunities for certain properties in an ongoing effort to continue to optimize our asset portfolio and as part of our ongoing efforts to maximize shareholder value. For example, we have engaged an investment banking firm to explore the sale of our production facilities located in Oregon and Idaho. In addition, with the assistance of our financial and legal advisors, we are considering a broad range of other options, including asset sales, a merger or other strategic transactions to better align our long-term value potential.

 

Competitive Strengths

 

We believe that our competitive strengths include:

 

Strong customer and supplier relationships. We have strong, extensive and long-standing close customer and supplier relationships, both domestic and international, for our specialty alcohols, renewable fuels and essential ingredients. We have an excellent reputation for developing specialty alcohols under stringent quality control standards. Our quality management systems are supported by ISO 9001, FSSC 22000, ICH Q7 and EXCiPACT certifications which are viewed by our customers as important attestations of our quality control.

 

Diverse product mix. We offer a wide range of specialty alcohols, essential ingredients and other products to meet customer demand. We offer multiple alcohol quality grades ranging from industrial-grade alcohol to the highest beverage grade low moisture 200 proof alcohol available. We also offer a wide variety of essential ingredients and other products for food, feed and other markets.

 

-4-

 

Barriers to entry. Our production facilities use specialized equipment, technologies and processes to achieve stringent quality controls, higher yields and efficient production of alcohols and essential ingredients. Our specialized equipment, technologies and processes, together with our quality management certifications, strict regulatory requirements, and close customer and supplier relationships create significant barriers to entry to new market participants.

 

Our experienced management. Our senior management team has a proven track record with significant operational and financial expertise and many years of experience in the alcohol production industry. Our senior executives have successfully navigated a wide variety of business and industry-specific challenges and deeply understand the business of successfully producing and marketing specialty alcohols, renewable fuels and essential ingredients.

 

The strategic location of our Midwest production facilities. We operate three distinct but integrated production facilities at our Pekin Campus in the Midwest. We are able to participate from that location in the largest regional specialty alcohol market in the United States as well as international markets.

 

We believe that our Midwest location enhances our overall hedging opportunities with a greater correlation to the highly liquid physical and paper markets in Chicago.

 

Our Midwest location provides excellent logistical access via rail, truck and barge. In particular, barge access via the Illinois River to the Mississippi River enables us to efficiently bring our products to international markets.

 

The relatively unique wet milling process at one of our production facilities at our Pekin Campus allows us to extract the highest use and value from each component of the corn kernel. As a result, the wet milling process generates a higher level of cost recovery from corn than that produced at a dry mill.

 

Our Midwest location allows us deep market insight and engagement in major specialty alcohol, fuel-grade ethanol, pet food and feed markets, thereby improving pricing opportunities.

 

Our Midwest location sits atop the Mount Simon formation, identified as one of the best and largest carbon storage locations in the country potentially allowing us to benefit from this close proximity to store CO2.

 

Overview of Our Key Markets and Market Opportunity

 

We produce specialty alcohols, renewable fuels and essential ingredients, focusing on five key markets: Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels.

 

Health, Home & Beauty

 

Our products for the health, home and beauty markets include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. We offer a variety of specialty alcohols for the health, home and beauty markets, depending on usage and regulatory requirements, including API-grade or USP-grade ethyl alcohols, and industrial-grade ethyl alcohol.

 

-5-

 

We have ISO 9001, FSSC 22000, ICH Q7 and EXCiPACT certifications, all of which are viewed as important attestations of quality control standards. In particular, our ICH Q7 certification qualifies our specialty alcohols for use as an API, and our EXCiPACT certification qualifies our specialty alcohols for use as an excipient in the pharmaceutical industry. These certifications enable us to offer products to a wider group of customers and generally at more profitable margins.

 

Food & Beverage

 

Our products for the food and beverage market include specialty alcohols used in alcoholic beverages, flavor extracts and vinegar as well as corn germ used for corn oils and CO2 used for beverage carbonation and dry ice. We offer grain neutral spirits, or GNS, alcohol as our primary specialty alcohol for beverage-grade products. In addition, we sell FCC 190 and USP 190 Ultra into vinegar markets. We also sell high-quality 192 proof and low-moisture 200-proof GNS products to customers in the beverage, food, flavor and personal care industries.

 

We believe the key drivers in the food and beverage market include consumer preferences for the social currency of brand authenticity and heritage; consumers seeking unique and personalized experiences; improved consumer access to spirits products; the growth of craft distillers; and the ability to meet wide-ranging consumer preferences through a broad diversity of spirits categories and cocktails.

 

Industry & Agriculture

 

Our products for the industry and agriculture market include alcohols and other products for paint applications, vehicle fluids and fertilizers.

 

Essential Ingredients

 

Our essential ingredients include dried yeast, corn protein meal, corn protein feed, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, we sell yeast for human consumption. We also produce and sell liquid CO2. The raw materials for our essential ingredients are generated as co-products from our production of alcohols. These co-products are further manufactured, altered and refined into our essential ingredients, including for special customer applications.

 

Many of our essential ingredients are used in a variety of food products to affect their nutrition, including protein and fat content, as well as other product attributes such as taste, texture, palatability and stability. Our high quality and high purity manufacturing enables our customers to use some of our essential ingredients in human foods while others are used solely in pet foods and animal feed.

 

We expect the essential ingredients market to grow significantly due to global demand for higher-grade protein feed, such as feed used in fisheries and other applications for plant-based proteins.

 

Renewable Fuels

 

Our renewable fuels products include fuel-grade ethanol primarily used as a transportation fuel additive and distillers corn oil used as a renewable diesel and biodiesel feedstock. Our renewable fuels business is supported by our own production of fuel-grade ethanol as well as fuel-grade ethanol produced by third parties.

 

Renewable fuels, primarily fuel-grade ethanol, are used for a variety of purposes, including as octane enhancers for premium gasoline and to enable refiners to produce greater quantities of lower octane blend stock; for fuel blending to extend fuel supplies and reduce reliance on crude oil and refined products; and to comply with a variety of governmental programs, in particular, the national Renewable Fuel Standard, or RFS, enacted to promote alternatives to fossil fuels. Under the RFS, the mandated use of all renewable fuels rose incrementally and peaked at 36.0 billion gallons in 2022, of which production of 15.0 billion gallons was required from conventional, or corn-based, ethanol. The RFS allows the Environmental Protection Agency, or EPA, to adjust the annual requirement based on certain facts and circumstances. The EPA set its annual requirement for conventional ethanol to 15.0 billion gallons for 2025. See “—Governmental Regulation.”

 

-6-

 

According to the Renewable Fuels Association, the domestic fuel-grade ethanol industry produced over 16.1 billion gallons of ethanol in 2024, up from 15.5 billion gallons of ethanol in 2023. According to the United States Department of Energy, total annual gasoline consumption in the United States is approximately 137 billion gallons and total annual fuel-grade ethanol blended with gasoline represented approximately 10.4% of this amount in 2024. We anticipate that continued limited opportunities for gasoline refinery expansions and the growing importance of reducing CO2 emissions using renewable fuels will generate additional growth in the demand for fuel-grade ethanol.

 

Overview of Alcohol Production Process

 

Alcohol production from starch- or sugar-based feedstock is a highly efficient process. Modern alcohol production requires large amounts of corn, or other high-starch grains, and water as well as chemicals, enzymes and yeast, in addition to natural gas and electricity.

 

Dry Milling Process

 

In the dry milling process, corn or other high-starch grain is first ground into flour, then slurried with water to form a mash. Enzymes are added to the mash to convert the starch into dextrose, a simple sugar. The mash is processed through a high temperature cooking procedure, which reduces bacteria levels prior to fermentation. The mash is then cooled and transferred to fermenters, where yeast is added and the conversion of sugar to alcohol and CO2 begins.

 

After fermentation, the resulting “beer” is transferred to distillation where the alcohol is separated from the residual “stillage.” The resulting alcohol is concentrated to 190 proof using conventional distillation methods. It can then be dehydrated to approximately 200 proof, representing 100% alcohol levels, in either a molecular sieve system or a grits system. For fuel-grade ethanol, the resulting anhydrous alcohol is then blended with up to 2.5% denaturant, usually gasoline, and then shipped to renewable fuels markets. For specialty alcohols, the products can be sold pure or as one of the Alcohol Tobacco Tax & Trade Bureau (TTB) approved specially denatured alcohol (SDA) formulations to meet customer specifications.

 

The residual stillage is separated into a coarse grain portion and a liquid portion through a screw press or centrifugation process. The soluble liquid portion is concentrated to about 40% dissolved solids by an evaporation process. This intermediate state is called condensed distillers solubles, or syrup. The coarse grain and syrup portions are then mixed to produce wet distillers grains with solubles, or WDGS, or can be mixed and dried to produce dried distillers grains with solubles, or DDGS. Both WDGS and DDGS are high-protein animal feed products.

 

Wet Milling Process

 

In the wet milling process, corn or other high-starch grain is first soaked or “steeped” in sulfurous acid for approximately 24 hours to soften the whole corn kernel prior to milling. After steeping, the grain is coarse milled to gently open the kernels to separate the corn germ and from which corn oil is further extracted in a separate process. The remaining fiber, protein and starch components are further separated and sold.

 

-7-

 

The stillage from the fermentation process is concentrated in an evaporator and is co-dried with the fiber component and sold as corn protein feed. The protein component is separated from the starch, filtered and dried to produce corn protein meal, a product with greater than 60% protein content. The starch component is processed into alcohol through fermentation. The fermentation process for alcohol at this stage is similar to the dry milling process. In addition, we separate and dry yeast to produce distillers yeast.

 

Overview of Distillers Grains Market

 

Distillers grains are produced as a co-product of alcohol production and are valuable components of feed rations primarily to dairies and beef cattle markets, both nationally and internationally. Our plants produce both WDGS and DDGS. WDGS is sold to customers proximate to the plants and DDGS is delivered by truck, rail and barge to customers in domestic and international markets. Producing WDGS uses up to one-third less process energy, thus reducing production costs and lowering the carbon footprint of our Western production facilities.

 

Historically, the market price for distillers grains has generally tracked the price of corn. We believe that the market price of WDGS and DDGS is determined by a number of factors, including the market prices of corn, soybean meal and other competitive ingredients, the performance or value of WDGS and DDGS in a particular feed formulation and general market forces of supply and demand, including export markets for these essential ingredients. The market price of distillers grains is also often influenced by nutritional models that calculate the feed value of distillers grains by nutritional content, as well as reliability of consistent supply.

 

Customers

 

Our Kinergy Marketing LLC, or Kinergy, subsidiary sells all of our produced alcohols and also markets fuel-grade ethanol produced by third parties. Our Alto Nutrients, LLC subsidiary sells all of the essential ingredients we produce. Our Alto Carbonic, LLC subsidiary sells all of the liquid CO2 we produce and our Eagle Alcohol business sells our alcohols and third-party alcohols in break bulk quantities to customers in the beverage, food, industrial and related-process industries.

 

We have extensive and long-standing customer relationships, both domestic and international, for our specialty alcohols and essential ingredients, including yeast for pet food and human foods. These customers include producers and distributors of ingredients for cosmetics, sanitizers and related products, distilled spirits producers, food products manufacturers, producers of personal health/consumer health and personal care hygiene products, and global trading firms.

 

Our renewable fuel customers are located throughout the Western and Midwestern United States and consist of integrated oil companies and gasoline marketers who blend fuel-grade ethanol into gasoline. Our customers depend on us to provide a reliable supply of fuel-grade ethanol and manage the logistics and timing of delivery. We secure additional fuel-grade ethanol supplies from third-party fuel-grade ethanol plants.

 

We market our essential ingredient feed products to dairies and feedlots, in many cases located near our production facilities. These customers use our feed products for livestock as a substitute for corn and other sources of starch and protein. We sell our corn oil to poultry, renewable diesel and biodiesel customers.

 

-8-

 

Our Pekin Campus production segment generated $416 million, $502 million and $521 million in net sales for the years ended December 31, 2024, 2023 and 2022, respectively, from the sale of alcohols. Our Pekin Campus production segment generated $169 million, $218 million and $226 million in net sales for the years ended December 31, 2024, 2023 and 2022, respectively, from the sale of essential ingredients.

 

During 2024, 2023 and 2022, our Pekin Campus production segment sold an aggregate of approximately 214 million, 209 million and 205 million gallons of alcohols and 906,300, 878,400, and 850,300 tons of essential ingredients, respectively, on a dry matter basis.

 

Our Western production segment generated $115 million, $167 million and $254 million in net sales for the years ended December 31, 2024, 2023 and 2022, respectively, from the sale of alcohols. Our Western production segment generated $37 million, $57 million and $90 million in net sales for the years ended December 31, 2024, 2023 and 2022, respectively, from the sale of essential ingredients.

 

During 2024, 2023 and 2022, our Western production segment sold an aggregate of approximately 61 million, 67 million and 92 million gallons of alcohols and 514,600, 642,300 and 787,100 tons of essential ingredients, respectively, on a dry matter basis.

 

Our marketing and distribution segment generated $217 million, $263 million and $229 million in net sales for the years ended December 31, 2024, 2023 and 2022, respectively, from the sale of our own alcohols and third-party produced alcohols.

 

Our Corporate and other segment, which includes Eagle Alcohol’s business, generated $11 million, $16 million and $16 million in net sales for the years ended December 31, 2024, 2023 and 2022, respectively, and sold 3.6 million, 4.0 million and 4.0 million gallons of alcohols, respectively, for those years.

 

During 2024, 2023 and 2022, we produced or purchased from third parties and resold an aggregate of 386 million, 383 million and 419 million gallons of alcohols to approximately 85, 88 and 114 customers, respectively. For 2024, 2023 and 2022, sales to our two largest customers, Chevron Products USA and Shell Trading (US) Company represented an aggregate of approximately 18%, 16% and 20% of our net sales, respectively. For 2024, 2023 and 2022, sales to each of our other customers represented less than 10% of our net sales.

 

Suppliers

 

Pekin Campus and Western Production Segments

 

Our production operations depend upon various raw materials suppliers, including suppliers of corn, natural gas, electricity and water. The cost of corn, including delivery costs, is the most important variable cost associated with our alcohol production. We source corn for our plants using standard contracts, including spot purchase, forward purchase and basis contracts. When resources are available, we seek to limit the exposure of our production operations to raw material price fluctuations by purchasing forward a portion of our corn requirements on a fixed price basis and by purchasing corn and other raw materials futures contracts and options.

 

During 2024, 2023 and 2022, purchases of corn from our three largest suppliers represented an aggregate of approximately 29%, 26% and 38% of our total corn purchases, respectively, for those periods. Purchases from each of our other corn suppliers represented less than 10% of total corn purchases in each of 2024, 2023 and 2022.

 

-9-

 

Marketing and Distribution Segment

 

Our marketing and distribution operations include alcohols and essential ingredients we produce but also depend upon various third-party producers of fuel-grade ethanol. In addition, we provide transportation, storage and delivery services through third-party service providers with whom we have contracted to receive fuel-grade ethanol at agreed upon locations from our third-party suppliers and to store and/or deliver the ethanol to agreed-upon locations on behalf of our customers. These contracts generally run from year-to-year, subject to termination by either party upon advance written notice before the end of the then-current annual term.

 

During 2024, 2023 and 2022, we purchased and resold from third parties an aggregate of approximately 108 million, 103 million and 118 million gallons, respectively, of fuel-grade ethanol.

 

During 2024, 2023 and 2022, purchases of fuel-grade ethanol from our four largest third-party suppliers represented 79%, 86% and 69%, respectively, of our total third-party ethanol purchases for each of those periods. Purchases from each of our other third-party ethanol suppliers represented less than 10% of total third-party ethanol purchases in each of 2024, 2023 and 2022.

 

Production Facilities

 

We operate five alcohol production facilities. Three of our production facilities are located in Illinois, one is located in Oregon and another is located in Idaho. We have an annual alcohol production capacity of up to 350 million gallons, including both fuel-grade ethanol and specialty alcohols ranging from industrial-, pharmaceutical-, and high-quality food- and beverage-grade alcohols. Of this amount, we are able to produce up to 110 million gallons annually of specialty alcohols, depending on our product mix among high-quality beverage-grade alcohol and other quality specification alcohols. We also own and operate a liquid CO2 production facility adjacent to our plant in Oregon for the offtake of CO2 gas from the plant for conversion to liquid CO2 and subsequent sale.

 

The tables below provide an overview of our five alcohol production facilities and our liquid CO2 production facility. As market conditions change, we may increase, decrease or idle production at one or more operating facilities or resume operations at any idled facility.

 

Pekin Campus Production Facilities

 

   Pekin
Wet Facility
  Pekin
Dry Facility
  Pekin
ICP Facility
Location  Pekin, IL  Pekin, IL  Pekin, IL
Current operating status  Operating  Operating  Operating
Approximate maximum annual alcohol production capacity (in millions of gallons)  100  60  90
Approximate maximum annual specialty alcohol production capacity (in millions of gallons)  74    66
Production milling process  Wet  Dry  Dry
Primary energy source  Natural Gas  Natural Gas  Natural Gas

 

-10-

 

Western Production Facilities

 

   Magic Valley
Facility
  Columbia
Facility
  Liquid CO2
Facility
 
Location  Burley, ID  Boardman, OR  Boardman, OR
Current operating status  Cold-Idled  Operating  Operating
Approximate maximum annual fuel-grade ethanol production capacity (in millions of gallons)  60  40  -
Approximate maximum annual liquid CO2 capacity (in thousands of tons)  -  -  70
Production milling process  Dry  Dry  N/A
Primary energy source  Natural Gas  Natural Gas  Electricity

 

Commodity Risk Management

 

We employ various risk mitigation techniques. For example, we may seek to mitigate our exposure to commodity price fluctuations by purchasing forward a portion of our corn and natural gas requirements through fixed-price or variable-price contracts with our suppliers, as well as entering derivative contracts for fuel-grade ethanol, corn and natural gas. To mitigate fuel-grade ethanol inventory price risks, we may sell a portion of our production forward under fixed- or index-price contracts, or both. We may hedge a portion of the price risks by entering exchange-traded futures contracts and options. Properly executing these risk mitigation strategies can reduce the volatility of our gross profit margins.

 

Specialty alcohols have relatively low price volatility and are usually priced at significant premiums to fuel-grade ethanol. The market price of fuel-grade ethanol is volatile, however, and subject to large fluctuations. Given the nature of our business, we cannot effectively hedge against extreme volatility or certain market conditions. For example, fuel-grade ethanol prices, as reported by the Chicago Mercantile Exchange, or CME, ranged from $1.38 to $2.12 per gallon during 2024, from $1.58 to $2.67 per gallon during 2023 and from $2.00 to $2.88 per gallon during 2022; and corn prices, as reported by the CME, ranged from $3.62 to $4.71 per bushel during 2024, from $4.50 to $6.85 per bushel during 2023 and from $5.64 to $8.18 per bushel during 2022.

 

Climate-Related and Other Risks

 

Short- to medium-term climate-related and other risks include high sensitivity to certain commodity prices such as corn and natural gas; regulatory changes and political volatility, both domestic and international; ethanol supply and demand imbalances; logistics and storage constraints from river access during inclement or volatile weather conditions; lack of automation of process optimization; high repair, maintenance and production costs resulting from older facilities; poor cooling capacity of our older facilities as water temperatures increase; and international market competition.

 

Long-term climate-related risks include water resource limitations; lower or volatile grain availability in local markets; market transition away from combustion fuels that include renewables; and the energy cost impact of technology such as wet milling and multiple distillation processes for high-quality alcohol. We also may be impacted by costs and regulatory burdens associated with carbon emissions from our production and distribution as well as truck transport and packaging associated with Eagle Alcohol’s use of drums and totes. See “Risk Factors.”

 

Marketing Arrangements

 

We market all the alcohols and essential ingredients produced at our facilities. We also market and distribute alcohols produced by third parties.

 

-11-

 

Competition

 

We are a leading producer of specialty alcohols in the United States.

 

Other significant producers of specialty alcohols in the United States are Archer-Daniels-Midland Company, Grain Processing Corporation, BioUrja Renewables, LLC, CIE and Greenfield Global Inc., which collectively make up a significant majority of the total installed specialty alcohol production capacity in the United States along with many smaller producers.

 

The largest producers of fuel-grade ethanol in the United States are POET, LLC, Valero Renewable Fuels Company, LLC, Archer-Daniels-Midland Company and Green Plains Inc., collectively with approximately 39% of the total installed fuel-grade ethanol production capacity in the United States. In addition, there are many mid-sized fuel-grade ethanol producers with several plants under ownership, smaller producers each with one or two plants, and several fuel-grade ethanol marketers that create significant competition. Overall, we believe there are over 200 fuel-grade ethanol production facilities in the United States with a total installed production capacity of approximately 18 billion gallons and many brokers and marketers with whom we compete for sales of fuel-grade ethanol and its co-products.

 

Our fuel-grade ethanol also competes on a global market against production from other countries, such as Brazil, which may have lower production costs than United States producers. Lower feedstock input costs such as sugarcane used in Brazil as compared to corn used in the Unites States may give foreign producers a competitive advantage. In addition, fuel-grade ethanol from sugarcane feedstock qualifies as an advanced biofuel, unlike corn ethanol, allowing certain producers to economically satisfy an advanced biofuel standard. Moreover, new products and production technologies are under continuous development, many of which, if adopted by competitors, could harm our ability to compete.

 

We believe that our competitive strengths include our customer and supplier relationships, our diverse product mix, the barriers to entry to our most profitable lines of business—including our certifications at our production facilities—our experienced management, and the strategic location of our Midwest production facilities. See “—Competitive Strengths.”

 

Governmental Regulation

 

Our business is subject to a wide range of federal, state and local laws and regulations directed at protecting public health and the environment, including those promulgated by the Occupational Safety and Health Administration, or OSHA, the U.S. Food and Drug Administration, or FDA, the EPA, and numerous state, local and international authorities. These laws, their underlying regulatory requirements and their potential enforcement, some of which are described below, impact, or may impact, nearly every aspect of our operations, including our alcohol production (including distillation), our liquid CO2 production, our essential ingredient production, our storage facilities, and our water usage, wastewater discharge, disposal of hazardous wastes and emissions, and other matters pertaining to our existing and proposed business by imposing:

 

restrictions on our existing and proposed operations and/or the need to install enhanced or additional controls;

 

special requirements applicable to food and drug additives;

 

the need to obtain and comply with permits and authorizations;

 

liability for exceeding applicable permit limits or legal requirements, in some cases for the remediation of contaminated soil and groundwater at our production facilities, contiguous and adjacent properties and other properties owned and/or operated by third parties; and

 

other specifications for the specialty alcohols and essential ingredients we produce, market and sell.

 

-12-

 

In addition, some governmental regulations are helpful to our production and marketing business. The fuel-grade ethanol industry in particular is supported by federal and state mandates and environmental regulations that favor the use of fuel-grade ethanol in motor fuel blends in North America. Some of the governmental regulations applicable to our production and marketing business are briefly described below.

 

Food and Drug Regulation

 

Our products for the Health, Home & Beauty, Food & Beverage and Essential Ingredients markets are subject to regulation by the FDA as well as similar state agencies. Under the Federal Food, Drug, and Cosmetic Act, or FDCA, the FDA regulates the processing, formulation, safety, manufacture, packaging, labeling and distribution of food ingredients, vitamins, cosmetics and pharmaceuticals for active and inactive ingredients. In 2022, The Modernization of Cosmetics Regulation Act (MoCRA) was added to the FDCA. This was a significant expansion to the FDCA, and established requirements for cosmetic product facility registration and product listing, widening regulatory oversight of many more of our customers’ products. Many of the FDA’s and FDCA’s rules and regulations apply directly to us as well as indirectly through their application in our customers’ products. For proper marketing and sale in the United States, an applicable product must be generally recognized as safe, approved and not adulterated or misbranded under the FDCA and relevant regulations issued under the FDCA. The FDA has broad authority to enforce the provisions of the FDCA. Failure to comply with the laws and regulations of the FDA or similar state agencies could prevent us from selling certain of our products or subject us to liability.

 

Renewable Fuels Energy Legislation

 

Under the RFS, the mandated use of all renewable fuels, including fuel-grade ethanol, rose incrementally and peaked at 36.0 billion gallons in 2022, of which 15.0 billion gallons are required from conventional, or corn-based, ethanol for 2025. Under the provisions of the Energy Independence and Security Act of 2007, the EPA has the authority to waive the mandated RFS requirements in whole or in part. To grant a waiver, the EPA administrator must determine, in consultation with the Secretaries of Agriculture and Energy, that there is inadequate domestic renewable fuel supply or implementation of the requirement would severely harm the economy or environment of a state, region or the United States as a whole.

 

Various bills in Congress introduced from time to time are also directed at altering existing renewable fuels energy legislation, but none have passed in recent years. Some legislative bills are directed at halting or reversing expansion of, or even eliminating, the renewable fuel program, while other bills are directed at bolstering the program or enacting further mandates or grants that would support the renewable fuels industry.

 

The EPA has allowed fuel and fuel-additive manufacturers to introduce into commercial gasoline up to 15% fuel-grade ethanol by volume, or E15, for vehicles from model year 2001 and after. According to the Renewable Fuels Association, E15 is explicitly approved by the manufacturer for use in approximately 95% of model year 2024 and newer cars and light trucks based on its annual review of vehicle owner’s manuals and warranty statements. Commercial sales of E15 have begun in a majority of states. E15 has historically been prohibited in most states during the summer driving season due to concerns over evaporative emissions and to meet federal clean air standards. For the 2024, 2023 and 2022 summer driving seasons, the EPA issued emergency fuel waivers to allow the sale of E15 to help alleviate high gasoline prices. E15 may, however, be sold year-round in states that have a reformulated gasoline program. In addition, the EPA proposed in late 2023 that E15 be permitted for sale year-round in various Midwestern states effective in April 2024. The U.S. Office of Management and Budget approved the proposal in February 2024 but deferred the effective date to April 2025.

 

-13-

 

Various states including California, Oregon and Washington, and other regions such as the Canadian province of British Columbia, have implemented low carbon fuel standards focused on reducing the carbon intensity of transportation fuels. Other states, including New York, Vermont, Massachusetts, Michigan, Illinois, Colorado and New Mexico, currently have proposed legislation or policies that would establish a low carbon fuel standard program. Blending fuel-grade ethanol into gasoline is one of the primary means of attaining these goals.

 

Additional Environmental Regulations

 

In addition to the governmental regulations applicable to the alcohol production and marketing industry described above, our business is subject to additional federal, state and local environmental regulations, including regulations established by the EPA and state regulatory agencies related to water quality and air pollution control. We cannot predict the manner by which, or extent to which, these regulations will harm or help our business or the alcohol production and marketing industry in general.

 

Human Capital Resources

 

As of March 12, 2025, we had approximately 393 full-time employees. Our human capital resources objectives include attracting and retaining well-qualified and highly skilled and motivated employees and executives. As of that same date, approximately 51% of our employees were represented by a labor union and covered by a collective bargaining agreement. We have never had a work stoppage or strike and we consider our relations with our employees to be good.

 

Our compensation program is designed to attract, retain and motivate our personnel. We use a mix of competitive salaries and other benefits to attract and retain employees and executives. Some of these benefits include matching 401K contributions of up to 6% of salary, health and wellness programs and a paid service day for employees to give back to their communities. At the direction and with the involvement of our Sustainability and Governance board committees, we have established a Sustainability working committee that draws from our many administrative and operational departments to review key policies and procedures, conduct employee engagement surveys, champion volunteering and charitable drives, develop and implement formalized recruiting and training efforts to prioritize collecting data and improving on key metrics from industry frameworks such as the Global Reporting Initiative (GRI) and Sustainability Accounting Standards Board (SASB) standards which are maintained by the International Sustainability Standards Board of the IFRS Foundation.

 

-14-

 

Item 1A. Risk Factors.

 

Before deciding to purchase, hold or sell our common stock, you should carefully consider the risks described below in addition to the other information contained in this Report and in our other filings with the Securities and Exchange Commission, including subsequent reports on Forms 10-Q and 8-K. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business. If any of these known or unknown risks or uncertainties actually occurs with material adverse effects on Alto Ingredients, our business, financial condition, results of operations and/or liquidity could be seriously harmed. In that event, the market price for our common stock will likely decline, and you may lose all or part of your investment.

 

Risks Related to our Business

 

Our results of operations and our ability to operate at a profit are largely dependent on our ability to manage the costs of corn, natural gas and other production inputs, with the prices of our alcohols and essential ingredients, all of which are subject to volatility and uncertainty.

 

Our results of operations are highly impacted by commodity prices, including the cost of corn, natural gas and other production inputs that we must purchase, and the prices of alcohols and essential ingredients that we sell. Prices and supplies are subject to and determined by numerous market and other forces over which we have no control, such as inclement or favorable weather, domestic and global demand, supply excesses or shortages, export conditions, inflationary conditions, global geopolitical tensions and various governmental policies in the United States and throughout the world.

 

Price volatility of corn, natural gas and other production inputs, and alcohols and essential ingredients, may cause our results of operations to fluctuate significantly. We may fail to generate expected levels of net sales and profits even under fixed-price and other contracts for the sale of specialty alcohols used in consumer products. Our customers may not pay us timely or at all, even under longer-term, fixed-price contracts for our specialty alcohols, and may seek to renegotiate prices under those contracts during periods of falling prices or high price volatility.

 

Historically, the spread between corn and fuel-grade ethanol prices has fluctuated significantly. Fluctuations are likely to continue to occur. A sustained negative or narrow spread, whether as a result of sustained high or increased corn prices or sustained low or decreased alcohol or essential ingredient prices, would adversely affect our results of operations and financial condition. Revenues from sales of alcohols, particularly fuel-grade ethanol, and essential ingredients have in the past and could in the future decline below the marginal cost of production, which have in the past and may again in the future force us to suspend production, particularly fuel-grade ethanol production, at some or all of our facilities. For example, we hot-idled our Magic Valley facility in early 2023 due to unfavorable market conditions and again hot-idled our Magic Valley facility in early 2024 in part due to unfavorable market conditions and to expedite the installation of additional equipment needed to achieve the intended production rate, quality and consistency from the corn oil and high protein system at the facility. We restarted the Magic Valley facility in July 2024, but due to challenging market economics, we cold-idled the plant at the end of 2024.

 

In addition, some of our fuel-grade ethanol marketing and distribution activities will likely be unprofitable in a market of generally declining prices due to the nature of our business. For example, to satisfy customer demand, we maintain certain quantities of fuel-grade ethanol inventory for subsequent resale. Moreover, we procure much of our fuel-grade ethanol inventory outside of contracted third-party marketing and distribution arrangements and therefore must buy fuel-grade ethanol at a price established at the time of purchase and sell fuel-grade ethanol at an index price established later at the time of sale that is generally reflective of movements in the market price of fuel-grade ethanol. As a result, our margins for fuel-grade ethanol sold in these transactions generally decline and may turn negative as the market price of fuel-grade ethanol declines.

 

-15-

 

We can provide no assurances that corn, natural gas or other production inputs can be purchased at or near current or any specific prices, or that our alcohols or essential ingredients will sell at or near current or any particular prices. Consequently, our results of operations and financial condition may be adversely affected by increases in the prices of corn, natural gas and other production inputs or decreases in the prices of our alcohols and essential ingredients.

 

The prices of our products are volatile and subject to large fluctuations, which may cause our results of operations to fluctuate significantly.

 

The prices of our products are volatile and subject to large fluctuations. For example, the market price of fuel-grade ethanol is dependent upon many factors, including the supply of ethanol and the price of gasoline, which is in turn dependent upon the price of petroleum which itself is highly volatile, difficult to forecast and influenced by a wide variety of global economic and geopolitical conditions, including decisions concerning petroleum output by the Organization of Petroleum Exporting Countries (OPEC) and their allies, an intergovernmental organization that seeks to manage the price and supply of oil on the global energy market. Other important factors that impact the price of petroleum include war and threats of war, attacks on or threats to shipping vessels as has recently occurred in the Red Sea, the consequent rerouting of supply lines to less direct or more expensive paths, and other supply chain disruptions.

 

Our fuel-grade ethanol sales are tied to prevailing spot market prices rather than long-term, fixed-price contracts. Fuel-grade ethanol prices, as reported by the Chicago Mercantile Exchange, ranged from $1.38 to $2.12 per gallon in 2024, from $1.58 to $2.67 per gallon in 2023 and from $2.00 to $2.88 per gallon in 2022. In addition, even under longer-term, fixed-price contracts for our specialty alcohols, our customers may seek to renegotiate prices under those contracts during periods of falling prices or high price volatility. Fluctuations in the prices of our products may cause our results of operations to fluctuate significantly.

 

We may engage in hedging transactions and other risk mitigation strategies that could harm our results of operations and financial condition.

 

To partially offset the effects of production input and product price volatility, in particular, corn and natural gas costs and fuel-grade ethanol prices, we may enter into contracts to purchase a portion of our corn or natural gas requirements on a forward basis or fix the sale price of portions of our alcohol production. In addition, we may engage in other hedging transactions involving exchange-traded futures contracts for corn, natural gas and unleaded gasoline from time to time. The financial statement impact of these activities is dependent upon, among other things, the prices involved and our ability to sell sufficient products to use all of the corn and natural gas for which forward commitments have been made. We have recognized losses in the past, and may suffer losses in the future, from our hedging arrangements. For example, for the year ended December 31, 2023, we recognized net losses of $8.0 million related to the change in the fair values of hedging contracts.

 

Hedging arrangements also expose us to the risk of financial loss in situations where our counterparty to the hedging contract defaults on its contract or, in the case of exchange-traded contracts, where there is a change in the expected differential between the underlying price in the hedging agreement and the actual prices paid or received by us. In addition, our open contract positions may require cash deposits to cover margin calls, negatively impacting our liquidity. As a result, our hedging activities and fluctuations in the price of corn, natural gas, fuel-grade ethanol and unleaded gasoline may adversely affect our results of operations, financial condition and liquidity.

 

-16-

 

Disruptions in our production or distribution, including from climate change and other weather effects, may adversely affect our business, results of operations and financial condition.

 

Our business depends on the continuing availability of rail, road, port, storage and distribution infrastructure. In particular, due to limited storage capacity at some of our production facilities and other considerations related to production efficiencies, certain facilities depend on timely delivery of corn. Alcohol production also requires a significant and uninterrupted supply of other raw materials and energy, primarily water, electricity and natural gas. Local water, electricity and gas utilities may fail to reliably supply the water, electricity and natural gas that our production facilities need or may fail to supply those resources on acceptable terms. In the past, poor weather has caused disruptions in rail transportation, which slowed the delivery of fuel-grade ethanol and/or corn by rail to and from our facilities.

 

For example, in the first quarter of 2024, extreme cold weather conditions in January at our Pekin Campus restricted barge deliveries and increased standby fees. To manage inventory levels, we transported more product by rail, a higher cost mode of transportation. Cold weather conditions also required us to shift to lower margin feed products and reduced our production rates across our Pekin Campus, hindering our ability to produce specialty alcohol at full capacity. In the third quarter of 2023 we experienced unusually high unscheduled production downtime for repairs and maintenance which reduced sales volumes and profits. In 2022, a lightning strike at the utility servicing our Pekin Campus disrupted our operations, cutting power to our facilities and materially affecting our production, resulting in unexpected repair and maintenance costs, lost production and degradation in the quality of work-in-progress inventories.

 

Disruptions in production or distribution, whether caused by labor difficulties, unscheduled downtimes and other operational hazards inherent in the alcohol production industry, including equipment failures, fires, explosions, abnormal pressures, blowouts, pipeline ruptures, transportation accidents, climate change and natural disasters such as earthquakes, floods and storms, or other weather effects, or human error or malfeasance or other reasons, could prevent timely deliveries of corn or other raw materials and energy, and could delay transport of our products to market, and may require us to halt production at one or more production facilities, any of which could have a material adverse effect on our business, results of operations and financial condition.

 

Some of these operational hazards may also cause personal injury or loss of life, severe damage to or destruction of property and equipment or environmental damage, and may result in suspension of operations and the imposition of civil or criminal penalties. Our insurance may not fully cover the potential hazards described above or we may be unable to renew our insurance on commercially reasonable terms or at all.

 

Increased alcohol or essential ingredient production or higher inventory levels may cause a decline in prices for those products, and may have other negative effects, materially and adversely impacting our results of operations, cash flows and financial condition.

 

The prices of our alcohols and essential ingredients are highly impacted by competing third-party supplies of those products. In addition, if fuel-grade ethanol production margins improve, we anticipate that owners of production facilities operating at below capacity, or owners of idled production facilities, will increase production levels, thereby resulting in more abundant fuel-grade ethanol supplies and inventories. Increases in the supply of alcohols and essential ingredients may not be commensurate with increases in demand for alcohols and essential ingredients, thus leading to lower prices. Any of these outcomes could have a material adverse effect on our results of operations, cash flows and financial condition.

 

-17-

 

We may suffer impairments in the value of our long-lived assets which may materially and adversely affect our results of operations.

 

We evaluate our long-lived assets annually for impairment or when circumstances indicate that the full carrying value of an asset may be unrecoverable. These evaluations rely on financial and other assumptions concerning the assets, any of which may not materialize in the future. For example, we recognized asset impairments of $24.8 million and $6.5 million for the years ended December 31, 2024 and 2023, respectively. We may recognize additional impairments of the values of our long-lived assets in the future based on then-prevailing financial and other circumstances. Impairments of our long-lived assets may materially and adversely affect our results of operations.

 

Our alcohol production relies on traditional corn-based feedstock and process technologies. New technologies could make corn-based alcohol production and traditional process technologies less competitive or even obsolete, materially and adversely harming our business.

 

We produce our alcohols from corn. Moreover, our plants are constructed and operate primarily as corn-based alcohol production facilities. Competitors and other third parties have undertaken research to develop competing products to corn-based alcohols, and ethanol in particular, as well as new process technologies. These research efforts seek alternatives to corn-based ethanol and traditional process technologies aimed at improving real or perceived problems with the fuel, such as the carbon and energy intensity of its production, its lower energy content compared to gasoline and its hydrophobic nature resulting in water separation in transit or at other times. Competitors and other third parties may develop new alcohols and processes that improve on any of these or other real or perceived problems with corn-based alcohols, including ethanol. If viable competing products or new process technologies are developed and attract widespread or even modest adoption, we may be forced to modify our production facilities, including our process technologies, if possible, to transition in full or in part to these other products or process technologies to remain competitive. Modifying our production facilities may require expertise that our personnel may not possess and would likely require significant capital expenditures the funding for which we may not have. An inability to remain competitive due to the introduction and adoption of competing products or new process technologies, or significant costs associated with the adoption of new products and process technologies, would materially and adversely affect our business, financial condition and results of operations.

 

Inflation and sustained higher prices may adversely impact our results of operations and financial condition.

 

We have experienced adverse inflationary impacts on key production inputs, wages and other costs of labor, equipment, services, and other business expenses. In addition, we have experienced adverse inflationary impacts on our budgets and expenses for many of our in-process and planned capital projects. Inflation and its negative impacts could escalate in future periods. Even if inflation stabilizes or abates, the prices of key production inputs, wages and other costs of labor, equipment, services, and other business expenses, and for our capital projects, will likely remain at elevated levels. We may not be able to include these additional costs in the prices of the products we sell. As a result, inflation and sustained higher prices may have a material adverse effect on our results of operations and financial condition.

 

Climate change, and governmental regulations aimed at addressing climate-related issues, may affect conditions to which our business is highly sensitive, many of which could materially and adversely harm our business, results of operations and financial condition.

 

Our business is highly sensitive to commodity prices, in particular, the prices of corn and natural gas. Inclement weather from climate change, including extreme temperatures or drought, may adversely affect growing conditions, which may reduce available corn supplies, our primary production input, and other grain substitutes, driving up prices and thereby increasing our production input costs. In addition, governmental regulators may disfavor carbon-based energy sources, such as natural gas, leading to regulations that disincentivize their use or otherwise make their production more difficult and costly, driving up their prices. Higher natural gas prices would likewise increase our production input costs.

 

-18-

 

Other factors that may result from climate change, or that may result from governmental regulations aimed at addressing climate-related issues, may also adversely affect our business, including the following:

 

water is one of our key production inputs; water resource limitations may result from drought and other inclement weather; water resource limitations may also result from rationing and other governmental regulations limiting water use;

 

higher water temperatures due to increased global or regional temperatures may negatively affect production efficiencies due to water temperature production requirements given the limited cooling capacities of our older facilities;

 

flooding and other inclement weather may negatively affect our river access, other transportation logistics and costs, and storage requirements;

 

an overall increase in energy costs will negatively impact our production costs generally and may critically impact certain high energy-intensive production technologies, such as our wet milling and multiple distillation processes for the highest quality specialty alcohols;

 

regulatory and market transition away from combustion fuels and fuel-grade ethanol blending may threaten the viability of our renewable fuels business; and

 

costs and regulatory burdens associated with governmental regulations that limit or tax greenhouse gas emissions, such as CO2, from alcohol production and distribution, or from truck transport and packaging associated with Eagle Alcohol’s business and use of drums and totes, will negatively impact us.

 

New legislation in the United States to address climate change issues, especially at the state and local levels, may be passed and implemented, materially and adversely impacting our business.

 

Any of these factors could materially and adversely harm our business, results of operations and financial condition.

 

Risks Related to our Finances

 

We have incurred significant losses and negative operating cash flow in the past and we may incur losses and negative operating cash flow in the future, which may hamper our operations and impede us from expanding our business.

 

We have incurred significant losses and negative operating cash flow in the past. For example, for the years ended December 31, 2024, 2023 and 2022, we incurred consolidated net losses of approximately $59.0 million, $28.0 million and $41.6 million, respectively. For the year ended December 31, 2024, we incurred negative operating cash flow of $3.5 million. We may incur losses and negative operating cash flow in the future. We expect to rely on cash on hand, cash, if any, generated from our operations, borrowing availability under our lines of credit and proceeds from our future financing activities, if any, to fund all of the cash requirements of our business. Additional losses and negative operating cash flow may hamper our operations and impede us from expanding our business.

 

-19-

 

We are engaged in multiple capital improvement projects. These projects, and their financing, costs, timing and effects, are based on our plans, expectations and various assumptions that may not eventuate. We may therefore be unable to timely achieve, or achieve at all, the results we expect, including as to projected additional EBITDA and Adjusted EBITDA.

 

We are engaged in multiple capital improvement projects to diversify and enhance our revenue streams and to expand margins and profitability by reducing costs. These projects have different timelines, returns on investment and risk profiles. In addition, we must raise significant additional capital to complete some of our projects, including our CCS project. Our expected financial and other results from these projects are based on assumptions around many factors, including their costs, timing, operation and market prices prevailing at project completion and thereafter, as well as tax and other favorable environmental attributes associated with low carbon alcohol that may accrue to our benefit. For example, our assumptions around the anticipated results of our CCS project rely heavily on the tax benefits that may accrue to us under the Inflation Reduction Act of 2022 as well as other favorable environmental attributes associated with carbon capture and storage and low carbon alcohol production. These tax and other benefits may change, including as a result of new or repealed laws, new administrations and the implementation or interpretation of existing laws, or the exhaustion of funds or benefits available under a particular program. For example, in January 2025, the new administration suspended all Inflation Reduction Act spending for 90 days. In addition, certain provisions of the Inflation Reduction Act lack proposed or final regulations and guidance. Regulators could issue new regulations or guidance that significantly narrows the application of clean energy tax incentives, and could even defer or withdraw regulations, which could materially and adversely affect the economic outcome of our CCS project. We can provide no assurances that any particular benefit will be available to us upon completion of our CCS project, or thereafter, or any other capital improvement project.

 

Capital improvement projects require significant outlays of capital and are often subject to material execution risks and delays. Our CCS project in particular requires Environmental Protection Agency, or EPA, approval but the EPA’s own projected timeline for approval has lengthened and may lengthen further. We may have insufficient financial resources, and we may be unable to raise sufficient capital, to complete our projects timely or at all. Although we intend to use reputable third-party contractors with expertise in their fields to implement our projects, adverse conditions and events as well as delays in capital projects are not uncommon. Moreover, the projects’ interaction with existing processes may result in the degradation of other plant operations. For example, operation of our corn oil and high protein system at our Magic Valley facility previously resulted in inconsistent product quality and degraded other operations at the plant, including production rates. In the past, we have extended our expected completion dates for various projects and, as circumstances require, may have to do so again.

 

In addition, our CCS project may be adversely affected by the SAFE CCS Act or the United States Supreme Court’s decision in the case of Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc., or both, as discussed below. The timing and economics of our CCS project may also be adversely affected by new rules proposed by the U.S. Department of Transportation’s Pipeline and Hazardous Materials Safety Administration that impose stronger standards for CO2 pipelines and establish new standards for transporting CO2 in a gaseous state via pipeline, adding additional requirements and costs to the project.

 

We can provide no assurances that our projects will be completed, or if completed, will be completed timely or within budget. We also can provide no assurances that our project assumptions will reflect prevailing future conditions or that our projects will achieve the results we expect, including as to projected additional EBITDA and Adjusted EBITDA. Failure to achieve our expected results may have a material adverse effect on our business, financial condition and results of operations.

 

-20-

 

We regularly incur significant expenses to repair, maintain and upgrade our production facilities and operating equipment, and any interruption in our operations would harm our operating performance.

 

We regularly incur significant expenses to repair, maintain and upgrade our production facilities and operating equipment, estimated at an average of $30.0 million per year. We incurred $35.0 million of these expenses for 2024. The machines and equipment we use to produce our alcohols and essential ingredients are complex, have many parts, and some operate on a continuous basis. We must perform routine equipment maintenance and must periodically replace a variety of parts such as motors, pumps, pipes and electrical parts, and engage in other repairs. In addition, our production facilities require periodic shutdowns to perform major maintenance and upgrades. Our production facilities also occasionally require unscheduled shutdowns to perform repairs. For example, we completed our biennial wet mill outage at our Pekin Campus in Spring 2024. The wet mill was offline for ten days, which negatively impacted sales and margins for the second quarter. In the first quarter of 2024, production at our Colombia facility was hampered by equipment issues that extended the facility’s regularly scheduled outage. In the third quarter of 2023 we experienced unusually high unscheduled production downtime for repairs and maintenance at our Pekin Campus which reduced sales volumes and increased losses. These scheduled and unscheduled shutdowns result in lower sales and increased costs in the periods during which a shutdown occurs and could result in unexpected operational issues in future periods resulting from changes to equipment and operational and mechanical processes made during shutdown.

 

Our indebtedness may expose us to risks that could negatively impact our business, prospects, liquidity, cash flows and results of operations.

 

We have incurred, and anticipate incurring additional, substantial indebtedness for our capital improvement projects. We expect that these projects, when completed, will generate financial returns sufficient to service and ultimately repay or refinance our indebtedness. However, the costs, timing, and effects of our capital improvement projects may not meet our projections. In addition, our indebtedness could:

 

make it more difficult to repay or refinance our indebtedness if it becomes due during adverse economic and industry conditions;

 

result in adverse consequences due to a breach of our financial or other covenants and obligations in favor of our lenders;

 

limit our flexibility to pursue strategic opportunities or react to changes in our business and the industries in which we operate and, consequently, place us at a competitive disadvantage to our competitors who have less debt;

 

require a substantial portion of our cash flows from operations for debt service payments, thereby reducing the availability of our cash flows to fund working capital, additional capital expenditures, acquisitions, dividend payments and for other general corporate purposes; or

 

limit our ability to procure additional financing for working capital or other purposes.

 

Our ability to generate operating results and sufficient cash to make all required principal and interest payments when due, and to satisfy our financial covenants and other obligations, depends on our performance, which is subject to a variety of factors beyond our control, including the cost of key production inputs, the supply of and demand for alcohols and essential ingredients, and many other factors related to the industries in which we operate. We cannot provide any assurance that we will be able to timely service or satisfy our debt obligations, including our financial covenants. Our failure to timely service or satisfy our debt obligations, including to meet our financial covenants, could result in our indebtedness being immediately due and payable, and would have a material adverse effect on our business, business prospects, liquidity, financial condition, cash flows and results of operations.

 

-21-

 

Our ability to utilize net operating loss carryforwards and certain other tax attributes may be limited.

 

Federal and state income tax laws impose restrictions on our use of net operating loss, or NOL, and tax credit carryforwards in the event that an “ownership change” occurs for tax purposes, as defined by section 382 of the Internal Revenue Code, or Code. In general, an ownership change occurs when stockholders owning 5% or more of a corporation entitled to use NOL or other loss carryforwards have increased their ownership by more than 50 percentage points during any three-year period. The annual base limitation under section 382 of the Code is calculated by multiplying the corporation’s value at the time of the ownership change by the greater of the long-term tax-exempt rate determined by the Internal Revenue Service in the month of the ownership change or the two preceding months. Our ability to utilize our NOL and other loss carryforwards may be substantially limited. These limitations could result in increased future tax obligations, which could have a material adverse effect on our financial condition and results of operations.

 

Risks Related to Legal and Regulatory Matters

 

We may be adversely affected by environmental, health and safety laws and regulations, as well as related liabilities that may not be adequately covered by insurance.

 

We are subject to various federal, state and local environmental laws and regulations, including those relating to the discharge of materials into the air, water and ground; the generation, storage, handling, use, transportation and disposal of hazardous materials and wastes; and the health and safety of our employees. In addition, some of these laws and regulations require us to operate under permits that are subject to renewal or modification. These laws, regulations and permits often require expensive pollution control equipment or operational changes to limit actual or potential impacts to the environment. Any violation of these laws and regulations or permit conditions may result in substantial fines, natural resource damages, criminal sanctions, permit revocations and/or production facility shutdowns. In addition, we have made, and expect to make, significant capital expenditures on an ongoing basis to comply with increasingly stringent environmental laws, regulations and permits.

 

We may be liable for the investigation and cleanup of environmental contamination at each of our production facilities and at off-site locations where we arrange for the disposal of hazardous substances or wastes. If these substances or wastes have been or are disposed of or released at sites that undergo investigation and/or remediation by regulatory agencies, we may be responsible under the Comprehensive Environmental Response, Compensation and Liability Act of 1980, or other environmental laws for all or part of the costs of investigation and/or remediation, and for damages to natural resources. We may also be subject to related claims by private parties alleging property damage and personal injury due to exposure to hazardous or other materials at or from those properties. Some of these matters may require us to expend significant amounts for investigation, cleanup or other costs not covered by insurance.

 

In addition, new laws, new interpretations of existing laws, increased governmental enforcement of environmental laws or other developments could require us to make significant additional expenditures. Continued government and public emphasis on environmental issues will likely result in increased future investments for environmental controls at our production facilities. Present and future environmental laws and regulations, and interpretations of those laws and regulations, applicable to our operations, more vigorous enforcement policies and discovery of currently unknown conditions may require substantial expenditures that could have a material adverse effect on our results of operations and financial condition.

 

-22-

 

The hazards and risks associated with producing and transporting our products (including fires, natural disasters, explosions and abnormal pressures and blowouts) may also result in personal injury claims or damage to property and third parties. As protection against operating hazards, we maintain insurance coverage against some, but not all, potential losses. However, we could sustain losses for uninsurable or uninsured risks, or in amounts in excess of existing insurance coverages. Events that result in significant personal injury or damage to our property or third parties or other losses that are not fully covered by insurance could have a material adverse effect on our results of operations and financial condition.

 

Our CCS project may be adversely affected by the SAFE CCS Act and other Regulations.

 

The SAFE CCS Act was signed into law in Illinois in July 2024. We are pursuing at our Pekin Campus, located in Illinois, a CCS project that will require significant financial and personnel resources. Our CCS project is our most important ongoing capital improvement initiative. The SAFE CCS Act establishes stringent safety, financial and insurance requirements on CO2 pipelines and imposes a moratorium on the construction of new CO2 pipelines until the U.S. Department of Transportation’s Pipeline and Hazardous Materials Safety Administration finalizes its new safety rules or July 1, 2026, whichever occur sooner. The SAFE CCS Act will result in increased compliance and other requirements likely adding costs and potentially adding time to complete our CCS project. In January 2025, the U.S. Department of Transportation’s Pipeline and Hazardous Materials Safety Administration proposed new rules that impose stronger standards for CO2 pipelines and establish new standards for transporting CO2 in a gaseous state via pipeline, adding additional requirements and costs to the project. We can provide no assurance that our CCS project will not be adversely affected by the SAFE CCS Act or other regulations or that it will be financially viable in light of any new requirements and potential delays.

 

We may be adversely affected by food and drug laws and regulations, as well as related liabilities that may not be adequately covered by insurance.

 

Some of our products are subject to regulation by the U.S. Food and Drug Administration, or FDA, as well as similar state agencies. The FDA regulates, under the Federal Food, Drug, and Cosmetic Act, or FDCA, the processing, formulation, safety, manufacture, packaging, labeling and distribution of food ingredients, vitamins, cosmetics and pharmaceuticals for active and inactive ingredients. Many of the FDA’s and FDCA’s rules and regulations apply directly to us as well as indirectly through their application in our customers’ products. To be properly marketed and sold in the United States, a relevant product must be generally recognized as safe, approved and not adulterated or misbranded under the FDCA and relevant regulations issued under the FDCA.

 

If we fail to comply with laws and FDA regulations or those of similar state agencies, we may be prevented from selling certain of our products and may also be subject to government agency enforcement liability. In addition, we may be subject to product liability and other claims by our customers or by individuals alleging personal injury from our products as food and drug additives.

 

We maintain insurance coverage against some, but not all, potential losses. Some of these matters, if they arise, may require us to expend significant amounts for investigation and defense or other costs not covered by insurance. We could sustain losses for uninsurable or uninsured risks, or in amounts in excess of existing insurance coverages. Events that result in significant personal injury or other losses that are not fully covered by insurance could have a material adverse effect on our results of operations and financial condition.

 

-23-

 

The United States fuel-grade ethanol industry is highly dependent upon various federal and state laws and regulations and any changes in or reinterpretations of those laws or regulations could have a material adverse effect on our results of operations, cash flows and financial condition.

 

The domestic market for fuel-grade ethanol is significantly impacted by federal mandates for volumes of renewable fuels (such as ethanol) required to be blended with gasoline. Future demand for fuel-grade ethanol will largely depend on incentives to blend ethanol into motor fuels, including the price of ethanol relative to the price of gasoline, the relative octane value of ethanol, constraints on the ability of vehicles to use higher ethanol blends, and the EPA’s, established volumes from time to time, small refinery waivers, and other applicable environmental requirements.

 

The EPA has implemented the Renewable Fuel Standard under the Energy Policy Act of 2005 and the Energy Independence and Security Act of 2007. The EPA, in coordination with the Secretary of Energy and the Secretary of Agriculture, determines annual quotas for the quantity of renewable fuels (such as fuel-grade ethanol) that must be blended into motor fuels consumed in the United States. The EPA finalized mandatory volumes of 15.0 billion gallons for each of 2023, 2024, and 2025 of conventional renewable fuels, or corn-based fuel-grade ethanol, which could decline in future years.

 

The EPA may issue small refinery waivers, in full or in part, to reduce or eliminate annual renewable fuel volume requirements for small refineries that process fewer than 75,000 barrels of petroleum daily. In the past, the EPA has issued small refinery waivers that have materially and adversely affected overall demand for and the price of fuel-grade ethanol. The U.S. Court of Appeals for the Fifth Circuit, in the fourth quarter of 2023, struck down the EPA’s decision to deny numerous small refinery waivers, finding that the EPA’s denials were impermissibly retroactive, contrary to law and counter to evidence in the litigation record. Accordingly, small refinery waivers from the EPA may be more likely in the future and could again materially and adversely affect overall demand for and the price of fuel-grade ethanol.

 

Various bills in Congress introduced from time to time are also directed at altering existing renewable fuels energy legislation, but none have passed in recent years. Some legislative bills are directed at halting or reversing expansion of, or even eliminating in its entirety, the renewable fuel program.

 

Our results of operations, cash flows and financial condition could be adversely impacted if the EPA reduces mandatory volumes or issues significant small refinery waivers, or if any legislation is enacted that reduces volume requirements or if existing legislation is reinterpreted to have the same effect.

 

Future demand for fuel-grade ethanol is uncertain and may be affected by changes to federal mandates, public perception, consumer acceptance and overall consumer demand for transportation fuel, any of which could negatively affect demand for fuel-grade ethanol and our results of operations.

 

Although many trade groups, academics and governmental agencies support ethanol as a fuel additive that promotes a cleaner environment, others criticize fuel-grade ethanol production and use as consuming considerably more energy and emitting more greenhouse gases than other biofuels and potentially depleting water resources. Some studies suggest that corn-based ethanol is less efficient than ethanol produced from other feedstock and that it negatively impacts consumers by causing increased prices for dairy, meat and other food generated from livestock that consume corn. Additionally, critics of fuel-grade ethanol contend that corn supplies are redirected from international food markets to domestic fuel markets. If negative views of corn-based ethanol production gain broader acceptance, support for existing measures promoting use and domestic production of corn-based ethanol as a fuel additive could decline, leading to a reduction or repeal of federal ethanol usage mandates, which would materially and adversely affect the demand for fuel-grade ethanol. These views could also negatively impact public perception of the fuel-grade ethanol industry and acceptance of ethanol as an alternative fuel.

 

-24-

 

There are limited markets for fuel-grade ethanol beyond those established by federal mandates. Discretionary blending and E85 blending (i.e., gasoline blended with up to 85% fuel-grade ethanol by volume) are important secondary markets. Discretionary blending is often determined by the price of fuel-grade ethanol relative to the price of gasoline. In periods when discretionary blending is financially unattractive, the demand for fuel-grade ethanol may decline. Also, the demand for fuel-grade ethanol is affected by the overall demand for transportation fuel. Demand for transportation fuel is affected by the number of miles traveled by consumers and vehicle fuel economy. Lower demand for fuel-grade ethanol and essential ingredients, including through the transition by consumers to alternative fuel vehicles such as electric vehicles and hybrid vehicles, would reduce the value of our ethanol and related products, erode our overall margins and diminish our ability to generate revenue or to operate profitably. In addition, we believe that additional consumer acceptance of E15 and E85 fuels is necessary before fuel-grade ethanol can achieve any significant growth in market share relative to other transportation fuels.

 

The United States Supreme Court’s decision in the case of Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc. may result in less industry-favorable rulemaking and agency interpretations of laws and regulations, which could materially and adversely affect our results of operations, cash flows and financial condition as well as the business and financial prospects of certain capital improvement projects, such as CCS.

 

The United States Supreme Court, in the landmark case of Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc., recently overturned its prior doctrine of judicial deference to administrative interpretations of laws and regulations. This outcome could materially and adversely affect rulemaking and agencies’ interpretations favorable to the renewable fuels industry, such as the EPA’s administration of the Renewable Fuel Standard. This outcome could also materially and adversely affect the Treasury Department’s ability to promulgate favorable regulations under the Inflation Reduction Act of 2022, including tax credits such as the section 45Q carbon capture and storage tax credits and section 45Z low carbon fuel tax credits, as well as other industry-favorable tax credits. Less industry-favorable rulemaking and agency interpretations of laws and regulations could materially and adversely affect our results of operations, cash flows and financial condition as well as the financial prospects of certain capital improvement projects, such as CCS.

 

Risks Related to Ownership of our Common Stock

 

Our stock price is highly volatile, which could result in substantial losses for investors purchasing shares of our common stock and in litigation against us.

 

The market price of our common stock has fluctuated significantly in the past and may continue to fluctuate significantly in the future. The market price of our common stock may continue to fluctuate in response to one or more of the following factors, or any of the other risks or uncertainties discussed in this report, many of which are beyond our control:

 

fluctuations in our quarterly or annual operating results;

 

fluctuations in the market prices of our products;

 

fluctuations in the costs of key production input commodities such as corn and natural gas;

 

the timing, cost and effects of, and our ability to fund, our capital improvement projects, including our CCS project;

 

anticipated trends in our financial condition and results of operations;

 

our ability to obtain any necessary financing;

 

-25-

 

the volume and timing of the receipt of orders for our products from major customers, including annual contracted sales volumes for our specialty alcohols;

 

competitive pricing pressures;

 

changes in market valuations of companies similar to us;

 

stock market price and volume fluctuations generally;

 

regulatory developments or increased enforcement;

 

additions or departures of key personnel;

 

environmental, product or other liabilities we may incur;

 

our financing activities and future sales of our common stock or other securities; and

 

our ability to maintain contracts that are critical to our operations.

 

The price at which you purchase shares of our common stock may not be indicative of the price that will prevail in the trading market. You may be unable to sell your shares of common stock at or above your purchase price, which may result in substantial losses to you and which may include the complete loss of your investment. In the past, securities class action litigation has often been brought against a company following periods of high stock price volatility. We may be the target of similar litigation in the future. Securities litigation could result in substantial costs and divert management’s attention and our resources away from our business.

 

Any of the risks described above could have a material adverse effect on our results of operations, the price of our common stock, or both.

 

Because we do not plan to pay any cash dividends on our shares of common stock, our stockholders will not be able to receive a return on their shares unless and until they sell them.

 

We intend to retain a significant portion of any future earnings to finance the development, operation and expansion of our business. We do not anticipate paying any cash dividends on our common stock in the near future. The declaration, payment, and amount of any future dividends will be made at the discretion of our board of directors, and will depend upon, among other things, our results of operations, cash flows, and financial condition, operating and capital requirements, compliance with any applicable debt covenants, and other factors our board of directors considers relevant. There is no assurance that future dividends will be paid, and, if dividends are paid, there is no assurance of the amount of any such dividend. Unless our board of directors determines to pay dividends, our stockholders will be required to look solely to appreciation in the value of our common stock to realize any gain on their investment. There can be no assurance that any such appreciation will occur.

 

Our bylaws contain exclusive forum provisions that could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or agents.

 

Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Delaware Court of Chancery shall be the sole and exclusive forum for (a) any derivative action or proceeding brought on our behalf, (b) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of us to us or our stockholders, (c) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, or (d) any action asserting a claim governed by the internal affairs doctrine.

 

-26-

 

Our bylaws also provide that, unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by applicable law, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, or the Securities Act, including all causes of action asserted against any defendant named in such complaint, including our officers and directors, underwriters for any offering giving rise to such complaint, and any other professional entity whose profession gives authority to a statement made by that person or entity and who has prepared or certified any part of the documents underlying the offering.

 

For the avoidance of doubt, the exclusive forum provisions described above do not apply to any claims arising under the Securities Act or the Securities Exchange Act of 1934, as amended, or the Exchange Act, to the extent federal law requires otherwise. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.

 

The choice of forum provisions in our bylaws may limit our stockholders’ ability to bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers, employees, agents or other third parties, which may discourage such lawsuits against us and our directors, officers, employees, agents and other third parties even though an action, if successful, might benefit our stockholders. The applicable courts may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments or results may be more favorable to us than to our stockholders. With respect to the provision making the Delaware Court of Chancery the sole and exclusive forum for certain types of actions, stockholders who do bring a claim in the Delaware Court of Chancery could face additional litigation costs in pursuing any such claim, particularly if they do not reside in or near Delaware. Finally, if a court were to find these provisions of our bylaws inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could have a material adverse effect on us.

 

General Risk Factors

 

Cyberattacks through security vulnerabilities could lead to disruption of our business, reduced revenue, increased costs, liability claims, or harm to our reputation or competitive position.

 

Security vulnerabilities may arise from our hardware, software, employees, contractors or policies we have deployed, which may result in external parties gaining access to our networks, data centers, cloud data centers, corporate computers, manufacturing systems, and/or access to accounts we have at our suppliers, vendors or customers. External parties may gain access to our data or our customers’ data, or attack the networks causing denial of service or attempt to hold our data or systems in ransom. The vulnerability could be caused by inadequate account security practices such as the failure to timely remove employee access when terminated. To mitigate these security issues, we have implemented measures throughout our organization, including firewalls, backups, encryption, employee information technology policies and user account policies. However, there can be no assurance that these measures will be sufficient to avoid cyberattacks. If any of these types of security breaches were to occur and we were unable to protect sensitive data, our relationships with our business partners and customers could be materially damaged, our reputation could be materially harmed, and we could be exposed to a risk of litigation and possible significant liability.

 

-27-

 

Further, if we fail to adequately maintain our information technology infrastructure, we may have outages and data loss. Excessive outages may affect our ability to timely and efficiently deliver products to customers or develop new products. Such disruptions and data loss may adversely impact our ability to fulfill orders and interrupt other processes. Delayed sales or lost customers resulting from these disruptions could adversely affect our financial results, stock price and reputation.

 

Our and our business partners’ or contractors’ failure to fully comply with applicable data privacy or similar laws could lead to significant fines and require onerous corrective action. In addition, data security breaches experienced by us or our business partners or contractors could result in the loss of trade secrets or other intellectual property, public disclosure of sensitive commercial data, and the exposure of personally identifiable information (including sensitive personal information) of our employees, customers, suppliers, contractors and others.

 

Unauthorized use or disclosure of, or access to, any personal information maintained by us or on our behalf, whether through breach of our systems, breach of the systems of our suppliers or vendors by an unauthorized party, or through employee or contractor error, theft or misuse, or otherwise, could harm our business. If any such unauthorized use or disclosure of, or access to, such personal information was to occur, our operations could be seriously disrupted, and we could be subject to demands, claims and litigation by private parties, and investigations, related actions, and penalties by regulatory authorities. In addition, we could incur significant costs in notifying affected persons and entities and otherwise complying with the multitude of foreign, federal, state and local laws and regulations relating to the unauthorized access to, or use or disclosure of, personal information. Finally, any perceived or actual unauthorized access to, or use or disclosure of, such information could harm our reputation, substantially impair our ability to attract and retain customers and have an adverse impact on our business, financial condition and results of operations.

 

Item 1B. Unresolved Staff Comments.

 

We have received no written comments regarding our periodic or current reports from the staff of the Securities and Exchange Commission that were issued 180 days or more preceding the end of our 2024 fiscal year and that remain unresolved.

 

Item 1C. Cybersecurity.

 

We recognize the critical importance of maintaining the trust and confidence of our customers, business partners, employees and other stakeholders. We engage in active oversight of cybersecurity, a cornerstone of our comprehensive enterprise risk management (ERM) program. Our cybersecurity framework is rooted in the National Institute of Standards and Technology, or NIST, Cybersecurity Framework, or CSF, as well as the International Organization for Standardization (ISO/IEC 27001), reflecting our commitment to uphold the highest cybersecurity standards. We align our policies, standards and practices with these benchmarks and dynamically refine them to address evolving cybersecurity threats.

 

Risk Management and Strategy

 

We maintain a cybersecurity program aligned with NIST CSF standards designed to identify critical assets and vulnerabilities, protect them with appropriate safeguards, promptly detect cybersecurity events, respond effectively to mitigate their impact and recover from incidents to restore services. Our cybersecurity program is designed to safeguard the confidentiality, integrity and availability of information. Our cybersecurity risk management strategy includes:

 

Governance: The Audit Committee of our Board of Directors oversees our cybersecurity risk management. Our Chief Financial Officer and Director of Information Technology, along with key executives, have roles in governance and facilitating alignment across our organization.

 

-28-

 

Compliance and Standards: We design our cybersecurity program for compliance with industry-specific and other regulations (e.g., the General Data Protection Regulation (GDPR) and the California Consumer Privacy Act (CCPA)) demonstrating our commitment to both domestic and international information security standards.

 

Technical Safeguards

 

We deploy technical defenses against cybersecurity risks of attack and other incidents, including firewalls, intrusion detection and prevention systems and access controls. We refine these measures based on our ongoing assessments, including cybersecurity threat intelligence updates.

 

Incident Response and Recovery Planning: We maintain incident response and recovery frameworks, tested twice yearly through backup restorations to critical systems, to improve our preparedness to effectively manage and mitigate cybersecurity incidents.

 

Education and Awareness: Our personnel and members of our Board of Directors undergo mandatory periodic training on cybersecurity threats, with updated insights into effective defense mechanisms and our evolving cybersecurity policies and practices.

 

Use of Third Parties: We collaborate with external cybersecurity service providers, including auditors, consultants and governmental agencies, to refine our cybersecurity measures. These service providers carry out cybersecurity risk evaluations such as periodic assessments and vulnerability scans to pinpoint potential security flaws and suggest enhancements. In addition, we employ third-party technology and other solutions to enhance our protection against cybersecurity risks. These solutions include our use of a managed security service provider to support our in-house technology team, an endpoint detection and response, or EDR, system for ongoing surveillance, detection, and action against threats, as well as a security information and event management, or SIEM, system designed to automate the real time identification, investigation and prioritization of critical alerts.

 

Third-Party Risk Management: We use a comprehensive due diligence process to manage third-party risks, emphasizing continuous monitoring and to ensure our business partners’ cybersecurity practices meet our stringent standards.

 

As of the filing of this report, we do not believe that any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect, Alto Ingredients, Inc.

 

Governance

 

We take a comprehensive and forward-looking approach to cybersecurity risk management under the oversight of our Audit Committee. Management, including our Chief Financial Officer and our Director of Information Technology, provide regular updates to ensure a strategic, unified response to cybersecurity challenges. Management is notified of, and monitors, cybersecurity incidents through our EDR and SIEM systems.

 

Our Director of Information Technology has over 20 years of experience in information technology and five years of experience serving directly as a Chief Information Security Officer for other organizations.

 

-29-

 

Our networks and systems are continuously monitored by a combination of third-party service providers and an internal cybersecurity team. Management is promptly notified of cybersecurity incidents.

 

Our Audit Committee is promptly notified by our management of any material cybersecurity breach.

 

Our Board of Directors is briefed at least quarterly on the state of our cybersecurity program.

 

Our internal cybersecurity team collaborates with external cybersecurity service providers, including auditors, consultants and governmental agencies, to refine our cybersecurity measures. These service providers carry out cybersecurity risk evaluations such as periodic assessments and vulnerability scans to pinpoint potential security flaws and suggest enhancements.

 

Engagement and Continuous Improvement

 

We periodically evaluate our cybersecurity measures through internal and external audits and assessments to ensure our cybersecurity program is at the forefront of industry best practices. The results of these audits and assessments inform adjustments to our cybersecurity program to improve our resilience against emerging cybersecurity threats.

 

Item 2. Properties.

 

Our corporate headquarters, located in Pekin, Illinois, consists of plants and facilities comprising our Pekin Campus production segment and totaling 145 acres on land we own. In Sacramento, California, we lease office space totaling approximately 3,400 square feet under a lease expiring in 2026. In St. Louis, Missouri, we lease warehouse space totaling approximately 84,000 square feet under a lease expiring in 2030. We have plants located in Boardman, Oregon, at a 25-acre facility, and Burley, Idaho, at a 25-acre facility. The land in Boardman, Oregon is leased under a lease expiring in 2076. We own the land in Burley, Idaho. The plants and facilities in Oregon and Idaho comprise our Western production segment. See “Business—Production Facilities.” Our properties are subject to deeds of trust and other encumbrances in favor of our lenders.

 

Item 3. Legal Proceedings.

 

We are subject to legal proceedings, claims and litigation arising in the ordinary course of business. While the amounts claimed may be substantial, the ultimate liability cannot presently be determined because of considerable uncertainties that exist. Therefore, it is possible that the outcome of those legal proceedings, claims and litigation could adversely affect our quarterly or annual operating results or cash flows when resolved in a future period. However, based on facts currently available, management believes such matters will not adversely affect in any material respect our financial position, results of operations or cash flows.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

-30-

 

PART II

 

Item 5. Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

 

Market Information

 

Our common stock trades on The Nasdaq Capital Market under the symbol “ALTO.” We also have non-voting common stock outstanding, which is convertible into our voting common stock, and which is not listed on an exchange.

 

Security Holders

 

As of March 12, 2025, we had 76,611,090 shares of common stock outstanding held of record by approximately 305 stockholders and 896 shares of non-voting common stock outstanding held of record by one stockholder. These holders of record include depositories that hold shares of stock for brokerage firms which, in turn, hold shares of stock for numerous beneficial owners. On March 12, 2025, the closing sales price of our common stock on The Nasdaq Capital Market was $1.39 per share.

 

Performance Graph

 

The graph below shows a comparison of the cumulative total stockholder return on our common stock with the cumulative total return on The Nasdaq Composite Index and The Nasdaq Clean Edge Green Energy Index, or Peer Group, in each case over the five-year period ended December 31, 2024.

 

The graph assumes $100 invested at the indicated starting date in our common stock and in each of The Nasdaq Composite Index and the Peer Group, with the reinvestment of all dividends. We have not paid or declared any cash dividends on our common stock and do not anticipate paying any cash dividends on our common stock in the foreseeable future. Stockholder returns over the indicated periods should not be considered indicative of future stock prices or stockholder returns. This graph assumes that the value of the investment in our common stock and each of the comparison groups was $100 on December 31, 2019.

 

 

   Years Ended 
   12/2019   12/2020   12/2021   12/2022   12/2023   12/2024 
                         
Alto Ingredients, Inc.   100.00    835.38    740.00    443.08    409.23    240.00 
Nasdaq Composite   100.00    144.92    177.06    119.45    172.77    223.87 
Nasdaq Clean Edge Green Energy   100.00    284.83    277.30    193.70    174.51    141.58 

 

-31-

 

Dividend Policy

 

We have never paid cash dividends on our common stock and do not intend to pay cash dividends on our common stock in the foreseeable future. We anticipate that we will retain any earnings for use in the continued development of our business.

 

Our current and future debt financing arrangements may limit or prevent cash distributions from our subsidiaries to us, depending upon the achievement of specified financial and other operating conditions and our ability to properly service our debt, thereby limiting or preventing us from paying cash dividends. Further, the holders of our outstanding Series B Preferred Stock are entitled to dividends of 7% per annum, payable quarterly in arrears. Accrued and unpaid dividends in respect of our Series B Preferred Stock must be paid prior to the payment of any dividends in respect of shares of our common stock.

 

For 2024, 2023 and 2022, we declared and paid cash dividends on our outstanding shares of Series B Preferred Stock as they became due.

 

Recent Sales of Unregistered Securities

 

None.

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

None.

 

Item 6. [Reserved]

 

Not Applicable.

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and notes to consolidated financial statements included elsewhere in this report. This discussion contains forward-looking statements, reflecting our plans and objectives that involve risks and uncertainties. Actual results and the timing of events may differ materially from those contained in these forward-looking statements due to a number of factors, including those discussed in the section entitled “Risk Factors” and elsewhere in this report.

 

Overview

 

We are a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States.

 

We operate five alcohol production facilities. Three of our production facilities are located in Illinois, one is located in Oregon and another is located in Idaho. We have an annual alcohol production capacity of 350 million gallons, including both renewable fuels and specialty alcohols ranging from industrial-, pharmaceutical-, and high-quality food- and beverage-grade alcohols. Of this amount, we can produce up to 110 million gallons annually of specialty alcohols, depending on our product mix among high-quality beverage-grade alcohol and other quality specification alcohols. We market and distribute all of the alcohols produced at our facilities as well as alcohols produced by third parties. In 2024, we marketed and distributed approximately 386 million gallons combined of our own produced alcohols as well as fuel-grade ethanol produced by third parties, and over 1.4 million tons of essential ingredients on a dry matter basis.

 

We also own and operate a liquid CO2 production facility adjacent to our plant in Oregon for the offtake of CO2 gas from the plant for conversion to liquid CO2 and subsequent sale.

 

In addition, we break bulk distribute specialty alcohols, produced by us and third parties, through our Eagle Alcohol business.

 

-32-

 

We report our financial and operating performance in three distinct segments:

 

Pekin production, which includes the production and sale of alcohols and essential ingredients produced at our three production facilities located in Pekin, Illinois, which we refer to as our Pekin Campus;

 

Marketing and distribution, which includes marketing and merchant trading for company-produced alcohols and essential ingredients on an aggregated basis, and sales of fuel-grade ethanol sourced from third parties; and

 

Western production, which includes the production and sale of renewable fuels and essential ingredients and, beginning in 2025, liquid CO2 produced at our western production facilities, including our liquid CO2 plant, on an aggregated basis, none of which are individually so significant as to be considered a separately reportable segment.

 

Our mission is to produce the highest quality, sustainable ingredients that make everyday products better. We intend to accomplish this goal in part by investing in our specialized and higher value specialty alcohol production and distribution infrastructure, expanding production in high-demand essential ingredients, expanding and extending the sale of our products into new regional and international markets, building efficiencies and economies of scale and by capturing a greater portion of the value stream.

 

Production Segments

 

We produce specialty alcohols, renewable fuels and essential ingredients, focusing on five key markets: Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels. Products for Health, Home & Beauty markets include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. Products for Food & Beverage markets include grain neutral spirits used in alcoholic beverages and vinegar and corn germ used for corn oils. Products for Industry & Agriculture markets include alcohols and other products for paint applications and fertilizers. Products for Essential Ingredients markets include dried yeast, corn protein meal, corn protein feed, corn germ, distillers grains, liquid CO2 and liquid feed used in commercial animal feed and pet foods. We also sell yeast and liquid CO2 for human consumption. Our products for the Renewable Fuels markets include fuel-grade ethanol and distillers corn oil used as a feedstock for renewable diesel and biodiesel fuels. Our specialty alcohols for the Industry & Agriculture, Food & Beverage and Health, Home & Beauty markets represented approximately 12%, 7% and 3%, respectively, of our sales in 2024 from these three markets.

 

We produce our alcohols and essential ingredients at our facilities described below. Our production facilities located in Illinois are in the heart of the Corn Belt, benefit from relatively low-cost and abundant feedstock and enjoy logistical advantages that enable us to provide our products to both domestic and international markets via truck, rail or barge. Our production facilities located in Oregon and Idaho are near their respective fuel and feed customers, offering significant timing, product transportation cost and logistical advantages.

 

-33-

 

All of our production facilities, other than our Magic Valley plant, were operating for all of 2024, subject to scheduled and unscheduled downtimes to address facility repair and maintenance.

 

In January 2024, we temporarily hot-idled our Magic Valley facility to minimize losses from negative regional crush margins and to expedite the installation of additional equipment to achieve the intended production rate, quality and consistency from our corn oil and high protein system at the facility. We restarted our Magic Valley facility in July 2024 and by October 2024, the facility consistently achieved average ethanol production rates at full capacity, the protein content yield from the plant reached 50% or greater, and we were able to expand our corn oil yields. Increases in regional corn basis and declining market prices for protein and corn oil resulted in overall margin compression, outweighing the economic benefits of our plant improvements. As a consequence, we cold-idled our Magic Valley facility on December 31, 2024 to minimize financial losses. We continue to provide terminal services at the plant and intend to resume operations at the facility when the economic environment in the region sustainably improves. We believe that the cold-idling of our Magic Valley facility will have a positive impact on our overall financial results in 2025 compared to 2024.

 

As market conditions change, we may increase, decrease or idle production at one or more operating facilities or resume operations at any idled facility.

 

Marketing and Distribution Segment

 

We market and distribute all the alcohols and essential ingredients we produce at our facilities. We also market and distribute alcohols produced by third parties.

 

We have extensive and long-standing customer relationships, both domestic and international, for our specialty alcohols, renewable fuels and essential ingredients. These customers include producers and distributors of ingredients for cosmetics, sanitizers and related products, distilled spirits producers, food products manufacturers, producers of personal health/consumer health and personal care hygiene products, and global trading firms.

 

Our renewable fuels customers are located throughout the Western and Midwestern United States and consist of integrated oil companies and gasoline marketers who blend fuel-grade ethanol into gasoline. Our customers depend on us to provide a reliable supply of fuel-grade ethanol and manage the logistics and timing of delivery. Our customers collectively require fuel-grade ethanol volumes in excess of the supplies we produce at our facilities. We secure additional fuel-grade ethanol supplies from third-party ethanol producers. We arrange for transportation, storage and delivery of fuel-grade ethanol purchased by our customers through our agreements with third-party service providers in the Western United States as well as in the Midwest from a variety of sources.

 

We market food-grade essential ingredients to human and pet food markets, our feed products (such as distillers grains) primarily to export markets from our Pekin Campus, and other feed products to dairies and feedlots, in many cases located near our production facilities. These customers use our feed products for livestock as a substitute for corn and other sources of starch and protein. We sell our corn oil to poultry, renewable diesel and biodiesel customers.

 

See “Note 4 – Segments” to our Notes to Consolidated Financial Statements included elsewhere in this report for financial information about our business segments.

 

Financial Review, Current Initiatives and Outlook

 

Our fourth quarter and full-year financial results reflect challenging market conditions, including lower crush margins, compared to the fourth quarter of 2023 and the prior full year. As discussed below, we took decisive action to rationalize our business which, together with over $30 million in associated asset impairments, resulted in a material portion of the substantial non-cash, one-time expenses for the fourth quarter and full year 2024, resetting our base. We also reduced our annual expense run rate by nearly $8 million. Together with improved performance at our Pekin Campus wet mill, our synergistic acquisition of premium liquid CO2 processing and our entry into the European market through International Sustainability and Carbon Certification, or ISCC, product sales, we are optimistic about 2025.

 

As part of our ongoing efforts to maximize shareholder value, we have engaged an investment banking firm to explore the sale of our production facilities located in Oregon and Idaho. In addition, with the assistance of our financial and legal advisors, we are considering a broad range of other options, including asset sales, a merger or other strategic transactions to better align our long-term value potential.

 

-34-

 

In January, we acquired Kodiak Carbonic, a beverage-grade liquid CO2 processor, for $7.6 million. This processing facility, renamed Alto Carbonic, is located adjacent to our Columbia plant in Boardman, Oregon and has been operating profitably since 2015.

 

Alto Carbonic processes biogenic CO2 gas produced as a byproduct of the fermentation process at our Columbia plant and converts it into premium liquid CO2. The finished product is sold into the Northwestern region of the United States for use in food and beverage processing, industrial cooling, and other applications. The facility produces an average of approximately 56,000 tons annually of liquid CO2 with the capacity to produce over 70,000 tons annually and the potential for further expansion. Alto Carbonic currently uses only 50% of our Columbia plant’s biogenic CO2 gas.

 

Simultaneous with this acquisition, we entered into an amended long-term sales offtake agreement with a leading North American industrial gas supplier. The acquisition is immediately accretive and has a compelling payback of approximately two years. We are in the process of integrating the liquid CO2 plant with our Columbia facility, improving coordination between operations. We expect to realize additional cost savings through synergies in production and overhead. We are also evaluating an opportunity to increase storage capacity at the site to improve logistics and take advantage of spot market demand for premium liquid CO2.

 

The acquisition immediately stems the recent lack of profitability at our Columbia plant, provides a stronger financial foundation to overcome competitive challenges for destination plants and significantly increases the value of these combined assets.

 

We integrated Eagle Alcohol’s high quality alcohol bulk operations and customers into our Pekin Campus and Kinergy businesses and have now turned our focus to converting Eagle Alcohol’s break-bulk warehousing and trucking operations into a profitable service center.

 

We also decreased staff at other operations, reducing overhead run-rates of both costs of goods sold and selling, general and administrative expenses. In total, we reduced headcount by 16% and expect to save nearly $8 million annually from these efficiencies, improving our bottom-line run rate and helping us manage our liquidity. We expect to realize the full annualized financial benefit from these cost saving initiatives beginning in the second quarter.

 

As an additional cost saving initiative, we cold-idled our Magic Valley facility at the end of 2024. For context, starting in 2022, we saw an opportunity to take advantage of premium prices for high quality protein and corn oil. Consistent with our business strategy to improve yields of high margin products, we undertook the installation and ultimate commissioning of high-quality protein and corn oil technology at our Magic Valley plant. The installation took much longer and cost significantly more than expected. In addition, we underestimated the negative impact that the buildout of renewable diesel and soy crush capacity would have on market prices for protein and corn oil in the region. Compounded by the dramatic swing in delivered corn prices for Western operations compared to our Midwestern facilities, it became impossible to operate our Magic Valley facility profitably. By cold idling the plant and reducing our variable and fixed costs as much as possible, we have stopped this drag on the profitable areas of our business. In the fourth quarter, we took a significant impairment charge related to the Magic Valley plant. To partially offset remaining carry expenses, and to serve our customers in the area, we are opportunistically using the facility as a renewable fuel terminal.

 

At our Pekin Campus, we continue to pursue opportunities to optimize carbon, which historically was considered a waste stream with only marginal value. In November, we achieved an important milestone by finalizing our CO2 transportation and sequestration agreement with Vault 44.01, or Vault. This partnership is critical to our carbon capture and storage, or CCS, project. In December, Vault submitted the formal application to the EPA for our CCS project to obtain the Class VI permit required to begin construction of the CCS pipeline and for long-term CO2 storage in deep geological formations.

 

-35-

 

CCS operations require significant development and planning. The EPA requires extensive site analysis, monitoring and safety measures to safeguard underground water supplies. The approval process is currently estimated to take at least two years. We expect that this approval timeline will also allow the time necessary to address Illinois’s current moratorium on new CO2 pipelines imposed as part of its SAFE CCS Act. The moratorium is in effect until the earlier of July 2026 or revised federal safety standards are established.

 

Although progress on our CCS project has been slow, significant changes have occurred in the political and regulatory environment, as well as the carbon market, during that time. Our deliberate pace has been advantageous as we navigate these changes and discover effective paths forward. The extended period required for regulatory approvals affords us additional time to develop the necessary infrastructure plans, including compression and energy solutions. We also intend to use the additional time to secure necessary financing. Finally, working with Vault, we are focused on meeting with local groups and authorities to educate the community about our CCS project, strengthen support and address concerns.

 

At our Pekin Campus, we are proactively modifying our operations to deliver higher value products. Following our biennial wet mill outage in spring 2024, we improved plant utilization, operating the wet mill at nameplate capacity of 100 million gallons. Pekin Campus production volume in the fourth quarter increased 3.8 million gallons over the prior year period. This 7% increase demonstrates the effectiveness of our maintenance program. Carrying these improvements into 2025, we expect to produce an additional 8 million gallons for the full year, lowering our per gallon cost of production and enabling us to produce a greater volume of specialty alcohols.

 

We applied for, and in late summer obtained for our Pekin Campus, ISCC certification for our renewable fuels business to allow us to ship qualified renewable fuel to the European Union where we typically are able to garner premium prices compared to domestic markets. We began exporting certified renewable fuel to European markets in the fourth quarter and anticipate expanding exports in 2025.

 

In our premium specialty alcohol business, we continue to materially differentiate our products through our certifications and customer relationships. For 2024, we sold nearly 92 million gallons of specialty alcohols. In 2025, our goal is to balance production levels between specialty alcohols and ISCC renewable fuels to maximize margins while addressing customer needs. We also completed another ISO 9001 audit with no adverse findings, a testament to our culture of quality.

 

For the fourth quarter, we sold 95.1 million gallons, up from 92.5 million gallons for the same period in 2023, largely reflecting production improvements at our Pekin Campus from our planned repairs and maintenance program. However, our sales price per gallon averaged $1.88 in the fourth quarter compared to $2.24 for the same period in 2023, reducing net sales by $38 million for the year over year period. Market crush margins declined nearly 18 cents per gallon in the fourth quarter resulting in an $8.7 million adverse impact to gross profit for the period. In addition, returns from protein sales were negatively impacted by expanded soy crush intended to meet renewable diesel demand, higher wet feed product mix and the inability of a key customer to take product deliveries following Hurricane Helene. Low carbon fuel credit prices also declined in the fourth quarter compared to the prior year period but improved sequentially from the third quarter of 2024 and continue to recover from market lows.

 

Our realized derivative losses, which are included in Adjusted EBITDA (defined below), were $3.5 million for the fourth quarter compared to $2.3 million for the prior year period. Unrealized derivative gains, which are excluded from Adjusted EBITDA, were $5.5 million for the fourth quarter compared to a loss of $8.2 million for the prior year period, resulting in a positive $13.7 million year-over-year net difference. Our non-cash, lower of cost or market adjustment on physical inventories and mark-to-market on corn commitments resulted in a $3.5 million reserve in the fourth quarter compared to $2.2 million in the prior year period. In the fourth quarter, we recognized final acquisition-related expenses for Eagle Alcohol of $5.7 million, of which $5.0 million was non-cash, compared to $0.7 million in the prior year period.

 

-36-

 

Asset impairments for the fourth quarter totaled $24.8 million, consisting of $21.4 million related to the cold idling of our Magic Valley plant and $3.4 million related to the impairment of intangibles from the integration of certain Eagle Alcohol activities, compared to a $6.0 million impairment in the prior year period related to Eagle Alcohol’s goodwill.

 

Use of Non-GAAP Financial Measures

 

Management believes that certain financial measures not in accordance with generally accepted accounting principles, or GAAP, are useful measures of operations. Management provides EBITDA and Adjusted EBITDA as non-GAAP financial measures so that investors will have the same financial information that management uses, which may assist investors in properly assessing our performance on a period-over-period basis.

 

We define EBITDA as unaudited consolidated net income (loss) before interest expense, interest income, provision for income taxes and depreciation and amortization expense. We define Adjusted EBITDA as unaudited consolidated net income (loss) before interest expense, interest income, unrealized derivative gains and losses, acquisition-related expense, provision for income taxes, asset impairments, and depreciation and amortization expense.

 

A table is provided below to reconcile Adjusted EBITDA to its most directly comparable GAAP measure, consolidated net income (loss). EBITDA and Adjusted EBITDA are not measures of financial performance under GAAP and should not be considered as alternatives to consolidated net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. EBITDA and Adjusted EBITDA have limitations as analytical tools and you should not consider these measures in isolation or as a substitute for analysis of our results as reported under GAAP.

 

Information reconciling forward-looking EBITDA or Adjusted EBITDA to forward-looking consolidated net income (loss) would require a forward-looking statement of consolidated net income (loss) prepared in accordance with GAAP, which is unavailable to us without unreasonable effort. We are not able to provide a quantitative reconciliation of forward-looking EBITDA or Adjusted EBITDA to forward-looking consolidated net income (loss) because certain items required for reconciliation are uncertain, outside of our control and/or cannot reasonably be predicted, such as net sales, cost of goods sold, unrealized derivative gains and losses, asset impairments and provision (benefit) for income taxes, which we view as the most material components of consolidated net income (loss) that are not presently estimable.

 

Reconciliation of Adjusted EBITDA to Consolidated Net Loss

 

   Three Months Ended
December 31,
   Years Ended
December 31,
 
(in thousands) (unaudited)  2024   2023   2024   2023 
Consolidated net loss  $(41,712)  $(18,945)  $(58,984)  $(28,005)
Adjustments:                    
Interest expense, net   2,474    2,126    7,644    7,425 
Interest income   (112)   (265)   (689)   (854)
Unrealized derivative (gains) losses   (5,495)   8,162    (13,574)   9,679 
Acquisition-related expense   5,676    700    7,701    2,800 
Asset impairments   24,790    5,970    24,790    6,544 
Provision for income taxes   173    97    173    97 
Depreciation and amortization expense   6,548    5,698    24,408    23,080 
Total adjustments   34,054    22,488    50,453    48,771 
Adjusted EBITDA  $(7,658)  $3,543   $(8,531)  $20,766

 

-37-

 

2024 Financial Performance Summary

 

Our consolidated net sales declined by $0.3 billion to $1.0 billion for 2024 from $1.2 billion for 2023. Our net loss attributable to common stockholders increased by $31.0 million to a net loss of $60.3 million for 2024 from a net loss of $29.3 million for 2023.

 

Factors that contributed to these results of operations for 2024 include:

 

Net sales. Our net sales decline of $0.3 billion was due to a decline in our average sales price per gallon and fewer tons of essential ingredients sold, partially offset by an increase in total alcohol gallons sold.

 

oOur average sales price per gallon declined by $0.52, or 21%, to $1.95 for 2024 from $2.47 for 2023. The decline was primarily driven by lower renewable fuel prices in 2024 largely due to lower oil and gasoline prices.

 

oOur volume of essential ingredients sold declined by 0.1 million tons, or 7%, to 1.4 million tons for 2024 from 1.5 million tons for 2023 primarily due to lower alcohol production volumes during 2024. Our average sales price for our essential ingredients also declined primarily due to lower corn prices.

 

oOur total gallons sold increased by 3.5 million gallons, or 1%, to 386.0 million gallons for 2024 from 382.5 million gallons for 2023.

 

Our specialty alcohol production sales volume increased by 14.8 million gallons, or 19%, to 91.5 million gallons for 2024 from 76.7 million gallons for 2023 primarily due to increased customer demand for specialty alcohols during the year.

 

Our third-party sales volume increased by 5.7 million gallons, or 6%, to 108.3 million gallons for 2024 from 102.6 million gallons for 2023. This increase resulted from our fulfillment of customer contracts for renewable fuels using third party volumes while our Magic Valley and Pekin Campus plants were offline in 2024.

 

Our renewable fuel production sales volume declined by 17.0 million gallons, or 8%, to 186.2 million gallons for 2024 from 203.2 million gallons for 2023, primarily due to reduced production in 2024 as our Magic Valley facility was hot-idled for most of the first half of 2024 coupled with scheduled production downtime at our Pekin Campus for repairs and maintenance.

 

Gross Profit. Our gross profit declined by $5.9 million to a gross profit of $9.7 million for 2024 from $15.7 million for 2023 partially due to weakened commodity crush margins from lower ethanol sales prices as well as lower corn prices which reduced profits from our essential ingredients. Our gross profit and margins were further impacted by production challenges at our Magic Valley plant as we continued to incur costs to implement our high-protein and corn oil system at the facility coupled with higher repairs and maintenance costs due to our scheduled downtime at our Pekin Campus.

 

-38-

 

Sales and Margins

 

We generate sales by marketing all of the alcohols produced by our three production facilities in Illinois, all of the fuel-grade ethanol produced by our production facilities in Oregon and Idaho, and fuel-grade ethanol purchased from third-party suppliers throughout the United States. We also market essential ingredients produced by our production facilities, including dried yeast, corn protein meal, corn protein feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. We also sell yeast and liquid CO2 for human consumption.

 

Our profitability is highly dependent on various commodity prices, including the market prices of corn, natural gas and fuel-grade ethanol.

 

Our consolidated average alcohol sales price declined by 21% to $1.95 per gallon for 2024 compared to $2.47 per gallon for 2023. The average price of fuel-grade ethanol as reported by the Chicago Mercantile Exchange, or CME, declined by 24% to $1.69 per gallon for 2024 compared to $2.22 per gallon for 2023. Our average cost of corn declined by 28% to $4.72 per bushel for 2024 from $6.58 per bushel for 2023. The average price of corn as reported by the CME declined by 25% to $4.24 per bushel for 2024 from $5.64 per bushel for 2023.

 

We believe that our gross profit margins depend primarily on the following key factors:

 

the prices of our specialty alcohols and the market price of fuel-grade ethanol, the latter of which is impacted by the price of gasoline and related petroleum products, and government regulation, including government ethanol mandates;

 

the market prices of key production input commodities, such as corn (including corn basis) and natural gas;

 

the market prices of our essential ingredients;

 

key variable costs (other than production input commodities), such as production and other personnel staffing;

 

our ability to anticipate trends in the market and contracted prices of our alcohols, essential ingredients, and costs of key input commodities, and our ability to implement appropriate risk management through hedging and other means, and opportunistic pricing strategies, as well as the financial results of those hedging activities;

 

the proportion of our sales of specialty alcohols to our sales of fuel-grade ethanol produced at our facilities relative to their respective market and contracted prices; and

 

the proportion of our sales of fuel-grade ethanol produced at our facilities to our sales of fuel-grade ethanol produced by unrelated third-parties relative to the market price of fuel-grade ethanol and marketing and distribution fees payable for third-party sales.

 

We seek to optimize our gross profit margins by anticipating the factors above and, when resources are available, implementing hedging transactions and taking other actions designed to lock in margins, limit risk and otherwise address these factors. For example, we may seek to reduce inventory levels in anticipation of declining alcohol or essential ingredient prices and increase production and inventory levels in anticipation of rising alcohol or essential ingredient prices. We may also seek to alter our proportion or timing, or both, of purchase and sales commitments.

 

Our inability to anticipate the factors described above or their relative importance, and adverse movements in the factors themselves, could result in declining or even negative gross profit margins over certain periods of time. Our ability to anticipate these factors or favorable movements in these factors may enable us to generate above-average gross profit margins. However, given the difficulty associated with successfully forecasting any of these factors, we are unable to estimate our future sales or gross profit margins.

 

Results of Operations

 

Selected Financial Information

 

The following selected financial information should be read in conjunction with our consolidated financial statements and notes to our consolidated financial statements included elsewhere in this report, and the other sections of “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in this report.

 

-39-

 

Certain performance metrics that we believe are important indicators of our results of operations include:

 

Certain performance metrics that we believe are important indicators of our results of operations include the following:

 

           Percentage Change 
   Years Ended December 31,   2024 vs   2023 vs 
   2024   2023   2022   2023   2022 
Alcohol Sales (gallons in millions)                    
Pekin Campus renewable fuel gallons sold   125.7    136.2    116.1    (8)%   17%
Western production renewable fuel gallons sold   60.5    67.0    92.4    (10)%   (27)%
Third-party renewable fuel gallons sold   108.3    102.6    117.9    6%   (13)%
Total renewable fuel gallons sold   294.5    305.8    326.4    (4)%   (6)%
Specialty alcohol gallons sold   91.5    76.7    92.5    19%   (17)%
Total gallons sold   386.0    382.5    418.9    1%   (9)%
                          
Sales Price per Gallon                         
Pekin Campus  $1.95   $2.40   $2.55    (19)%   (6)%
Western production  $1.91   $2.49   $2.75    (23)%   (9)%
Marketing and distribution  $2.00   $2.56   $2.83    (22)%   (10)%
Total  $1.95   $2.47   $2.64    (21)%   (6)%
                          
Alcohol Production (gallons in millions)                         
Pekin Campus   212.4    209.7    208.8    1%   0%
Western production   58.7    68.1    91.2    (14)%   (25)%
Total   271.1    277.8    300.0    (2)%   (7)%
                          
Corn Cost per Bushel                         
Pekin Campus  $4.45   $6.32   $7.32    (30)%   (14)%
Western production  $5.73   $7.45   $8.97    (23)%   (17)%
Total  $4.72   $6.58   $7.77    (28)%   (15)%
                          
Average Market Metrics                         
PLATTS Ethanol price per gallon  $1.69   $2.22   $2.47    (24)%   (10)%
CME Corn cost per bushel  $4.24   $5.64   $6.94    (25)%   (19)%
Board corn crush per gallon (1)  $0.18   $0.21   $0.00    (14)%    
                          
Essential Ingredients Sold (in thousands of tons)                         
Pekin Campus                         
Distillers grains   336.4    332.7    334.4    1%   (1)%
CO2   188.6    182.4    164.8    3%   11%
Corn wet feed   121.8    95.0    89.9    28%   6%
Corn dry feed   87.2    90.6    81.6    (4)%   11%
Corn oil and germ   75.1    73.8    66.7    2%   11%
Syrup and other   38.6    41.2    56.9    (6)%   (28)%
Corn meal   35.4    36.8    32.1    (4)%   15%
Yeast   23.2    25.9    23.9    (10)%   8%
Total Pekin Campus   906.3    878.4    850.3    3%   3%
                          
Western production                         
Distillers grains   394.5    459.7    643.7    (14)%   (29)%
CO2   57.7    119.1    77.4    (52)%   54%
Syrup and other   54.8    55.5    55.8    (1)%   (1)%
Corn oil   7.6    8.0    10.2    (5)%   (22)%
Total Western Production   514.6    642.3    787.1    (20)%   (18)%
                          
Total Essential Ingredients Sold   1,420.9    1,520.7    1,637.4    (7)%   (7)%
                          
Essential Ingredients return % (2)                         
Pekin Campus Return   49.7%   45.7%   41.3%   9%   11%
Western Production Return   32.0%   33.4%   31.6%   (4)%   6%
Consolidated Total Return   45.2%   42.4%   37.9%   7%   12%

 

 

(1)Assumes corn conversion of 2.80 gallons of alcohol per bushel of corn.
(2)Essential ingredients revenues as a percentage of total corn costs consumed.

 

-40-

 

Year Ended December 31, 2024 Compared to the Year Ended December 31, 2023

 

   Years Ended
December 31,
   Dollar   Percentage   Results as a Percentage
of Net Sales for the
Years Ended
December 31,
 
   2024   2023   Change   Change   2024   2023 
   (dollars in thousands)     
Net sales  $965,258   $1,222,940   $(257,682)   (21.1)%   100.0%   100.0%
Cost of goods sold   955,536    1,207,287    (251,751)   (20.9)%   99.0%   98.7%
Gross profit   9,722    15,653    (5,931)   (37.9)%   1.0%   1.3%
Selling, general and administrative expenses   (29,736)   (29,864)   (128)   (0.4)%   (3.1)%   (2.4)%
Acquisition-related expenses   (7,701)   (2,800)   4,901    175.0%   (0.8)%   (0.2)%
Gain (loss) on sale (disposal) of assets   830    (293)   1,123      *    (0.0)%   (0.0)%
Asset impairments   (24,790)   (6,544)   18,246    278.8%   (2.6)%   (0.5)%
Loss from operations   (51,675)   (23,848)   27,827    116.7%   (5.4)%   (2.0)%
Income from cash grant       2,812    (2,812)   (100.0)%   0.0%   0.2%
Interest expense, net   (7,644)   (7,425)   219    2.9%   (0.8)%   (0.6)%
Other income, net   508    553    (45)   (8.1)%   0.1%   0.0%
Loss before provision for income taxes   (58,811)   (27,908)   30,903    110.7%   (6.1)%   (2.3)%
Provision for income taxes   173    97    76    78.4%   0.0%   0.0%
Consolidated net loss  $(58,984)  $(28,005)  $30,979    110.6%   (6.1)%   (2.3)%
Preferred stock dividends   (1,269)   (1,265)   4    0.3%   (0.1)%   (0.1)%
Loss attributable to common stockholders  $(60,253)  $(29,270)  $30,983    105.9%   (6.2)%   (2.4)%

 

 

*Not meaningful.

 

-41-

 

Net Sales

 

The decline in our consolidated net sales for 2024 as compared to 2023 was due to a decrease in our average sales price per gallon for our alcohols and lower volumes of essential ingredients sold at lower prices, partially offset by a higher volume of alcohol sold. Our average sales price per gallon declined primarily due to lower fuel-grade ethanol prices largely driven by lower oil and gasoline prices in 2024 compared to the prior year.

 

We also produced and sold fewer tons of essential ingredients primarily due to lower alcohol production in 2024 compared to 2023. Our average sales price for our essential ingredients declined primarily due to lower corn prices.

 

Partially offsetting these declines, we sold more total gallons for 2024 as compared to 2023 resulting primarily from an increase in our specialty alcohol gallons sold and third-party gallons sold, partially offset by lower renewable fuel production gallons sold due to downtime at both our Magic Valley facility and our Pekin Campus, as discussed above. We were able to produce and sell more specialty alcohol due in part to higher production from our Pekin Campus wet mill after our biennial maintenance outage during the year.

 

Pekin Campus Production Segment

 

Net sales of alcohol from our Pekin Campus production segment declined by $86.5 million, or 17%, to $415.7 million for 2024 as compared to $502.2 million for 2023. Our total volume of production gallons sold, however, increased by 4.7 million gallons, or 2%, to 213.6 million gallons for 2024 as compared to 208.9 million gallons for 2023, due to production benefits realized in second half of the year from our biennial maintenance performed in Spring 2024 resulting in higher production rates.

 

At the segment’s average sales price per gallon of $1.95 for 2024, we generated $9.1 million in additional net sales from the 4.7 million additional gallons of alcohol sold in 2024 as compared to 2023. However, a decrease of $0.45, or 19%, in the segment’s average sales price per gallon in 2024 as compared to 2023 resulted in a $95.6 million decline in net sales as compared to 2023.

 

Net sales of essential ingredients declined by $48.4 million, or 22%, to $169.3 million for 2024 as compared to $217.7 million for 2023. Our total volume of essential ingredients sold increased by 27,900 tons, or 3%, to 906,300 tons for 2024 from 878,400 tons for 2023. Sales volumes of essential ingredients from our Pekin Campus were higher in 2024 due to higher production rates for the year. At our average sales price per ton of $186.81 for 2024, we generated $5.2 million in additional net sales from the 27,900 additional tons of essential ingredients sold in 2024 as compared to 2023. A decrease of $61.03, or 25%, in our average sales price per ton in 2024 as compared to 2023 resulted in a $53.6 million decline in net sales as compared to 2023.

 

Marketing and Distribution Segment

 

Net sales of renewable fuel from our marketing and distribution segment, excluding intersegment sales, decreased by $46.5 million, or 18%, to $216.5 million for 2024 as compared to $263.0 million for 2023.

 

Our volume of third-party renewable fuel sold reported gross by the segment increased by 5.7 million gallons, or 6%, to 108.3 million gallons for 2024 as compared to 102.6 million gallons for 2023. This increase resulted from a shift in the source of renewable fuel from our Magic Valley facility to third-party suppliers. At the segment’s average sales price per gallon of $2.00 for 2024, net sales were $11.4 million higher as a result of the 5.7 million additional gallons sold in 2024 as compared to 2023. This increase was partially offset by the $0.56 decrease in our average sales price per gallon for 2024. The decrease of $0.56, or 22%, in our average sales price per gallon in 2024 as compared to 2023 resulted in a $57.9 million decline in net sales from our third-party renewable fuel sold by the segment compared to 2023.

 

-42-

 

Western Production Segment

 

Net sales of alcohol from our Western production segment declined by $51.6 million, or 31%, to $115.4 million for 2024 as compared to $167.0 million for 2023. Our total volume of gallons sold declined by 6.5 million gallons, or 10%, to 60.5 million gallons for 2024 as compared to 67.0 million gallons for 2023. This decline in sales volume primarily resulted from lower production from our Magic Valley facility. At the segment’s average sales price of $1.91 per gallon for 2024, net sales were $12.4 million lower as a result of the 6.5 million fewer gallons sold in 2024 as compared to 2023. A decline of $0.58, or 23%, in our average sales price per gallon in 2024 as compared to 2023 resulted in a $39.2 million decrease in net sales of alcohol from the segment compared to 2023.

 

Net sales of essential ingredients declined by $20.3 million, or 35%, to $37.0 million for 2024 as compared to $57.3 million for 2023. Our total volume of essential ingredients sold declined by 127,700 tons, or 20%, to 514,600 tons for 2024 from 642,300 tons for 2023. At our average sales price of $71.81 per ton for 2024, net sales were $9.2 million lower as a result of the 127,700 fewer tons sold in 2024 as compared to 2023. In addition, our sales price declined by $17.35 per ton for 2024. The decline of $17.35, or 19%, in our average sales price per ton in 2024 as compared to 2023 resulted in a decrease of $11.1 million in net sales of essential ingredients from the segment compared to 2023.

 

Corporate and Other Segment

 

Net sales from our Corporate and other segment declined by $4.4 million or 28% to $11.4 million for 2024 as compared to $15.8 million for 2023. These results are from Eagle Alcohol’s business.

 

Cost of Goods Sold and Gross Profit

 

Our consolidated gross profit declined to a gross profit of $9.7 million, representing a gross margin of 1.0% for 2024, from $15.7 million, representing a gross margin of 1.3%, for 2023. Our consolidated gross profit declined due to lower overall commodity crush margins, particularly for renewable fuel, primarily due to lower sales prices as well as lower margins on essential ingredients sold due to lower corn prices. We spent a total of $34.6 million for repairs and maintenance, in-line with our 2024 estimate.

 

Pekin Campus Production Segment

 

Our Pekin Campus production segment’s gross profit improved by $12.7 million to a gross profit of $25.9 million from $13.3 million. Of this increase, $12.1 million is attributable to higher commodity crush margins and $0.6 million is attributable to increased sales volumes in 2024 as compared to 2023.

 

Marketing and Distribution Segment

 

Our marketing and distribution segment’s gross profit declined by $0.2 million to a gross profit of $4.0 million for 2024 from $4.2 million for 2023. Of this decrease, $0.4 million is attributable to lower margins from sales of third-party renewable fuel, partially offset by an increase of $0.2 million attributable to higher marketing volumes of third-party renewable fuel sold reported gross in 2024 as compared to 2023.

 

Western Production Segment

 

Our Western production segment’s gross loss worsened by $13.8 million to a gross loss of $19.3 million for 2024 as compared to a gross loss of $5.5 million for 2023. Of this decline, $15.8 million is attributable to significantly lower margins for renewable fuel, partially offset by $2.0 million attributable to lower sales volumes at negative margins in 2024 as compared to 2023.

 

-43-

 

Corporate and Other Segment

 

Gross profit and loss from our Corporate and other segment was a gross loss of $0.9 million for 2024 and a gross profit of $3.7 million for 2023, primarily from Eagle Alcohol’s business.

 

Selling, General and Administrative Expenses

 

Our selling, general and administrative, or SG&A, expenses decreased by $0.1 million to $29.7 million for 2024 as compared to $29.8 million for 2023. SG&A expenses decreased primarily due to lower professional fees.

 

Acquisition-related Expenses

 

Our acquisition-related expenses increased by $4.9 million to $7.7 million for 2024 as compared to $2.8 million for 2023. These expenses relate to the acceleration of stock payments to the former owners of Eagle Alcohol.

 

Asset Impairments

 

We recorded asset impairment charges of $24.8 million for 2024 as compared $6.5 million for 2023. The 2024 impairments reflect $21.4 million for our Magic Valley asset group, as we cold-idled the plant at the end of the year, and $3.4 million for intangible assets of Eagle Alcohol. The 2023 impairments relate to the goodwill associated with our acquisition of Eagle Alcohol.

 

Interest Expense, net

 

Interest expense, net, increased by $0.2 million to $7.6 million for 2024 from $7.4 million for 2023. The increase in interest expense, net, is primarily due to higher debt balances, as well as higher interest rates under Kinergy’s line of credit.

 

Year Ended December 31, 2023, Compared to the Year Ended December 31, 2022

 

An analysis of our financial results comparing 2023 to 2022 can be found under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Securities and Exchange Commission on March 14, 2024, which is available free of charge on the Securities and Exchange Commission’s website at www.sec.gov.

 

Liquidity and Capital Resources

 

During the year ended December 31, 2024, we funded our operations primarily from cash on hand and proceeds from Kinergy’s operating line of credit. In addition to funding our operations, we used our capital resources to continue our capital improvement projects, make an annual cash payment related to our acquisition of Eagle Alcohol and pay preferred stock dividends.

 

As of December 31, 2024, we had $35.5 million in cash and cash equivalents and $23.1 million available for borrowing under Kinergy’s operating line of credit. In addition, we have up to an additional $65.0 million that may be available for capital improvement projects under our Orion term loan discussed below, subject to certain conditions. We believe we have sufficient sources of liquidity to meet our anticipated working capital, debt service, capital expenditure and other liquidity needs for at least the next twelve months from the date of this report.

 

-44-

 

Quantitative Year-End Liquidity Status

 

We believe that the following amounts provide insight into our liquidity and capital resources. The following selected financial information should be read in conjunction with our consolidated financial statements and notes to consolidated financial statements included elsewhere in this report, and the other sections of “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in this report (dollars in thousands).

 

   December 31,
2024
   December 31,
2023
   Change 
Cash, cash equivalents and restricted cash  $36,211   $45,480    (20)%
Current assets  $153,118   $168,770    (9)%
Property and equipment, net  $214,742   $248,748    (14)%
Current liabilities  $57,804   $65,288    (11)%
Long-term debt, noncurrent portion  $92,904   $82,097    13%
Working capital  $95,314   $103,482    (8)%
Working capital ratio   2.65    2.59    2%

 

Restricted Net Assets

 

At December 31, 2024, we had approximately $54.1 million of net assets at our subsidiaries that were not available to be transferred to Alto Ingredients, Inc. in the form of dividends, distributions, loans or advances due to restrictions contained in our subsidiaries’ credit facilities.

 

Changes in Working Capital and Cash Flows

 

Working capital declined to $95.3 million at December 31, 2024 from $103.5 million at December 31, 2023 as a result of a $15.7 million decrease in current assets, partially offset by a $7.5 million decrease in current liabilities.

 

Current assets declined primarily due to decreases in restricted cash, inventories and other current assets. Our current liabilities declined primarily due to decreases in derivative instruments and accrued liabilities.

 

Our cash, cash equivalents and restricted cash declined by $9.3 million due to $3.5 million of cash used in our operating activities and $13.5 million of cash used in our investing activities primarily for our capital improvement projects, partially offset by $7.7 million in cash provided by our financing activities, primarily due to proceeds from our operating line of credit.

 

Cash used in our Operating Activities

 

We used $3.5 million in cash in our operating activities during 2024, as compared to $22.0 million in cash generated from our operating activities in 2023. Specific factors that contributed significantly to the change in cash generated by our operating activities include:

 

an increase of $31.0 million in net loss primarily due to lower commodity crush margins and increased asset impairments;

 

a decrease of $19.1 million related to changes in the fair value of our derivative instruments due to changes in commodity prices at period-end 2024 as compared to 2023;

 

a decrease of $8.9 million related to accounts receivable balances primarily due to the timing of sales and collections; and

 

a decrease of $7.3 million in inventories due to lower period-end commodity prices.

 

-45-

 

 

These amounts were partially offset by:

 

an increase of $22.5 million related to accounts payable and accrued expenses due to the timing of payments; and

 

an increase of $18.2 million in asset impairments primarily related to the cold-idling of our Magic Valley facility.

 

Cash used in our Investing Activities

 

We used $13.5 million of cash in our investing activities for 2024, of which $11.1 million was for additions to property and equipment resulting from our capital improvement projects and $2.8 million is attributable to cash paid for our acquisition of Eagle Alcohol.

 

Cash provided by our Financing Activities

 

Cash provided by our financing activities was $7.7 million for 2024, of which $9.0 million is attributable to net proceeds from Kinergy’s line of credit, partially offset by $1.3 million of preferred stock dividends.

 

Kinergy’s Operating Line of Credit

 

Kinergy maintains an operating line of credit for an aggregate amount of up to $100.0 million. The credit facility matures on November 7, 2027. Interest accrues under the credit facility at a rate equal to (i) the daily Secured Overnight Financing Rate, plus (ii) a specified applicable margin ranging from 1.25% to 1.75%. The credit facility’s monthly unused line fee is 0.25% to 0.375% of the amount by which the maximum credit under the facility exceeds the average daily principal balance during the immediately preceding month. Payments that may be made by Kinergy to Alto Ingredients, Inc. as reimbursement for management and other services provided by Alto Ingredients, Inc. to Kinergy are limited under the terms of the credit facility to $1.5 million per fiscal quarter. The credit facility also includes the accounts receivable of our indirect wholly-owned subsidiary, Alto Nutrients, LLC, or Alto Nutrients, as additional collateral. Payments that may be made by Alto Nutrients to Alto Ingredients, Inc. as reimbursement for management and other services provided by Alto Ingredients, Inc. to Alto Nutrients are limited under the terms of the credit facility to $0.5 million per fiscal quarter. Alto Nutrients markets our essential ingredients and also provides raw material procurement services to our subsidiaries. In addition, the amount of cash distributions that Kinergy or Alto Nutrients may make to us is also limited to up to 75% of excess cash flow.

 

For all monthly periods in which excess borrowing availability falls below a specified level, Kinergy and Alto Nutrients must collectively maintain a fixed-charge coverage ratio (calculated as a twelve-month rolling earnings before interest, taxes, depreciation and amortization divided by the sum of interest expense, capital expenditures, principal payments of indebtedness, indebtedness from capital leases and taxes paid during such twelve-month rolling period) of at least 1.1 and are prohibited from incurring certain additional indebtedness (other than specific intercompany indebtedness). The obligations of Kinergy and Alto Nutrients under the credit facility are secured by all of our tangible and intangible assets.

 

-46-

 

We believe Kinergy and Alto Nutrients are in compliance with the fixed-charge coverage ratio covenant as of the filing of this report. The following table sets forth the fixed-charge coverage ratio financial covenant and the actual results for the periods presented:

 

   Years Ended
December 31,
 
   2024   2023 
         
Fixed-Charge Coverage Ratio Requirement   1.10    1.10 
Actual   3.53    5.22 
Excess   2.43    4.12 

 

Alto Ingredients, Inc. has guaranteed all of Kinergy’s obligations under the credit facility. As of December 31, 2024, Kinergy had an outstanding balance of $39.7 million and $23.1 million of unused borrowing availability under the credit facility.

 

Orion Term Loan

 

On November 7, 2022, we entered into a credit agreement with certain funds managed by Orion Infrastructure Capital, or Lenders, under which the Lenders extended a senior secured credit facility in the amount of up to $125.0 million, or Term Loan. The Term Loan is secured by a first priority lien on certain of our assets and a second priority lien on certain assets of Kinergy and Alto Nutrients. Interest accrues on the unpaid principal amount of the Term Loan at a fixed rate of 10% per annum. The Term Loan matures on November 7, 2028, or earlier upon acceleration.

 

We must prepay amounts outstanding under the Term Loan on a semi-annual basis beginning with the six-month period ending December 31, 2023 in an amount equal to a percentage of our excess cash flow based on a specified leverage ratio, as follows: (i) if our leverage ratio is greater than or equal to 3.0x, then the mandatory prepayment amount will equal 100% of our excess cash flow, (ii) if our leverage ratio is less than 3.0x and greater than or equal to 1.5x, then the mandatory prepayment amount will equal 50% of our excess cash flow, and (iii) if our leverage ratio is less than 1.5x, then the mandatory prepayment amount will equal 25% of our excess cash flow.

 

As of December 31, 2024 and 2023, the principal amount outstanding under the Term Loan was $60.0 million.

 

Other Cash Obligations

 

As of December 31, 2024, we had future commitments for certain capital projects totaling $9.1 million. These commitments are scheduled to be satisfied through 2025.

 

In connection with our acquisition of Eagle Alcohol, we are committed to pay contingent payments of up to $2.7 million in the first half of 2025.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of net sales and expenses for each period. The following represents a summary of our critical accounting policies and related estimates, defined as those policies that we believe are the most important to the portrayal of our financial condition and results of operations and that require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effects of matters that are inherently uncertain.

 

-47-

 

Accounting for Business Combinations

 

Determining the fair value of assets acquired and liabilities assumed in a business combination is considered a critical accounting estimate because the allocation of the purchase price to assets acquired and liabilities assumed based upon fair values requires significant management judgment and the use of subjective measurements. Variability in industry conditions and changes in assumptions or subjective measurements used to allocate fair value are reasonably possible and may have a material impact on our financial position, liquidity or results of operations.

 

Revenue Recognition

 

We recognize revenue primarily from sales of alcohols and essential ingredients.

 

We have five alcohol production facilities from which we produce and sell alcohols to our customers through our subsidiary, Kinergy. Kinergy enters into sales contracts with customers under exclusive intercompany sales agreements with each of our five production facilities. Kinergy also acts as a principal when it purchases third party fuel-grade ethanol which it resells to its customers. Finally, in 2022, Kinergy had exclusive sales agreements with two third-party owned fuel-grade ethanol plants under which it sold the plants’ fuel-grade ethanol production for a fee plus the costs to deliver the ethanol to Kinergy’s customers. Kinergy has since terminated these contracts. These sales are referred to as third-party agent sales. Revenue from these third-party agent sales is recorded on a net basis, with Kinergy recognizing its predetermined fees and any associated delivery costs.

 

We have five production facilities from which we produce and sell essential ingredients to our customers through our subsidiary, Alto Nutrients. Alto Nutrients enters into sales contracts with essential ingredient customers under exclusive intercompany sales agreements with each of our five production facilities.

 

We recognize revenue from sales of alcohols and essential ingredients at the point in time when the customer obtains control of the products, which typically occurs upon delivery depending on the terms of the underlying contracts. In some instances, we enter into contracts with customers that contain multiple performance obligations to deliver volumes of alcohols or essential ingredients over a contractual period of less than 12 months. We allocate the transaction price to each performance obligation identified in the contract based on relative standalone selling prices and recognize the related revenue as control of each individual product is transferred to the customer in satisfaction of the corresponding performance obligations.

 

When we are the agent, the supplier controls the products before they are transferred to the customer because the supplier is primarily responsible for fulfilling the promise to provide the product, has inventory risk before the product has been transferred to a customer and has discretion in establishing the price for the product. When we are the principal, we control the products before they are transferred to the customer because we are primarily responsible for fulfilling the promise to provide the products, we have inventory risk before the product has been transferred to a customer and we have discretion in establishing the price for the product.

 

See “Note 4 – Segments” of the Notes to Consolidated Financial Statements for our revenue breakdown by type of contract.

 

Impairment of Long-Lived Assets

 

Our long-lived assets have been primarily associated with our production facilities, reflecting their original cost, adjusted for depreciation and amortization and any subsequent impairment.

 

-48-

 

We assess the impairment of long-lived assets, including property and equipment, when events or changes in circumstances indicate that the fair value of an asset group could be less than the net book value of the asset group. Generally, we assess long-lived assets for impairment by first determining the forecasted, undiscounted cash flows each asset is expected to generate plus the net proceeds expected from the sale of the asset group. If the total amount of the undiscounted cash flows is less than the carrying value of the asset group, we then determine the fair value of the asset group. When the estimated fair value of the asset group is less than its carrying value, we recognize an impairment expense equal to the difference between the asset group’s carrying value and estimated fair value. Forecasts of future cash flows are estimates based on our experience and knowledge of our operations and the industry in which we operate. These estimates could be significantly affected by future changes in market conditions, the economic environment, including inflation, and the purchasing decisions of our customers. As a result, we recorded asset impairments of $21.4 million and $0.6 million with respect to our Magic Valley facility and right of use assets associated with our operating leases for the years ended December 31, 2024 and 2023, respectively.

 

We review our intangible assets, including goodwill, with indefinite lives at least annually or more frequently if impairment indicators arise. In our review, we determine the fair value of these assets using market multiples and discounted cash flow modeling and compare it to the net book value of the reporting unit. Any assessed impairments will be recorded permanently and expensed in the period in which the impairment is determined. We performed our annual review of impairment and recognized asset impairments of $3.4 million and $6.0 million against our intangible assets and goodwill for the years ended December 31, 2024 and 2023, respectively. We did not recognize any asset impairments for the year ended December 31, 2022.

 

Valuation Allowance for Deferred Taxes

 

We account for income taxes under the asset and liability approach, where deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and are measured using enacted tax rates and laws that are expected to be in effect when the differences reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized.

 

We evaluate our deferred tax asset balance for realizability. To the extent we believe it is more likely than not that some portion or all of our deferred tax assets will not be realized, we will establish a valuation allowance against the deferred tax assets. Realization of our deferred tax assets is dependent upon future taxable income during the periods in which the associated temporary differences become deductible. We consider the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. These changes, if any, may require possible material adjustments to these deferred tax assets, resulting in a reduction in net income or an increase in net loss in the period when such determinations are made.

 

We had pre-tax consolidated net losses of $58.8 million, $27.9 million and $39.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. Based on our current and prior results, we do not have sufficient evidence to support a conclusion that we will more likely than not be able to benefit from our remaining deferred tax assets. As such, we have recorded a valuation allowance against our net deferred tax assets.

 

Derivative Instruments

 

We evaluate our contracts to determine whether the contracts are derivative instruments. Management may elect to exempt certain forward contracts that meet the definition of a derivative from derivative accounting as normal purchases or normal sales. Normal purchases and normal sales are contracts that provide for the purchase or sale of something other than a financial instrument or derivative instrument that will be delivered in quantities expected to be used or sold over a reasonable period in the normal course of business. Contracts that meet the requirements of normal purchases or sales are documented as normal and exempted from the fair value accounting and reporting requirements of derivative accounting.

 

-49-

 

We enter into short-term cash, option and futures contracts as a means of securing purchases of corn, natural gas and sales of fuel-grade ethanol and managing exposure to changes in commodity prices. All of our exchange-traded derivatives are designated as non-hedge derivatives for accounting purposes, with changes in fair value recognized in net income. Although the contracts are economic hedges of specified risks, they are not designated or accounted for as hedging instruments.

 

Realized and unrealized gains and losses related to exchange-traded derivative contracts are included as a component of cost of goods sold in the accompanying financial statements. The fair values of contracts entered through commodity exchanges are presented on the accompanying balance sheet as derivative assets or liabilities. The selection of normal purchase or sales contracts, and use of hedge accounting, are accounting policies that can change the timing of recognition of gains and losses in the statement of operations.

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

 

We are exposed to various market risks, including changes in commodity prices, as discussed below. Market risk is the potential loss arising from adverse changes in market rates and prices. In the ordinary course of business, we may enter into various types of transactions involving financial instruments to manage and reduce the impact of changes in commodity prices. We do not have material exposure to interest rate risk. We do not expect to have any exposure to foreign currency risk as we conduct all of our transactions in U.S. dollars.

 

We produce and distribute specialty alcohol, fuel-grade ethanol and essential ingredients. Our business is sensitive to changes in the prices of ethanol and corn. In the ordinary course of business, we may enter into various types of transactions involving financial instruments to manage and reduce the impact of changes in ethanol and corn prices. We do not enter into derivatives or other financial instruments for trading or speculative purposes.

 

We are subject to market risk with respect to ethanol and corn pricing. Ethanol prices are sensitive to global and domestic ethanol supply; crude-oil supply and demand; crude-oil refining capacity; carbon intensity; government regulation; and consumer demand for alternative fuels. Our ethanol sales are priced using contracts that are either based on a fixed price or an indexed price tied to a specific market, such as Chicago Ethanol (Platts) or the Oil Price Information Service. Under these fixed-priced arrangements, we are exposed to risk of a decrease in the market price of ethanol between the time the price is fixed and the time the alcohol is sold.

 

We satisfy our physical corn needs, the principal raw material used to produce alcohol and essential ingredients, based on purchases from our corn vendors. Generally, we determine the purchase price of our corn at or near the time we begin to grind. Additionally, we also enter into volume contracts with our vendors to fix the purchase price. As such, we are also subject to market risk with respect to the price of corn. The price of corn is subject to wide fluctuations due to unpredictable factors such as weather conditions, farmer planting decisions, governmental policies with respect to agriculture and international trade and global supply and demand. Under the fixed price arrangements, we assume the risk of a decrease in the market price of corn between the time the price is fixed and the time the corn is utilized.

 

-50-

 

Essential ingredients are sensitive to various demand factors such as numbers of livestock on feed, prices for feed alternatives and supply factors, primarily production of ethanol co-products by ethanol plants and other sources.

 

As noted above, we may attempt to reduce the market risk associated with fluctuations in the price of ethanol or corn by employing a variety of risk management and hedging strategies. Strategies include the use of derivative financial instruments such as futures and options executed on the CME and/or the New York Mercantile Exchange, as well as the daily management of physical corn.

 

These derivatives are not designated for special hedge accounting treatment, and as such, the changes in the fair values of these contracts are recorded on the balance sheet and recognized immediately in cost of goods sold. We recognized net gains of $11.0 million, net losses of $8.0 million and net gains of $19.3 million related to the change in the fair values of these contracts for the years ended December 31, 2024, 2023 and 2022, respectively.

 

We prepared a sensitivity analysis as of December 31, 2024 to estimate our exposure to ethanol and corn. Market risk related to these factors was estimated as the potential change in pre-tax income resulting from a hypothetical 10% adverse change in the prices of our expected ethanol and corn volumes. The analysis uses average CME prices for the year and does not factor in future contracted volumes. The results of this analysis for the year ended December 31, 2024, which may differ materially from actual results, are as follows (in millions):

 

Commodity  Volume  Unit of Measure  Approximate
Adverse Change to
Pre-Tax Income
 
Ethanol  294.5  Gallons  $31.6 
Corn  66.5  Bushels  $28.2 

 

Item 8. Financial Statements and Supplementary Data.

 

Reference is made to the financial statements, which begin at page F-1 of this report.

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

 

None.

 

Item 9A. Controls and Procedures.

 

We conducted an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. The term “disclosure controls and procedures,” as defined in Rules 13a-15I and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded as of December 31, 2024 that our disclosure controls and procedures were effective at a reasonable assurance level.

 

-51-

 

Management’s Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:

 

(i)pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

 

(ii)provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

 

(iii)provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

A material weakness is defined by the Public Company Accounting Oversight Board’s Audit Standards AS 2201 as being a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework set forth in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework set forth in Internal Control — Integrated Framework (2013), our management concluded that our internal control over financial reporting was effective as of December 31, 2024.

 

RSM US LLP, an independent registered public accounting firm, has issued an attestation report on our internal control over financial reporting as of December 31, 2024. That report is included in Part IV of this report.

 

-52-

 

Inherent Limitations on the Effectiveness of Controls

 

Management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control systems are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in a cost-effective control system, no evaluation of internal control over financial reporting can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been or will be detected.

 

These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of a simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

 

Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Item 9B. Other Information.

 

During the three months ended December 31, 2024, none of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) informed us of the adoption, modification or termination of a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).

 

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

 

Not applicable.

 

-53-

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance.

 

The information under the captions “Information about our Board of Directors, Board Committees and Related Matters” appearing in the Proxy Statement, is hereby incorporated by reference.

 

Item 11. Executive Compensation.

 

The information under the caption “Executive Compensation and Related Information,” appearing in the Proxy Statement, is hereby incorporated by reference.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 

The information under the captions “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation Plan Information,” appearing in the Proxy Statement, is hereby incorporated by reference.

 

Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

The information under the captions “Certain Relationships and Related Transactions” and “Information about our Board of Directors, Board Committees and Related Matters—Director Independence” appearing in the Proxy Statement, is hereby incorporated by reference.

 

Item 14. Principal Accountant Fees and Services.

 

The information under the caption “Audit Matters—Principal Accountant Fees and Services,” appearing in the Proxy Statement, is hereby incorporated by reference.

 

-54-

 

PART IV

 

Item 15. Exhibits and Financial Statement Schedules.

 

(a)(1) Financial Statements

 

Reference is made to the financial statements listed on and attached following the Index to Consolidated Financial Statements contained on page F-1 of this report.

 

(a)(2) Financial Statement Schedules

 

None.

 

(a)(3) Exhibits

 

Reference is made to the exhibits listed on the Index to Exhibits.

 

Item 16. Form 10-K Summary.

 

None.

 

-55-

 

Index to Consolidated Financial Statements

 

Reports of Independent Registered Public Accounting Firm (PCAOB ID: 49)   F-2
     
Consolidated Balance Sheets as of December 31, 2024 and 2023   F-5
     
Consolidated Statements of Operations for the Years Ended December 31, 2024, 2023 and 2022   F-7
     
Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2024, 2023 and 2022   F-8
     
Consolidated Statements of Stockholders’ Equity for the Years Ended December 31, 2024, 2023 and 2022   F-9
     
Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023 and 2022   F-10
     
Notes to Consolidated Financial Statements   F-11

 

F-1

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Stockholders and the Board of Directors of Alto Ingredients, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Alto Ingredients, Inc. and its subsidiaries (the Company) as of December 31, 2024 and 2023, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2024, and the related notes to the consolidated financial statements (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

 

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013, and our report dated March 13, 2025, expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.

 

F-2

 

Long-lived asset impairment

 

As described in Note 1 to the financial statements, the Company assesses the impairment of long-lived assets when events or changes in circumstances indicate that the fair value of assets could be less than their carrying value. In such event, the Company assesses long-lived assets for impairment by first determining the forecasted, undiscounted cash flows the asset group is expected to generate plus the net proceeds expected from the sale of the asset group. If this amount is less than the carrying value of the asset group, the Company will then determine the fair value of the asset group. When the estimated fair value of the asset group is less than its carrying value, the Company recognizes an impairment expense equal to the difference between the asset group’s carrying value and estimated fair value. The Company’s assessment resulted in an asset impairment of $24,790,000 for the year ended December 31, 2024.

 

We identified the evaluation of the fair value of asset groups, where fair value was required to be determined as part of the impairment analysis, as a critical audit matter because of the significant estimates management makes when determining fair value. This required a high degree of auditor judgment when performing audit procedures to evaluate whether management appropriately determined fair value.

 

Our audit procedures related to the evaluation of fair value, where fair value was required to be determined as part of the impairment analysis, included the following, among others:

 

We obtained an understanding of management’s process and the internal controls over management’s determination of fair value and tested the operating effectiveness of the controls

 

We obtained management’s determination of fair value and evaluated management’s determination by:

 

oComparing it to publicly available information related to sales of comparable asset groups sold by the Company and others in the industry

 

oComparing the sales price per nameplate production gallons to the carrying value of the asset group

 

/s/ RSM US LLP  
   
We have served as the Company’s auditor since 2015.
   
Rochester, Minnesota  
March 13, 2025  

 

F-3

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Stockholders and the Board of Directors of Alto Ingredients, Inc.

 

Opinion on the Internal Control Over Financial Reporting

 

We have audited Alto Ingredients, Inc.’s (the Company) internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013.

 

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets as of December 31, 2024 and 2023, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2024, and the related notes to the consolidated financial statements of the Company and our report dated March 13, 2025, expressed an unqualified opinion.

 

Basis for Opinion

 

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

Definition and Limitations of Internal Control Over Financial Reporting

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

/s/ RSM US LLP  
   
Rochester, Minnesota  
March 13, 2025  

 

F-4

 

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except shares and par value)

 

   December 31, 
   2024   2023 
ASSETS        
         
Current Assets:        
Cash and cash equivalents  $35,469   $30,014 
Restricted cash   742    15,466 
Accounts receivable, net of allowance for credit losses of $23 and $85, respectively   58,217    58,729 
Inventories   49,914    52,611 
Derivative instruments   3,313    2,412 
Other current assets   5,463    9,538 
Total current assets   153,118    168,770 
           
Property and equipment, net   214,742    248,748 
Other Assets:          
Right of use operating lease assets, net   20,553    22,597 
Intangible assets, net   4,509    8,498 
Other assets   8,516    5,628 
Total other assets   33,578    36,723 
Total Assets  $401,438   $454,241 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS (CONTINUED)
(in thousands, except shares and par value)

 

   December 31, 
   2024   2023 
LIABILITIES AND STOCKHOLDERS’ EQUITY        
         
Current Liabilities:        
Accounts payable  $20,369   $20,752 
Accrued liabilities   24,214    20,205 
Current portion – operating leases   4,851    4,333 
Derivative instruments   1,177    13,849 
Other current liabilities   7,193    6,149 
Total current liabilities   57,804    65,288 
           
Long-term debt, net   92,904    82,097 
Operating leases, net of current portion   16,913    19,029 
Other liabilities   8,754    8,270 
Total Liabilities   176,375    174,684 
           
Commitments and contingencies (Notes 1, 8, 9, 10 and 14)   
 
    
 
 
           
Stockholders’ Equity:          
Preferred stock, $0.001 par value; 10,000,000 shares authorized:   
 
    
 
 
Series A: 1,684,375 shares authorized; no shares issued and outstanding as of December 31, 2024 and 2023   
    
 
Series B: 1,580,790 shares authorized; 926,942 shares issued and outstanding as of December 31, 2024 and 2023; liquidation preference of $18,075 as of December 31, 2024   1    1 
Common stock, $0.001 par value; 300,000,000 shares authorized; 76,565,072 and 75,703,100 shares issued and outstanding as of December 31, 2024 and 2023, respectively   77    76 
Non-voting common stock, $0.001 par value; 3,553,000 shares authorized; 896 shares issued and outstanding as of December 31, 2024 and 2023   
    
 
Additional paid-in capital   1,044,176    1,040,912 
Accumulated other comprehensive income   4,975    2,481 
Accumulated deficit   (824,166)   (763,913)
Total stockholders’ equity   225,063    279,557 
Total Liabilities and Stockholders’ Equity  $401,438   $454,241 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6

 

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)

 

   Years Ended December 31, 
   2024   2023   2022 
Net sales  $965,258   $1,222,940   $1,335,621 
Cost of goods sold   955,536    1,207,287    1,363,171 
Gross profit (loss)   9,722    15,653    (27,550)
Selling, general and administrative expenses   (29,736)   (29,864)   (28,079)
Acquisition-related expenses   (7,701)   (2,800)   (3,500)
Gain (loss) on sale or disposal of assets   830    (293)   (2,230)
Asset impairments   (24,790)   (6,544)   
 
Loss from operations   (51,675)   (23,848)   (61,359)
Income from cash grant   
    2,812    22,652 
Interest expense, net   (7,644)   (7,425)   (1,827)
Other income, net   508    553    862 
Loss before provision for income taxes   (58,811)   (27,908)   (39,672)
Provision for income taxes   173    97    1,925 
Consolidated net loss  $(58,984)  $(28,005)  $(41,597)
Preferred stock dividends  $(1,269)  $(1,265)  $(1,265)
Loss attributable to common stockholders  $(60,253)  $(29,270)  $(42,862)
Loss per share, basic and diluted  $(0.82)  $(0.40)  $(0.60)
Weighted-average shares outstanding, basic and diluted   73,482    73,339    71,944 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-7

 

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands)

 

   Years Ended December 31, 
   2024   2023   2022 
Consolidated net loss  $(58,984)  $(28,005)  $(41,597)
Other comprehensive income– net gain arising during the period on defined benefit pension plans   2,494    659    2,106 
Total comprehensive loss  $(56,490)  $(27,346)  $(39,491)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-8

 

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands)

 

           Common Stock and   Additional       Accum. Other     
   Preferred Stock   Non-Voting Common   Paid-In   Accumulated   Comprehensive     
   Shares   Amount   Shares   Amount   Capital   Deficit   Income (Loss)   Total 
Balances, December 31, 2021   927   $1    72,778   $73   $1,037,205   $(691,781)  $(284)  $345,214 
Stock-based compensation       
      —
        
    3,333    
    
    —
    3,333 
Restricted stock issued to employees and directors, net of cancellations and tax       
    496    
    (2,291)   
    
    (2,291)
Shares issued for Eagle       
    949    1    
    
    
    1 
Shares issued to Orion       
    1,282    1    3,912    
    
    3,913 
Stock repurchases       
    (351)   
    (1,325)   
    
    (1,325)
Pension plan adjustment       
        
    
    
    2,106    2,106 
Preferred stock dividends       
        
    
    (1,265)   
    (1,265)
Net loss       
        
    
    (41,597)   
    (41,597)
Balances, December 31, 2022   927   $1    75,154   $75   $1,040,834   $(734,643)  $1,822   $308,089 
Stock-based compensation       
        
    3,896    
    
    3,896 
Restricted stock issued to employees and directors, net of cancellations and tax       
    2,234    2    (145)   
    
    (143)
Stock repurchases       
    (1,685)   (1)   (3,673)   
    
    (3,674)
Pension plan adjustment       
        
    
    
    659    659 
Preferred stock dividends       
        
    
    (1,265)   
    (1,265)
Net loss       
        
    
    (28,005)   
    (28,005)
Balances, December 31, 2023   927   $1    75,703   $76   $1,040,912   $(763,913)  $2,481   $279,557 
Stock-based compensation       
        
    4,357    
    
    4,357 
Restricted stock issued to employees and directors, net of cancellations and tax       
    862    1    (1,093)   
    
    (1,092)
Pension plan adjustment       
        
    
    
    2,494    2,494 
Preferred stock dividends       
        
    
    (1,269)   
    (1,269)
Net loss       
        
    
    (58,984)   
    (58,984)
Balances, December 31, 2024   927   $1    76,565   $77   $1,044,176   $(824,166)  $4,975   $225,063 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-9

 

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

 

   For the Years Ended December 31,   
   2024   2023   2022 
Operating Activities:            
Consolidated net loss  $(58,984)  $(28,005)  $(41,597)
Adjustments to reconcile consolidated net loss to cash (used in) provided by operating activities:               
Depreciation and amortization of intangibles   24,408    23,080    25,095 
Asset impairments   24,790    6,544    
 
(Gain) loss on sale or disposal of assets   (830)   293    2,230 
Inventory valuation   2,050    2,201    4,612 
Losses (gains) on derivative instruments   (11,045)   8,031    (19,263)
Amortization of deferred financing costs   1,016    1,048    177 
Amortization of debt discounts   804    801    126 
Stock-based compensation   4,357    3,896    3,333 
Bad debt (recovery) expense   (50)   427    (217)
Changes in operating assets and liabilities:               
Accounts receivable   562    9,499    23,967 
Inventories   4,484    11,816    (15,479)
Other current assets   931    310    7,690 
Operating leases   (5,965)   (5,362)   (5,128)
Accounts payable and accrued expenses   9,951    (12,554)   20,503 
Net cash (used in) provided by operating activities  $(3,521)  $22,025   $6,049 
Investing Activities:               
Additions to property and equipment  $(11,066)  $(29,531)  $(37,744)
Deferred purchase price payments for Eagle Alcohol   (2,800)   (3,500)   
 
Proceeds from sale of assets   400    
    
 
Purchase of Eagle Alcohol, net of cash acquired   
    
    (14,685)
Proceeds from principal payments on notes receivable   
    
    14,766 
Net cash used in investing activities  $(13,466)  $(33,031)  $(37,663)
Financing Activities:               
Net proceeds from (payments on) Kinergy’s line of credit  $8,987   $12,614   $(32,325)
Net proceeds from term loan   
    
    59,100 
Stock repurchases   
    (3,674)   (1,325)
Debt issuance costs   
    (714)   (5,171)
Preferred stock dividend payments   (1,269)   (1,265)   (1,265)
Net cash provided by financing activities  $7,718   $6,961   $19,014 
Net decrease in cash, cash equivalents and restricted cash   (9,269)   (4,045)   (12,600)
Cash, cash equivalents and restricted cash at beginning of period   45,480    49,525    62,125 
Cash, cash equivalents and restricted cash at end of period  $36,211   $45,480   $49,525 
                         
Reconciliation of total cash, cash equivalents and restricted cash:                        
Cash and cash equivalents  $ 35,469     $ 30,014     $ 36,456  
Restricted cash     742       15,466       13,069  
Total cash, cash equivalents and restricted cash   $ 36,211     $ 45,480     $ 49,525  
                         
Supplemental Information:                        
Interest paid (net of capitalized interest)   $ 8,319     $ 7,923     $ 2,208  
Capitalized interest   $ 2,517     $ 2,454     $ 720  
Income tax refunds (payments)   $ 627     $ (324 )   $ (2,262 )

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-10

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1. ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES.

 

Organization and Business – The consolidated financial statements include, for all periods presented, the accounts of Alto Ingredients, Inc., a Delaware corporation (“Alto Ingredients”), and its direct and indirect wholly-owned subsidiaries (collectively, the “Company”), including Kinergy Marketing LLC, an Oregon limited liability company (“Kinergy”), Alto Nutrients, LLC, a California limited liability company (“Alto Nutrients”), Alto Op Co., a Delaware corporation, Alto Pekin, LLC, a Delaware limited liability company (“Alto Pekin”) and Alto ICP, LLC, a Delaware limited liability company (“ICP”), and the Company’s production facilities in Oregon and Idaho.

 

As discussed in Note 2, on January 14, 2022, the Company acquired Eagle Alcohol Company LLC, a Missouri limited liability company (“Eagle Alcohol”). On that date, Eagle Alcohol became a wholly-owned subsidiary of the Company. Eagle Alcohol specializes in break bulk distribution of specialty alcohols.

 

As discussed in Note 16, On January 1, 2025, the Company’s wholly-owned subsidiary, Alto Carbonic, LLC (“Alto Carbonic”), acquired Kodiak Carbonic, LLC, a beverage-grade liquid CO2 processor for $7.6 million. Alto Carbonic is co-located at the Company’s Columbia ethanol facility. The Company plans to report the results of Alto Carbonic in the Company’s Western Production segment beginning January 1, 2025.

 

The Company produces and distributes renewable fuels, essential ingredients and specialty alcohols. The Company also markets fuel-grade ethanol produced by third parties. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and fuel-grade ethanol customers.

 

The Company has a combined alcohol production capacity of 350 million gallons per year and produces, on an annualized basis, over 1.4 million tons of essential ingredients, such as dried yeast, corn protein meal, corn protein feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company markets and distributes fuel-grade ethanol produced by third parties.

 

The Company focuses on Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels markets. Products for the Health, Home & Beauty market include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. Products for the Food & Beverage markets include grain neutral spirits used in alcoholic beverages and vinegar as well as corn germ used for corn oils. Products for Industry & Agriculture markets include alcohols and other products for paint applications and fertilizers. Products for Essential Ingredients markets include dried yeast, corn protein meal, corn protein feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. Products for Renewable Fuels markets include fuel-grade ethanol and distillers corn oil used as a feedstock for renewable diesel and biodiesel fuels.

 

The Company’s production facilities, other than its Magic Valley plant, were operating for all periods presented subject to scheduled and unscheduled downtimes to address facility repair and maintenance. In January 2024, the Company temporarily hot-idled its Magic Valley facility to minimize losses from negative regional crush margins and to expedite the installation of additional equipment to achieve the intended production rate, quality and consistency from the Company’s corn oil and high protein system at the facility. The Company restarted its Magic Valley facility in July 2024 and by October 2024, the facility consistently achieved average ethanol production rates at full capacity, the protein content yield from the plant reached 50% or greater, and the Company was able to expand its corn oil yields. Increases in regional corn basis and declining market prices for protein and corn oil resulted in overall margin compression, outweighing the economic benefits of these plant improvements. As a consequence, the Company cold-idled its Magic Valley facility on December 31, 2024 to minimize financial losses. The Company continues to provide terminal services at the plant and intends to resume operations at the facility when the economic environment in the region sustainably improves.

 

Basis of Presentation – The consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

F-11

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Segments – A segment is a component of an enterprise whose operating results are regularly reviewed by the enterprise’s chief operating decision maker (“CODM”) to make decisions about resources to be allocated to the segment and assess its performance, and for which discrete financial information is available. The Company determines and discloses its segments in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Section 280, Segment Reporting, which defines how to determine segments. The Company has adopted the guidance issued under ASU 2023-07, Segment Reporting (Topic 280), which enhances disclosures about the Company’s segments. The Company’s CODM is the Company’s executive committee, which is led by the Company’s Chief Executive Officer (“CEO”) and includes its Chief Financial Officer, Chief Operating Officer, Chief Commercial Officer and Chief Legal Officer (“Executive Committee”). The Company manages and assesses the performance of its reportable segments by its gross profit (loss). As part of the Executive Committee’s review of segment-level performance, each member of the Executive Committee reviews the gross profit of the Company’s reportable segments and provides expertise and analysis from their respective areas which drive the evaluation of the performance of the Company’s reportable segments and allocation of resources to those segments. Even though the CEO has the authority to override the other members for strategic or other reasons, key decisions are made jointly by the Executive Committee.

 

The Company reports financial and operating performance in three reportable segments (1) Pekin production, which includes the entire campus in Pekin, Illinois (“Pekin Campus”), (2) marketing and distribution, which includes marketing and merchant trading for Company-produced specialty alcohols, fuel-grade ethanol and essential ingredients, and sales of fuel-grade ethanol sourced from third parties, and (3) Western production, which includes the Company’s two western production facilities and, beginning in 2025, its liquid CO2 plant on an aggregated basis (“Western production”).

 

Cash and Cash Equivalents – The Company considers all highly-liquid investments with an original maturity of three months or less to be cash equivalents. The Company maintains its accounts at several financial institutions. These cash balances regularly exceed amounts insured by the Federal Deposit Insurance Corporation; however, the Company does not believe it is exposed to any significant credit risk on these balances.

 

Restricted Cash – The Company’s restricted cash comprises cash collateral balances held in derivative brokerage accounts.

 

Accounts Receivable and Allowance for Credit Losses – Trade accounts receivable are presented at original invoice amount, net of the allowance for credit losses. The Company sells specialty alcohols to large consumer product companies, sells fuel-grade ethanol to gasoline refining and distribution companies, sells essential ingredients to animal feed customers, including distillers grains and other feed co-products to dairy operators and animal feedlots and corn oil to poultry and renewable diesel and biodiesel customers, in each case generally without requiring collateral. Due to a limited number of customers, the Company had significant concentrations of credit risk from sales as of December 31, 2024 and 2023, as described below.

 

The carrying amount of accounts receivable is reduced by a valuation allowance that reflects the Company’s best estimate of the amounts that will not be collected. The Company regularly reviews accounts receivable and based on assessments of current customer creditworthiness, estimates the portion, if any, of the customer balance that will not be collected.

 

Of the accounts receivable balance, approximately $44,750,000 and $51,315,000 at December 31, 2024 and 2023, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for credit losses was $23,000 and $85,000 as of December 31, 2024 and 2023, respectively. The Company recorded a bad debt recovery of $50,000, bad debt expense of $427,000 and a bad debt recovery of $217,000 for the years ended December 31, 2024, 2023 and 2022, respectively. The Company does not have any off-balance sheet credit exposure related to its customers.

 

Concentration Risks – Credit risk represents the accounting loss that would be recognized at the reporting date if counterparties failed completely to perform as contracted. Concentrations of credit risk, whether on- or off-balance sheet, that arise from financial instruments exist for groups of customers or counterparties when they have similar economic characteristics that would cause their ability to meet contractual obligations to be similarly affected by changes in economic or other conditions described below. Financial instruments that subject the Company to credit risk consist of cash balances maintained in excess of federal depository insurance limits and accounts receivable which have no collateral or security. The Company has not experienced any significant losses in such accounts.

 

F-12

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company sells specialty alcohols to consumer product companies and fuel-grade ethanol to gasoline refining and distribution companies. The Company sold to customers representing 10% or more of the Company’s total net sales, as follows.

 

   Years Ended December 31, 
   2024   2023   2022 
Customer A   11%   9%   10%
Customer B   7%   7%   10%

 

The Company had accounts receivable due from these customers totaling $5,187,000 and $4,302,000, representing 9% and 7% of total accounts receivable, as of December 31, 2024 and 2023, respectively.

 

The Company purchases corn, its largest cost component in producing alcohols, from its suppliers. The Company purchased corn from suppliers representing 10% or more of the Company’s total corn purchases, as follows:

 

   Years Ended December 31, 
   2024   2023   2022 
Supplier A   16%   14%   11%
Supplier B   13%   12%   12%
Supplier C   %    %    15%

 

As of December 31, 2024, approximately 44% of the Company’s employees were covered by a collective bargaining agreement.

 

Inventories – Inventories consisted primarily of bulk ethanol, specialty alcohols, corn, essential ingredients and unleaded fuel, and are valued at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventory is net of valuation adjustments of $2,050,000 and $2,201,000 as of December 31, 2024 and 2023, respectively. Of the inventory balance, approximately $35,495,000 and $41,041,000 at December 31, 2024 and 2023, respectively, were used as collateral under Kinergy’s operating line of credit. Inventory balances consisted of the following (in thousands):

 

   December 31, 
   2024   2023 
Finished goods  $31,120   $35,765 
Work in progress   4,203    5,063 
Raw materials   8,989    10,313 
Other   5,602    1,470 
Total  $49,914   $52,611 

 

Property and EquipmentProperty and equipment are stated at cost. Depreciation is computed using the straight-line method over the following estimated useful lives:

 

Buildings   40 years 
Facilities and plant equipment   1025 years 
Other equipment, vehicles and furniture   510 years 

 

The cost of normal maintenance and repairs is charged to operations as incurred. Significant capital expenditures that increase the life of an asset are capitalized and depreciated over the estimated remaining useful life of the asset. The cost of property and equipment sold, or otherwise disposed of, and the related accumulated depreciation or amortization are removed from the accounts, and any resulting gains or losses are reflected in current operations.

 

F-13

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Intangible Assets – The Company amortizes intangible assets with definite lives using the straight-line method over their estimated lives of 10-12 years. Additionally, the Company assesses indefinite-lived intangible assets for impairment annually, or more frequently if circumstances indicate impairment may have occurred. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. If the Company determines that an impairment charge is needed, the charge will be recorded as an asset impairment in the consolidated statements of operations.

 

Leases – The Company accounts for leases under ASC Section 842, Leases (“ASC 842), whereby lessees are required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: (1) a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted cash flow basis; and (2) a “right of use” asset, which is an asset that represents the lessee’s right to use the specified asset for the lease term. See Note 9 for further information.

 

Derivative Instruments and Hedging Activities – Derivative transactions, which can include exchange-traded futures contracts, options and futures positions on the New York Mercantile Exchange or the Chicago Mercantile Exchange, are recorded on the balance sheet as assets and liabilities based on the derivative’s fair value. Changes in the fair value of derivative contracts are recognized currently in income unless specific hedge accounting criteria are met. If derivatives meet those criteria, and hedge accounting is elected, effective gains and losses are deferred in accumulated other comprehensive income (loss) and later recorded together with the hedged item in consolidated income (loss). For derivatives designated as a cash flow hedge, the Company formally documents the hedge and assesses the effectiveness with associated transactions. The Company has designated and documented contracts for the physical delivery of commodity products to and from counterparties as normal purchases and normal sales.

 

Revenue Recognition – The Company recognizes revenue under ASC Section 606, Revenue from Contracts with Customers (“ASC 606”). The provisions of ASC 606 include a five-step process by which an entity will determine revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which an entity expects to be entitled in exchange for those goods or services. ASC 606 requires the Company to apply the following steps: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, the Company satisfies the performance obligation.

 

The Company recognizes revenue primarily from sales of alcohols and essential ingredients.

 

The Company has five production facilities from which it produces and sells alcohols to its customers through Kinergy. Kinergy enters into back-to-back sales contracts with its customers under exclusive intercompany sales agreements with each of the Company’s five production facilities. Kinergy also acts as a principal when it purchases third party fuel-grade ethanol which it resells to its customers. Finally, for the year ended December 31, 2022, Kinergy had exclusive sales agreements with certain third-party owned fuel-grade ethanol production facilities under which it sold the facilities’ fuel-grade ethanol for a fee plus the costs to deliver the ethanol to Kinergy’s customers. These sales were referred to as third-party agent sales. Revenue from these third-party agent sales was recorded on a net basis, with Kinergy recognizing its predetermined fees and any associated delivery costs. Kinergy has terminated these contracts, and as a result, did not have any related sales for the year ended December 31, 2024 and 2023. The Company’s balances of accounts receivable, net of allowance for credit losses, were $58,217,000, $58,729,000 and $68,655,000, as of December 31, 2024, 2023 and 2022, respectively.

 

The Company has five production facilities from which it produces and sells essential ingredients to its customers through Alto Nutrients. Alto Nutrients enters into sales contracts with essential ingredient customers under exclusive intercompany sales agreements with each of the Company’s five production facilities.

 

The Company recognizes revenue from sales of alcohols and essential ingredients at the point in time when the customer obtains control of the products, which typically occurs upon delivery depending on the terms of the underlying contracts. In some instances, the Company enters into contracts with customers that contain multiple performance obligations to deliver volumes of alcohols or essential ingredients over a contractual period of less than 12 months. The Company allocates the transaction price to each performance obligation identified in the contract based on relative standalone selling prices and recognizes the related revenue as control of each individual product is transferred to the customer in satisfaction of the corresponding performance obligations.

 

F-14

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

When the Company is the agent, the supplier controls the products before they are transferred to the customer because the supplier is primarily responsible for fulfilling the promise to provide the product, has inventory risk before the product has been transferred to a customer and has discretion in establishing the price for the product. When the Company is the principal, the Company controls the products before they are transferred to the customer because the Company is primarily responsible for fulfilling the promise to provide the products, has inventory risk before the product has been transferred to a customer and has discretion in establishing the price for the product.

 

See the tables in Note 4 for the Company’s revenue by type of contracts.

 

Shipping and Handling Costs – The Company accounts for shipping and handling costs relating to contracts with customers as costs to fulfill its promise to transfer its products. Accordingly, the costs are classified as a component of cost of goods sold in the accompanying consolidated statements of operations.

 

Selling Costs – Selling costs associated with the Company’s product sales are classified as a component of selling, general and administrative expenses in the accompanying consolidated statements of operations.

 

Stock-Based Compensation – The Company accounts for the cost of employee services received in exchange for the award of equity instruments based on the fair value of the award, determined on the date of grant. The expense is recognized over the period during which an employee is required to provide services in exchange for the award. The Company accounts for forfeitures as they occur. The Company recognizes stock-based compensation expense as a component of either cost of goods sold or selling, general and administrative expenses in the consolidated statements of operations.

 

Goodwill – Goodwill represents the excess of cost of an acquired entity over the net of the amounts assigned to net assets acquired and liabilities assumed. Annually, or more frequently, if indications of impairment arise, the Company performs a review for impairment. This review includes the determination of each reporting unit’s fair value using market multiples and discounted cash flow modeling. The estimates of future cash flows are judgments based on management’s experience and knowledge of the Company’s operations and the industries in which the Company operates. These estimates can be significantly affected by future changes in market conditions, the economic environment, including inflation, and capital spending decisions of the Company’s customers. Any assessed impairments will be permanent and expensed in the period in which the impairment is determined. If the Company determines through its assessment process that any of its goodwill requires impairment charges, the charges will be recorded in asset impairment expenses in the consolidated statements of operations.

 

The Company performed its annual review of impairment of goodwill and recognized an asset impairment loss of $6.0 million for the year ended December 31, 2023. No impairment losses for goodwill were recognized for the year ended December 31, 2024 and 2022.

 

Impairment of Long-Lived Assets – The Company assesses the impairment of long-lived assets, including property and equipment, internally developed software and purchased intangibles subject to amortization, when events or changes in circumstances indicate that the fair value of assets could be less than their net book value. In such event, the Company assesses long-lived assets for impairment by first determining the forecasted, undiscounted cash flows the asset group is expected to generate plus the net proceeds expected from the sale of the asset group. If this amount is less than the carrying value of the asset, the Company will then determine the fair value of the asset group. When the estimated fair value of the asset group is less than its carrying value, the Company recognizes an impairment expense equal to the difference between the asset group’s carrying value and estimated fair value. Forecasts of future cash flows are judgments based on the Company’s experience and knowledge of its operations and the industries in which it operates. These forecasts could be significantly affected by future changes in market conditions, the economic environment, including inflation, and purchasing decisions of the Company’s customers. The Company’s assessment resulted in an asset impairment of $24,790,000 primarily from the cold-idling of the Company’s Magic Valley facility due to increased regional corn basis and overall margin compression and the Company’s changes to its Eagle Alcohol business, for the year ended December 31, 2024. The Company’s assessment resulted in an asset impairment of $574,000 related to amendments to certain of the Company’s lease agreements, for the year ended December 31, 2023. The Company’s impairment analysis performed during the year ended December 31, 2022 did not result in an impairment charge.

 

F-15

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Deferred Financing Costs – Deferred financing costs are costs incurred to obtain debt financing, including all related fees, and are amortized as interest expense over the term of the related financing using the straight-line method, which approximates the effective interest rate method. Amortization of deferred financing costs, included in interest expense, net, in the accompanying consolidated statements of operations, was approximately $1,016,000, $1,048,000 and $177,000 for the years ended December 31, 2024, 2023 and 2022, respectively. Unamortized deferred financing costs were approximately $3,684,000 and $4,700,000 as of December 31, 2024 and 2023, respectively, and are recorded as a reduction of long-term debt in the consolidated balance sheets.

 

Provision for Income Taxes – Income taxes are accounted for under the asset and liability approach, where deferred tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities and are measured using enacted tax rates and laws that are expected to be in effect when the differences reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized.

 

The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining whether it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. An uncertain tax position is considered effectively settled on completion of an examination by a taxing authority if certain other conditions are satisfied. Should the Company incur interest and penalties relating to tax uncertainties, such amounts would be classified as a component of interest expense, net, and other income (expense), net, respectively. Deferred tax assets and liabilities are classified as noncurrent in the Company’s consolidated balance sheets.

 

The Company files a consolidated federal income tax return. This return includes all wholly owned subsidiaries as well as the Company’s pro-rata share of taxable income from pass-through entities in which the Company owns less than 100%. State tax returns are filed on a consolidated, combined or separate basis depending on the applicable laws relating to the Company and its subsidiaries. The Company does not have any foreign operations.

 

Loss Per Share – Basic loss per share is computed on the basis of the weighted-average number of shares of common stock outstanding during the period. Preferred dividends are deducted from net loss attributed to Alto Ingredients, Inc. and are considered in the calculation of loss attributable to common stockholders in computing basic loss per share. Common stock equivalents to preferred stock are considered participating securities and are also included in this calculation when dilutive.

 

The following tables compute basic and diluted loss per share (in thousands, except per share data):

 

   Year Ended December 31, 2024 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(58,984)          
Less: Preferred stock dividends   (1,269)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(60,253)   73,482   $(0.82)

 

   Year Ended December 31, 2023 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(28,005)          
Less: Preferred stock dividends   (1,265)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(29,270)   73,339   $(0.40)

 

   Year Ended December 31, 2022 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(41,597)          
Less: Preferred stock dividends   (1,265)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(42,862)   71,944   $(0.60)

 

F-16

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

There were an aggregate of 981,000, 981,000 and 964,000 potentially dilutive shares from convertible securities outstanding for the years ended December 31, 2024, 2023 and 2022, respectively. These convertible securities were not considered in calculating diluted loss per common share for the years ended December 31, 2024, 2023 and 2022 as their effect would be anti-dilutive. In addition, there were an aggregate of 3,188,000 weighted-average anti-dilutive shares from outstanding out-of-the-money warrants for the year ended December 31, 2022.

 

Financial Instruments – The carrying values of cash and cash equivalents, restricted cash, accounts receivable, derivative instruments, accounts payable and accrued liabilities are reasonable estimates of their fair values because of the short maturity of these items. The Company believes the carrying value of its long-term debt instruments are not considered materially different than fair value.

 

Business Combinations – Business acquisitions are accounted for in accordance with ASC Section 805, Business Combinations. ASC 805 requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable tangible and intangible assets acquired and liabilities assumed and recognize and measure goodwill or a gain from the purchase. Assets acquired and liabilities assumed are recorded at their fair values and the excess of the purchase price over the amounts assigned is recorded as goodwill. Adjustments to fair value assessments are recorded to goodwill over the measurement period (not longer than twelve months).

 

Income from Cash Grant – For the years ended December 31, 2023 and 2022, the Company received $2,812,000 and $22,652,000, respectively, in cash from the USDA’s Biofuel Producer Program. The Company did not receive any cash from this program for the year ended December 31, 2024. The program was created as part of the CARES Act of 2020, which allocated $700,000,000 to support biofuel producers who experienced market losses due to the pandemic. The Company is not required to repay the grants. Since these funds are provided to subsidize historical losses of the Company, and are not required to be repaid, the Company accounted for the proceeds by analogy to International Accounting Standards 20, Accounting for Government Grants and Disclosure of Government Assistance, and reported the amount as income from cash grant in the accompanying consolidated statements of operations.

 

Employment-related Benefits – Employment-related benefits associated with pensions and postretirement health care are expensed based on actuarial analysis. The recognition of expense is affected by estimates made by management, such as discount rates used to value certain liabilities, investment rates of return on plan assets, increases in future wage amounts and future health care costs. Discount rates are determined based on a spot yield curve that includes bonds with maturities that match the expected timing of benefit payments under the plan.

 

Share Repurchase Program – On September 12, 2022, the Company announced a share repurchase program under which it may repurchase up to $50,000,000 of its common stock with an initial purchase authorization of $10,000,000. The Company’s lender has further limited the Company’s purchase authorization to $5,000,000. Amounts in excess of the purchase authorization of $5,000,000 will require additional lender consent and amounts in excess of the initial purchase authorization of $10,000,000 will require additional board and preferred stockholder authorization. The share repurchase program does not have an expiration date, does not require the repurchase of any particular amount of shares, and may be implemented, modified, suspended or discontinued in whole or in part at any time and without further notice. As repurchases are made, the Company will retire the shares, resulting in a reduction of issued and outstanding shares. For the years ended December 31, 2023 and 2022, the Company repurchased an aggregate of 1,685,000 shares and 351,000 shares for $3,674,000 and $1,325,000 in cash, respectively. No shares were repurchased during the year ended December 31, 2024.

 

Nonvoting Common Stock – In 2015, the Company issued nonvoting common stock convertible at a holder’s election into voting common stock. As of December 31, 2024, an aggregate of 3,539,236 shares of nonvoting common stock had been converted into an equal number of shares of the Company’s voting common stock. As of December 31, 2024, there were 896 shares of nonvoting common stock outstanding.

 

F-17

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Estimates and Assumptions – The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining net realizable value of inventory, long-lived asset impairments, goodwill impairment, valuation allowances on deferred income taxes and the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.

 

Recent Accounting Pronouncements – In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40), which provides for more detailed information about the types of expenses aggregated in common expense captions in the statement of operations. ASU 2024-03 is effective for the Company for the year ended December 31, 2027, with early adoption permitted. The Company is currently evaluating the impact of this ASU.

 

Subsequent Events – Management evaluates, as of each reporting period, events or transactions that occur after the balance sheet date through the date that the financial statements are issued for either disclosure or adjustment to the consolidated financial results. See Note 16.

 

2. ACQUISITION OF EAGLE ALCOHOL.

 

On January 14, 2022, the Company purchased 100% of the membership interests of Eagle Alcohol. The purchase price was $14.0 million in cash plus an estimated net working capital adjustment of $1.3 million in cash. The selling members of Eagle Alcohol were eligible to receive up to an additional $14.0 million of contingent consideration, payable through a combination of $9.0 million in cash over the succeeding three years and an aggregate of $5.0 million in the Company’s common stock on the fourth- and fifth-year anniversaries of the closing date, subject to the satisfaction of certain conditions. Subsequently, the Company made organizational changes at Eagle Alcohol, and accelerated the vesting of the Company’s common stock under the terms of the purchase agreement. With respect to these payments, the Company accrued $7.7 million and $2.8 million in other current liabilities in the accompanying consolidated balance sheets as of December 31, 2024 and 2023, respectively, with the expense included in acquisition-related expenses in the accompanying consolidated statements of operations for the years then ended.

 

Eagle Alcohol specializes in break bulk distribution of specialty alcohols. Eagle Alcohol delivers products to customers in the beverage, food, industrial and related-process industries via its own dedicated trucking fleet and common carriers.

 

As part of the Company’s original allocation of purchase price for its acquisition of Eagle Alcohol, the Company recorded a customer relationships intangible asset of $6.5 million, a trade name intangible asset of $0.4 million and goodwill of $6.0 million. See Note 6.

 

F-18

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

3. INTERCOMPANY AGREEMENTS.

 

The Company, directly or through one of its subsidiaries, has entered into the following management and marketing agreements:

 

Affiliate Management Agreement – Alto Ingredients entered into an Affiliate Management Agreement (“AMA”) with its operating subsidiaries under which Alto Ingredients agreed to provide operational, administrative and staff support services. These services generally include, but are not limited to, administering the subsidiaries’ compliance with their credit agreements and performing billing, collection, record keeping and other administrative and ministerial tasks. Alto Ingredients agreed to supply all labor and personnel required to perform its services under the AMA, including the labor and personnel required to operate and maintain the production facilities and marketing activities. These services are billed at a predetermined amount per subsidiary each month plus out of pocket costs such as employee wages and benefits.

 

The AMAs had an initial term of one year and have automatic successive one year renewal periods. Alto Ingredients may terminate the AMA, and any subsidiary may terminate the AMA, at any time by providing at least 90 days prior notice of termination.

 

Alto Ingredients recorded revenues of approximately $18,000,000, $13,200,000 and $12,403,000 related to the AMAs in place for the years ended December 31, 2024, 2023 and 2022, respectively. These amounts have been eliminated upon consolidation.

 

Ethanol Marketing Agreements – Kinergy entered into separate marketing agreements with each of the Company’s production facilities which granted Kinergy the exclusive right to purchase, market and sell the alcohols produced at those facilities. Under the terms of the marketing agreements, within ten days after delivering alcohol to Kinergy, an amount is paid to Kinergy equal to (i) the estimated purchase price payable by the third-party purchaser of the alcohol, minus (ii) the estimated amount of transportation costs to be incurred, minus (iii) the estimated incentive fee payable to Kinergy, which equals 1% of the aggregate third-party purchase price, provided that the marketing fee shall not be less than $0.015 per gallon and not more than $0.0225 per gallon. Each of the marketing agreements had an initial term of one year and has successive one year renewal periods at the option of the production facility.

 

Kinergy recorded revenues of approximately $5,407,000, $5,431,000 and $5,746,000 related to the marketing agreements for the years ended December 31, 2024, 2023 and 2022, respectively. These amounts have been eliminated upon consolidation.

 

Corn Procurement and Handling Agreements – Alto Nutrients entered into separate corn procurement and handling agreements with each of the Company’s production facilities. Under the terms of the corn procurement and handling agreements, each facility appointed Alto Nutrients as its exclusive agent to solicit, negotiate, enter into and administer, on its behalf, corn supply arrangements to procure the corn necessary to operate the facility. Alto Nutrients also provides grain handling services including, but not limited to, receiving, unloading and conveying corn into the facility’s storage and, in the case of whole corn delivered, processing and hammering the whole corn.

 

Under these agreements, Alto Nutrients receives a fee of $0.03 per bushel of corn delivered to each production facility as consideration for its procurement and handling services, payable monthly. Each corn procurement and handling agreement had an initial term of one year and successive one year renewal periods at the option of the individual facility. Alto Nutrients recorded revenues of approximately $2,910,000, $3,007,000 and $3,207,000 related to the corn procurement and handling agreements for the years ended December 31, 2024, 2023 and 2022, respectively. These amounts have been eliminated upon consolidation.

 

F-19

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Essential Ingredients Marketing Agreements – Alto Nutrients entered into separate marketing agreements with each of the Company’s production facilities (except for the Company’s Magic Valley facility), which grant Alto Nutrients the exclusive right to market, purchase and sell the various essential ingredients produced at each facility. Under the terms of the marketing agreements, within ten days after a facility delivers essential ingredients to Alto Nutrients, the production facility is paid an amount equal to (i) the estimated purchase price payable by the third-party purchaser of the essential ingredients, minus (ii) the estimated amount of transportation costs to be incurred, minus (iii) the estimated amount of fees and taxes payable to governmental authorities in connection with the tonnage of the essential ingredients produced or marketed, minus (iv) the estimated incentive fee payable to the Company, which equals (a) 5% of the aggregate third-party purchase price for wet corn protein feed, wet distillers grains, corn condensed distillers solubles and distillers grains with solubles, or (b) 1% of the aggregate third-party purchase price for corn protein meal, dry corn protein feed, dry distillers grains, corn germ and corn oil. Each marketing agreement had an initial term of one year and has successive one year renewal periods at the option of the production facility.

 

Alto Nutrients recorded revenues of approximately $2,516,000, $3,216,500 and $3,505,000 related to the marketing agreements for the years ended December 31, 2024, 2023 and 2022, respectively. These amounts have been eliminated upon consolidation.

 

4.SEGMENTS.

 

The Company reports its financial and operating performance in three segments: (1) Pekin Campus production, which includes the production and sale of alcohols and essential ingredients produced at the Company’s Pekin, Illinois campus, (2) marketing and distribution, which includes marketing and merchant trading for Company-produced alcohols and essential ingredients on an aggregated basis, and sales of fuel-grade ethanol sourced from third parties, and (3) Western production, which includes the production and sale of fuel-grade ethanol and essential ingredients, including liquid CO2, produced at the Company’s two western production facilities and its liquid CO2 plant on an aggregated basis, none of which are individually so significant to be considered a separately reportable segment.

 

The Company manages and assesses the performance of its reportable segments by its gross profit (loss). As part of the Executive Committee’s review of segment-level performance, each member of the Executive Committee reviews the gross profit of the Company’s reportable segments and provides expertise and analysis from their respective areas which drive the evaluation of the performance of the Company’s reportable segments and allocation of resources to those segments. Even though the CEO has the authority to override the other members for strategic or other reasons, key decisions are made jointly by the Executive Committee.

 

Included in income (loss) before provision for income taxes are management fees charged by Alto Ingredients to each of the segments. The Pekin Campus production segment incurred $7,200,000, $5,280,000 and $5,046,000 in management fees for the years ended December 31, 2024, 2023 and 2022, respectively. The marketing and distribution segment incurred $5,400,000, $3,960,000 and $3,840,000 in management fees for the years ended December 31, 2024, 2023 and 2022, respectively. The Western production segment incurred $3,600,000, $2,640,000 and $2,400,000 in management fees for the years ended December 31, 2024, 2023 and 2022, respectively. Corporate and other includes the results of Eagle Alcohol and selling, general and administrative expenses, consisting primarily of corporate employee compensation, professional fees and overhead costs not directly related to a specific operating segment.

 

During the normal course of business, the segments do business with each other. The preponderance of this activity occurs when the Company’s marketing and distribution segment markets alcohol produced by the production segments for a marketing fee, as discussed in Note 3. These intersegment activities are considered arms’-length transactions. Consequently, although these transactions impact segment performance, they do not impact the Company’s consolidated results since all revenues and corresponding costs are eliminated upon consolidation.

 

For the years ended December 31, 2024, 2023 and 2022, capital expenditures incurred by the Pekin Campus segment were approximately $6.8 million, $17.7 million and $25.7 million, and capital expenditures incurred by the Western production segment were approximately $4.3 million, $11.8 million and $12.3 million, respectively.

 

F-20

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The following tables set forth certain financial data for the Company’s operating segments (in thousands):

 

   Years Ended December 31, 
Net Sales  2024   2023   2022 
Pekin Campus production, recorded as gross:            
Alcohol sales  $415,710   $502,217   $521,273 
Essential ingredient sales   169,308    217,702    225,871 
Intersegment sales   1,243    1,427    1,212 
Total Pekin Campus sales   586,261    721,346    748,356 
                
Marketing and distribution:               
Alcohol sales, gross  $216,295   $262,587   $227,626 
Alcohol sales, net   229    365    1,225 
Intersegment sales   10,833    11,654    12,459 
Total marketing and distribution sales   227,357    274,606    241,310 
                
Western Production, recorded as gross:               
Alcohol sales  $115,389   $166,971   $253,605 
Essential ingredient sales   36,953    57,264    90,209 
Intersegment sales   (122)   134    22 
Total Western production sales   152,220    224,369    343,836 
                
Corporate and other   11,374    15,834    15,812 
Intersegment eliminations   (11,954)   (13,215)   (13,693)
Net sales as reported  $965,258   $1,222,940   $1,335,621 
                
Cost of goods sold:            
Pekin Campus production  $563,033   $710,088   $772,755 
Marketing and distribution   213,023    259,234    229,288 
Western production   172,209    230,445    353,775 
Corporate and other   12,285    12,122    12,167 
Intersegment eliminations   (5,014)   (4,602)   (4,814)
Cost of goods sold as reported  $955,536   $1,207,287   $1,363,171 
             
Gross profit (loss):            
Pekin Campus production  $23,228   $11,258   $(24,399)
Marketing and distribution   14,334    15,372    12,022 
Western production   (19,989)   (6,076)   (9,939)
Corporate and other   (911)   3,712    3,645 
Intersegment eliminations   (6,940)   (8,613)   (8,879)
   $9,722   $15,653   $(27,550)
Income (loss) before provision for income taxes:               
Pekin Campus production  $6,308   $(1,560)  $(27,376)
Marketing and distribution   5,261    7,644    3,748 
Western production   (51,086)   (13,506)   (7,209)
Corporate and other   (19,294)   (20,486)   (8,835)
   $(58,811)  $(27,908)  $(39,672)
Asset impairments:               
Western production  $21,389   $
   $
 
Corporate and other   3,401    6,544    
 
   $24,790   $6,544   $
 
Depreciation and amortization expense:               
Pekin Campus production  $21,017   $19,789   $19,136 
Western production   2,409    2,381    5,085 
Corporate and other   982    910    874 
   $24,408   $23,080   $25,095 
Interest expense, net of capitalized interest:            
Pekin Campus production  $1,765   $(207)  $(381)
Marketing and distribution   389    822    1,658 
Western production   2,829    1,164    (339)
Corporate and other   2,661    5,646    889 
   $7,644   $7,425   $1,827 

F-21

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The following table sets forth the Company’s total assets by operating segment (in thousands): 

 

   December 31, 
   2024   2023 
Total assets:        
Pekin Campus production  $223,934    251,048 
Marketing and distribution   102,895    101,196 
Western production   44,992    57,533 
Corporate and other   29,617    44,464 
   $401,438   $454,241 

 

5. PROPERTY AND EQUIPMENT.

 

Property and equipment consisted of the following (in thousands):

 

   December 31, 
   2024   2023 
Facilities and plant equipment  $420,456   $405,010 
Land   3,594    3,687 
Other equipment, vehicles and furniture   20,636    9,719 
Construction in progress   11,154    50,505 
    455,840    468,921 
Accumulated depreciation   (241,098)   (220,173)
   $214,742   $248,748 

 

Depreciation expense was $23,820,000, $22,492,000 and $24,528,000 for the years ended December 31, 2024, 2023 and 2022, respectively. The Company capitalized interest of $2,517,000, $2,454,000 and $720,000 for the years ended December 31, 2024, 2023 and 2022, respectively, related to its capital investment activities. The Company recorded an asset impairment of $19,000,000 for the year ended December 31, 2024. The Company did not record any impairment on its property and equipment for the years ended December 31, 2023 and 2022.

 

The Company’s property and equipment are substantially pledged as collateral under the Company’s Term Loan.

 

F-22

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

6. INTANGIBLE ASSETS.

 

Intangible assets, including goodwill, consisted of the following (in thousands):

 

       December 31, 2024   December 31, 2023 
   Useful
Life
(Years)
   Gross   Accumulated
Amortization/
Impairment
   Net Book
Value
   Gross   Accumulated
Amortization/
Impairment
   Net Book
Value
 
Non-Amortizing:                            
Goodwill       $5,970   $(5,970)  $
   $5,970   $(5,970)  $
 
Kinergy tradename        2,678    
    2,678    2,678    
    2,678 
Amortizing:                                   
Customer relationships   12    6,556    (5,021)   1,535    6,556    (1,074)   5,482 
Eagle Alcohol tradename   10    420    (124)   296    420    (82)   338 
Total goodwill and intangible assets       $15,624   $(11,115)  $4,509   $15,624   $(7,126)  $8,498 

 

Goodwill The Company recorded goodwill of $5,970,000 in its Corporate and other segment resulted from the Company’s acquisition of Eagle Alcohol. As part of the Company’s annual goodwill testing, it impaired the full amount of goodwill of $5,970,000 and recognized the amount in asset impairments in the consolidated statements of operations for the year ended December 31, 2023. The Company did not record any goodwill impairment for the years ended December 31, 2024 and 2022.

 

Kinergy Tradename – The Company recorded tradename of $2,678,000 as part of the Company’s merger with Kinergy in 2006. The Company determined that the tradename has an indefinite life and therefore, rather than being amortized, will be tested annually for impairment. The Company did not record any impairment on its tradename for the years ended December 31, 2024, 2023 and 2022.

 

Customer Relationships The Company recorded customer relationships of $6,556,000 from the Company’s acquisition of Eagle Alcohol. As part of the Company’s impairment testing, it impaired this intangible asset by $3,401,000 and recognized the amount in asset impairments in the consolidated statement of operations for the year ended December 31, 2024. The Company did not record any asset impairment on its customer relationships for the years ended December 31, 2023 and 2022.

 

Eagle Alcohol Tradename The Company recorded tradename of $420,000 from the Company’s acquisition of Eagle Alcohol. The Company did not record any tradename impairment for the years ended December 31, 2024, 2023 and 2022.

 

Amortization expense associated with intangible assets totaled $588,000, $588,000 and $567,000 for the years ended December 31, 2024, 2023 and 2022. The weighted-average unamortized life of the customer relationships and tradename is 8.7 years.

 

The expected amortization expense relating to amortizable intangible assets in each of the five years after December 31, 2024 are (in thousands):

 

Years Ended December 31,  Amount 
2025  $213 
2026   213 
2027   213 
2028   213 
2029   213 
Thereafter   766 
Total  $1,831 

 

F-23

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

7. DERIVATIVES.

 

The business and activities of the Company expose it to a variety of market risks, including risks related to changes in commodity prices. The Company monitors and manages these financial exposures as an integral part of its risk management program. This program recognizes the unpredictability of financial markets and seeks to reduce the potentially adverse effects that market volatility could have on operating results.

 

Commodity RiskCash Flow Hedges – The Company uses derivative instruments to protect cash flows from fluctuations caused by volatility in commodity prices for periods of up to twelve months in order to protect gross profit margins from potentially adverse effects of market and price volatility on alcohol sales and purchase commitments where the prices are set at a future date and/or if the contracts specify a floating or index-based price. In addition, the Company hedges anticipated sales of alcohol to minimize its exposure to the potentially adverse effects of price volatility. These derivatives may be designated and documented as cash flow hedges and effectiveness is evaluated by assessing the probability of the anticipated transactions and regressing commodity futures prices against the Company’s purchase and sales prices. Ineffectiveness, which is defined as the degree to which the derivative does not offset the underlying exposure, is recognized immediately in cost of goods sold. For the years ended December 31, 2024, 2023 and 2022, the Company did not designate any of its derivatives as cash flow hedges.

 

Commodity Risk – Non-Designated Hedges – The Company uses derivative instruments to lock in prices for certain amounts of corn and alcohols by entering into exchange-traded futures contracts or options for those commodities. These derivatives are not designated for hedge accounting treatment. The changes in fair value of these contracts are recorded on the balance sheet and recognized immediately in cost of goods sold. The Company recognized net gains of $11,045,000, net losses of $8,031,000 and net gains of $19,263,000 as the change in the fair value of these contracts for the years ended December 31, 2024, 2023 and 2022, respectively.

 

Non-Designated Derivative InstrumentsThe classification and amounts of the Company’s derivatives not designated as hedging instruments, and related cash collateral balances, are as follows (in thousands):

 

   As of December 31, 2024
   Assets  Liabilities
Type of Instrument  Balance Sheet Location  Fair  Value   Balance Sheet Location  Fair Value 
               
Cash collateral balance  Restricted cash  $742         
Commodity contracts  Derivative instruments  $3,313   Derivative instruments  $1,177 

 

   As of December 31, 2024
   Assets  Liabilities
Type of Instrument  Balance Sheet Location  Fair Value   Balance Sheet Location  Fair Value 
               
Cash collateral balance  Restricted cash  $15,466         
Commodity contracts  Derivative instruments  $2,412   Derivative instruments  $13,849 

 

The above amounts represent the gross balances of the contracts; however, the Company does have a right of offset with each of its derivative brokers, but the Company’s intent is to close out positions individually, therefore the positions are reported at gross.

 

F-24

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The classification and amounts of the Company’s recognized gains (losses) for its derivatives not designated as hedging instruments are as follows (in thousands):

 

      Realized Gains (Losses) 
      For the Years Ended December 31, 
Type of Instrument  Statements of Operations Location  2024   2023   2022 
                
Commodity contracts  Cost of goods sold  $(2,529)  $1,647   $23,280 
      $(2,529)  $1,647   $23,280 

 

      Unrealized Gains (Losses) 
      For the Years Ended December 31, 
Type of Instrument  Statements of Operations Location  2024   2023   2022 
                
Commodity contracts  Cost of goods sold  $13,574   $(9,678)  $(4,017)
      $13,574   $(9,678)  $(4,017)

 

8. DEBT.

 

Long-term borrowings are summarized as follows (in thousands):

 

   December 31,
2024
   December 31,
2023
 
Kinergy line of credit  $39,677   $30,690 
Orion term loan   60,000    60,000 
    99,677    90,690 
Less unamortized debt discount   (3,089)   (3,893)
Less unamortized debt financing costs   (3,684)   (4,700)
Less current portion   
    
 
Long-term debt  $92,904   $82,097 

 

Kinergy Line of Credit – Kinergy has an operating line of credit for an aggregate amount of up to $100,000,000. The line of credit matures on November 7, 2027. The credit facility is based on Kinergy’s eligible accounts receivable and inventory levels, subject to certain concentration reserves. The credit facility is subject to certain other sublimits, including inventory loan limits. Interest accrues under the line of credit at a rate equal to (i) the daily Secured Overnight Financing Rate, plus (ii) a specified applicable margin ranging between 1.25% and 1.75%. The applicable margin was 1.50%, for a total rate of 6.06%, at December 31, 2024. The credit facility’s monthly unused line fee is an annual rate equal to 0.25% to 0.375% depending on the average daily principal balance during the immediately preceding month. Payments that may be made by Kinergy to the Company as reimbursement for management and other services provided by the Company to Kinergy are limited under the terms of the credit facility to $1,500,000 per fiscal quarter. The credit facility also includes the accounts receivable of Alto Nutrients as additional collateral. Payments that may be made by Alto Nutrients to the Company as reimbursement for management and other services provided by the Company to Alto Nutrients are limited under the terms of the credit facility to $500,000 per fiscal quarter. Kinergy and Alto Nutrients may also make distributions to the Company of up to 75% of their excess cash flow.

 

If the monthly excess borrowing availability of Kinergy and Alto Nutrients falls below certain thresholds, they are collectively required to maintain a fixed-charge coverage ratio (calculated as a twelve-month rolling earnings before interest, taxes, depreciation and amortization divided by the sum of interest expense, capital expenditures, principal payments of indebtedness, indebtedness from capital leases and taxes paid during such twelve-month rolling period) of at least 1.1 and are prohibited from incurring certain additional indebtedness (other than specific intercompany indebtedness).

 

F-25

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The obligations of Kinergy and Alto Nutrients under the credit facility are secured by first-priority security interests in all of their assets in favor of the lender. Alto Ingredients has guaranteed all of Kinergy’s obligations under the line of credit. As of December 31, 2024, Kinergy had $23.1 million in unused borrowing availability under the credit facility.

 

Orion Term Loan – On November 7, 2022, the Company entered into a credit agreement with certain funds managed by Orion Infrastructure Capital (collectively, the “Lenders”), and OIC Investment Agent, LLC, as administrative agent and collateral agent (“OIC”), under which the Lenders agreed to extend a senior secured credit facility in the amount of up to $125,000,000 (the “Term Loan”). The Term Loan is secured by a first priority lien on certain assets of the Company and a second priority lien on certain assets of Kinergy and Alto Nutrients.

 

The Lenders agreed to advance to the Company up to $100,000,000, with up to $25,000,000 more upon the satisfaction of certain additional conditions. The Company also agreed to issue to the Lenders upon its first funding request, an aggregate of 1,282,051 shares of the Company’s common stock, and up to an additional 320,513 shares of the Company’s common stock upon additional funding or fundings.

 

On November 23, 2022, the Company received its initial funding of $60,000,000 and issued 1,282,051 shares of common stock. As of December 31, 2024, 2023 and 2022, the principal amount outstanding under the Term Loan was $60,000,000. The Company allocated $3,912,000 of the loan proceeds to additional paid-in capital for the common stock issued based on the relative fair values of the debt and equity instruments and recorded a corresponding amount as a debt issuance discount that will be amortized to interest expense over the term of the loan.

 

As of December 31, 2024, interest accrued on the unpaid principal amount of the Term Loan at a fixed rate of 10% per annum. On January 1, 2025, the annual fixed rate of interest on the Term Loan increased to 10.75% in connection with the Company’s amendment of various terms under the Term Loan. The Term Loan matures on November 7, 2028, or earlier upon acceleration.

 

The Company must prepay amounts outstanding under the Term Loan on a semi-annual basis beginning with the six-month period ended December 31, 2023 in an amount equal to a percentage of the Company’s excess cash flow based on a specified leverage ratio, as follows: (i) if the leverage ratio is greater than or equal to 3.0x, then the mandatory prepayment amount will equal 100% of the Company’s excess cash flow, (ii) if the leverage ratio is less than 3.0x and greater than or equal to 1.5x, then the mandatory prepayment amount will equal 50% of the Company’s excess cash flow and (iii) if the leverage ratio is less than 1.5x, then the mandatory prepayment amount will equal 25% of the Company’s excess cash flow.

 

The terms and conditions of the Term Loan also contain customary and other representations, warranties, covenants and obligations, including events of default, and other terms and conditions.

 

Registration Rights Agreement - On November 7, 2022, the Company entered into a registration rights agreement with the Lenders and agreed to register for resale with the Securities and Exchange Commission the shares of common stock issued to the Lenders under the Term Loan. The related registration statement has been declared effective by the Securities and Exchange Commission.

 

Maturities of Long-term DebtThe Company’s long-term debt matures as follows (in thousands):

 

December 31:    
2027  $39,677 
2028   60,000 
   $99,677 

 

F-26

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

9. LEASES.

 

The Company leases equipment and land for certain of its facilities. Operating lease right of use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate, unless an implicit rate is readily determinable, as the discount rate for each lease in determining the present value of lease payments. For the years ended December 31, 2024 and 2023, the Company’s weighted-average discount rate was approximately 7.78%. Operating lease expense is recognized on a straight-line basis over the lease term.

 

Upon the adoption of ASC 842, the Company elected the following practical expedients allowable under the guidance: not to reassess whether any expired or existing contracts are or contain leases; not to reassess the lease classification for any expired or existing leases; not to reassess initial direct costs for any existing leases; not to separately identify lease and non-lease components; and not to evaluate historical land easements. Additionally, the Company elected the short-term lease exemption policy, applying the requirements of ASC 842 to only long-term (greater than 1 year) leases.

 

The Company determines if an arrangement is a lease or contains a lease at inception. The Company’s leases have remaining lease terms of approximately 1 year to 51 years, which includes options to extend the lease when it is reasonably certain the Company will exercise those options. For the year ended December 31, 2024, the weighted-average remaining lease terms of equipment and land-related leases were 4.14 years and 16.42 years, respectively. For the year ended December 31, 2023, the weighted-average remaining lease terms of equipment and land-related leases were 4.73 years and 15.41 years, respectively. The Company does not have lease arrangements with residual value guarantees, sale-leaseback terms or material restrictive covenants. The Company does not have any material finance lease obligations nor sublease agreements.

 

Leases consist of the following (in thousands):

 

   Classification  December 31, 
Assets     2024   2023 
Operating  Right of use operating lease assets, net  $20,553   $22,597 
Liabilites             
Operating - Current  Current portion, operating leases  $4,851   $4,333 
Operating - Noncurrent  Operating leases, net of current portion  $16,913   $19,029 

 

The Components of lease costs were as follows (in thousands):

 

   Years Ended December 31, 
   2024   2023   2022 
             
Fixed lease cost  $5,989   $5,722   $5,224 
Variable lease cost   529    871    124 
Net lease cost  $6,518   $6,593   $5,348 

 

F-27

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The following table summarizes the remaining maturities of the Company’s operating lease liabilities, assuming all land lease extensions are taken, as of December 31, 2024 (in thousands):

 

Year Ended:   Equipment     Land Related  
2025   $ 5,334     $ 1,060  
2026     4,761       1,037  
2027     4,152       1,011  
2028     3,368       1,024  
2029     1,992       660  
2030-76     119       3,881  
Less interest     (3,299 )     (3,336 )
    $ 16,427     $ 5,337  

 

10. PENSION PLANS.

 

Retirement Plan - The Company sponsors a defined benefit pension plan (the “Retirement Plan”) that is noncontributory, and covers only “grandfathered” unionized employees at its Alto Pekin production facilities. Benefits are based on a prescribed formula based upon the employee’s years of service. Employees hired after November 1, 2010, are not eligible to participate in the Retirement Plan. The Company uses a December 31st measurement date for its Retirement Plan. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations.

 

Information related to the Retirement Plan as of and for the years ended December 31, 2024 and 2023 is presented below (dollars in thousands):

 

   2024   2023 
Changes in plan assets:        
Fair value of plan assets, beginning  $18,485   $16,688 
Actual gains   1,711    2,376 
Benefits paid   (829)   (834)
Company contributions   800    255 
Participant contributions   
    
 
Fair value of plan assets, ending  $20,167   $18,485 
Less: projected accumulated benefit obligation  $17,530   $18,590 
Funded status, overfunded (underfunded)  $2,637   $(105)
           
Amounts recognized in the consolidated balance sheets:          
Other assets  $2,637   $
 
Other liabilities  $
   $(105)
Accumulated other comprehensive income  $(4,167)  $(2,231)
           
Assumptions used in computation of benefit obligations:          
Discount rate   5.50%   4.90%
Expected long-term return on plan assets   6.50%   6.50%
Rate of compensation increase   
    
 

 

   Years Ended December 31, 
   2024   2023   2022 
Components of net periodic benefit costs are as follows:            
Service cost  $267   $249   $404 
Interest cost   887    900    655 
Expected return on plan assets   (1,103)   (993)   (1,090)
Net periodic cost (benefit)  $51   $156   $(31)

 

F-28

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company does not expect to make any contributions in the year ending December 31, 2025. Net periodic benefit for 2025 is estimated to be approximately $0.5 million.

 

The following table summarizes the expected benefit payments for the Company’s Retirement Plan for each of the next five fiscal years and in the aggregate for the five fiscal years thereafter (in thousands):

 

December 31:      
2025   $ 1,000  
2026     1,040  
2027     1,080  
2028     1,130  
2029     1,160  
2030-34     6,480  
    $ 11,890  

 

See Note 15 for discussion of the Retirement Plan’s fair value disclosures.

 

Historical and future expected returns of multiple asset classes were analyzed to develop a risk-free real rate of return and risk premiums for each asset class. The overall rate for each asset class was developed by combining a long-term inflation component, the risk-free real rate of return, and the associated risk premium. A weighted-average rate was developed based on those overall rates and the target asset allocation of the Retirement Plan.

 

The Company’s pension committee is responsible for overseeing the investment of pension plan assets. The pension committee is responsible for determining and monitoring the appropriate asset allocations and for selecting or replacing investment managers, trustees, and custodians. The Retirement Plan’s current investment target allocations are 50% equities and 50% debt. The pension committee periodically reviews the actual asset allocation in light of these targets and rebalances investments as necessary. The pension committee also evaluates the performance of investment managers as compared to the performance of specified benchmarks and peers and monitors the investment managers to ensure adherence to their stated investment style and to the Retirement Plan’s investment guidelines.

 

Postretirement Plan - The Company also sponsors a health care plan and life insurance plan (the “Postretirement Plan”) that provides postretirement medical benefits and life insurance to certain “grandfathered” unionized employees at its Alto Pekin production facilities. Employees hired after December 31, 2000, are not eligible to participate in the Postretirement Plan. The plan is contributory, with contributions required at the same rate as active employees. Benefit eligibility under the plan reduces at age 65 from a defined benefit to a defined dollar cap based upon years of service.

 

Information related to the Postretirement Plan as of December 31, 2024 and 2023 is presented below (dollars in thousands):

 

   2024   2023 
Amounts at the end of the year:        
Accumulated/projected benefit obligation  $3,783   $4,294 
Fair value of plan assets   
    
 
Funded status, underfunded  $(3,783)  $(4,294)
           
Amounts recognized in the consolidated balance sheets:          
Accrued liabilities  $(280)  $(320)
Other liabilities  $(3,503)  $(3,974)
Accumulated other comprehensive income  $(808)  $(250)
           
Discount rate used in computation of benefit obligations   5.30%   4.75%

 

F-29

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

   Years Ended December 31, 
   2024   2023   2022 
Components of net periodic benefit costs are as follows:            
Service cost  $19   $14   $26 
Interest cost   196    186    105 
Amortization of prior service cost   
    (53)   
 
Net periodic benefit cost  $215   $147   $131 
Amounts recognized in the plan for the year:               
Participant contributions  $35   $36   $43 
Benefits paid  $204   $201   $215 

 

The Company does not expect to recognize any amortization of net actuarial loss during the year ended December 31, 2025.

 

The following table summarizes the expected benefit payments for the Company’s Postretirement Plan for each of the next five fiscal years and in the aggregate for the five fiscal years thereafter (in thousands):

 

December 31:      
2025   $ 280  
2026     360  
2027     390  
2028     420  
2029     400  
2030-2034     1,780  
    $ 3,630  

 

For purposes of determining the cost and obligation for pre-Medicare postretirement medical benefits, a 8.50% annual rate of increase in the per capita cost of covered benefits (i.e., health care trend rate) was assumed for the Postretirement Plan in 2026, adjusted to a rate of 4.50% in 2035. Assumed health care cost trend rates have a significant effect on the amounts reported for health care plans.

 

11. INCOME TAXES.

 

The Company recorded a provision for income taxes as follows (in thousands):

 

   Years Ended December 31, 
   2024   2023   2022 
Current provision  $173   $97   $1,925 
Deferred provision            
Total  $173   $97   $1,925 

 

F-30

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

A reconciliation of the differences between the United States statutory federal income tax rate and the effective tax rate as provided in the consolidated statements of operations is as follows:

 

   Years Ended December 31, 
   2024   2023   2022 
Statutory rate   21.0%   21.0%   21.0%
State income taxes, net of federal benefit   5.5    4.6    5.8 
Change in valuation allowance   (29.3)   (23.4)   (33.9)
Stock-based compensation   (0.4)   (2.3)   3.1 
Non-deductible items   (0.1)   0.8    (1.6)
Other   3.0    (1.0)   0.6 
Effective rate   (0.3)%   (0.3)%   (5.0)%

 

Deferred income taxes are provided using the asset and liability method to reflect temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities using presently enacted tax rates and laws. The components of deferred income taxes included in the consolidated balance sheets were as follows (in thousands):

 

   December 31, 
   2024   2023 
Deferred tax assets:        
Net operating loss carryforwards  $64,901   $57,870 
Capital loss   26,692    26,518 
Disallowed interest   5,048    3,457 
R&D, Energy and AMT credits   3,742    3,742 
Derivatives   
    3,051 
Intangibles   2,981    1,201 
Pension liability   1,016    1,173 
Railcar contracts   1,090    818 
Stock-based compensation   803    696 
Allowance for credit losses and other assets   1,059    296 
Other   4,971    3,340 
Total gross deferred tax assets   112,303    102,162 
Less: valuation allowance   (110,687)   (93,506)
Total deferred tax assets, net of valuation allowance   1,616    8,656 
           
Deferred tax liabilities:          
Property and equipment   (703)   (7,720)
Derivatives   (574)   
 
Other   (575)   (1,172)
Total deferred tax liabilities   (1,852)   (8,892)
           
Net deferred tax liabilities, included in other liabilities  $(236)  $(236)

 

F-31

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

A portion of the Company’s net operating loss carryforwards are subject to provisions of the tax law that limit the use of losses incurred by a corporation prior to the date certain ownership changes occur. These limitations also apply to certain depreciation deductions associated with assets on hand at the time of the ownership change and otherwise allowable during the five-year period following the ownership change. As the five-year limitation period lapsed in 2019, these disallowed deductions are reflected in property and equipment in the schedule above but continue to be subject to the annual limitation that applies to the pre-change net operating losses. Due to the limitation on the use of net operating losses and depreciation deductions, a significant portion of these carryforwards will expire regardless of whether the Company generates future taxable income. After reducing these net operating loss carryforwards for the amount which will expire due to this limitation, the Company had remaining federal net operating loss carryforwards of approximately $227,673,000 and state net operating loss carryforwards of approximately $276,424,000 at December 31, 2024. These net operating loss carryforwards expire as follows (in thousands):

 

Tax Years  Federal   State 
2025–2029  $
   $30,603 
2030–2034   15,126    76,920 
2035–2039   83,771    112,608 
2040 and after*   128,776    56,293 
Total NOLs  $227,673   $276,424 

 

 

*Includes indefinite life federal net operating losses of $128.8 million generated after 2017.

 

Approximately $155,452,000 is available to utilize against federal taxable income for 2025.

 

To the extent amounts are not utilized in any year, they may be carried forward to the next year until expiration. These amounts may change if there are future additional limitations on their utilization.

 

Federal capital loss of $100,487,000 may be carried forward for 5 years and will expire in 2025. State capital loss of $95,469,000 may be carried forward for 5 years for most of the states in which the Company files returns and will expire in 2025.

 

In assessing whether the deferred tax assets are realizable, a more likely than not standard is applied. If it is determined that it is more likely than not that deferred tax assets will not be realized, a valuation allowance must be established against the deferred tax assets. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which the associated temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.

 

A valuation allowance was established in the amount of $110,687,000 and $93,506,000 as of December 31, 2024 and 2023, respectively, based on the Company’s assessment of the future realizability of certain deferred tax assets. The valuation allowance on deferred tax assets is related to future deductible temporary differences and net operating loss carryforwards for which the Company has concluded it is more likely than not that these items will not be realized in the ordinary course of operations.

 

F-32

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

For the year ended December 31, 2024, the Company recorded an increase in valuation allowance of $17,181,000. This was primarily related to additional net operating losses accumulated for the year. For the year ended December 31, 2023, the Company recorded an increase in valuation allowance of $5,557,000. This was primarily related to additional net operating losses accumulated for the year. For the year ended December 31, 2022, the Company recorded an increase in valuation allowance of $12,365,000. This was primarily related to additional net operating losses accumulated for the year.

 

Unrecognized Tax Benefits

 

A reconciliation of the beginning balance and the ending balance of gross unrecognized tax benefits, before interest and penalties, for the period presented is as follows (in thousands):

 

   December 31, 
   2024   2023 
Unrecognized tax benefits at beginning of year  $739   $739 
Increases related to current year tax positions   
    
 
Decreases related to current year tax positions   
    
 
Increases related to prior year tax positions   
    
 
Decreases related to prior year tax positions   
    
 
Decreases related to expiration of prior year tax positions   
    
 
Decreases related to settlements of prior year tax positions   
    
 
Unrecognized tax benefits at end of year  $739   $739 

 

The Company recorded unrecognized tax benefits for uncertain tax positions of approximately $739,000 as of December 31, 2024 and 2023, of which $739,000 would impact the effective tax rate, if recognized.

 

The Company recognizes interest and penalties related to income tax matters as a component of interest expense and other income, net, respectively. As of December 31, 2024, the Company accrued penalties of $74,000 and interest of $134,000 related to uncertain tax positions. The Company does not expect the unrecognized tax benefits to change significantly over the next 12 months.

 

F-33

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The Company is subject to income tax in the United States federal jurisdiction and various state jurisdictions and has identified its federal tax return and tax returns in state jurisdictions below as “major” tax filings. These jurisdictions, along with the years still open to audit under the applicable statutes of limitation, are as follows:

 

Jurisdiction   Tax Years
Federal   2021 – 2023
Alabama   2021 – 2023
Arizona   2020 – 2023
Arkansas   2021 – 2023
California   2020 – 2023
Colorado   2020 – 2023
Connecticut   2021 – 2023
Georgia   2021 – 2023
Idaho   2021 – 2023
Illinois   2021 – 2023
Indiana   2021 – 2023
Iowa   2021 – 2023
Kansas   2021 – 2023
Louisiana   2021 – 2023
Michigan   2021 – 2023
Minnesota   2021 – 2023
Mississippi   2021 – 2023
Missouri   2021 – 2023
Nebraska   2021 – 2023
New Mexico   2021 – 2023
Oklahoma   2021 – 2023
Oregon   2021 – 2023
Pennsylvania   2021 – 2023
Rhode Island   2021 – 2023
South Carolina   2021 – 2023
Tennessee   2021 – 2023
Texas   2020 – 2023

 

However, because the Company had net operating losses and credits carried forward in several of the jurisdictions, including the United States federal and California jurisdictions, certain items attributable to closed tax years are still subject to adjustment by applicable taxing authorities through an adjustment to tax attributes carried forward to open years.

 

12. PREFERRED STOCK.

 

The Company has 6,734,835 undesignated shares of authorized and unissued preferred stock, which may be designated and issued in the future on the authority of the Company’s Board of Directors. As of December 31, 2024, the Company had the following designated classes of preferred stock:

 

Series A Preferred Stock – The Company has authorized 1,684,375 shares of Series A Cumulative Redeemable Convertible Preferred Stock (“Series A Preferred Stock”), with none outstanding at December 31, 2024 and 2023. Shares of Series A Preferred Stock that are converted into shares of the Company’s common stock revert to undesignated shares of authorized and unissued preferred stock.

 

F-34

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Upon any issuance, the Series A Preferred Stock would rank senior in liquidation and dividend preferences to the Company’s common stock. Holders of Series A Preferred Stock would be entitled to quarterly cumulative dividends payable in arrears in cash in an amount equal to 5% per annum of the purchase price per share of the Series A Preferred Stock. The holders of the Series A Preferred Stock would have conversion rights initially equivalent to two shares of common stock for each share of Series A Preferred Stock, subject to customary antidilution adjustments. Certain specified issuances will not result in antidilution adjustments. The shares of Series A Preferred Stock would also be subject to forced conversion upon the occurrence of a transaction that would result in an internal rate of return to the holders of the Series A Preferred Stock of 25% or more. Accrued but unpaid dividends on the Series A Preferred Stock are to be paid in cash upon any conversion of the Series A Preferred Stock.

 

The holders of Series A Preferred Stock would have a liquidation preference over the holders of the Company’s common stock equivalent to the purchase price per share of the Series A Preferred Stock plus any accrued and unpaid dividends on the Series A Preferred Stock. A liquidation would be deemed to occur upon the happening of customary events, including transfer of all or substantially all of the Company’s capital stock or assets or a merger, consolidation, share exchange, reorganization or other transaction or series of related transactions, unless holders of 66 2/3% of the Series A Preferred Stock vote affirmatively in favor of or otherwise consent to such transaction.

 

Series B Preferred Stock – The Company has authorized 1,580,790 shares of Series B Cumulative Convertible Preferred Stock (“Series B Preferred Stock”), with 926,942 shares outstanding at December 31, 2024 and 2023. Shares of Series B Preferred Stock that are converted into shares of the Company’s common stock revert to undesignated shares of authorized and unissued preferred stock.

 

The Series B Preferred Stock ranks senior in liquidation and dividend preferences to the Company’s common stock. Holders of Series B Preferred Stock are entitled to quarterly cumulative dividends payable in arrears in cash in an amount equal to 7.00% per annum of the purchase price per share of the Series B Preferred Stock; however, subject to the provisions of the Letter Agreement described below, such dividends may, at the option of the Company, be paid in additional shares of Series B Preferred Stock based initially on the liquidation value of the Series B Preferred Stock. In addition to the quarterly cumulative dividends, holders of the Series B Preferred Stock are entitled to participate in any common stock dividends declared by the Company to its common stockholders. The holders of Series B Preferred Stock have a liquidation preference over the holders of the Company’s common stock initially equivalent to $19.50 per share of the Series B Preferred Stock plus any accrued and unpaid dividends on the Series B Preferred Stock. A liquidation will be deemed to occur upon the happening of customary events, including the transfer of all or substantially all of the capital stock or assets of the Company or a merger, consolidation, share exchange, reorganization or other transaction or series of related transactions (each, a “transaction”), unless holders of 66 2/3% of the Series B Preferred Stock vote affirmatively in favor of or otherwise consent that such transaction shall not be treated as a liquidation. The Company believes that such liquidation events are within its control and therefore has classified the Series B Preferred Stock in stockholders’ equity.

 

As of December 31, 2024, the Series B Preferred Stock was convertible into 980,712 shares of the Company’s common stock. The conversion ratio is subject to customary antidilution adjustments. In addition, antidilution adjustments are to occur in the event that the Company issues equity securities, including derivative securities convertible into equity securities (on an as-converted or as-exercised basis), at a price less than the conversion price then in effect. The shares of Series B Preferred Stock are also subject to forced conversion upon the occurrence of a transaction that would result in an internal rate of return to the holders of the Series B Preferred Stock of 25% or more. The forced conversion is to be based upon the conversion ratio as last adjusted. Accrued but unpaid dividends on the Series B Preferred Stock are to be paid in cash upon any conversion of the Series B Preferred Stock.

 

F-35

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The holders of Series B Preferred Stock vote together as a single class with the holders of the Company’s common stock on all actions to be taken by the Company’s stockholders. Each share of Series B Preferred Stock entitles the holder to approximately 0.03 votes per share on all matters to be voted on by the stockholders of the Company. Notwithstanding the foregoing, the holders of Series B Preferred Stock are afforded numerous customary protective provisions with respect to certain actions that may only be approved by holders of a majority of the shares of Series B Preferred Stock, including, among other provisions, the right to approve any transaction that does not result in an internal rate of return of at least 25% to the holders of the Series B Preferred Stock.

 

In 2008, the Company entered into Letter Agreements with Lyles United LLC (“Lyles United”) and other purchasers under which the Company expressly waived its rights under the Certificate of Designations relating to the Series B Preferred Stock to make dividend payments in additional shares of Series B Preferred Stock in lieu of cash dividend payments without the prior written consent of Lyles United and the other purchasers.

 

Registration Rights Agreement – In connection with the sale of its Series B Preferred Stock, the Company entered into a registration rights agreement with Lyles United. The registration rights agreement is effective until the holders of the Series B Preferred Stock, and their affiliates, as a group, own less than 10% for each of the series issued, including common stock into which such Series B Preferred Stock has been converted. The registration rights agreement provides that holders of a majority of the Series B Preferred Stock, including common stock into which such Series B Preferred Stock has been converted, may demand and cause the Company to register on their behalf the shares of common stock issued, issuable or that may be issuable upon conversion of the Preferred Stock and as payment of dividends thereon, and upon exercise of the related warrants (collectively, the “Registrable Securities”). The Company is required to keep such registration statement effective until such time as all of the Registrable Securities are sold or until such holders may avail themselves of Rule 144 for sales of Registrable Securities without registration under the Securities Act of 1933, as amended. The holders are entitled to two demand registrations on Form S-1 and unlimited demand registrations on Form S-3; provided, however, that the Company is not obligated to effect more than one demand registration on Form S-3 in any calendar year. In addition to the demand registration rights afforded the holders under the registration rights agreement, the holders are entitled to unlimited “piggyback” registration rights. These rights entitle the holders who so elect to be included in registration statements to be filed by the Company with respect to other registrations of equity securities. The Company is responsible for all costs of registration, plus reasonable fees of one legal counsel for the holders, which fees are not to exceed $25,000 per registration. The registration rights agreement includes customary representations and warranties on the part of both the Company and the holders and other customary terms and conditions.

 

F-36

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

13. STOCK-BASED COMPENSATION.

 

On June 16, 2016, the Company’s shareholders approved the 2016 Stock Incentive Plan, which authorizes the issuance of incentive stock options and non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, direct stock issuances and other stock-based awards to the Company’s officers, directors or key employees or to consultants that do business with the Company initially for up to an aggregate of 1,150,000 shares of common stock. On June 14, 2018, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 3,650,000 shares. On November 7, 2019, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 5,650,000 shares. On November 18, 2020, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 7,400,000 shares. On June 23, 2022, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 8,900,000 shares. On June 22, 2023, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 11,400,000 shares. On June 20, 2024, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 15,200,000 shares.

 

Restricted Stock – A summary of unvested restricted stock activity is as follows (shares in thousands):

 

   Number of
Shares
   Weighted-
Average
Grant Date
Fair Value
Per Share
 
Unvested at December 31, 2022   1,169   $5.95 
Issued   2,375   $1.87 
Vested   (547)  $5.61 
Canceled   (56)  $3.14 
Unvested at December 31, 2023   2,941   $2.77 
           
Issued   1,530   $1.91 
Vested   (1,597)  $3.08 
Canceled   (143)  $2.16 
Unvested at December 31, 2024   2,731   $2.14 

 

The fair value of the common stock at vesting aggregated $3,142,000, $929,000 and $6,900,000 for the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense related to employee and non-employee restricted stock and option grants recognized in the accompanying consolidated statements of operations, was as follows (in thousands):

 

   Years Ended December 31, 
   2024   2023   2022 
Employees  $3,960   $3,345   $2,689 
Non-employees   397    551    644 
Total stock-based compensation expense  $4,357   $3,896   $3,333 

 

Employee grants typically have a two or three-year vesting schedule, while non-employee grants have a one-year vesting schedule. At December 31, 2024, the total compensation expense related to unvested awards which had not been recognized was $3,678,000 and the associated weighted-average period over which the compensation expense attributable to those unvested awards will be recognized was approximately 0.67 years.

 

F-37

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

14. COMMITMENTS AND CONTINGENCIES.

 

Commitments – The following is a description of significant commitments at December 31, 2024:

 

Sales Commitments – At December 31, 2024, the Company had entered into sales contracts with its major customers to sell certain quantities of alcohol and essential ingredients. The Company had open alcohol indexed-price contracts for 74,375,000 gallons as of December 31, 2024 and open fixed-price alcohol sales contracts totaling $166,794,000 as of December 31, 2024. The Company had open fixed-price sales contracts for essential ingredients totaling $5,952,000 and open indexed-price sales contracts of essential ingredients for 47,000 tons as of December 31, 2024. These sales contracts are scheduled for completion over the next twelve months.

 

Purchase Commitments – At December 31, 2024, the Company had indexed-price purchase contracts to purchase 23,028,000 gallons of alcohol and fixed-price purchase contracts to purchase $220,000 of alcohol from its suppliers. The Company had fixed-price purchase contracts to purchase $34,731,000 of corn from its suppliers as of December 31, 2024. The Company had indexed-price purchase contracts for 2,520,000 MMBTU of natural gas. The Company had future commitments for certain capital projects totaling $9,059,000. The Company also had a future commitment for $7,250,000 for the purchase of Kodiak Carbonic, LLC. See Note 16. These purchase commitments are scheduled to be satisfied through 2025.

 

Contingencies – The following is a description of significant contingencies at December 31, 2024:

 

Litigation The Company is subject to various claims and contingencies in the ordinary course of its business, including those related to litigation, business transactions, employee-related matters, and others. When the Company is aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, the Company will record a liability for the loss. If the loss is not probable or the amount of the loss cannot be reasonably estimated, the Company discloses the claim if the likelihood of a potential loss is reasonably possible, and the amount involved could be material. While the Company can provide no assurances, the Company does not expect that any of its pending legal proceedings will have a material financial impact on the Company’s operating results.

 

15.FAIR VALUE MEASUREMENTS.

 

The fair value hierarchy prioritizes the inputs used in valuation techniques into three levels, as follows:

 

Level 1 – Observable inputs – unadjusted quoted prices in active markets for identical assets and liabilities;

 

Level 2 – Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and

 

Level 3 – Unobservable inputs – includes amounts derived from valuation models where one or more significant inputs are unobservable. For fair value measurements using significant unobservable inputs, a description of the inputs and the information used to develop the inputs is required along with a reconciliation of Level 3 values from the prior reporting period.

 

F-38

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Pooled Separate Accounts – Pooled separate accounts invest primarily in domestic and international stocks, commercial paper or single mutual funds. The net asset value is used as a practical expedient to determine fair value for these accounts. Each pooled separate account provides for redemptions by the Retirement Plan at reported net asset values per share, with little to no advance notice requirement, therefore these funds are classified within Level 2 of the valuation hierarchy.

 

Derivative Instruments – The Company’s derivative instruments consist of commodity positions. The fair values of the commodity positions are based on quoted prices on the commodity exchanges and are designated as Level 1 inputs.

 

Long-Lived Assets – Long-lived assets consist of the Company’s estimated fair value associated with its Magic Valley facility. See Note 1 for additional information. The fair value of the long-lived assets are based on present value of estimated future cash flows and are designated as Level 3 inputs.

 

The following table summarizes recurring and nonrecurring fair value measurements by level at December 31, 2024 (in thousands):

 

                   Benefit Plan 
                  Percentage 
   Fair Value   Level 1   Level 2   Level 3   Allocation 
Assets:                    
Derivative financial instruments  $3,313   $3,313   $   $      
Long-lived assets – Magic Valley   19,397            19,397      
Defined benefit plan assets(1) (pooled separate accounts):                         
Large U.S. Equity(2)   6,962        6,962        34%
Small/Mid U.S. Equity(3)   3,636        3,636        18%
International Equity(4)   2,762        2,762        14%
Fixed Income(5)   6,807        6,807        34%
   $42,877   $3,313   $20,167   $19,397      
                          
Liabilities:                         
Derivative financial instruments  $1,177   $1,177   $   $      

 

F-39

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

The following table summarizes recurring and nonrecurring fair value measurements by level at December 31, 2023 (in thousands):

 

                   Benefit Plan 
   Fair               Percentage 
   Value   Level 1   Level 2   Level 3   Allocation 
Assets:                    
Derivative financial instruments  $2,412   $2,412   $
   $
      
Defined benefit plan assets(1) (pooled separate accounts):                         
Large U.S. Equity(2)   5,608    
    5,608    
    30%
Small/Mid U.S. Equity(3)   3,350    
    3,350    
    18%
International Equity(4)   2,682    
    2,682    
    15%
Fixed Income(5)   6,845    
    6,845    
    37%
   $20,897   $2,412   $18,485   $
      
                          
Liabilities:                         
Derivative financial instruments  $13,849   $13,849   $
   $
      

 

 

(1)See Note 10 for accounting discussion.

 

(2)This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

 

(3)This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

 

(4)This category includes investments in funds comprised of equity securities of foreign companies, including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

 

(5)This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

 

16.SUBSEQUENT EVENTS.

 

On January 1, 2025, the Company’s wholly-owned subsidiary, Alto Carbonic, LLC, acquired 100% of the equity interests in Kodiak Carbonic, LLC, a beverage-grade liquid CO2 processor for $7.6 million in cash. The transaction also involved an improved, long-term sales contract with a third party for the sale of beverage-grade liquid CO2, which will improve the financial results of the production facility. Alto Carbonic’s facility is co-located at the Columbia ethanol facility. Based on its preliminary assessment, the Company expects to record at fair value $3.9 million in property and equipment and $3.7 million of intangible assets related to the long-term sales contract. The Company does not expect to record any goodwill with the transaction and plans to report the results of Alto Carbonic in the Company’s Western Production segment.

 

F-40

 

INDEX TO EXHIBITS

 

      Where Located
Exhibit
Number
  Description*  Form  File
Number
  Exhibit
Number
  Filing Date  Filed
Herewith
                   
3.1  Certificate of Incorporation  10-Q  000-21467  3.1  11/06/2015   
                   
3.2  Certificate of Designations, Powers, Preferences and Rights of the Series A Cumulative Redeemable Convertible Preferred Stock  10-Q  000-21467  3.2  11/06/2015   
                   
3.3  Certificate of Designations, Powers, Preferences and Rights of the Series B Cumulative Convertible Preferred Stock  10-Q  000-21467  3.3  11/06/2015   
                   
3.4  Certificate of Amendment to Certificate of Incorporation dated June 3, 2010  10-Q  000-21467  3.4  11/06/2015   
                   
3.5  Certificate of Amendment to Certificate of Incorporation effective June 8, 2011  10-Q  000-21467  3.5  11/06/2015   
                   
3.6  Certificate of Amendment to Certificate of Incorporation effective May 14, 2013  10-Q  000-21467  3.6  11/06/2015   
                   
3.7  Certificate of Amendment to Certificate of Incorporation effective July 1, 2015  10-Q  000-21467  3.7  11/06/2015   
                   
3.8  Certificate of Amendment to Certificate of Incorporation effective January 12, 2021  8-K  000-21467  3.1  01/13/2021   
                   
3.9  Amended and Restated Bylaws  8-K  000-21467  3.1  03/06/2024   
                   
4.1  Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934  10-K  000-21467  4.1  03/30/2020   
                   
10.1  2016 Stock Incentive Plan, as amended#  S-8  333-280351  4.11  06/20/2024   
                   
10.2  Form of Employee Restricted Stock Agreement under 2016 Stock Incentive Plan#  10-K  000-21467  10.5  03/15/2018   
                   
10.3  Form of Non-Employee Director Restricted Stock Agreement under 2016 Stock Incentive Plan#  10-K  000-21467  10.6  03/15/2017   
                   
10.4  Form of Performance Share Agreement under 2016 Stock Incentive Plan#  10-Q  000-21467  10.3  05/08/2024   
                   
10.5  Second Amended and Restated Executive Employment Agreement dated September 17, 2023 between the Registrant and Bryon T. McGregor#  8-K  000-21467  10.1  09/20/2023   
                   
10.6  Amended and Restated Executive Employment Agreement dated November 7, 2016 between the Registrant and James R. Sneed#  10-K  000-21467  10.12  03/15/2017   

 

-56-

 

      Where Located
Exhibit
Number
  Description*  Form  File
Number
  Exhibit
Number
  Filing Date  Filed
Herewith
                   
10.7  Second Amended and Restated Employment Agreement dated April 1, 2024 between the Registrant and Todd E. Benton#  8-K  000-21467  10.1  03/21/2024   
                   
10.8  Employment Agreement dated February 1, 2022 between the Registrant and Auste M. Graham#  10-K  000-21467  10.9  03/15/2022   
                   
10.9  Second Amended and Restated Employment Agreement dated September 17, 2023 between the Registrant and Robert R. Olander#  8-K  000-21467  10.3  09/20/2023   
                   
10.10  Form of Indemnity Agreement between the Registrant and each of its Executive Officers and Directors#  10-K  000-21467  10.46  03/31/2010   
                   
10.11  Policy for Recoupment of Incentive Compensation dated March 29, 2018#  10-K  000-21467  10.17  03/18/2019   
                   
10.12  Form of Clawback Policy Acknowledgement and Agreement#  10-K  000-21467  10.18  03/18/2019   
                   
10.13  Registration Rights Agreement dated March 27, 2008 between the Registrant and Lyles United, LLC  8-K  000-21467  10.4  03/27/2008   
                   
10.14  Letter Agreement dated March 27, 2008 between the Registrant and Lyles United, LLC  8-K  000-21467  10.5  03/27/2008   
                   
10.15  Letter Agreement dated May 22, 2008 among the Registrant, Neil M. Koehler, Bill Jones, Paul P. Koehler and Thomas D. Koehler#  8-K  000-21467  10.3  05/23/2008   
                   
10.16  Second Amended and Restated Credit Agreement dated August 2, 2017 among Kinergy Marketing LLC, Pacific Ag. Products, LLC, Wells Fargo Bank, National Association, and the parties thereto from time to time as lenders  8-K  000-21467  10.1  08/08/2017   
                   
10.17  Amendment No. 1 to Second Amended and Restated Credit Agreement dated March 27, 2019 by and among Kinergy Marketing LLC, Pacific Ag. Products, LLC and Wells Fargo Bank, National Association  10-Q  000-21467  10.7  05/03/2019   
                   
10.18  Amendment No. 2 to Second Amended and Restated Credit Agreement dated July 31, 2019 by and among Kinergy Marketing LLC, Pacific Ag. Products, LLC, the parties thereto from time to time as lenders and Wells Fargo Bank, National Association  8-K  000-21467  10.1  08/06/2019   
                   
10.19  Amendment No. 3 to Second Amended and Restated Credit Agreement dated November 19, 2019 by and among Kinergy Marketing LLC, Pacific Ag. Products, LLC, the parties thereto from time to time as lenders and Wells Fargo Bank, National Association  10-K  000-21467  10.61  03/30/2020   

 

-57-

 

      Where Located
Exhibit
Number
  Description*  Form  File
Number
  Exhibit
Number
  Filing Date  Filed
Herewith
                   
10.20  Waiver, Consent and Amendment No. 4 to Second Amended and Restated Credit Agreement dated March 8, 2021 by and among Kinergy Marketing LLC, Alto Nutrients, LLC and Wells Fargo Bank, National Association  10-K  000-21467  10.20  03/15/2022   
                   
10.21  Waiver, Consent, and Amendment No. 5 to Second Amended and Restated Credit Agreement dated June 10, 2021 by and among Kinergy Marketing LLC, Alto Nutrients, LLC and Wells Fargo Bank, National Association  10-K  000-21467  10.21  03/15/2022   
                   
10.22  Amendment No. 6 to Second Amended and Restated Credit Agreement dated November 7, 2022 by and among Kinergy Marketing LLC, Alto Nutrients, LLC and Wells Fargo Bank, National Association  8-K  000-21467  10.2  11/14/2022   
                   
10.23  Second Amended and Restated Guarantee dated August 2, 2017 by the Registrant in favor of Wells Fargo Bank, National Association, for and on behalf of the lenders  8-K  000-21467  10.2  08/08/2017   
                   
10.24  Credit Agreement dated November 7, 2022 by and among the Registrant, the subsidiary guarantors signatory thereto, Orion Energy Credit Opportunities Fund III, L.P., Orion Energy Credit Opportunities Fund III GPFA PV, L.P., Orion Energy Credit Opportunities Fund III GPFA, L.P., Orion Energy Credit Opportunities Fund III PV, L.P., and OIC Investment Agent, LLC  8-K  000-21467  10.1  11/14/2022   
                   
10.25  First Amendment to Credit Agreement dated November 6, 2023 between the Registrant and OIC Investment Agent, LLC  10-K  000-21467  10.24  03/14/2024   
                   
10.26  Second Amendment to Credit Agreement dated November 6, 2024 between the Registrant and OIC Investment Agent, LLC              X
                   
10.27  Consent and Third Amendment to Credit Agreement dated January 1, 2025 between the Registrant and OIC Investment Agent, LLC              X
                   
10.28  Registration Rights Agreement dated November 7, 2022 by and among the Registrant, Orion Energy Credit Opportunities Fund III, L.P., Orion Energy Credit Opportunities Fund III GPFA PV, L.P., Orion Energy Credit Opportunities Fund III GPFA, L.P. and Orion Energy Credit Opportunities Fund III PV, L.P.  8-K  000-21467  10.3  11/14/2022   
                   
10.29  CO2 Transportation and Sequestration Agreement dated November 4, 2024 between Alto Pekin, LLC and Vault Dragon CCS Holdings LP  8-K  000-21467  10.1  11/12/2024   

 

-58-

 

      Where Located
Exhibit
Number
  Description*  Form  File
Number
  Exhibit
Number
  Filing Date  Filed
Herewith
                   
19.1  Policy Statement on Insider Trading and Other Prohibited Trading Activities              X
                   
21.1  Subsidiaries of the Registrant              X
                   
23.1  Consent of Independent Registered Public Accounting Firm              X
                   
31.1  Certification Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002              X
                   
31.2  Certification Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002              X
                   
32.1  Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002              X
                   
97.1  Alto Ingredients, Inc. Dodd-Frank Clawback Policy  10-K  000-21467  97.1  03/14/2024   
                   
101.INS  Inline XBRL Instance Document              X
                   
101.SCH  Inline XBRL Taxonomy Extension Schema              X
                   
101.CAL  Inline XBRL Taxonomy Extension Calculation Linkbase              X
                   
101.DEF  Inline XBRL Taxonomy Extension Definition Linkbase              X
                   
101.LAB  Inline XBRL Taxonomy Extension Label Linkbase              X
                   
101.PRE  Inline XBRL Taxonomy Extension Presentation Linkbase              X
                   
104  Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101)              X

 

 

(#)A contract, compensatory plan or arrangement to which a director or executive officer is a party or in which one or more directors or executive officers are eligible to participate.

 

(*)Certain of the agreements filed as exhibits contain representations and warranties made by the parties thereto. The assertions embodied in such representations and warranties are not necessarily assertions of fact, but a mechanism for the parties to allocate risk. Accordingly, investors should not rely on the representations and warranties as characterizations of the actual state of facts or for any other purpose at the time they were made or otherwise.

 

-59-

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 13th day of March, 2025.

 

  ALTO INGREDIENTS, INC.
   
  /s/ BRYON T. MCGREGOR
  Bryon T. McGregor
  President and Chief Executive Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ DOUGLAS L. KIETA   Chairman of the Board and Director   March 13, 2025
Douglas L. Kieta        
         
/s/ BRYON T. MCGREGOR   President, Chief Executive Officer   March 13, 2025
Bryon T. McGregor   (Principal Executive Officer) and Director    
         
/s/ ROBERT R. OLANDER   Chief Financial Officer   March 13, 2025
Robert R. Olander   (Principal Financial and Accounting Officer)    
         
/s/ MICHAEL D. KANDRIS   Director   March 13, 2025
Michael D. Kandris        
         
/s/ GILBERT E. NATHAN   Director   March 13, 2025
Gilbert E. Nathan        
         
/s/ DIANNE S. NURY   Director   March 13, 2025
Dianne S. Nury        
         
/s/ MARIA G. GRAY   Director   March 13, 2025
Maria G. Gray        

 

 

-60-

 

http://fasb.org/us-gaap/2024#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2024#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent 0000778164 false FY 0000778164 2024-01-01 2024-12-31 0000778164 2024-06-28 0000778164 2025-03-12 0000778164 2024-12-31 0000778164 2023-12-31 0000778164 us-gaap:SeriesAPreferredStockMember 2024-12-31 0000778164 us-gaap:SeriesAPreferredStockMember 2023-12-31 0000778164 us-gaap:SeriesBPreferredStockMember 2024-12-31 0000778164 us-gaap:SeriesBPreferredStockMember 2023-12-31 0000778164 us-gaap:NonvotingCommonStockMember 2024-12-31 0000778164 us-gaap:NonvotingCommonStockMember 2023-12-31 0000778164 2023-01-01 2023-12-31 0000778164 2022-01-01 2022-12-31 0000778164 us-gaap:PreferredStockMember 2021-12-31 0000778164 alto:CommonStockAndNonVotingCommonMember 2021-12-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000778164 us-gaap:RetainedEarningsMember 2021-12-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000778164 2021-12-31 0000778164 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0000778164 alto:CommonStockAndNonVotingCommonMember 2022-01-01 2022-12-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000778164 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000778164 us-gaap:PreferredStockMember 2022-12-31 0000778164 alto:CommonStockAndNonVotingCommonMember 2022-12-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000778164 us-gaap:RetainedEarningsMember 2022-12-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000778164 2022-12-31 0000778164 us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0000778164 alto:CommonStockAndNonVotingCommonMember 2023-01-01 2023-12-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0000778164 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0000778164 us-gaap:PreferredStockMember 2023-12-31 0000778164 alto:CommonStockAndNonVotingCommonMember 2023-12-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000778164 us-gaap:RetainedEarningsMember 2023-12-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000778164 us-gaap:PreferredStockMember 2024-01-01 2024-12-31 0000778164 alto:CommonStockAndNonVotingCommonMember 2024-01-01 2024-12-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0000778164 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0000778164 us-gaap:PreferredStockMember 2024-12-31 0000778164 alto:CommonStockAndNonVotingCommonMember 2024-12-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000778164 us-gaap:RetainedEarningsMember 2024-12-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000778164 2024-10-01 2024-12-31 0000778164 us-gaap:SubsequentEventMember 2025-01-01 2025-01-01 0000778164 us-gaap:OtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0000778164 us-gaap:OtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0000778164 us-gaap:CollectiveBargainingArrangementOtherMember us-gaap:SupplierConcentrationRiskMember alto:SuppliersMember 2024-01-01 2024-12-31 0000778164 us-gaap:InventoriesMember 2024-12-31 0000778164 us-gaap:InventoriesMember 2023-12-31 0000778164 srt:MinimumMember 2024-12-31 0000778164 srt:MaximumMember 2024-12-31 0000778164 alto:EquityMethodInvestmentMember 2024-12-31 0000778164 2022-09-12 0000778164 2022-09-12 2022-09-12 0000778164 us-gaap:NonvotingCommonStockMember us-gaap:CommonStockMember 2024-12-31 0000778164 alto:CustomerAMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0000778164 alto:CustomerAMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0000778164 alto:CustomerAMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000778164 alto:CustomerBMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0000778164 alto:CustomerBMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0000778164 alto:CustomerBMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000778164 alto:PurchaseMember us-gaap:CustomerConcentrationRiskMember alto:SupplierAMember 2024-01-01 2024-12-31 0000778164 alto:PurchaseMember us-gaap:CustomerConcentrationRiskMember alto:SupplierAMember 2023-01-01 2023-12-31 0000778164 alto:PurchaseMember us-gaap:CustomerConcentrationRiskMember alto:SupplierAMember 2022-01-01 2022-12-31 0000778164 alto:PurchaseMember us-gaap:CustomerConcentrationRiskMember alto:SupplierBMember 2024-01-01 2024-12-31 0000778164 alto:PurchaseMember us-gaap:CustomerConcentrationRiskMember alto:SupplierBMember 2023-01-01 2023-12-31 0000778164 alto:PurchaseMember us-gaap:CustomerConcentrationRiskMember alto:SupplierBMember 2022-01-01 2022-12-31 0000778164 alto:PurchaseMember us-gaap:CustomerConcentrationRiskMember alto:SupplierCMember 2024-01-01 2024-12-31 0000778164 alto:PurchaseMember us-gaap:CustomerConcentrationRiskMember alto:SupplierCMember 2023-01-01 2023-12-31 0000778164 alto:PurchaseMember us-gaap:CustomerConcentrationRiskMember alto:SupplierCMember 2022-01-01 2022-12-31 0000778164 us-gaap:BuildingMember 2024-12-31 0000778164 srt:MinimumMember us-gaap:EquipmentMember 2024-12-31 0000778164 srt:MaximumMember us-gaap:EquipmentMember 2024-12-31 0000778164 srt:MinimumMember alto:OtherEquipmentVehiclesandFurnitureMember 2024-12-31 0000778164 srt:MaximumMember alto:OtherEquipmentVehiclesandFurnitureMember 2024-12-31 0000778164 alto:AcquisitionOfEagleAlcoholMember 2022-01-14 0000778164 alto:AcquisitionOfEagleAlcoholMember 2022-01-14 2022-01-14 0000778164 alto:AcquisitionOfEagleAlcoholMember 2024-12-31 0000778164 alto:AcquisitionOfEagleAlcoholMember 2023-12-31 0000778164 alto:AffiliateManagementAgreementMember 2024-01-01 2024-12-31 0000778164 alto:AltoIngredientsIncMember 2023-01-01 2023-12-31 0000778164 alto:AltoIngredientsIncMember 2022-01-01 2022-12-31 0000778164 alto:EthanolMarketingAgreementsMember 2024-01-01 2024-12-31 0000778164 alto:EthanolMarketingAgreementsMember 2023-01-01 2023-12-31 0000778164 alto:EthanolMarketingAgreementsMember 2022-01-01 2022-12-31 0000778164 alto:CornProcurementAndHandlingAgreementsMember 2024-01-01 2024-12-31 0000778164 alto:CornProcurementAndHandlingAgreementsMember 2023-01-01 2023-12-31 0000778164 alto:CornProcurementAndHandlingAgreementsMember 2022-01-01 2022-12-31 0000778164 alto:EssentialIngredientsMarketingAgreementsMember 2024-01-01 2024-12-31 0000778164 alto:EssentialIngredientsMarketingAgreementsMember 2023-01-01 2023-12-31 0000778164 alto:EssentialIngredientsMarketingAgreementsMember 2022-01-01 2022-12-31 0000778164 alto:PekinCampusProductionSegmentMember 2024-01-01 2024-12-31 0000778164 alto:PekinCampusProductionSegmentMember 2023-01-01 2023-12-31 0000778164 alto:PekinCampusProductionSegmentMember 2022-01-01 2022-12-31 0000778164 alto:MarketingAndDistributionSegmentMember 2024-01-01 2024-12-31 0000778164 alto:MarketingAndDistributionSegmentMember 2023-01-01 2023-12-31 0000778164 alto:MarketingAndDistributionSegmentMember 2022-01-01 2022-12-31 0000778164 alto:WesternProductionSegmentMember 2024-01-01 2024-12-31 0000778164 alto:WesternProductionSegmentMember 2023-01-01 2023-12-31 0000778164 alto:WesternProductionSegmentMember 2022-01-01 2022-12-31 0000778164 alto:PekinCampusSegmentMember 2024-01-01 2024-12-31 0000778164 alto:PekinCampusSegmentMember 2023-01-01 2023-12-31 0000778164 alto:PekinCampusSegmentMember 2022-01-01 2022-12-31 0000778164 alto:EthanolAlcoholSalesMember alto:PekinCampusProductionMember 2024-01-01 2024-12-31 0000778164 alto:EthanolAlcoholSalesMember alto:PekinCampusProductionMember 2023-01-01 2023-12-31 0000778164 alto:EthanolAlcoholSalesMember alto:PekinCampusProductionMember 2022-01-01 2022-12-31 0000778164 alto:EssentialIngredientSalesMember alto:PekinCampusProductionMember 2024-01-01 2024-12-31 0000778164 alto:EssentialIngredientSalesMember alto:PekinCampusProductionMember 2023-01-01 2023-12-31 0000778164 alto:EssentialIngredientSalesMember alto:PekinCampusProductionMember 2022-01-01 2022-12-31 0000778164 alto:IntersegmentSaleMember alto:PekinCampusProductionMember 2024-01-01 2024-12-31 0000778164 alto:IntersegmentSaleMember alto:PekinCampusProductionMember 2023-01-01 2023-12-31 0000778164 alto:IntersegmentSaleMember alto:PekinCampusProductionMember 2022-01-01 2022-12-31 0000778164 alto:IntersegmentSaleMember alto:TotalPekinCampusSalesMember 2024-01-01 2024-12-31 0000778164 alto:IntersegmentSaleMember alto:TotalPekinCampusSalesMember 2023-01-01 2023-12-31 0000778164 alto:IntersegmentSaleMember alto:TotalPekinCampusSalesMember 2022-01-01 2022-12-31 0000778164 alto:AlcoholSalesGrossMember alto:MarketingAndDistributionsMember 2024-01-01 2024-12-31 0000778164 alto:AlcoholSalesGrossMember alto:MarketingAndDistributionsMember 2023-01-01 2023-12-31 0000778164 alto:AlcoholSalesGrossMember alto:MarketingAndDistributionsMember 2022-01-01 2022-12-31 0000778164 alto:AlcoholSalesNetMember alto:MarketingAndDistributionsMember 2024-01-01 2024-12-31 0000778164 alto:AlcoholSalesNetMember alto:MarketingAndDistributionsMember 2023-01-01 2023-12-31 0000778164 alto:AlcoholSalesNetMember alto:MarketingAndDistributionsMember 2022-01-01 2022-12-31 0000778164 alto:IntersegmentSaleMember alto:MarketingAndDistributionsMember 2024-01-01 2024-12-31 0000778164 alto:IntersegmentSaleMember alto:MarketingAndDistributionsMember 2023-01-01 2023-12-31 0000778164 alto:IntersegmentSaleMember alto:MarketingAndDistributionsMember 2022-01-01 2022-12-31 0000778164 alto:IntersegmentSaleMember alto:TotalMarketingAndDistributionSalesMember 2024-01-01 2024-12-31 0000778164 alto:IntersegmentSaleMember alto:TotalMarketingAndDistributionSalesMember 2023-01-01 2023-12-31 0000778164 alto:IntersegmentSaleMember alto:TotalMarketingAndDistributionSalesMember 2022-01-01 2022-12-31 0000778164 alto:AlcoholSalesMember alto:WesternProductionSegmentMember 2024-01-01 2024-12-31 0000778164 alto:AlcoholSalesMember alto:WesternProductionSegmentMember 2023-01-01 2023-12-31 0000778164 alto:AlcoholSalesMember alto:WesternProductionSegmentMember 2022-01-01 2022-12-31 0000778164 alto:EssentialIngredientSalesMember alto:WesternProductionSegmentMember 2024-01-01 2024-12-31 0000778164 alto:EssentialIngredientSalesMember alto:WesternProductionSegmentMember 2023-01-01 2023-12-31 0000778164 alto:EssentialIngredientSalesMember alto:WesternProductionSegmentMember 2022-01-01 2022-12-31 0000778164 alto:IntersegmentSaleMember alto:WesternProductionSegmentMember 2024-01-01 2024-12-31 0000778164 alto:IntersegmentSaleMember alto:WesternProductionSegmentMember 2023-01-01 2023-12-31 0000778164 alto:IntersegmentSaleMember alto:WesternProductionSegmentMember 2022-01-01 2022-12-31 0000778164 alto:IntersegmentSaleMember alto:WesternProductionSegmentMember alto:TotalWesternProductionSalesMember 2024-01-01 2024-12-31 0000778164 alto:IntersegmentSaleMember alto:WesternProductionSegmentMember alto:TotalWesternProductionSalesMember 2023-01-01 2023-12-31 0000778164 alto:IntersegmentSaleMember alto:WesternProductionSegmentMember alto:TotalWesternProductionSalesMember 2022-01-01 2022-12-31 0000778164 us-gaap:CorporateAndOtherMember 2024-01-01 2024-12-31 0000778164 us-gaap:CorporateAndOtherMember 2023-01-01 2023-12-31 0000778164 us-gaap:CorporateAndOtherMember 2022-01-01 2022-12-31 0000778164 alto:IntersegmentEliminationsMember 2024-01-01 2024-12-31 0000778164 alto:IntersegmentEliminationsMember 2023-01-01 2023-12-31 0000778164 alto:IntersegmentEliminationsMember 2022-01-01 2022-12-31 0000778164 alto:PekinCampusProductionMember 2024-01-01 2024-12-31 0000778164 alto:PekinCampusProductionMember 2023-01-01 2023-12-31 0000778164 alto:PekinCampusProductionMember 2022-01-01 2022-12-31 0000778164 alto:MarketingAndDistributionsMember 2024-01-01 2024-12-31 0000778164 alto:MarketingAndDistributionsMember 2023-01-01 2023-12-31 0000778164 alto:MarketingAndDistributionsMember 2022-01-01 2022-12-31 0000778164 alto:WesternProductionMember 2024-01-01 2024-12-31 0000778164 alto:WesternProductionMember 2023-01-01 2023-12-31 0000778164 alto:WesternProductionMember 2022-01-01 2022-12-31 0000778164 alto:PekinCampusProductionMember 2024-12-31 0000778164 alto:PekinCampusProductionMember 2023-12-31 0000778164 alto:MarketingAndDistributionsMember 2024-12-31 0000778164 alto:MarketingAndDistributionsMember 2023-12-31 0000778164 alto:WesternProductionMember 2024-12-31 0000778164 alto:WesternProductionMember 2023-12-31 0000778164 us-gaap:CorporateAndOtherMember 2024-12-31 0000778164 us-gaap:CorporateAndOtherMember 2023-12-31 0000778164 alto:KinergyTradenameMember 2024-01-01 2024-12-31 0000778164 us-gaap:CustomerRelationshipsMember 2024-01-01 2024-12-31 0000778164 alto:EagleAlcoholTradenameMember 2024-01-01 2024-12-31 0000778164 alto:CustomerRelationshipsAndTradenameMember 2024-01-01 2024-12-31 0000778164 us-gaap:GoodwillMember 2024-12-31 0000778164 us-gaap:GoodwillMember 2023-12-31 0000778164 alto:KinergyTradenameMember 2024-12-31 0000778164 alto:KinergyTradenameMember 2023-12-31 0000778164 us-gaap:CustomerRelationshipsMember 2024-12-31 0000778164 us-gaap:CustomerRelationshipsMember 2023-12-31 0000778164 alto:EagleAlcoholTradenameMember 2024-12-31 0000778164 alto:EagleAlcoholTradenameMember 2023-12-31 0000778164 alto:CashCollateralBalanceMember 2024-12-31 0000778164 us-gaap:CommodityContractMember 2024-12-31 0000778164 alto:CashCollateralBalanceMember 2023-12-31 0000778164 us-gaap:CommodityContractMember 2023-12-31 0000778164 alto:RealizedGainsLossesMember us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2024-01-01 2024-12-31 0000778164 alto:RealizedGainsLossesMember us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2023-01-01 2023-12-31 0000778164 alto:RealizedGainsLossesMember us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0000778164 alto:RealizedGainsLossesMember us-gaap:CostOfSalesMember 2024-01-01 2024-12-31 0000778164 alto:RealizedGainsLossesMember us-gaap:CostOfSalesMember 2023-01-01 2023-12-31 0000778164 alto:RealizedGainsLossesMember us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0000778164 alto:UnrealizedGainsLossesMember us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2024-01-01 2024-12-31 0000778164 alto:UnrealizedGainsLossesMember us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2023-01-01 2023-12-31 0000778164 alto:UnrealizedGainsLossesMember us-gaap:CommodityContractMember us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0000778164 alto:UnrealizedGainsLossesMember us-gaap:CostOfSalesMember 2024-01-01 2024-12-31 0000778164 alto:UnrealizedGainsLossesMember us-gaap:CostOfSalesMember 2023-01-01 2023-12-31 0000778164 alto:UnrealizedGainsLossesMember us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0000778164 srt:ScenarioForecastMember alto:KinergyLineOfCreditMember 2027-11-07 0000778164 srt:MinimumMember 2024-01-01 2024-12-31 0000778164 srt:MaximumMember 2024-01-01 2024-12-31 0000778164 alto:KinergyLineOfCreditMember 2024-12-31 0000778164 alto:KinergyMember 2024-01-01 2024-12-31 0000778164 alto:AltoNutrientsMember 2024-01-01 2024-12-31 0000778164 alto:OrionTermLoanMember 2024-01-01 2024-12-31 0000778164 2022-11-23 2022-11-23 0000778164 2022-11-23 0000778164 alto:OrionTermLoanMember 2024-12-31 0000778164 2025-01-01 2025-01-01 0000778164 alto:IfLeverageRatioIsGreaterThanOrEqualToThreePointZeroxMember 2024-01-01 2024-12-31 0000778164 alto:IfTheLeverageRatioIsLessThanThreePointZeroxAndGreaterThanOrEqualToOnePointFivexMember 2024-01-01 2024-12-31 0000778164 alto:IfTheLeverageRatioIsLessThan15xMember 2024-01-01 2024-12-31 0000778164 alto:KinergyLineOfCreditMember 2023-12-31 0000778164 alto:OrionTermLoanMember 2023-12-31 0000778164 us-gaap:EquipmentMember 2024-12-31 0000778164 us-gaap:LandMember 2024-12-31 0000778164 us-gaap:EquipmentMember 2023-12-31 0000778164 us-gaap:LandMember 2023-12-31 0000778164 us-gaap:EquipmentMember 2024-12-31 0000778164 alto:LandRelatedMember 2024-12-31 0000778164 srt:ScenarioForecastMember 2025-01-01 2025-12-31 0000778164 us-gaap:DefinedBenefitPlanEquitySecuritiesMember 2024-12-31 0000778164 us-gaap:DefinedBenefitPlanDebtSecurityMember 2024-12-31 0000778164 alto:PreMedicarePostretirementMember 2024-12-31 0000778164 alto:PostretirementPlanMember 2024-01-01 2024-12-31 0000778164 alto:RetirementPlanMember 2023-12-31 0000778164 alto:RetirementPlanMember 2022-12-31 0000778164 alto:RetirementPlanMember 2024-01-01 2024-12-31 0000778164 alto:RetirementPlanMember 2023-01-01 2023-12-31 0000778164 alto:RetirementPlanMember 2024-12-31 0000778164 alto:RetirementPlanMember 2022-01-01 2022-12-31 0000778164 alto:PostretirementPlanMember 2023-01-01 2023-12-31 0000778164 alto:PostretirementPlanMember 2022-01-01 2022-12-31 0000778164 alto:PostretirementPlanMember 2024-12-31 0000778164 us-gaap:DomesticCountryMember 2024-12-31 0000778164 us-gaap:StateAndLocalJurisdictionMember 2024-12-31 0000778164 alto:TaxYear2025Member 2024-12-31 0000778164 alto:TaxYear2025Member 2024-01-01 2024-12-31 0000778164 alto:AssessmentMember 2024-12-31 0000778164 alto:AssessmentMember 2023-12-31 0000778164 alto:TwoThousandAndTwentyFiveAndTwoThousandAndTwentyNineMember us-gaap:DomesticCountryMember 2024-12-31 0000778164 alto:TwoThousandAndTwentyFiveAndTwoThousandAndTwentyNineMember us-gaap:StateAndLocalJurisdictionMember 2024-12-31 0000778164 alto:TwoThousandAndThirtyAndTwoThousandAndThirtyFourMember us-gaap:DomesticCountryMember 2024-12-31 0000778164 alto:TwoThousandAndThirtyAndTwoThousandAndThirtyFourMember us-gaap:StateAndLocalJurisdictionMember 2024-12-31 0000778164 alto:TwoThousandThirtyFiveAndTwoThousandAndThirtyNineMember us-gaap:DomesticCountryMember 2024-12-31 0000778164 alto:TwoThousandThirtyFiveAndTwoThousandAndThirtyNineMember us-gaap:StateAndLocalJurisdictionMember 2024-12-31 0000778164 alto:TwoThousandAndFortyAndAfterMember us-gaap:DomesticCountryMember 2024-12-31 0000778164 alto:TwoThousandAndFortyAndAfterMember us-gaap:StateAndLocalJurisdictionMember 2024-12-31 0000778164 alto:FederalMember 2024-01-01 2024-12-31 0000778164 alto:AlabamaMember 2024-01-01 2024-12-31 0000778164 alto:ArizonaMember 2024-01-01 2024-12-31 0000778164 alto:ArkansasMember 2024-01-01 2024-12-31 0000778164 alto:CaliforniaMember 2024-01-01 2024-12-31 0000778164 alto:ColoradoMember 2024-01-01 2024-12-31 0000778164 alto:ConnecticutMember 2024-01-01 2024-12-31 0000778164 alto:GeorgiaMember 2024-01-01 2024-12-31 0000778164 alto:IdahoMember 2024-01-01 2024-12-31 0000778164 alto:IllinoisMember 2024-01-01 2024-12-31 0000778164 alto:IndianaMember 2024-01-01 2024-12-31 0000778164 alto:IowaMember 2024-01-01 2024-12-31 0000778164 alto:KansasMember 2024-01-01 2024-12-31 0000778164 alto:LouisianaMember 2024-01-01 2024-12-31 0000778164 alto:MichiganMember 2024-01-01 2024-12-31 0000778164 alto:MinnesotaMember 2024-01-01 2024-12-31 0000778164 alto:MississippiMember 2024-01-01 2024-12-31 0000778164 alto:MissouriMember 2024-01-01 2024-12-31 0000778164 alto:NebraskaMember 2024-01-01 2024-12-31 0000778164 alto:NewMexicoMember 2024-01-01 2024-12-31 0000778164 alto:OklahomaMember 2024-01-01 2024-12-31 0000778164 alto:OregonMember 2024-01-01 2024-12-31 0000778164 alto:PennsylvaniaMember 2024-01-01 2024-12-31 0000778164 alto:RhodeIslandMember 2024-01-01 2024-12-31 0000778164 alto:SouthCarolinaMember 2024-01-01 2024-12-31 0000778164 alto:TennesseeMember 2024-01-01 2024-12-31 0000778164 alto:TexasMember 2024-01-01 2024-12-31 0000778164 srt:BoardOfDirectorsChairmanMember 2024-12-31 0000778164 us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-12-31 0000778164 us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-12-31 0000778164 2016-06-16 0000778164 alto:TwoThousandSixteenStockIncentivePlanMember 2018-06-14 0000778164 alto:TwoThousandSixteenStockIncentivePlanMember 2019-11-07 0000778164 alto:TwoThousandSixteenStockIncentivePlanMember 2020-11-18 0000778164 alto:TwoThousandSixteenStockIncentivePlanMember 2022-06-23 0000778164 alto:TwoThousandSixteenStockIncentivePlanMember 2023-06-22 0000778164 alto:TwoThousandSixteenStockIncentivePlanMember 2024-06-20 0000778164 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0000778164 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0000778164 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0000778164 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-12-31 0000778164 us-gaap:RestrictedStockUnitsRSUMember 2024-12-31 0000778164 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2024-01-01 2024-12-31 0000778164 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2023-01-01 2023-12-31 0000778164 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2022-01-01 2022-12-31 0000778164 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2024-01-01 2024-12-31 0000778164 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2023-01-01 2023-12-31 0000778164 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2022-01-01 2022-12-31 0000778164 alto:SalesCommitmentsMember 2024-01-01 2024-12-31 0000778164 alto:AlcoholSalesContractsMember 2024-12-31 0000778164 alto:AlcoholFromItsSuppliersMember alto:EthanolPurchaseContractsMember 2024-01-01 2024-12-31 0000778164 alto:AlcoholFromItsSuppliersMember alto:EthanolPurchaseContractsMember 2024-12-31 0000778164 alto:CornFromSuppliersMember alto:EthanolPurchaseContractsMember 2024-12-31 0000778164 us-gaap:NaturalGasProductionMember alto:EthanolPurchaseContractsMember 2024-01-01 2024-12-31 0000778164 alto:KodiakCarbonicLLCMember 2024-01-01 2024-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember 2024-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0000778164 alto:LonglivedAssetsMagicValleyMember 2024-12-31 0000778164 alto:LonglivedAssetsMagicValleyMember us-gaap:FairValueInputsLevel1Member 2024-12-31 0000778164 alto:LonglivedAssetsMagicValleyMember us-gaap:FairValueInputsLevel2Member 2024-12-31 0000778164 alto:LonglivedAssetsMagicValleyMember us-gaap:FairValueInputsLevel3Member 2024-12-31 0000778164 alto:LargeUSEquityMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:LargeUSEquityMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:LargeUSEquityMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:LargeUSEquityMember 2024-12-31 0000778164 alto:SmallMidUSEquityMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:SmallMidUSEquityMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:SmallMidUSEquityMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:SmallMidUSEquityMember 2024-12-31 0000778164 alto:InternationalEquityMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:InternationalEquityMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:InternationalEquityMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:InternationalEquityMember 2024-12-31 0000778164 alto:FixedIncomeMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:FixedIncomeMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:FixedIncomeMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:FixedIncomeMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel1Member 2024-12-31 0000778164 us-gaap:FairValueInputsLevel2Member 2024-12-31 0000778164 us-gaap:FairValueInputsLevel3Member 2024-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-12-31 0000778164 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2024-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:LargeUSEquityMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:LargeUSEquityMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:LargeUSEquityMember 2023-12-31 0000778164 alto:LargeUSEquityMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:SmallMidUSEquityMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:SmallMidUSEquityMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:SmallMidUSEquityMember 2023-12-31 0000778164 alto:SmallMidUSEquityMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:InternationalEquityMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:InternationalEquityMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:InternationalEquityMember 2023-12-31 0000778164 alto:InternationalEquityMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:FixedIncomeMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:FixedIncomeMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:FixedIncomeMember 2023-12-31 0000778164 alto:FixedIncomeMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel1Member 2023-12-31 0000778164 us-gaap:FairValueInputsLevel2Member 2023-12-31 0000778164 us-gaap:FairValueInputsLevel3Member 2023-12-31 0000778164 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-12-31 0000778164 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2023-12-31 0000778164 alto:KodiakCarbonicLLCMember us-gaap:SubsequentEventMember 2025-01-01 0000778164 us-gaap:SubsequentEventMember 2025-01-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares utr:gal utr:T xbrli:pure utr:dth

Exhibit 10.26

 

SECOND AMENDMENT TO CREDIT AGREEMENT This SECOND AMENDMENT TO CREDIT AGREEMENT (this Amendment ), dated as of November 6 , 2024 (the Second Amendment Effective Date ), by and between Alto Ingredients, Inc . , a Delaware corporation ( Borrower ), and OIC Investment Agent, LLC, a Delaware limited liability company, as Administrative Agent and Collateral Agent, (in such capacities, Administrative Agent ) . Borrower and Administrative Agent may occasionally be referred to collectively herein as the Parties or individually as a Party . WHEREAS , Borrower and Administrative Agent entered into that certain Credit Agreement dated as of November 7 , 2022 , among Borrower, the Subsidiary Guarantors signatory thereto, the Lenders from time to time party thereto, and Administrative Agent, as Administrative Agent and Collateral Agent (as amended by that certain First Amendment to Credit Agreement dated as of November 6 , 2023 , the Existing Credit Agreement and the Existing Credit Agreement as expressly amended by this Amendment, the Credit Agreement ) ; WHEREAS , pursuant and subject to Section 10 . 02 (b) of the Credit Agreement, the Parties now desire to modify certain portions of the Existing Credit Agreement, all as set forth herein . NOW, THEREFORE , for and in consideration of the mutual covenants and premises set forth herein, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the Parties agree as follows : Section 1 . Amendments to the Existing Credit Agreement . Effective as of the Second Amendment Effective Date, each of Administrative Agent (acting on behalf of the Required Lenders) and Borrower hereby agrees to amend the Existing Credit Agreement as follows : (a) Section 1 . 01 of the Existing Credit Agreement is hereby amended to amend and restate each of the following definitions set forth therein, each to read in their entirety as follows : Adjusted EBITDA means, for any date of determination, an amount equal to Consolidated EBITDA. Consolidated EBITDA means, for any period, an amount equal to consolidated EBITDA for such period as publicly filed or reported. Excess Cash Flow means, for any period: (a) Consolidated EBITDA for such period, less (b) the sum, without duplication, of : (i) the aggregate amount of all principal payments under this Agreement made in cash during such period (including the amount of any scheduled repayment of Loans pursuant 1

 

to Section 2 . 04 , any voluntary prepayments pursuant to Section 2 . 05 (a) and any mandatory prepayments pursuant to Section 2 . 05 (b) but excluding mandatory prepayments pursuant to Section 2 . 05 (b)(iv) ) ; (ii) the aggregate amount of all interest payments under this Agreement and the ABL Credit Agreement made in cash during such period ; (iii) any amounts paid in cash in connection with the Loans during such period to the extent not funded with Indebtedness ; (iv) the aggregate amount of Capital Expenditures incurred in accordance with the Capital Expenditures Plan and Budget and paid in cash during such period to the extent financed with internally generated cash ; (v) the aggregate amount of scheduled fees and other similar fees payable under the Financing Documents paid in cash during such period ; (vi) the aggregate amount of cash taxes paid by the Loan Parties in such period ; (vii) the aggregate amount necessary to meet the Minimum Liquidity Threshold ; and (viii) the aggregate amount of any Restricted Payments made pursuant to Section 6 . 06 (f) in such period ; plus (c) the sum, without duplication, of the Net Proceeds of any extraordinary, non - recurring or unusual cash income or gains of the Loan Parties for such period, in each case to the extent not included in Consolidated EBITDA for such period . Notwithstanding anything in the definition of any term used in the definition of Excess Cash Flow to the contrary, all components of Excess Cash Flow shall be computed for the Loan Parties on a consolidated basis . Incremental Commitment Expiration Date means April 7 , 2026 . Specified CapEx Commitment Expiration Date means April 7 , 2026 . Section 2 . CO 2 Transportation and Sequestration Agreement . Parties agree and acknowledge that (a) Alto Pekin, LLC, a Subsidiary of the Borrower, and Vault Dragon CCS Holdings LP, a Delaware limited partnership, are contemplating entering into that certain CO 2 Transportation and Sequestration Agreement and (b) other than as set forth in the Credit Agreement, Administrative Agent has not consented to any credit support, guarantee or other form of Indebtedness of the Borrower related thereto . Section 3. Representations and Warranties . 2

 

(a) Authorization, Etc . Borrower has full corporate, limited liability company, limited partnership or other organizational powers, authority and legal right to enter into, deliver and perform its respective obligations under this Amendment and to consummate each of the transactions contemplated herein, and has taken all necessary corporate, limited liability company, limited partnership or other organizational action to authorize the execution, delivery and performance by it of this Amendment . This Amendment has been duly executed and delivered by Borrower and is in full force and effect and constitutes a legal, valid and binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as enforcement may be limited (i) by Bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws affecting creditors' rights generally, (ii) by general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law) or (iii) by implied covenants of good faith and fair dealing . (b) No Conflict . The execution, delivery and performance by Borrower of this Amendment, as well as the consummation of the transactions contemplated herein, do not and will not (i) conflict with the Organizational Documents of Borrower, (ii) conflict with or result in a breach of, or constitute a default under, any indenture, loan agreement, mortgage, deed of trust or other instrument or agreement to which any Loan Party is a party or by which it is bound or to which any Loan Party's property or assets are subject, except where such contravention, breach or default, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect, (iii) conflict with or result in a breach of, or constitute a default under, in any material respect, any Applicable Law (including, assuming the accuracy of the representations and warranties of the Lenders set forth in a certificate or certificates delivered by the Lenders to Borrower at or prior to any issuance of Participation Shares, federal and state securities laws and regulations and the rules and regulations of any self - regulatory organization to which Borrower or its securities are subject), except where such contravention or breach could not reasonably be expected to have a Material Adverse Effect, or (iv) with respect to each Loan Party, result in the creation or imposition of any Lien (other than a Permitted Lien) upon any Loan Party's property or the Collateral . (c) No Default or Event of Default has occurred and is continuing. (d) The representations and warranties of each Loan Party set forth in the Financing Documents are true and correct in all material respects (except where already qualified by materiality or Material Adverse Effect, in which case, such representations and warranties are true and correct in all respects) on and as of the Second Amendment Effective Date (unless stated to relate solely to an earlier date, in which case such representations and warranties were true and correct as of such earlier date) . Section 4. Miscellaneous . (a) This Amendment shall become effective on the date first set forth above . On and after the Second Amendment Effective Date, each reference in the Credit Agreement to this Agreement , hereunder , hereof' or words of like import, referring to 3

 

the Credit Agreement and each reference in each other Financing Document to the Credit Agreement , thereunder , thereof' or words of like import referring to the Credit Agreement shall mean and be a reference to the Existing Credit Agreement as amended or otherwise modified by this Amendment . This Amendment shall constitute a Financing Document for purposes of the Credit Agreement . (b) THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AMENDMENT AND ANY DISPUTE OF CLAIMS ARISING IN CONNECTION THEREWITH SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK . (c) Except as expressly set forth in this Amendment, all other terms and conditions of the Credit Agreement shall remain in full force and effect and the execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any default of Borrower or any right, power or remedy of Administrative Agent or the Lenders under any of the Financing Documents, nor constitute a waiver of any provision of any of the Financing Documents . All capitalized terms used herein and not otherwise defined or redefined herein shall have the meanings assigned to them in the Credit Agreement, and all terms defined or redefined herein shall be given the meaning set out herein . (d) Sections 10 . 07 (Severability), 10 . 09 (Governing Law ; Jurisdiction ; Etc . ) and 10 . 11 (Headings) of the Credit Agreement are hereby incorporated by reference herein, mutatis mutandis . (e) This Amendment shall constitute an integral part of the Credit Agreement and be effective as stipulated above and upon signature by the respective Parties and shall remain valid until the date the Credit Agreement expires or otherwise terminates . (f) The undersigned hereby acknowledge that it has read and fully understands the terms of this Amendment, the terms and conditions of which are hereby incorporated and acknowledged by this reference . This Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument . This Amendment is binding upon and shall inure to the benefit of Administrative Agent, the Lenders and the Loan Parties and their respective successors and permitted assigns . (g) The undersigned individuals certify that they are competent and authorized to enter into this Amendment on behalf of the Party for whom he or she purports to sign . [ Signature Pages Follow ] 4

 

IN WITNESS WHEREOF, the Parties, by their authorized representatives, have duly executed this Amendment as of the Second Amendment Effective Date. ALTO INGREDIENTS, INC., as the Borrower By: Name: Robert R. Olander Title: CFO [ Signature Page to Alto Second Amendment to Credit Agreement ]

 

OIC INVESTMENT AGENT, LLC , as Administrative Agent By: Name: Ethan Shoemaker Title: Investment Partner [ Signature Page to Alto Second Amendment to Credit Agreement ]

 

Exhibit 10.27

 

Execution Version 

 

CONSENT AND THIRD AMENDMENT TO CREDIT AGREEMENT

 

This CONSENT AND THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is dated as of January 1, 2025 (the “Third Amendment Effective Date”), by and between Alto Ingredients, Inc., a Delaware corporation as Borrower (“Borrower”), and OIC Investment Agent, LLC, a Delaware limited liability company as Administrative Agent and Collateral Agent (in such capacities, “Administrative Agent”). Borrower and Administrative Agent may occasionally be referred to collectively herein as the “Parties” or individually as a “Party.”

 

WHEREAS, Borrower and Administrative Agent entered into that certain Credit Agreement dated as of November 7, 2022, among Borrower, the Subsidiary Guarantors signatory thereto, the Lenders from time to time party thereto, and Administrative Agent, as Administrative Agent and Collateral Agent (as amended by that certain First Amendment to Credit Agreement dated as of November 6, 2023 and that certain Second Amendment to Credit Agreement dated as of November 6, 2024, the “Existing Credit Agreement” and the Existing Credit Agreement as expressly amended by this Amendment, the “Credit Agreement”);

 

WHEREAS, in connection with the execution and delivery of this Amendment, Alto Columbia, LLC, a Delaware limited liability company (“Purchaser”) is entering into that certain Membership Interest Purchase Agreement dated as of the date hereof (the “MIPA”) and, together with each other agreement, instrument or certificate executed and/or delivered in connection with the MIPA, collectively, the “MIPA Documents”, among Purchaser, Kodiak Carbonic, LLC, a Wyoming limited liability company (“Company”), and each of John D. Coons, an individual (“Coons”), Michael F. Ray, an individual (“Ray”) and Michael E. Deiker, an individual (“Deiker” and, together with Coons and Ray, each, a “Seller” and, collectively, “Sellers”), pursuant to which, among other things, Purchaser purchases 100% of the issued and outstanding membership interests of Company from Sellers, on the terms and subject to the conditions set forth in the MIPA (the “Acquisition”);

 

WHEREAS, Company entered into that certain Liquid Carbon Dioxide Product Supply Agreement dated as of September 25, 2014, among Company, as seller, and Air Liquide Industrial U.S. LP, a Delaware limited partnership, as buyer (as amended by that certain Amendment Number 1 dated as of January 8, 2016, Amendment Number 2 dated as of April 30, 2021, Amendment Number 3 dated as of April 30, 2021, the “Existing Offtake Contract”);

 

WHEREAS, in connection with the execution and delivery of this Amendment and the MIPA, Company, Alto Carbonic, LLC, a wholly-owned subsidiary of Alto Columbia, LLC (and eventual successor in interest to Company), and Airgas USA, LLC desire to amend and restate the Existing Offtake Contract by entering into that certain Amended and Restated Liquid Carbon Product Supply Agreement dated as of January 1, 2025 (the “Amended and Restated Supply Agreement”) which reflects, among other things, a reduction in the annual take-or-pay volume;

 

WHEREAS, the consummation of the Acquisition by a Loan Party is not permitted under Section 6.04 of the Credit Agreement; and

 

 

 

WHEREAS, the Loan Parties have requested that Administrative Agent (on behalf of the Required Lenders) (i) approve the Acquisition and (ii) make certain other modifications to the Existing Credit Agreement, and Administrative Agent (on behalf of the Required Lenders) have agreed to the foregoing request of the Loan Parties, all on the terms and subject to the conditions set forth herein.

 

NOW THEREFORE, for and in consideration of the mutual covenants and premises set forth herein, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the Parties agree as follows:

 

1. Amendments to the Existing Credit Agreement. Effective as of the Third Amendment Effective Date, each of Administrative Agent (acting on behalf of the Required Lenders) and Borrower hereby agrees to amend the Existing Credit Agreement as follows:

 

a. Section 1.01 of the Existing Credit Agreement is hereby amended to amend and restate each of the following definitions set forth therein, each to read in its entirety as follows:

 

Interest Rate” means a rate per annum equal to 10.75%.

 

b. Section 1.01 of the Existing Credit Agreement is hereby amended to include the following definition in appropriate alphabetical order:

 

Third Amendment Effective Date” means January 1, 2025.

 

c. Section 2.05(c)(ii) of the Existing Credit Agreement is hereby amended and restated in its entirety as follows:

 

(ii) Each prepayment of Loans shall be accompanied by payment of all accrued interest on the amount prepaid, the Prepayment Premium (other than in the case of Section 2.05(b)(i) and 2.05(b)(iv) above) and any additional amounts required pursuant to Section 2.09; provided that no Prepayment Premium shall be required to be paid in connection with any prepayment of principal of Loans pursuant to Section 2.05(a), Section 2.05(b)(ii) or Section 2.05(b)(iii) that occurs from the Third Amendment Effective Date until December 31, 2025 so long as the aggregate amount of all such principal prepayments during such period does not exceed $5,000,000.

 

d. Section 6.04(d) of the Existing Credit Agreement is hereby amended and restated in its entirety as follows:

 

(d) with respect to any Loan Parties (other than the Marketing Affiliates), any acquisition of all or substantially all the assets of a Person, or any Capital Stock in a Person that becomes a Subsidiary Guarantor (provided such Person becomes a Subsidiary Guarantor within the time limits set forth in Section 5.16 to the extent required thereunder), in a single transaction or series of related transactions, if immediately after giving effect thereto: (a) no Event of Default shall have occurred and be continuing prior to or as a result of such acquisition, (b) any acquired or newly formed Subsidiary Guarantor shall not be liable for any Indebtedness, (c) to the extent required by the Collateral and Guarantee Requirement, (i) the property, assets and businesses acquired in such purchase or other acquisition shall constitute Collateral and (ii) any such newly created or acquired Subsidiary shall become a Guarantor, in each case, in accordance with Section 5.16 and (d) such acquisition is funded by (i) Retained Excess Cash Flow, (ii) the proceeds of any cash equity contribution to the common equity of Borrower, or (iii) Capital Stock of the Borrower;

 

2

 

 

2. Limited Consent. Administrative Agent hereby consents by its execution of this Amendment, and subject to the satisfaction of the conditions set forth in Section 3 below and the occurrence of the Third Amendment Effective Date and in reliance on the representations and warranties in Section 5 below, to (i) the consummation of the Acquisition and (ii) the entering into the MIPA on the terms and conditions set forth therein. The foregoing is a limited consent, and except as expressly set forth in this Amendment, the foregoing consent (a) shall not be deemed to operate as, or obligate Administrative Agent or any Lender to grant, any future consent or modification of any other term or condition of the Financing Documents, (b) shall not constitute a modification or alteration of the terms, conditions or covenants of the Existing Credit Agreement or any other Financing Document and (c) shall not be deemed to prejudice any right or rights which Administrative Agent or any Lender may now have or may have in the future under or in connection with any Financing Document or any of the instruments or agreements referred to therein, as the same may be amended from time to time.

 

3. Conditions to Effectiveness. This Amendment shall become effective on the Third Amendment Effective Date when, and only when, each of the applicable conditions set forth below has been satisfied (or waived by Administrative Agent) in accordance with the terms herein:

 

a. this Amendment shall have been executed and delivered by Borrower and Administrative Agent;

 

b. Administrative Agent and the Lenders shall have received (i) an executed copy of the MIPA and the other material MIPA Documents, (ii) a confirmation from Borrower that (A) the closing of the Acquisition was consummated prior to, or substantially simultaneously with, the closing of this Amendment and (B) the filings, permits, authorizations, consents and approvals contemplated under the MIPA were obtained (or waived) prior to, or substantially simultaneously with, the closing of this Amendment, and (iii) evidence satisfactory to Administrative Agent and the Lenders that, at the closing of the Acquisition, all Liens (other than Permitted Liens) on the assets of Company shall be terminated and released substantially simultaneously with the Third Amendment Effective Date;

 

c. Administrative Agent and the Lenders shall have received an executed copy of the Amended and Restated Supply Agreement;

 

d. [reserved];

 

e. Administrative Agent and the Lenders shall have received certificates of status, existence and good standing or the equivalent in the jurisdiction of incorporation or formation of the applicable Loan Party, dated a recent date, for each Loan Party from each of the jurisdictions where such Loan Party is organized or formed, as applicable;

 

f. the representations and warranties of Borrower and the other Loan Parties contained in Section 5 below and in Article III of the Existing Credit Agreement and any other Financing Documents shall be true and correct in all material respects on and as of the Third Amendment Effective Date (except where already qualified by materiality or Material Adverse Effect, in which case, such representations and warranties are true and correct in all respects) on and as of the Third Amendment Effective Date (unless stated to relate solely to an earlier date, in which case such representations and warranties were true and correct as of such earlier date);

 

g. Borrower shall have paid all fees and expenses due and payable to Administrative Agent and the Lenders pursuant to the Financing Documents and shall reimburse Administrative Agent and the Lenders for all reasonable and documented out- of-pocket costs and expenses (including the reasonable fees and expenses of counsel to Administrative Agent) incurred by Administrative Agent and the Lenders in connection with the evaluation, negotiation, preparation, execution, delivery and performance of this Amendment;

 

h. all proceedings taken in connection with the transactions contemplated by this Amendment and all documents, instruments and other legal matters incident thereto shall be reasonably satisfactory to Administrative Agent and its legal counsel; and

 

i. no Default or Event of Default shall have occurred and be continuing.

 

3

 

 

4. Security. Each Loan Party expressly acknowledges and agrees that all security interests, liens, pledges and mortgages granted to Collateral Agent for the benefit of itself and the Secured Parties in connection with the Credit Agreement, as amended by this Amendment, or hereafter granted to Collateral Agent for the benefit of itself and the Secured Parties, and all other supplements to the Credit Agreement or any Financing Document, extend to and cover all of the Obligations of the Loan Parties to the Lenders, now existing or hereafter arising, including, without limitation, those arising in connection with the Credit Agreement, as amended by this Amendment, upon the terms set forth in such agreements, and all of such security interests, liens, pledges, and mortgages are hereby ratified, reaffirmed, confirmed and approved. Each Loan Party hereby restates, ratifies and reaffirms each and every term and condition set forth in the Credit Agreement, as amended by this Amendment, and the other Financing Documents effective as of the date hereof, including, without limitation, the grant of security interests and liens by Borrower and the other Loan Parties under the Security Documents and confirms and agrees that such security interests and liens hereafter secure all of the Obligations as amended hereby. The validity and enforceability of any appointment of Administrative Agent as proxy or attorney-in-fact under any Financing Document is ratified and reaffirmed as of the date hereof, which appointment remains IRREVOCABLE and coupled with an interest and shall continue in full force and effect until the Payment in Full of Term Loan Debt, for the purpose of carrying out the provisions of the Financing Documents, in accordance with the terms of, and to the extent provided in, such Financing Documents.

 

5. Representations and Warranties.

 

a. Authorization, Etc. Borrower has full corporate, limited liability company, limited partnership or other organizational powers, authority and legal right to enter into, deliver and perform its respective obligations under this Amendment and to consummate each of the transactions contemplated herein, and has taken all necessary corporate, limited liability company, limited partnership or other organizational action to authorize the execution, delivery and performance by it of this Amendment. This Amendment has been duly executed and delivered by Borrower and is in full force and effect and constitutes a legal, valid and binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as enforcement may be limited (i) by Bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws affecting creditors’ rights generally, (ii) by general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law) or (iii) by implied covenants of good faith and fair dealing.

 

b. No Conflict. The execution, delivery and performance by Borrower of this Amendment, as well as the consummation of the transactions contemplated herein, do not and will not (i) conflict with the Organizational Documents of Borrower, (ii) conflict with or result in a breach of, or constitute a default under, any indenture, loan agreement, mortgage, deed of trust or other instrument or agreement to which any Loan Party is a party or by which it is bound or to which any Loan Party’s property or assets are subject, except where such contravention, breach or default, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect, (iii) conflict with or result in a breach of, or constitute a default under, in any material respect, any Applicable Law (including, assuming the accuracy of the representations and warranties of the Lenders set forth in a certificate or certificates delivered by the Lenders to Borrower at or prior to any issuance of Participation Shares, federal and state securities laws and regulations and the rules and regulations of any self-regulatory organization to which Borrower or its securities are subject), except where such contravention or breach could not reasonably be expected to have a Material Adverse Effect, or (iv) with respect to each Loan Party, result in the creation or imposition of any Lien (other than a Permitted Lien) upon any Loan Party’s property or the Collateral.

 

c. No Default or Event of Default has occurred and is continuing.

 

d. The representations and warranties of each Loan Party set forth in the Financing Documents are true and correct in all material respects (except where already qualified by materiality or Material Adverse Effect, in which case, such representations and warranties are true and correct in all respects) on and as of the Third Amendment Effective Date (unless stated to relate solely to an earlier date, in which case such representations and warranties were true and correct as of such earlier date).

 

4

 

 

6. Miscellaneous.

 

a. This Amendment shall become effective on the date first set forth above. On and after the Third Amendment Effective Date, each reference in the Credit Agreement to “this Agreement”, “hereunder”, “hereof” or words of like import, referring to the Credit Agreement and each reference in each other Financing Document to “the Credit Agreement”, “thereunder”, “thereof” or words of like import referring to the Credit Agreement shall mean and be a reference to the Existing Credit Agreement as amended or otherwise modified by this Amendment. This Amendment shall constitute a Financing Document for purposes of the Credit Agreement.

 

b. THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AMENDMENT AND ANY DISPUTE OF CLAIMS ARISING IN CONNECTION THEREWITH SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

 

c. Except as expressly set forth in this Amendment, all other terms and conditions of the Credit Agreement shall remain in full force and effect and the execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any default of Borrower or any right, power or remedy of Administrative Agent or the Lenders under any of the Financing Documents, nor constitute a waiver of any provision of any of the Financing Documents. All capitalized terms used herein and not otherwise defined or redefined herein shall have the meanings assigned to them in the Credit Agreement, and all terms defined or redefined herein shall be given the meaning set out herein.

 

d. Sections 10.07 (Severability), 10.09 (Governing Law; Jurisdiction; Etc.) and 10.11 (Headings) of the Credit Agreement are hereby incorporated by reference herein, mutatis mutandis.

 

e. This Amendment shall constitute an integral part of the Credit Agreement and be effective as stipulated above and upon signature by the respective Parties and shall remain valid until the date the Credit Agreement expires or otherwise terminates.

 

f. The undersigned hereby acknowledge that it has read and fully understands the terms of this Amendment, the terms and conditions of which are hereby incorporated and acknowledged by this reference. This Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This Amendment is binding upon and shall inure to the benefit of Administrative Agent, the Lenders and the Loan Parties and their respective successors and permitted assigns.

 

g. The undersigned individuals certify that they are competent and authorized to enter into this Amendment on behalf of the Party for whom he or she purports to sign.

 

5

 

 

IN WITNESS WHEREOF, the Parties, by their authorized representatives, have duly executed this Amendment as of the Third Amendment Effective Date.

 

ALTO INGREDIENTS, INC.   OIC INVESTMENT AGENT, LLC
         
By: /s/ Bryon T. McGregor   By: /s/ Ethan Shoemaker
Name: Bryon T. McGregor   Name: Ethan Shoemaker
Title: President and CEO   Title: Investment Partner and Head of Infrastructure Credit

  

[Signature Page to Alto Third Amendment to Credit Agreement]

 

 

 

Exhibit 19.1

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

  

Title:POLICY STATEMENT ON INSIDER TRADING AND OTHER PROHIBITED TRADING ACTIVITIES

 

Policy:This Policy Statement on Insider Trading and Other Prohibited Trading Activities (the “Policy Statement”) defines the processes for preventing, detecting and managing the occurrence of insider trading and other prohibited trading activities by Alto Ingredients’ directors, officers and employees and other people who gain access to material non-public information of Alto Ingredients and its subsidiaries, including any contractors and consultants (collectively, “Covered Persons”).

 

Purpose:The U.S. securities laws regulate the sale and purchase of securities in the interest of protecting the investing public. Applicable U.S. securities laws give Alto Ingredients and Covered Persons the responsibility to ensure that information about Alto Ingredients is not used unlawfully in the purchase and sale of securities.

 

All Covered Persons should pay particularly close attention to the laws against trading on material non-public information (often called “inside information”). These laws are based upon the belief that all persons trading in a company’s securities should have equal access to all “material” information about that company. For example, if a director, officer, employee, contractor or consultant of a company knows material non-public information about the company, that person is prohibited from buying or selling shares in the company until the material non-public information has been formally disclosed to the public. This is because that person knows information that will probably cause the share price to change, and it would be unfair for that person to have an advantage (i.e., knowledge that the share price will change) that the rest of the investing public does not have. In fact, it is more than unfair; it is considered to be fraudulent and illegal. Civil and criminal penalties for this kind of activity are severe.

 

The general rule can be stated as follows: It is a violation of federal securities laws for any person to buy or sell securities if he or she is in possession of material nonpublic information. Information is “material” if there is a substantial likelihood that a reasonable investor would consider it important in making an investment decision. It is “non-public information” if it has not been publicly disclosed in a manner making it available to investors generally on a broad-based non-exclusionary basis, and/or such investors have not been given the opportunity to absorb the information. Furthermore, it is illegal for any person in possession of material non-public information to provide other people with such information or to recommend that they buy or sell the securities. This is called “tipping.” In that case, both the person who provided the tip (i.e., the “tipper”) and the person who received and acted on the tip (i.e., the “tippee”) may be held liable.

 

1

 

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

 

It should be noted that although it is technically necessary for a person to “know” the information before he or she can be accused of illegally trading on such information, knowledge could be presumed if the person has any kind of relationship (e.g., director, officer, employee, contractor or consultant) with Alto Ingredients. Hindsight can be remarkably acute, and an accusation can always be made that at any particular time a purchase or sale of securities by a person was motivated by undisclosed favorable or unfavorable non-public information. In such circumstances, the appearance of impropriety can be as problematic as an actual abuse, both to Alto Ingredients and to the individual(s) involved.

 

The U.S. Securities and Exchange Commission (the “SEC”), the stock exchanges, including Nasdaq upon which Alto Ingredients’ common stock is listed and traded, and plaintiffs’ lawyers focus on uncovering insider trading. A breach of the insider trading laws could expose the insider to criminal fines up to several times the profits earned and imprisonment for a substantial length of time, in addition to civil penalties (up to several times the profits earned), and injunctive actions. In addition, punitive damages may be imposed under applicable state laws. Securities laws also subject controlling persons to substantial civil penalties for illegal insider trading by employees. Controlling persons include directors, officers, and supervisors. Employees who violate this Policy Statement may be subject to disciplinary action by Alto Ingredients, including dismissal for cause.

 

This Policy Statement has been prepared to assist you in avoiding liability. Insider trading becomes very critical in a company such as Alto Ingredients. Alto Ingredients cannot afford to have its reputation for integrity and ethical conduct damaged by improper conduct.

 

Scope:This Policy Statement and the prohibition against trading on material non-public information applies to Covered Persons and to other people who gain access to that information, including the immediate family members (i.e., child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships) of any Covered Person and anyone else who resides in the household of a Covered Person and any family members who do not reside in the household of a Covered Person but whose transactions in Alto Ingredients’ securities are directed by a Covered Person or who are subject to a Covered Person’s influence or control (collectively referred to as “Family Members”). The restrictions applicable to Covered Persons are also applicable to any entities that are influenced or controlled by a Covered Person, including any corporations, partnerships or trusts (collectively referred to as “Controlled Entities”). Covered Persons are also responsible for communicating the requirements of this Policy Statement to Family Members and Controlled Entities and ensuring that they adhere to this Policy Statement.

 

2

 

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

 

In addition, Control Persons with inside knowledge of material non-public information may be subject to additional ad hoc restrictions on trading from time to time. This Policy Statement continues to apply to transactions in Alto Ingredients securities even after an individual has ended employment with, or otherwise ceased providing services to, Alto Ingredients if such individual is aware of material nonpublic information when the employment or service relationship ends. Such individual may not trade in Alto Ingredients securities until that information has become public or is no longer material.

 

Procedures:

 

1.0Alto Ingredients Policy.
  
 Any Covered Person who is aware of material non-public information regarding Alto Ingredients or regarding any other company shall not trade directly or indirectly in the securities of Alto Ingredients or the securities of such other company, or disclose such information to other persons likely to trade in such securities. Such Covered Persons must also refrain from recommending the purchase or sale of Alto Ingredients securities while in possession of material non-public information, and from knowingly assisting anyone who is engaged in any of the activities prohibited by this Policy Statement.

 

2.0Prohibited Activities.

 

2.1Insider Trading in Alto Ingredients Securities.

 

If you are aware of material non-public information relating to Alto Ingredients, you are prohibited from trading in Alto Ingredients securities, directly or indirectly and from disclosing such information to any other persons (including Family Members, friends, brokers, investment advisers, etc.).

 

The term “non-public information” is information which has not been sufficiently disseminated to the public marketplace so that purchasers and sellers alike are on equal footing regarding the information. It is information from a source within Alto Ingredients or from a source to which Alto Ingredients owes a duty of confidentiality. As a practical matter, it is sometimes difficult to determine whether you possess non-public information. Any information, positive or negative, is “material” if it would be expected to (i) affect the decision of a reasonable investor in determining whether to purchase, sell or hold Alto Ingredients securities or (ii) significantly alter the market price of Alto Ingredients securities. Information may be material for this purpose even if it would not alone determine the investor’s decision. While it may be difficult under this standard to determine whether particular non-public information is material, there are various categories of information that are particularly sensitive and, as a general rule, should always be considered potentially material.

 

3

 

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

 

The following is a non-exclusive list of the types of information or events that are likely to be considered material:

 

dividend information;

 

internal information about revenues, earnings or other aspects of financial performance including such information that departs in any way from what the market would expect based upon prior disclosures;

 

significant product pricing changes;

 

the introduction of new products or services, or developments regarding customers or suppliers;

 

receipt of or change to a large product order;

 

information about hedging policies, activities and/or results;

 

investments, joint ventures or changes in assets;

 

important business developments such as mergers, acquisitions, joint ventures, corporate partnerships, licenses and disposition of assets;

 

the addition or loss of a substantial customer, supplier or contract;

 

a significant disruption in operations or loss, potential loss, breach or unauthorized access of property or assets, including Alto Ingredients’ ethanol facilities and information technology infrastructure, such as a cybersecurity event;

 

events regarding Alto Ingredients’ securities, such as a stock split or private or public offerings of securities and repurchase plans;

 

regulatory or government activity;

 

bankruptcies or receiverships;

 

major litigation;

 

extraordinary management developments including changes in management or compensation policy;

 

changes in corporate strategy;

 

restructurings or layoffs;

 

auditor changes or notification from auditors of a significant event such as notification that Alto Ingredients may no longer rely on the auditor’s audit report; or

 

any similar event without having appropriate disclosure to the public through a press release or filing with the SEC.

 

4

 

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

 

It is important to note that the above list is merely illustrative and other information not mentioned on the above list may be considered material non-public information.

 

The following guidelines should be followed in order to ensure compliance with applicable laws and with this Policy Statement:

 

Do not recommend or suggest that anyone else buy, sell or retain the stock or other securities of Alto Ingredients while you have material non-public information about Alto Ingredients.

 

Information may be considered “non-public” if it has not been disseminated in Alto Ingredients’ filings with the SEC or in Alto Ingredients’ annual reports to stockholders or has not been the subject of a prior widely-disseminated press release by Alto Ingredients. Unless Alto Ingredients publicly confirms information reported in wire service dispatches and other news media, market letters or other third-party sources, such information may still be considered nonpublic. You should be aware that it is Alto Ingredients’ policy not to comment on such information.

 

Do not disclose any non-public information to anyone outside Alto Ingredients, including Family Members, except when such disclosure is needed to enable Alto Ingredients to carry on its business properly and effectively, and appropriate steps have been taken by Alto Ingredients to prevent misuse of the information. When questions arise about the necessity for such disclosure, contact Alto Ingredients’ Chief Legal Officer (the “Chief Legal Officer”) for advice.

 

Only disclose non-public information within Alto Ingredients in the ordinary course of business and when you have no reason to believe the information will be misused.

 

Transactions that may be necessary or justifiable for independent reasons, such as the need to raise money for an emergency expenditure are not permitted. Even the appearance of an improper transaction must be avoided to preserve the reputation of Alto Ingredients for adhering to the highest standards of conduct.

 

It is impossible to overstate the importance of understanding and complying with the insider trading laws. You need not be a director or officer of Alto Ingredients to be subject to the insider trading laws. Any Covered Person is subject to prosecution for a violation.

 

The prohibitions and guidelines discussed above do not prevent you from trading under a written plan (a “Rule 10b5-1 Plan”) that has been adopted in conformity with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). See Section 7.0 below for a discussion of Rule 10b5-1 Plans.

 

5

 

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

 

2.2Nondisclosure/Trading in Securities of Other Companies.

 

No Covered Person or any Family Member or Controlled Entity of a Covered Person, in the course of such Covered Person’s employment or involvement with Alto Ingredients who knows of or obtains any material non-public information regarding another company may communicate that information except to persons within Alto Ingredients whose positions require them to know it, or third parties who, due to the nature of their work with Alto Ingredients, have a need to know, and who are subject to an obligation to keep such information confidential. No Covered Person, nor any of a Covered Person’s Family Members or Controlled Entities, may place a purchase or sale order, offer to purchase or sell, or recommend that another person place a purchase or sale order, in the securities of another company, if, in the course of such Covered Person’s employment or involvement with Alto Ingredients (directly or through a Family Member who is a director, officer, or employee of Alto Ingredients), such person learns or possesses material non-public information about the other company that is likely to affect the value of those securities. For example, it would be a violation of the securities laws and this Policy Statement if a Covered Person learned confidential information in the course of such Covered Person’s employment or involvement with Alto Ingredients that Alto Ingredients intended to purchase assets from (or securities of) another company, and then placed an order to buy or sell securities in that other company because of the likely increase or decrease in the value of such company’s securities. Similarly, it would be a violation to place an order to buy or sell securities of a supplier, customer, or competitor of Alto Ingredients after obtaining material non-public information about such supplier, customer, or competitor through a person’s employment or involvement with Alto Ingredients.

 

2.3Trading Window Policy.

 

Generally, except as set forth below, all directors and officers of Alto Ingredients, all employees of the accounting department of Alto Ingredients, and all other persons who are notified by the Chief Legal Officer that they are subject to Alto Ingredients’ trading window policy (collectively, the “Restricted Group”), may not buy or sell stock or other securities of Alto Ingredients except during a “trading window period” that begins at 9:30 am Eastern Time on the third (3rd) business day after the earlier of (a) the issuance of Alto Ingredients’ quarterly earnings press release, or (b) the filing with the SEC of Alto Ingredients’ annual or quarterly reports, and ends at 4:00 pm Eastern Time on the fifteenth (15th) day of the last calendar month of the then current fiscal quarter (i.e., March, June, September and December), except with respect to the fourth fiscal quarter. During the fourth fiscal quarter, the “trading window period” will not open again until 9:30 am Eastern Time on the third (3rd) business day after the earlier of (i) the issuance of Alto Ingredients’ annual earnings press release that includes a discussion of fourth quarter earnings, or (ii) the filing of Alto Ingredients’ annual report on Form 10-K with the SEC.

 

6

 

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

 

This “trading window period” may be closed early or may not open if, in the judgment of the Chief Executive Officer or the Chief Financial Officer each in consultation with the Chief Legal Officer, there exists undisclosed information that would make trades by members of the Restricted Group inappropriate. Anyone who is subject to the “trading window period” policy who believes that special circumstances require him or her to trade outside the “trading window period” (i.e., during a “trading blackout period”) should consult with the Chief Legal Officer. Permission to trade during a “trading blackout period” will be granted only where the circumstances are extenuating and there appears to be no significant risk that the trade may subsequently be questioned.

 

Note that the limitations in Section 2.1 above relating to material non-public information remain applicable even during periods when trading is otherwise permitted by this Section 2.3. The two sections apply independently. In other words, you are not permitted, even during an open trading window period, to trade if you are in possession of material non-public information.

 

In some circumstances, standing trading orders to buy or sell Alto Ingredients’ securities extend beyond the open “trading window period” into a “trading blackout period”. As a result, members of the Restricted Group and other Covered Persons could be in the position of buying or selling Alto Ingredients securities based on such pre-existing orders during the “trading blackout period” or while in possession of material, non-public information, each of which is a violation of this Policy Statement. Consequently, members of the Restricted Group should not place trading orders with brokers that extend into “trading blackout periods,” and must immediately cancel any such orders that inadvertently extend into blackout periods to prevent trades after close of the applicable open “trading window period”. Rule 10b5-1 Plans (as described in Section 7.0 below), which generally may operate without regard for open “trading window periods” or “trading blackout periods,” are the appropriate vehicle for such automated trading programs.

 

All directors, officer and employees of Alto Ingredients, even those not considered part of the Restricted Group, must first pre-clear any transaction in Alto Ingredients’ securities with the Chief Legal Officer at least two (2) days in advance of the proposed transaction, as provided below. This pre-clearance requirement is intended to permit Alto Ingredients to provide assistance in meeting reporting requirements, to monitor insider trading concerns and to avoid even the appearance of impropriety (which could result, for example, where an employee engages in a trade while unaware of a pending major development). The pre-clearance requirement applies to any purchase or sale in the open market or other transfer of beneficial ownership including certain gifts or the exercise of an outstanding stock option. Directors, officers and employees contemplating transactions in Alto Ingredients’ securities should contact the Chief Legal Officer personally, or send notice by email to “[REDACTED].” The Chief Legal Officer will then determine whether the transaction may proceed. Any clearance (i) granted for directors and executive officers will be effective only until the end of the second (2nd) trading day following the day the approval is given, and (ii) granted for non-executive officers and other employees will be effective until the end of the fifth (5th) trading day following the day the approval is given. Alto Ingredients may, at its discretion, shorten such period of time for non-executive officers and other employees.

 

7

 

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

 

The prohibitions set forth above do not apply to any of the following:

 

Any purchase or sale of Alto Ingredients securities pursuant to an Approved Rule 10b-5 Plan (as defined in Section 7.0 below).

 

Any exercise of a director or employee stock option, or to the exercise of a tax withholding right pursuant to which an election is made to have Alto Ingredients withhold shares subject to an option to satisfy tax withholding requirements. The prohibitions on trading and the pre-clearance procedures do apply, however, to any sale of stock as part of a broker-assisted cashless exercise of an option, or any other market sale for the purpose of generating the cash needed to pay the exercise price of an option. The prohibitions on trading and the pre-clearance procedures apply in the same manner to exercises of any stock appreciation rights granted under any Alto Ingredients stock incentive plan.

 

The vesting of restricted stock, or to the exercise of a tax withholding right pursuant to which an election is made to have Alto Ingredients withhold shares of stock to satisfy tax withholding requirements upon the vesting of any restricted stock. The prohibitions on trading and the pre-clearance procedures do apply, however, to any market sale of restricted stock.

 

The acquisition or disposition of stock in a stock split.

 

Stock dividends and other such transactions affecting all stockholders generally.

 

The prohibitions set forth above do apply to certain bona fide gifts of Company stock. Directors, officers and employees of Alto Ingredients may not make a gift or donation of Alto Ingredients stock while aware of material non-public information or during a blackout period, if the director, officer or employee of Alto Ingredients (i) anticipates that the gift or donation recipient will sell the securities before the non-public information is made public or before the blackout period expires, as applicable, or (ii) will receive value related to the gift or donation (e.g., the director, officer or employee of Alto Ingredients would receive a tax deduction related to a charitable donation). With respect to other bona fide gifts of Alto Ingredients stock and transfers of Alto Ingredients stock to a family trust that is controlled by a director, officer or other insider of Alto Ingredients, the prohibitions on trading and the preclearance procedures discussed above do not apply. However, directors, executive officers and other insiders of Alto Ingredients are responsible for communicating the requirements of this Policy Statement to the recipient(s) of such gifts or transfers if they are made to Controlled Entities or Family Members.

 

8

 

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

  

2.4Other Prohibitive Trading Activities.

 

All directors, officers and employees as well as their respective Family Members are prohibited from engaging in the following activities:

 

hedging transactions (including transactions involving market-traded or privately-negotiated options, puts, calls, prepaid variable forward contracts, equity swaps, collars and exchange funds or other derivatives) that are designed to hedge or speculate on any change in the market value of Alto Ingredients’ equity securities; and

 

effecting short sales in shares of Alto Ingredients common stock, including short sales “against the box” (i.e., where the director, officer or employee holds a number of shares of Alto Ingredients common stock at least equal to the number of such shares of common stock sold in the short.

 

Covered Persons are prohibited from pledging securities of Alto Ingredients as collateral for a loan because such pledged securities might be sold at a time when the borrower is aware of material non-public information or is otherwise not permitted to trade. In addition, if a Covered Person terminates service or employment with Alto Ingredients and is aware of material non-public information, such Covered Person may not engage in any transaction in Alto Ingredients’ securities until that information has become public or is no longer material.

 

3.0Violations of this Policy Statement.
  
 Applicable federal laws impose severe monetary and criminal penalties for insider trading violations. In addition, Alto Ingredients will subject Covered Persons who are also employees of Alto Ingredients who violate this Policy Statement to appropriate disciplinary action, which could include termination of employment, independent of any governmental action or penalty. Violations of the laws against insider trading and tipping by Covered Persons can expose them and Alto Ingredients to severe civil and criminal liability, including as follows:

 

For individuals who trade on non-public information or tip information to others:

 

oa civil penalty of up to three times the profit gained or losses avoided;
   
oa criminal fine (no matter how small the profit) of up to $5 million; and
   
oa jail term of up to 20 years.

 

9

 

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

 

For Alto Ingredients and its supervisory personnel that fail to take appropriate action to prevent illegal trading:

 

oa civil penalty of the greater of $1 million or three times the profit gained or loss avoided as a result of the violation; and
   
oa criminal fine of up to $25 million.

 

Needless to say, any of the above consequences, even an SEC investigation that does not result in prosecution, can tarnish one’s reputation and irreparably damage a career.

 

4.0Confidentiality.
  
 In order to help you protect yourselves and Alto Ingredients, it is imperative that you hold certain information in strict confidence. This not only includes matters relating to major projects and initiatives, but also to materials that may look like inconsequential memoranda or correspondence. Serious issues could be caused for Alto Ingredients by unauthorized disclosure of internal information about Alto Ingredients, whether or not for the purpose of facilitating improper trading in the stock. Directors, officers and employees should not discuss information classified Alto Ingredients Confidential or Alto Ingredients Restricted (see II-060 Data Classification) with anyone outside Alto Ingredients, except as required in the performance of regular corporate duties and in accordance with the Data Classification policy.
  
 Inquiries made by the financial press, investment analysts or others in the financial community should be handled by a properly authorized Alto Ingredients representative. Please refer to II-050 Corporate Communications and Disclosure for further clarification regarding the release of sensitive company information to sources outside of Alto Ingredients.

 

5.0Individual Responsibility.
  
 Each Covered Person is individually responsible for complying with this Policy Statement and applicable laws and regulations. Any person who has any questions about this Policy Statement or about specific transactions may obtain additional guidance from the Chief Legal Officer. However, this Policy Statement does not replace your individual responsibility to understand and comply with legal restrictions on insider trading. Covered Persons are encouraged to consult with your own legal and financial advisors, as necessary.

 

6.0Reporting Insider Trading.
  
 The success of this Policy Statement rests on internal awareness and confidential reporting. Any person with knowledge of insider trading or tipping should make a report to the Chief Legal Officer or the Chairman of the Audit Committee. The reports will be confidential and can be made without fear of retribution. 

 

10

 

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

 

In addition, Congress has permitted the SEC to pay a bounty to any informant whose testimony leads to the imposition of a civil penalty. The bounty is not to exceed 10% of the imposed penalty and is to be taken from the penalty when paid. Informants should first inform the Chief Legal Officer or the Chairman of the Audit Committee prior to approaching the SEC so that Alto Ingredients can take immediate action to prevent further violations.

 

7.0Rule 10b5-1 Plans.
  
 Members of the Restricted Group can create an affirmative defense to a charge of insider trading by developing an Approved Rule 10b5-1 Plan for future sales under the Exchange Act.

 

For purposes of this Policy Statement, an “Approved 10b5-1 Plan” is a pre-existing written plan, contract, instruction, or arrangement under Rule 10b5-1(c) of the Exchange Act that meets the following requirements: (i) review and approval by the Chief Legal Officer at least five (5) days in advance of being entered into (or, if revised or amended, such proposed revision or amendment has been reviewed and approved by the Chief Legal Officer at least five (5) days in advance of being entered into); (ii) such plan specifies (or establishes a formula for determining) the dates, prices and amounts of the contemplated transactions or gives a third party, who does not possess any material non-public information about Alto Ingredients, the discretionary authority to execute such purchases and sales, outside the control of the individual covered under this Policy Statement who enters into such plan, and (iii) such plan complies with the applicable requirements of Rule 10b5-1(c) of the Exchange Act, including the applicable cooling-off period, certification and good faith requirements specified therein.

 

If a member of the Restricted Group is considering entering into, modifying or terminating an Approved 10b5-1 Plan or have any questions regarding Rule 10b5-1 Plans, please contact the Chief Legal Officer. You should also consult your own legal and tax advisors before entering into, modifying or terminating an Approved 10b5-1 Plan. The Chief Legal Officer will not approve the adoption or modification of an Approved 10b5-1 Plan during a “trading blackout period”.

 

All transactions carried out pursuant to an Approved 10b5-1 Plan must still be reported on Form 4, and brokers effecting such transactions must agree to notify Alto Ingredients immediately upon execution of the transaction.

 

11

 

 

  POLICIES AND PROCEDURES
     
DEPARTMENT: CORPORATE   SOP# II-033

  

SEC rules require Alto Ingredients to disclose whether, during Alto Ingredients’ most recent fiscal quarter, any director or executive officer adopted or terminated any Rule 10b5-1 Plan.

 

Alto Ingredients prohibits the adoption of non-Rule 10b5-1 trading arrangements (as defined herein to align with Item 408 of Regulation S-K). If any member of the Restricted Group is seeking to enter into any written trading arrangement involving our securities, such member must get prior approval from the Chief Legal Officer, who will determine whether such arrangement is permitted by this policy. A “non-Rule 10b5-1 trading arrangement” arises when, at a time a person is not aware of any material non-public information, such person adopts a written arrangement for trading Alto Ingredients securities which does not satisfy all of the conditions of Rule 10b5-1(c) of the Exchange Act, and which (i) specifies the amount of securities to be purchased or sold and the price(s) at which and the date(s) on which the securities are to be purchased or sold, (ii) includes a written formula or algorithm, or computer program, for determining the amount of securities to be purchased or sold and the price(s) at which and the date(s) on which the securities are to be purchased or sold, or (iii) does not permit such person to exercise any subsequent influence over how, when, or whether to effect purchases or sales.

  

 

12

 

Exhibit 21.1

 

SUBSIDIARIES OF THE REGISTRANT

 

Subsidiary Name  

State or Jurisdiction of

Incorporation or Organization

Kinergy Marketing LLC   Oregon
Alto Nutrients, LLC   California
Alto Op Co.   Delaware
Alto West, LLC   Delaware
Alto Columbia, LLC   Delaware
Alto Magic Valley, LLC   Delaware
Alto Central, LLC   Delaware
Alto Pekin, LLC   Delaware
Alto ICP, LLC   Delaware
Eagle Alcohol Company LLC   Missouri
Alto Carbonic, LLC   Delaware

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in Registration Statements (Nos. 333-250180, 333-266035, 333-272836 and 333-280351) on Form S-8 and (Nos. 333-268583 and 333-272884) on Form S-3 of Alto Ingredients, Inc. of our reports dated March 13, 2025, relating to the consolidated financial statements and the effectiveness of internal control over financial reporting of Alto Ingredients, Inc., appearing in this Annual Report on Form 10-K of Alto Ingredients, Inc. for the year ended December 31, 2024.

 

/s/ RSM US LLP

 

Rochester, Minnesota

March 13, 2025

EXHIBIT 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Bryon T. McGregor, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Alto Ingredients, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 13, 2025 /s/ BRYON T. MCGREGOR
  Bryon T. McGregor
  President and Chief Executive Officer
(Principal Executive Officer)

 

EXHIBIT 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Robert R. Olander, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Alto Ingredients, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 13, 2025 /s/ ROBERT R. OLANDER
  Robert R. Olander
  Chief Financial Officer
(Principal Financial Officer)

 

EXHIBIT 32.1

 

CERTIFICATIONS OF
CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Alto Ingredients, Inc. (the “Company”) for the year ended December 31, 2024 (the “Report”), the undersigned hereby certify in their capacities as Chief Executive Officer and Chief Financial Officer of the Company, respectively, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: March 13, 2025 By: /s/ BRYON T. MCGREGOR
    Bryon T. McGregor
    President and Chief Executive Officer
(Principal Executive Officer)

 

Dated: March 13, 2025 By: /s/ ROBERT R. OLANDER
    Robert R. Olander
    Chief Financial Officer
(Principal Financial Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

v3.25.0.1
Cover - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Mar. 12, 2025
Jun. 28, 2024
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Transition Report false    
Document Financial Statement Error Correction [Flag] false    
Entity Interactive Data Current Yes    
ICFR Auditor Attestation Flag true    
Amendment Flag false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Documents Incorporated by Reference [Text Block]

The information required by Part III of this Report, to the extent not set forth herein, is incorporated herein by reference from the registrant’s definitive Proxy Statement relating to the 2025 Annual Meeting of Stockholders (“Proxy Statement”), which definitive Proxy Statement shall be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this Report relates.

   
Entity Information [Line Items]      
Entity Registrant Name ALTO INGREDIENTS, INC.    
Entity Central Index Key 0000778164    
Entity File Number 000-21467    
Entity Tax Identification Number 41-2170618    
Entity Incorporation, State or Country Code DE    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Shell Company false    
Entity Filer Category Accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Public Float     $ 105
Entity Contact Personnel [Line Items]      
Entity Address, Address Line One 1300 South Second Street    
Entity Address, City or Town Pekin    
Entity Address, State or Province IL    
Entity Address, Postal Zip Code 61554    
Entity Phone Fax Numbers [Line Items]      
City Area Code (833)    
Local Phone Number 710-2586    
Entity Listings [Line Items]      
Title of 12(b) Security Common Stock, $0.001 par value    
Trading Symbol ALTO    
Security Exchange Name NASDAQ    
Entity Common Stock, Shares Outstanding   76,611,090  
v3.25.0.1
Audit Information
12 Months Ended
Dec. 31, 2024
Auditor [Table]  
Auditor Name RSM US LLP
Auditor Firm ID 49
Auditor Location Rochester, Minnesota
Auditor Opinion [Text Block]

Opinion on the Internal Control Over Financial Reporting

We have audited Alto Ingredients, Inc.’s (the Company) internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets as of December 31, 2024 and 2023, the related consolidated statements of operations, comprehensive income (loss), stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2024, and the related notes to the consolidated financial statements of the Company and our report dated March 13, 2025, expressed an unqualified opinion.

v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 35,469 $ 30,014
Restricted cash 742 15,466
Accounts receivable, net of allowance for credit losses of $23 and $85, respectively 58,217 58,729
Inventories 49,914 52,611
Derivative instruments 3,313 2,412
Other current assets 5,463 9,538
Total current assets 153,118 168,770
Property and equipment, net 214,742 248,748
Other Assets:    
Right of use operating lease assets, net 20,553 22,597
Intangible assets, net 4,509 8,498
Other assets 8,516 5,628
Total other assets 33,578 36,723
Total Assets 401,438 454,241
Current Liabilities:    
Accounts payable 20,369 20,752
Accrued liabilities 24,214 20,205
Current portion – operating leases 4,851 4,333
Derivative instruments 1,177 13,849
Other current liabilities 7,193 6,149
Total current liabilities 57,804 65,288
Long-term debt, net 92,904 82,097
Operating leases, net of current portion 16,913 19,029
Other liabilities 8,754 8,270
Total Liabilities 176,375 174,684
Commitments and contingencies (Notes 1, 8, 9, 10 and 14)
Stockholders’ Equity:    
Preferred stock, value
Common stock, value 77 76
Additional paid-in capital 1,044,176 1,040,912
Accumulated other comprehensive income 4,975 2,481
Accumulated deficit (824,166) (763,913)
Total stockholders’ equity 225,063 279,557
Total Liabilities and Stockholders’ Equity 401,438 454,241
Series A Preferred Stock    
Stockholders’ Equity:    
Preferred stock, value
Series B Preferred Stock    
Stockholders’ Equity:    
Preferred stock, value 1 1
Non-voting common stock    
Stockholders’ Equity:    
Common stock, value
v3.25.0.1
Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Accounts receivable, net of allowance (in Dollars) $ 23 $ 85
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 76,565,072 75,703,100
Common stock, shares outstanding 76,565,072 75,703,100
Series A Preferred Stock    
Preferred stock, shares authorized 1,684,375 1,684,375
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock    
Preferred stock, shares authorized 1,580,790 1,580,790
Preferred stock, shares issued 926,942 926,942
Preferred stock, shares outstanding 926,942 926,942
Preferred stock, liquidation preference (in Dollars) $ 18,075 $ 18,075
Non-voting common stock    
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 3,553,000 3,553,000
Common stock, shares issued 896 896
Common stock, shares outstanding 896 896
v3.25.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 965,258 $ 1,222,940 $ 1,335,621
Cost of goods sold 955,536 1,207,287 1,363,171
Gross profit (loss) 9,722 15,653 (27,550)
Selling, general and administrative expenses (29,736) (29,864) (28,079)
Acquisition-related expenses (7,701) (2,800) (3,500)
Gain (loss) on sale or disposal of assets 830 (293) (2,230)
Asset impairments (24,790) (6,544)
Loss from operations (51,675) (23,848) (61,359)
Income from cash grant 2,812 22,652
Interest expense, net (7,644) (7,425) (1,827)
Other income, net 508 553 862
Loss before provision for income taxes (58,811) (27,908) (39,672)
Provision for income taxes 173 97 1,925
Consolidated net loss (58,984) (28,005) (41,597)
Preferred stock dividends (1,269) (1,265) (1,265)
Loss attributable to common stockholders $ (60,253) $ (29,270) $ (42,862)
Loss per share, basic (in Dollars per share) $ (0.82) $ (0.4) $ (0.6)
Loss per share, diluted (in Dollars per share) $ (0.82) $ (0.4) $ (0.6)
Weighted-average shares outstanding, basic (in Shares) 73,482,000 73,339,000 71,944,000
Weighted-average shares outstanding, diluted (in Shares) 73,482,000 73,339,000 71,944,000
v3.25.0.1
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Statement of Comprehensive Income [Abstract]      
Consolidated net loss $ (58,984) $ (28,005) $ (41,597)
Other comprehensive income– net gain arising during the period on defined benefit pension plans 2,494 659 2,106
Total comprehensive loss $ (56,490) $ (27,346) $ (39,491)
v3.25.0.1
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock
Common Stock and Non-Voting Common
Additional Paid-In Capital
Accumulated Deficit
Accum. Other Comprehensive Income (Loss)
Total
Balances at Dec. 31, 2021 $ 1 $ 73 $ 1,037,205 $ (691,781) $ (284) $ 345,214
Balances (in Shares) at Dec. 31, 2021 927 72,778        
Stock-based compensation 3,333 3,333
Restricted stock issued to employees and directors, net of cancellations and tax (2,291) (2,291)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)   496        
Shares issued for Eagle $ 1 1
Shares issued for Eagle (in Shares)   949        
Shares issued to Orion $ 1 3,912 3,913
Shares issued to Orion (in Shares)   1,282        
Stock repurchases (1,325) (1,325)
Stock repurchases (in Shares)   (351)        
Pension plan adjustment 2,106 2,106
Preferred stock dividends (1,265) (1,265)
Net loss (41,597) (41,597)
Balances at Dec. 31, 2022 $ 1 $ 75 1,040,834 (734,643) 1,822 308,089
Balances (in Shares) at Dec. 31, 2022 927 75,154        
Stock-based compensation 3,896 3,896
Restricted stock issued to employees and directors, net of cancellations and tax $ 2 (145) (143)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)   2,234        
Stock repurchases $ (1) (3,673) (3,674)
Stock repurchases (in Shares)   (1,685)        
Pension plan adjustment 659 659
Preferred stock dividends (1,265) (1,265)
Net loss (28,005) (28,005)
Balances at Dec. 31, 2023 $ 1 $ 76 1,040,912 (763,913) 2,481 279,557
Balances (in Shares) at Dec. 31, 2023 927 75,703        
Stock-based compensation 4,357 4,357
Restricted stock issued to employees and directors, net of cancellations and tax $ 1 (1,093) (1,092)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)   862        
Pension plan adjustment 2,494 2,494
Preferred stock dividends (1,269) (1,269)
Net loss (58,984) (58,984)
Balances at Dec. 31, 2024 $ 1 $ 77 $ 1,044,176 $ (824,166) $ 4,975 $ 225,063
Balances (in Shares) at Dec. 31, 2024 927 76,565        
v3.25.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating Activities:      
Consolidated net loss $ (58,984) $ (28,005) $ (41,597)
Adjustments to reconcile consolidated net loss to cash (used in) provided by operating activities:      
Depreciation and amortization of intangibles 24,408 23,080 25,095
Asset impairments 24,790 6,544
(Gain) loss on sale or disposal of assets (830) 293 2,230
Inventory valuation 2,050 2,201 4,612
Losses (gains) on derivative instruments (11,045) 8,031 (19,263)
Amortization of deferred financing costs 1,016 1,048 177
Amortization of debt discounts 804 801 126
Stock-based compensation 4,357 3,896 3,333
Bad debt (recovery) expense (50) 427 (217)
Changes in operating assets and liabilities:      
Accounts receivable 562 9,499 23,967
Inventories 4,484 11,816 (15,479)
Other current assets 931 310 7,690
Operating leases (5,965) (5,362) (5,128)
Accounts payable and accrued expenses 9,951 (12,554) 20,503
Net cash (used in) provided by operating activities (3,521) 22,025 6,049
Investing Activities:      
Additions to property and equipment (11,066) (29,531) (37,744)
Deferred purchase price payments for Eagle Alcohol (2,800) (3,500)
Proceeds from sale of assets 400
Purchase of Eagle Alcohol, net of cash acquired (14,685)
Proceeds from principal payments on notes receivable 14,766
Net cash used in investing activities (13,466) (33,031) (37,663)
Financing Activities:      
Net proceeds from (payments on) Kinergy’s line of credit 8,987 12,614 (32,325)
Net proceeds from term loan 59,100
Stock repurchases (3,674) (1,325)
Debt issuance costs (714) (5,171)
Preferred stock dividend payments (1,269) (1,265) (1,265)
Net cash provided by financing activities 7,718 6,961 19,014
Net decrease in cash, cash equivalents and restricted cash (9,269) (4,045) (12,600)
Cash, cash equivalents and restricted cash at beginning of period 45,480 49,525 62,125
Cash, cash equivalents and restricted cash at end of period 36,211 45,480 49,525
Reconciliation of total cash, cash equivalents and restricted cash:      
Cash and cash equivalents 35,469 30,014 36,456
Restricted cash 742 15,466 13,069
Total cash, cash equivalents and restricted cash 36,211 45,480 49,525
Supplemental Information:      
Interest paid (net of capitalized interest) 8,319 7,923 2,208
Capitalized interest 2,517 2,454 720
Income tax refunds (payments) $ 627 $ (324) $ (2,262)
v3.25.0.1
Organization and Significant Accounting Policies
12 Months Ended
Dec. 31, 2024
Organization and Significant Accounting Policies [Abstract]  
ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES

1. ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES.

 

Organization and Business – The consolidated financial statements include, for all periods presented, the accounts of Alto Ingredients, Inc., a Delaware corporation (“Alto Ingredients”), and its direct and indirect wholly-owned subsidiaries (collectively, the “Company”), including Kinergy Marketing LLC, an Oregon limited liability company (“Kinergy”), Alto Nutrients, LLC, a California limited liability company (“Alto Nutrients”), Alto Op Co., a Delaware corporation, Alto Pekin, LLC, a Delaware limited liability company (“Alto Pekin”) and Alto ICP, LLC, a Delaware limited liability company (“ICP”), and the Company’s production facilities in Oregon and Idaho.

 

As discussed in Note 2, on January 14, 2022, the Company acquired Eagle Alcohol Company LLC, a Missouri limited liability company (“Eagle Alcohol”). On that date, Eagle Alcohol became a wholly-owned subsidiary of the Company. Eagle Alcohol specializes in break bulk distribution of specialty alcohols.

 

As discussed in Note 16, On January 1, 2025, the Company’s wholly-owned subsidiary, Alto Carbonic, LLC (“Alto Carbonic”), acquired Kodiak Carbonic, LLC, a beverage-grade liquid CO2 processor for $7.6 million. Alto Carbonic is co-located at the Company’s Columbia ethanol facility. The Company plans to report the results of Alto Carbonic in the Company’s Western Production segment beginning January 1, 2025.

 

The Company produces and distributes renewable fuels, essential ingredients and specialty alcohols. The Company also markets fuel-grade ethanol produced by third parties. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and fuel-grade ethanol customers.

 

The Company has a combined alcohol production capacity of 350 million gallons per year and produces, on an annualized basis, over 1.4 million tons of essential ingredients, such as dried yeast, corn protein meal, corn protein feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company markets and distributes fuel-grade ethanol produced by third parties.

 

The Company focuses on Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels markets. Products for the Health, Home & Beauty market include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. Products for the Food & Beverage markets include grain neutral spirits used in alcoholic beverages and vinegar as well as corn germ used for corn oils. Products for Industry & Agriculture markets include alcohols and other products for paint applications and fertilizers. Products for Essential Ingredients markets include dried yeast, corn protein meal, corn protein feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. Products for Renewable Fuels markets include fuel-grade ethanol and distillers corn oil used as a feedstock for renewable diesel and biodiesel fuels.

 

The Company’s production facilities, other than its Magic Valley plant, were operating for all periods presented subject to scheduled and unscheduled downtimes to address facility repair and maintenance. In January 2024, the Company temporarily hot-idled its Magic Valley facility to minimize losses from negative regional crush margins and to expedite the installation of additional equipment to achieve the intended production rate, quality and consistency from the Company’s corn oil and high protein system at the facility. The Company restarted its Magic Valley facility in July 2024 and by October 2024, the facility consistently achieved average ethanol production rates at full capacity, the protein content yield from the plant reached 50% or greater, and the Company was able to expand its corn oil yields. Increases in regional corn basis and declining market prices for protein and corn oil resulted in overall margin compression, outweighing the economic benefits of these plant improvements. As a consequence, the Company cold-idled its Magic Valley facility on December 31, 2024 to minimize financial losses. The Company continues to provide terminal services at the plant and intends to resume operations at the facility when the economic environment in the region sustainably improves.

 

Basis of Presentation – The consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated in consolidation.

Segments – A segment is a component of an enterprise whose operating results are regularly reviewed by the enterprise’s chief operating decision maker (“CODM”) to make decisions about resources to be allocated to the segment and assess its performance, and for which discrete financial information is available. The Company determines and discloses its segments in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Section 280, Segment Reporting, which defines how to determine segments. The Company has adopted the guidance issued under ASU 2023-07, Segment Reporting (Topic 280), which enhances disclosures about the Company’s segments. The Company’s CODM is the Company’s executive committee, which is led by the Company’s Chief Executive Officer (“CEO”) and includes its Chief Financial Officer, Chief Operating Officer, Chief Commercial Officer and Chief Legal Officer (“Executive Committee”). The Company manages and assesses the performance of its reportable segments by its gross profit (loss). As part of the Executive Committee’s review of segment-level performance, each member of the Executive Committee reviews the gross profit of the Company’s reportable segments and provides expertise and analysis from their respective areas which drive the evaluation of the performance of the Company’s reportable segments and allocation of resources to those segments. Even though the CEO has the authority to override the other members for strategic or other reasons, key decisions are made jointly by the Executive Committee.

 

The Company reports financial and operating performance in three reportable segments (1) Pekin production, which includes the entire campus in Pekin, Illinois (“Pekin Campus”), (2) marketing and distribution, which includes marketing and merchant trading for Company-produced specialty alcohols, fuel-grade ethanol and essential ingredients, and sales of fuel-grade ethanol sourced from third parties, and (3) Western production, which includes the Company’s two western production facilities and, beginning in 2025, its liquid CO2 plant on an aggregated basis (“Western production”).

 

Cash and Cash Equivalents – The Company considers all highly-liquid investments with an original maturity of three months or less to be cash equivalents. The Company maintains its accounts at several financial institutions. These cash balances regularly exceed amounts insured by the Federal Deposit Insurance Corporation; however, the Company does not believe it is exposed to any significant credit risk on these balances.

 

Restricted Cash – The Company’s restricted cash comprises cash collateral balances held in derivative brokerage accounts.

 

Accounts Receivable and Allowance for Credit Losses – Trade accounts receivable are presented at original invoice amount, net of the allowance for credit losses. The Company sells specialty alcohols to large consumer product companies, sells fuel-grade ethanol to gasoline refining and distribution companies, sells essential ingredients to animal feed customers, including distillers grains and other feed co-products to dairy operators and animal feedlots and corn oil to poultry and renewable diesel and biodiesel customers, in each case generally without requiring collateral. Due to a limited number of customers, the Company had significant concentrations of credit risk from sales as of December 31, 2024 and 2023, as described below.

 

The carrying amount of accounts receivable is reduced by a valuation allowance that reflects the Company’s best estimate of the amounts that will not be collected. The Company regularly reviews accounts receivable and based on assessments of current customer creditworthiness, estimates the portion, if any, of the customer balance that will not be collected.

 

Of the accounts receivable balance, approximately $44,750,000 and $51,315,000 at December 31, 2024 and 2023, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for credit losses was $23,000 and $85,000 as of December 31, 2024 and 2023, respectively. The Company recorded a bad debt recovery of $50,000, bad debt expense of $427,000 and a bad debt recovery of $217,000 for the years ended December 31, 2024, 2023 and 2022, respectively. The Company does not have any off-balance sheet credit exposure related to its customers.

 

Concentration Risks – Credit risk represents the accounting loss that would be recognized at the reporting date if counterparties failed completely to perform as contracted. Concentrations of credit risk, whether on- or off-balance sheet, that arise from financial instruments exist for groups of customers or counterparties when they have similar economic characteristics that would cause their ability to meet contractual obligations to be similarly affected by changes in economic or other conditions described below. Financial instruments that subject the Company to credit risk consist of cash balances maintained in excess of federal depository insurance limits and accounts receivable which have no collateral or security. The Company has not experienced any significant losses in such accounts.

The Company sells specialty alcohols to consumer product companies and fuel-grade ethanol to gasoline refining and distribution companies. The Company sold to customers representing 10% or more of the Company’s total net sales, as follows.

 

   Years Ended December 31, 
   2024   2023   2022 
Customer A   11%   9%   10%
Customer B   7%   7%   10%

 

The Company had accounts receivable due from these customers totaling $5,187,000 and $4,302,000, representing 9% and 7% of total accounts receivable, as of December 31, 2024 and 2023, respectively.

 

The Company purchases corn, its largest cost component in producing alcohols, from its suppliers. The Company purchased corn from suppliers representing 10% or more of the Company’s total corn purchases, as follows:

 

   Years Ended December 31, 
   2024   2023   2022 
Supplier A   16%   14%   11%
Supplier B   13%   12%   12%
Supplier C   %    %    15%

 

As of December 31, 2024, approximately 44% of the Company’s employees were covered by a collective bargaining agreement.

 

Inventories – Inventories consisted primarily of bulk ethanol, specialty alcohols, corn, essential ingredients and unleaded fuel, and are valued at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventory is net of valuation adjustments of $2,050,000 and $2,201,000 as of December 31, 2024 and 2023, respectively. Of the inventory balance, approximately $35,495,000 and $41,041,000 at December 31, 2024 and 2023, respectively, were used as collateral under Kinergy’s operating line of credit. Inventory balances consisted of the following (in thousands):

 

   December 31, 
   2024   2023 
Finished goods  $31,120   $35,765 
Work in progress   4,203    5,063 
Raw materials   8,989    10,313 
Other   5,602    1,470 
Total  $49,914   $52,611 

 

Property and Equipment – Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the following estimated useful lives:

 

Buildings   40 years 
Facilities and plant equipment   10 – 25 years 
Other equipment, vehicles and furniture   5 – 10 years 

 

The cost of normal maintenance and repairs is charged to operations as incurred. Significant capital expenditures that increase the life of an asset are capitalized and depreciated over the estimated remaining useful life of the asset. The cost of property and equipment sold, or otherwise disposed of, and the related accumulated depreciation or amortization are removed from the accounts, and any resulting gains or losses are reflected in current operations.

Intangible Assets – The Company amortizes intangible assets with definite lives using the straight-line method over their estimated lives of 10-12 years. Additionally, the Company assesses indefinite-lived intangible assets for impairment annually, or more frequently if circumstances indicate impairment may have occurred. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. If the Company determines that an impairment charge is needed, the charge will be recorded as an asset impairment in the consolidated statements of operations.

 

Leases – The Company accounts for leases under ASC Section 842, Leases (“ASC 842), whereby lessees are required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: (1) a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted cash flow basis; and (2) a “right of use” asset, which is an asset that represents the lessee’s right to use the specified asset for the lease term. See Note 9 for further information.

 

Derivative Instruments and Hedging Activities – Derivative transactions, which can include exchange-traded futures contracts, options and futures positions on the New York Mercantile Exchange or the Chicago Mercantile Exchange, are recorded on the balance sheet as assets and liabilities based on the derivative’s fair value. Changes in the fair value of derivative contracts are recognized currently in income unless specific hedge accounting criteria are met. If derivatives meet those criteria, and hedge accounting is elected, effective gains and losses are deferred in accumulated other comprehensive income (loss) and later recorded together with the hedged item in consolidated income (loss). For derivatives designated as a cash flow hedge, the Company formally documents the hedge and assesses the effectiveness with associated transactions. The Company has designated and documented contracts for the physical delivery of commodity products to and from counterparties as normal purchases and normal sales.

 

Revenue Recognition – The Company recognizes revenue under ASC Section 606, Revenue from Contracts with Customers (“ASC 606”). The provisions of ASC 606 include a five-step process by which an entity will determine revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which an entity expects to be entitled in exchange for those goods or services. ASC 606 requires the Company to apply the following steps: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, the Company satisfies the performance obligation.

 

The Company recognizes revenue primarily from sales of alcohols and essential ingredients.

 

The Company has five production facilities from which it produces and sells alcohols to its customers through Kinergy. Kinergy enters into back-to-back sales contracts with its customers under exclusive intercompany sales agreements with each of the Company’s five production facilities. Kinergy also acts as a principal when it purchases third party fuel-grade ethanol which it resells to its customers. Finally, for the year ended December 31, 2022, Kinergy had exclusive sales agreements with certain third-party owned fuel-grade ethanol production facilities under which it sold the facilities’ fuel-grade ethanol for a fee plus the costs to deliver the ethanol to Kinergy’s customers. These sales were referred to as third-party agent sales. Revenue from these third-party agent sales was recorded on a net basis, with Kinergy recognizing its predetermined fees and any associated delivery costs. Kinergy has terminated these contracts, and as a result, did not have any related sales for the year ended December 31, 2024 and 2023. The Company’s balances of accounts receivable, net of allowance for credit losses, were $58,217,000, $58,729,000 and $68,655,000, as of December 31, 2024, 2023 and 2022, respectively.

 

The Company has five production facilities from which it produces and sells essential ingredients to its customers through Alto Nutrients. Alto Nutrients enters into sales contracts with essential ingredient customers under exclusive intercompany sales agreements with each of the Company’s five production facilities.

 

The Company recognizes revenue from sales of alcohols and essential ingredients at the point in time when the customer obtains control of the products, which typically occurs upon delivery depending on the terms of the underlying contracts. In some instances, the Company enters into contracts with customers that contain multiple performance obligations to deliver volumes of alcohols or essential ingredients over a contractual period of less than 12 months. The Company allocates the transaction price to each performance obligation identified in the contract based on relative standalone selling prices and recognizes the related revenue as control of each individual product is transferred to the customer in satisfaction of the corresponding performance obligations.

When the Company is the agent, the supplier controls the products before they are transferred to the customer because the supplier is primarily responsible for fulfilling the promise to provide the product, has inventory risk before the product has been transferred to a customer and has discretion in establishing the price for the product. When the Company is the principal, the Company controls the products before they are transferred to the customer because the Company is primarily responsible for fulfilling the promise to provide the products, has inventory risk before the product has been transferred to a customer and has discretion in establishing the price for the product.

 

See the tables in Note 4 for the Company’s revenue by type of contracts.

 

Shipping and Handling Costs – The Company accounts for shipping and handling costs relating to contracts with customers as costs to fulfill its promise to transfer its products. Accordingly, the costs are classified as a component of cost of goods sold in the accompanying consolidated statements of operations.

 

Selling Costs – Selling costs associated with the Company’s product sales are classified as a component of selling, general and administrative expenses in the accompanying consolidated statements of operations.

 

Stock-Based Compensation – The Company accounts for the cost of employee services received in exchange for the award of equity instruments based on the fair value of the award, determined on the date of grant. The expense is recognized over the period during which an employee is required to provide services in exchange for the award. The Company accounts for forfeitures as they occur. The Company recognizes stock-based compensation expense as a component of either cost of goods sold or selling, general and administrative expenses in the consolidated statements of operations.

 

Goodwill – Goodwill represents the excess of cost of an acquired entity over the net of the amounts assigned to net assets acquired and liabilities assumed. Annually, or more frequently, if indications of impairment arise, the Company performs a review for impairment. This review includes the determination of each reporting unit’s fair value using market multiples and discounted cash flow modeling. The estimates of future cash flows are judgments based on management’s experience and knowledge of the Company’s operations and the industries in which the Company operates. These estimates can be significantly affected by future changes in market conditions, the economic environment, including inflation, and capital spending decisions of the Company’s customers. Any assessed impairments will be permanent and expensed in the period in which the impairment is determined. If the Company determines through its assessment process that any of its goodwill requires impairment charges, the charges will be recorded in asset impairment expenses in the consolidated statements of operations.

 

The Company performed its annual review of impairment of goodwill and recognized an asset impairment loss of $6.0 million for the year ended December 31, 2023. No impairment losses for goodwill were recognized for the year ended December 31, 2024 and 2022.

 

Impairment of Long-Lived Assets – The Company assesses the impairment of long-lived assets, including property and equipment, internally developed software and purchased intangibles subject to amortization, when events or changes in circumstances indicate that the fair value of assets could be less than their net book value. In such event, the Company assesses long-lived assets for impairment by first determining the forecasted, undiscounted cash flows the asset group is expected to generate plus the net proceeds expected from the sale of the asset group. If this amount is less than the carrying value of the asset, the Company will then determine the fair value of the asset group. When the estimated fair value of the asset group is less than its carrying value, the Company recognizes an impairment expense equal to the difference between the asset group’s carrying value and estimated fair value. Forecasts of future cash flows are judgments based on the Company’s experience and knowledge of its operations and the industries in which it operates. These forecasts could be significantly affected by future changes in market conditions, the economic environment, including inflation, and purchasing decisions of the Company’s customers. The Company’s assessment resulted in an asset impairment of $24,790,000 primarily from the cold-idling of the Company’s Magic Valley facility due to increased regional corn basis and overall margin compression and the Company’s changes to its Eagle Alcohol business, for the year ended December 31, 2024. The Company’s assessment resulted in an asset impairment of $574,000 related to amendments to certain of the Company’s lease agreements, for the year ended December 31, 2023. The Company’s impairment analysis performed during the year ended December 31, 2022 did not result in an impairment charge.

Deferred Financing Costs – Deferred financing costs are costs incurred to obtain debt financing, including all related fees, and are amortized as interest expense over the term of the related financing using the straight-line method, which approximates the effective interest rate method. Amortization of deferred financing costs, included in interest expense, net, in the accompanying consolidated statements of operations, was approximately $1,016,000, $1,048,000 and $177,000 for the years ended December 31, 2024, 2023 and 2022, respectively. Unamortized deferred financing costs were approximately $3,684,000 and $4,700,000 as of December 31, 2024 and 2023, respectively, and are recorded as a reduction of long-term debt in the consolidated balance sheets.

 

Provision for Income Taxes – Income taxes are accounted for under the asset and liability approach, where deferred tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities and are measured using enacted tax rates and laws that are expected to be in effect when the differences reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized.

 

The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining whether it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. An uncertain tax position is considered effectively settled on completion of an examination by a taxing authority if certain other conditions are satisfied. Should the Company incur interest and penalties relating to tax uncertainties, such amounts would be classified as a component of interest expense, net, and other income (expense), net, respectively. Deferred tax assets and liabilities are classified as noncurrent in the Company’s consolidated balance sheets.

 

The Company files a consolidated federal income tax return. This return includes all wholly owned subsidiaries as well as the Company’s pro-rata share of taxable income from pass-through entities in which the Company owns less than 100%. State tax returns are filed on a consolidated, combined or separate basis depending on the applicable laws relating to the Company and its subsidiaries. The Company does not have any foreign operations.

 

Loss Per Share – Basic loss per share is computed on the basis of the weighted-average number of shares of common stock outstanding during the period. Preferred dividends are deducted from net loss attributed to Alto Ingredients, Inc. and are considered in the calculation of loss attributable to common stockholders in computing basic loss per share. Common stock equivalents to preferred stock are considered participating securities and are also included in this calculation when dilutive.

 

The following tables compute basic and diluted loss per share (in thousands, except per share data):

 

   Year Ended December 31, 2024 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(58,984)          
Less: Preferred stock dividends   (1,269)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(60,253)   73,482   $(0.82)

 

   Year Ended December 31, 2023 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(28,005)          
Less: Preferred stock dividends   (1,265)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(29,270)   73,339   $(0.40)

 

   Year Ended December 31, 2022 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(41,597)          
Less: Preferred stock dividends   (1,265)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(42,862)   71,944   $(0.60)

There were an aggregate of 981,000, 981,000 and 964,000 potentially dilutive shares from convertible securities outstanding for the years ended December 31, 2024, 2023 and 2022, respectively. These convertible securities were not considered in calculating diluted loss per common share for the years ended December 31, 2024, 2023 and 2022 as their effect would be anti-dilutive. In addition, there were an aggregate of 3,188,000 weighted-average anti-dilutive shares from outstanding out-of-the-money warrants for the year ended December 31, 2022.

 

Financial Instruments – The carrying values of cash and cash equivalents, restricted cash, accounts receivable, derivative instruments, accounts payable and accrued liabilities are reasonable estimates of their fair values because of the short maturity of these items. The Company believes the carrying value of its long-term debt instruments are not considered materially different than fair value.

 

Business Combinations – Business acquisitions are accounted for in accordance with ASC Section 805, Business Combinations. ASC 805 requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable tangible and intangible assets acquired and liabilities assumed and recognize and measure goodwill or a gain from the purchase. Assets acquired and liabilities assumed are recorded at their fair values and the excess of the purchase price over the amounts assigned is recorded as goodwill. Adjustments to fair value assessments are recorded to goodwill over the measurement period (not longer than twelve months).

 

Income from Cash Grant – For the years ended December 31, 2023 and 2022, the Company received $2,812,000 and $22,652,000, respectively, in cash from the USDA’s Biofuel Producer Program. The Company did not receive any cash from this program for the year ended December 31, 2024. The program was created as part of the CARES Act of 2020, which allocated $700,000,000 to support biofuel producers who experienced market losses due to the pandemic. The Company is not required to repay the grants. Since these funds are provided to subsidize historical losses of the Company, and are not required to be repaid, the Company accounted for the proceeds by analogy to International Accounting Standards 20, Accounting for Government Grants and Disclosure of Government Assistance, and reported the amount as income from cash grant in the accompanying consolidated statements of operations.

 

Employment-related Benefits – Employment-related benefits associated with pensions and postretirement health care are expensed based on actuarial analysis. The recognition of expense is affected by estimates made by management, such as discount rates used to value certain liabilities, investment rates of return on plan assets, increases in future wage amounts and future health care costs. Discount rates are determined based on a spot yield curve that includes bonds with maturities that match the expected timing of benefit payments under the plan.

 

Share Repurchase Program – On September 12, 2022, the Company announced a share repurchase program under which it may repurchase up to $50,000,000 of its common stock with an initial purchase authorization of $10,000,000. The Company’s lender has further limited the Company’s purchase authorization to $5,000,000. Amounts in excess of the purchase authorization of $5,000,000 will require additional lender consent and amounts in excess of the initial purchase authorization of $10,000,000 will require additional board and preferred stockholder authorization. The share repurchase program does not have an expiration date, does not require the repurchase of any particular amount of shares, and may be implemented, modified, suspended or discontinued in whole or in part at any time and without further notice. As repurchases are made, the Company will retire the shares, resulting in a reduction of issued and outstanding shares. For the years ended December 31, 2023 and 2022, the Company repurchased an aggregate of 1,685,000 shares and 351,000 shares for $3,674,000 and $1,325,000 in cash, respectively. No shares were repurchased during the year ended December 31, 2024.

 

Nonvoting Common Stock – In 2015, the Company issued nonvoting common stock convertible at a holder’s election into voting common stock. As of December 31, 2024, an aggregate of 3,539,236 shares of nonvoting common stock had been converted into an equal number of shares of the Company’s voting common stock. As of December 31, 2024, there were 896 shares of nonvoting common stock outstanding.

Estimates and Assumptions – The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining net realizable value of inventory, long-lived asset impairments, goodwill impairment, valuation allowances on deferred income taxes and the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.

 

Recent Accounting Pronouncements – In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40), which provides for more detailed information about the types of expenses aggregated in common expense captions in the statement of operations. ASU 2024-03 is effective for the Company for the year ended December 31, 2027, with early adoption permitted. The Company is currently evaluating the impact of this ASU.

 

Subsequent Events – Management evaluates, as of each reporting period, events or transactions that occur after the balance sheet date through the date that the financial statements are issued for either disclosure or adjustment to the consolidated financial results. See Note 16.

v3.25.0.1
Acquisition of Eagle Alcohol
12 Months Ended
Dec. 31, 2024
Acquisition of Eagle Alcohol [Abstract]  
ACQUISITION OF EAGLE ALCOHOL

2. ACQUISITION OF EAGLE ALCOHOL.

 

On January 14, 2022, the Company purchased 100% of the membership interests of Eagle Alcohol. The purchase price was $14.0 million in cash plus an estimated net working capital adjustment of $1.3 million in cash. The selling members of Eagle Alcohol were eligible to receive up to an additional $14.0 million of contingent consideration, payable through a combination of $9.0 million in cash over the succeeding three years and an aggregate of $5.0 million in the Company’s common stock on the fourth- and fifth-year anniversaries of the closing date, subject to the satisfaction of certain conditions. Subsequently, the Company made organizational changes at Eagle Alcohol, and accelerated the vesting of the Company’s common stock under the terms of the purchase agreement. With respect to these payments, the Company accrued $7.7 million and $2.8 million in other current liabilities in the accompanying consolidated balance sheets as of December 31, 2024 and 2023, respectively, with the expense included in acquisition-related expenses in the accompanying consolidated statements of operations for the years then ended.

 

Eagle Alcohol specializes in break bulk distribution of specialty alcohols. Eagle Alcohol delivers products to customers in the beverage, food, industrial and related-process industries via its own dedicated trucking fleet and common carriers.

 

As part of the Company’s original allocation of purchase price for its acquisition of Eagle Alcohol, the Company recorded a customer relationships intangible asset of $6.5 million, a trade name intangible asset of $0.4 million and goodwill of $6.0 million. See Note 6.

v3.25.0.1
Intercompany Agreements
12 Months Ended
Dec. 31, 2024
Intercompany Agreements [Abstract]  
INTERCOMPANY AGREEMENTS

3. INTERCOMPANY AGREEMENTS.

 

The Company, directly or through one of its subsidiaries, has entered into the following management and marketing agreements:

 

Affiliate Management Agreement – Alto Ingredients entered into an Affiliate Management Agreement (“AMA”) with its operating subsidiaries under which Alto Ingredients agreed to provide operational, administrative and staff support services. These services generally include, but are not limited to, administering the subsidiaries’ compliance with their credit agreements and performing billing, collection, record keeping and other administrative and ministerial tasks. Alto Ingredients agreed to supply all labor and personnel required to perform its services under the AMA, including the labor and personnel required to operate and maintain the production facilities and marketing activities. These services are billed at a predetermined amount per subsidiary each month plus out of pocket costs such as employee wages and benefits.

 

The AMAs had an initial term of one year and have automatic successive one year renewal periods. Alto Ingredients may terminate the AMA, and any subsidiary may terminate the AMA, at any time by providing at least 90 days prior notice of termination.

 

Alto Ingredients recorded revenues of approximately $18,000,000, $13,200,000 and $12,403,000 related to the AMAs in place for the years ended December 31, 2024, 2023 and 2022, respectively. These amounts have been eliminated upon consolidation.

 

Ethanol Marketing Agreements – Kinergy entered into separate marketing agreements with each of the Company’s production facilities which granted Kinergy the exclusive right to purchase, market and sell the alcohols produced at those facilities. Under the terms of the marketing agreements, within ten days after delivering alcohol to Kinergy, an amount is paid to Kinergy equal to (i) the estimated purchase price payable by the third-party purchaser of the alcohol, minus (ii) the estimated amount of transportation costs to be incurred, minus (iii) the estimated incentive fee payable to Kinergy, which equals 1% of the aggregate third-party purchase price, provided that the marketing fee shall not be less than $0.015 per gallon and not more than $0.0225 per gallon. Each of the marketing agreements had an initial term of one year and has successive one year renewal periods at the option of the production facility.

 

Kinergy recorded revenues of approximately $5,407,000, $5,431,000 and $5,746,000 related to the marketing agreements for the years ended December 31, 2024, 2023 and 2022, respectively. These amounts have been eliminated upon consolidation.

 

Corn Procurement and Handling Agreements – Alto Nutrients entered into separate corn procurement and handling agreements with each of the Company’s production facilities. Under the terms of the corn procurement and handling agreements, each facility appointed Alto Nutrients as its exclusive agent to solicit, negotiate, enter into and administer, on its behalf, corn supply arrangements to procure the corn necessary to operate the facility. Alto Nutrients also provides grain handling services including, but not limited to, receiving, unloading and conveying corn into the facility’s storage and, in the case of whole corn delivered, processing and hammering the whole corn.

 

Under these agreements, Alto Nutrients receives a fee of $0.03 per bushel of corn delivered to each production facility as consideration for its procurement and handling services, payable monthly. Each corn procurement and handling agreement had an initial term of one year and successive one year renewal periods at the option of the individual facility. Alto Nutrients recorded revenues of approximately $2,910,000, $3,007,000 and $3,207,000 related to the corn procurement and handling agreements for the years ended December 31, 2024, 2023 and 2022, respectively. These amounts have been eliminated upon consolidation.

Essential Ingredients Marketing Agreements – Alto Nutrients entered into separate marketing agreements with each of the Company’s production facilities (except for the Company’s Magic Valley facility), which grant Alto Nutrients the exclusive right to market, purchase and sell the various essential ingredients produced at each facility. Under the terms of the marketing agreements, within ten days after a facility delivers essential ingredients to Alto Nutrients, the production facility is paid an amount equal to (i) the estimated purchase price payable by the third-party purchaser of the essential ingredients, minus (ii) the estimated amount of transportation costs to be incurred, minus (iii) the estimated amount of fees and taxes payable to governmental authorities in connection with the tonnage of the essential ingredients produced or marketed, minus (iv) the estimated incentive fee payable to the Company, which equals (a) 5% of the aggregate third-party purchase price for wet corn protein feed, wet distillers grains, corn condensed distillers solubles and distillers grains with solubles, or (b) 1% of the aggregate third-party purchase price for corn protein meal, dry corn protein feed, dry distillers grains, corn germ and corn oil. Each marketing agreement had an initial term of one year and has successive one year renewal periods at the option of the production facility.

 

Alto Nutrients recorded revenues of approximately $2,516,000, $3,216,500 and $3,505,000 related to the marketing agreements for the years ended December 31, 2024, 2023 and 2022, respectively. These amounts have been eliminated upon consolidation.

v3.25.0.1
Segments
12 Months Ended
Dec. 31, 2024
Segments [Abstract]  
SEGMENTS
4.SEGMENTS.

 

The Company reports its financial and operating performance in three segments: (1) Pekin Campus production, which includes the production and sale of alcohols and essential ingredients produced at the Company’s Pekin, Illinois campus, (2) marketing and distribution, which includes marketing and merchant trading for Company-produced alcohols and essential ingredients on an aggregated basis, and sales of fuel-grade ethanol sourced from third parties, and (3) Western production, which includes the production and sale of fuel-grade ethanol and essential ingredients, including liquid CO2, produced at the Company’s two western production facilities and its liquid CO2 plant on an aggregated basis, none of which are individually so significant to be considered a separately reportable segment.

 

The Company manages and assesses the performance of its reportable segments by its gross profit (loss). As part of the Executive Committee’s review of segment-level performance, each member of the Executive Committee reviews the gross profit of the Company’s reportable segments and provides expertise and analysis from their respective areas which drive the evaluation of the performance of the Company’s reportable segments and allocation of resources to those segments. Even though the CEO has the authority to override the other members for strategic or other reasons, key decisions are made jointly by the Executive Committee.

 

Included in income (loss) before provision for income taxes are management fees charged by Alto Ingredients to each of the segments. The Pekin Campus production segment incurred $7,200,000, $5,280,000 and $5,046,000 in management fees for the years ended December 31, 2024, 2023 and 2022, respectively. The marketing and distribution segment incurred $5,400,000, $3,960,000 and $3,840,000 in management fees for the years ended December 31, 2024, 2023 and 2022, respectively. The Western production segment incurred $3,600,000, $2,640,000 and $2,400,000 in management fees for the years ended December 31, 2024, 2023 and 2022, respectively. Corporate and other includes the results of Eagle Alcohol and selling, general and administrative expenses, consisting primarily of corporate employee compensation, professional fees and overhead costs not directly related to a specific operating segment.

 

During the normal course of business, the segments do business with each other. The preponderance of this activity occurs when the Company’s marketing and distribution segment markets alcohol produced by the production segments for a marketing fee, as discussed in Note 3. These intersegment activities are considered arms’-length transactions. Consequently, although these transactions impact segment performance, they do not impact the Company’s consolidated results since all revenues and corresponding costs are eliminated upon consolidation.

 

For the years ended December 31, 2024, 2023 and 2022, capital expenditures incurred by the Pekin Campus segment were approximately $6.8 million, $17.7 million and $25.7 million, and capital expenditures incurred by the Western production segment were approximately $4.3 million, $11.8 million and $12.3 million, respectively.

The following tables set forth certain financial data for the Company’s operating segments (in thousands):

 

   Years Ended December 31, 
Net Sales  2024   2023   2022 
Pekin Campus production, recorded as gross:            
Alcohol sales  $415,710   $502,217   $521,273 
Essential ingredient sales   169,308    217,702    225,871 
Intersegment sales   1,243    1,427    1,212 
Total Pekin Campus sales   586,261    721,346    748,356 
                
Marketing and distribution:               
Alcohol sales, gross  $216,295   $262,587   $227,626 
Alcohol sales, net   229    365    1,225 
Intersegment sales   10,833    11,654    12,459 
Total marketing and distribution sales   227,357    274,606    241,310 
                
Western Production, recorded as gross:               
Alcohol sales  $115,389   $166,971   $253,605 
Essential ingredient sales   36,953    57,264    90,209 
Intersegment sales   (122)   134    22 
Total Western production sales   152,220    224,369    343,836 
                
Corporate and other   11,374    15,834    15,812 
Intersegment eliminations   (11,954)   (13,215)   (13,693)
Net sales as reported  $965,258   $1,222,940   $1,335,621 
                
Cost of goods sold:            
Pekin Campus production  $563,033   $710,088   $772,755 
Marketing and distribution   213,023    259,234    229,288 
Western production   172,209    230,445    353,775 
Corporate and other   12,285    12,122    12,167 
Intersegment eliminations   (5,014)   (4,602)   (4,814)
Cost of goods sold as reported  $955,536   $1,207,287   $1,363,171 
             
Gross profit (loss):            
Pekin Campus production  $23,228   $11,258   $(24,399)
Marketing and distribution   14,334    15,372    12,022 
Western production   (19,989)   (6,076)   (9,939)
Corporate and other   (911)   3,712    3,645 
Intersegment eliminations   (6,940)   (8,613)   (8,879)
   $9,722   $15,653   $(27,550)
Income (loss) before provision for income taxes:               
Pekin Campus production  $6,308   $(1,560)  $(27,376)
Marketing and distribution   5,261    7,644    3,748 
Western production   (51,086)   (13,506)   (7,209)
Corporate and other   (19,294)   (20,486)   (8,835)
   $(58,811)  $(27,908)  $(39,672)
Asset impairments:               
Western production  $21,389   $
   $
 
Corporate and other   3,401    6,544    
 
   $24,790   $6,544   $
 
Depreciation and amortization expense:               
Pekin Campus production  $21,017   $19,789   $19,136 
Western production   2,409    2,381    5,085 
Corporate and other   982    910    874 
   $24,408   $23,080   $25,095 
Interest expense, net of capitalized interest:            
Pekin Campus production  $1,765   $(207)  $(381)
Marketing and distribution   389    822    1,658 
Western production   2,829    1,164    (339)
Corporate and other   2,661    5,646    889 
   $7,644   $7,425   $1,827 

The following table sets forth the Company’s total assets by operating segment (in thousands): 

 

   December 31, 
   2024   2023 
Total assets:        
Pekin Campus production  $223,934    251,048 
Marketing and distribution   102,895    101,196 
Western production   44,992    57,533 
Corporate and other   29,617    44,464 
   $401,438   $454,241 
v3.25.0.1
Property and Equipment
12 Months Ended
Dec. 31, 2024
Property and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

5. PROPERTY AND EQUIPMENT.

 

Property and equipment consisted of the following (in thousands):

 

   December 31, 
   2024   2023 
Facilities and plant equipment  $420,456   $405,010 
Land   3,594    3,687 
Other equipment, vehicles and furniture   20,636    9,719 
Construction in progress   11,154    50,505 
    455,840    468,921 
Accumulated depreciation   (241,098)   (220,173)
   $214,742   $248,748 

 

Depreciation expense was $23,820,000, $22,492,000 and $24,528,000 for the years ended December 31, 2024, 2023 and 2022, respectively. The Company capitalized interest of $2,517,000, $2,454,000 and $720,000 for the years ended December 31, 2024, 2023 and 2022, respectively, related to its capital investment activities. The Company recorded an asset impairment of $19,000,000 for the year ended December 31, 2024. The Company did not record any impairment on its property and equipment for the years ended December 31, 2023 and 2022.

 

The Company’s property and equipment are substantially pledged as collateral under the Company’s Term Loan.

v3.25.0.1
Intangible Assets
12 Months Ended
Dec. 31, 2024
Intangible Assets [Abstract]  
INTANGIBLE ASSETS.

6. INTANGIBLE ASSETS.

 

Intangible assets, including goodwill, consisted of the following (in thousands):

 

       December 31, 2024   December 31, 2023 
   Useful
Life
(Years)
   Gross   Accumulated
Amortization/
Impairment
   Net Book
Value
   Gross   Accumulated
Amortization/
Impairment
   Net Book
Value
 
Non-Amortizing:                            
Goodwill       $5,970   $(5,970)  $
   $5,970   $(5,970)  $
 
Kinergy tradename        2,678    
    2,678    2,678    
    2,678 
Amortizing:                                   
Customer relationships   12    6,556    (5,021)   1,535    6,556    (1,074)   5,482 
Eagle Alcohol tradename   10    420    (124)   296    420    (82)   338 
Total goodwill and intangible assets       $15,624   $(11,115)  $4,509   $15,624   $(7,126)  $8,498 

 

Goodwill The Company recorded goodwill of $5,970,000 in its Corporate and other segment resulted from the Company’s acquisition of Eagle Alcohol. As part of the Company’s annual goodwill testing, it impaired the full amount of goodwill of $5,970,000 and recognized the amount in asset impairments in the consolidated statements of operations for the year ended December 31, 2023. The Company did not record any goodwill impairment for the years ended December 31, 2024 and 2022.

 

Kinergy Tradename – The Company recorded tradename of $2,678,000 as part of the Company’s merger with Kinergy in 2006. The Company determined that the tradename has an indefinite life and therefore, rather than being amortized, will be tested annually for impairment. The Company did not record any impairment on its tradename for the years ended December 31, 2024, 2023 and 2022.

 

Customer Relationships The Company recorded customer relationships of $6,556,000 from the Company’s acquisition of Eagle Alcohol. As part of the Company’s impairment testing, it impaired this intangible asset by $3,401,000 and recognized the amount in asset impairments in the consolidated statement of operations for the year ended December 31, 2024. The Company did not record any asset impairment on its customer relationships for the years ended December 31, 2023 and 2022.

 

Eagle Alcohol Tradename The Company recorded tradename of $420,000 from the Company’s acquisition of Eagle Alcohol. The Company did not record any tradename impairment for the years ended December 31, 2024, 2023 and 2022.

 

Amortization expense associated with intangible assets totaled $588,000, $588,000 and $567,000 for the years ended December 31, 2024, 2023 and 2022. The weighted-average unamortized life of the customer relationships and tradename is 8.7 years.

 

The expected amortization expense relating to amortizable intangible assets in each of the five years after December 31, 2024 are (in thousands):

 

Years Ended December 31,  Amount 
2025  $213 
2026   213 
2027   213 
2028   213 
2029   213 
Thereafter   766 
Total  $1,831 
v3.25.0.1
Derivatives
12 Months Ended
Dec. 31, 2024
Derivatives [Abstract]  
DERIVATIVES

7. DERIVATIVES.

 

The business and activities of the Company expose it to a variety of market risks, including risks related to changes in commodity prices. The Company monitors and manages these financial exposures as an integral part of its risk management program. This program recognizes the unpredictability of financial markets and seeks to reduce the potentially adverse effects that market volatility could have on operating results.

 

Commodity RiskCash Flow Hedges – The Company uses derivative instruments to protect cash flows from fluctuations caused by volatility in commodity prices for periods of up to twelve months in order to protect gross profit margins from potentially adverse effects of market and price volatility on alcohol sales and purchase commitments where the prices are set at a future date and/or if the contracts specify a floating or index-based price. In addition, the Company hedges anticipated sales of alcohol to minimize its exposure to the potentially adverse effects of price volatility. These derivatives may be designated and documented as cash flow hedges and effectiveness is evaluated by assessing the probability of the anticipated transactions and regressing commodity futures prices against the Company’s purchase and sales prices. Ineffectiveness, which is defined as the degree to which the derivative does not offset the underlying exposure, is recognized immediately in cost of goods sold. For the years ended December 31, 2024, 2023 and 2022, the Company did not designate any of its derivatives as cash flow hedges.

 

Commodity Risk – Non-Designated Hedges – The Company uses derivative instruments to lock in prices for certain amounts of corn and alcohols by entering into exchange-traded futures contracts or options for those commodities. These derivatives are not designated for hedge accounting treatment. The changes in fair value of these contracts are recorded on the balance sheet and recognized immediately in cost of goods sold. The Company recognized net gains of $11,045,000, net losses of $8,031,000 and net gains of $19,263,000 as the change in the fair value of these contracts for the years ended December 31, 2024, 2023 and 2022, respectively.

 

Non-Designated Derivative Instruments – The classification and amounts of the Company’s derivatives not designated as hedging instruments, and related cash collateral balances, are as follows (in thousands):

 

   As of December 31, 2024
   Assets  Liabilities
Type of Instrument  Balance Sheet Location  Fair  Value   Balance Sheet Location  Fair Value 
               
Cash collateral balance  Restricted cash  $742         
Commodity contracts  Derivative instruments  $3,313   Derivative instruments  $1,177 

 

   As of December 31, 2024
   Assets  Liabilities
Type of Instrument  Balance Sheet Location  Fair Value   Balance Sheet Location  Fair Value 
               
Cash collateral balance  Restricted cash  $15,466         
Commodity contracts  Derivative instruments  $2,412   Derivative instruments  $13,849 

 

The above amounts represent the gross balances of the contracts; however, the Company does have a right of offset with each of its derivative brokers, but the Company’s intent is to close out positions individually, therefore the positions are reported at gross.

The classification and amounts of the Company’s recognized gains (losses) for its derivatives not designated as hedging instruments are as follows (in thousands):

 

      Realized Gains (Losses) 
      For the Years Ended December 31, 
Type of Instrument  Statements of Operations Location  2024   2023   2022 
                
Commodity contracts  Cost of goods sold  $(2,529)  $1,647   $23,280 
      $(2,529)  $1,647   $23,280 

 

      Unrealized Gains (Losses) 
      For the Years Ended December 31, 
Type of Instrument  Statements of Operations Location  2024   2023   2022 
                
Commodity contracts  Cost of goods sold  $13,574   $(9,678)  $(4,017)
      $13,574   $(9,678)  $(4,017)
v3.25.0.1
Debt
12 Months Ended
Dec. 31, 2024
Debt [Abstract]  
DEBT

8. DEBT.

 

Long-term borrowings are summarized as follows (in thousands):

 

   December 31,
2024
   December 31,
2023
 
Kinergy line of credit  $39,677   $30,690 
Orion term loan   60,000    60,000 
    99,677    90,690 
Less unamortized debt discount   (3,089)   (3,893)
Less unamortized debt financing costs   (3,684)   (4,700)
Less current portion   
    
 
Long-term debt  $92,904   $82,097 

 

Kinergy Line of Credit – Kinergy has an operating line of credit for an aggregate amount of up to $100,000,000. The line of credit matures on November 7, 2027. The credit facility is based on Kinergy’s eligible accounts receivable and inventory levels, subject to certain concentration reserves. The credit facility is subject to certain other sublimits, including inventory loan limits. Interest accrues under the line of credit at a rate equal to (i) the daily Secured Overnight Financing Rate, plus (ii) a specified applicable margin ranging between 1.25% and 1.75%. The applicable margin was 1.50%, for a total rate of 6.06%, at December 31, 2024. The credit facility’s monthly unused line fee is an annual rate equal to 0.25% to 0.375% depending on the average daily principal balance during the immediately preceding month. Payments that may be made by Kinergy to the Company as reimbursement for management and other services provided by the Company to Kinergy are limited under the terms of the credit facility to $1,500,000 per fiscal quarter. The credit facility also includes the accounts receivable of Alto Nutrients as additional collateral. Payments that may be made by Alto Nutrients to the Company as reimbursement for management and other services provided by the Company to Alto Nutrients are limited under the terms of the credit facility to $500,000 per fiscal quarter. Kinergy and Alto Nutrients may also make distributions to the Company of up to 75% of their excess cash flow.

 

If the monthly excess borrowing availability of Kinergy and Alto Nutrients falls below certain thresholds, they are collectively required to maintain a fixed-charge coverage ratio (calculated as a twelve-month rolling earnings before interest, taxes, depreciation and amortization divided by the sum of interest expense, capital expenditures, principal payments of indebtedness, indebtedness from capital leases and taxes paid during such twelve-month rolling period) of at least 1.1 and are prohibited from incurring certain additional indebtedness (other than specific intercompany indebtedness).

The obligations of Kinergy and Alto Nutrients under the credit facility are secured by first-priority security interests in all of their assets in favor of the lender. Alto Ingredients has guaranteed all of Kinergy’s obligations under the line of credit. As of December 31, 2024, Kinergy had $23.1 million in unused borrowing availability under the credit facility.

 

Orion Term Loan – On November 7, 2022, the Company entered into a credit agreement with certain funds managed by Orion Infrastructure Capital (collectively, the “Lenders”), and OIC Investment Agent, LLC, as administrative agent and collateral agent (“OIC”), under which the Lenders agreed to extend a senior secured credit facility in the amount of up to $125,000,000 (the “Term Loan”). The Term Loan is secured by a first priority lien on certain assets of the Company and a second priority lien on certain assets of Kinergy and Alto Nutrients.

 

The Lenders agreed to advance to the Company up to $100,000,000, with up to $25,000,000 more upon the satisfaction of certain additional conditions. The Company also agreed to issue to the Lenders upon its first funding request, an aggregate of 1,282,051 shares of the Company’s common stock, and up to an additional 320,513 shares of the Company’s common stock upon additional funding or fundings.

 

On November 23, 2022, the Company received its initial funding of $60,000,000 and issued 1,282,051 shares of common stock. As of December 31, 2024, 2023 and 2022, the principal amount outstanding under the Term Loan was $60,000,000. The Company allocated $3,912,000 of the loan proceeds to additional paid-in capital for the common stock issued based on the relative fair values of the debt and equity instruments and recorded a corresponding amount as a debt issuance discount that will be amortized to interest expense over the term of the loan.

 

As of December 31, 2024, interest accrued on the unpaid principal amount of the Term Loan at a fixed rate of 10% per annum. On January 1, 2025, the annual fixed rate of interest on the Term Loan increased to 10.75% in connection with the Company’s amendment of various terms under the Term Loan. The Term Loan matures on November 7, 2028, or earlier upon acceleration.

 

The Company must prepay amounts outstanding under the Term Loan on a semi-annual basis beginning with the six-month period ended December 31, 2023 in an amount equal to a percentage of the Company’s excess cash flow based on a specified leverage ratio, as follows: (i) if the leverage ratio is greater than or equal to 3.0x, then the mandatory prepayment amount will equal 100% of the Company’s excess cash flow, (ii) if the leverage ratio is less than 3.0x and greater than or equal to 1.5x, then the mandatory prepayment amount will equal 50% of the Company’s excess cash flow and (iii) if the leverage ratio is less than 1.5x, then the mandatory prepayment amount will equal 25% of the Company’s excess cash flow.

 

The terms and conditions of the Term Loan also contain customary and other representations, warranties, covenants and obligations, including events of default, and other terms and conditions.

 

Registration Rights Agreement - On November 7, 2022, the Company entered into a registration rights agreement with the Lenders and agreed to register for resale with the Securities and Exchange Commission the shares of common stock issued to the Lenders under the Term Loan. The related registration statement has been declared effective by the Securities and Exchange Commission.

 

Maturities of Long-term Debt – The Company’s long-term debt matures as follows (in thousands):

 

December 31:    
2027  $39,677 
2028   60,000 
   $99,677 
v3.25.0.1
Leases
12 Months Ended
Dec. 31, 2024
Leases [Abstract]  
LEASES

9. LEASES.

 

The Company leases equipment and land for certain of its facilities. Operating lease right of use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate, unless an implicit rate is readily determinable, as the discount rate for each lease in determining the present value of lease payments. For the years ended December 31, 2024 and 2023, the Company’s weighted-average discount rate was approximately 7.78%. Operating lease expense is recognized on a straight-line basis over the lease term.

 

Upon the adoption of ASC 842, the Company elected the following practical expedients allowable under the guidance: not to reassess whether any expired or existing contracts are or contain leases; not to reassess the lease classification for any expired or existing leases; not to reassess initial direct costs for any existing leases; not to separately identify lease and non-lease components; and not to evaluate historical land easements. Additionally, the Company elected the short-term lease exemption policy, applying the requirements of ASC 842 to only long-term (greater than 1 year) leases.

 

The Company determines if an arrangement is a lease or contains a lease at inception. The Company’s leases have remaining lease terms of approximately 1 year to 51 years, which includes options to extend the lease when it is reasonably certain the Company will exercise those options. For the year ended December 31, 2024, the weighted-average remaining lease terms of equipment and land-related leases were 4.14 years and 16.42 years, respectively. For the year ended December 31, 2023, the weighted-average remaining lease terms of equipment and land-related leases were 4.73 years and 15.41 years, respectively. The Company does not have lease arrangements with residual value guarantees, sale-leaseback terms or material restrictive covenants. The Company does not have any material finance lease obligations nor sublease agreements.

 

Leases consist of the following (in thousands):

 

   Classification  December 31, 
Assets     2024   2023 
Operating  Right of use operating lease assets, net  $20,553   $22,597 
Liabilites             
Operating - Current  Current portion, operating leases  $4,851   $4,333 
Operating - Noncurrent  Operating leases, net of current portion  $16,913   $19,029 

 

The Components of lease costs were as follows (in thousands):

 

   Years Ended December 31, 
   2024   2023   2022 
             
Fixed lease cost  $5,989   $5,722   $5,224 
Variable lease cost   529    871    124 
Net lease cost  $6,518   $6,593   $5,348 

The following table summarizes the remaining maturities of the Company’s operating lease liabilities, assuming all land lease extensions are taken, as of December 31, 2024 (in thousands):

 

Year Ended:   Equipment     Land Related  
2025   $ 5,334     $ 1,060  
2026     4,761       1,037  
2027     4,152       1,011  
2028     3,368       1,024  
2029     1,992       660  
2030-76     119       3,881  
Less interest     (3,299 )     (3,336 )
    $ 16,427     $ 5,337  
v3.25.0.1
Pension Plans
12 Months Ended
Dec. 31, 2024
Pension Plans [Abstract]  
PENSION PLANS

10. PENSION PLANS.

 

Retirement Plan - The Company sponsors a defined benefit pension plan (the “Retirement Plan”) that is noncontributory, and covers only “grandfathered” unionized employees at its Alto Pekin production facilities. Benefits are based on a prescribed formula based upon the employee’s years of service. Employees hired after November 1, 2010, are not eligible to participate in the Retirement Plan. The Company uses a December 31st measurement date for its Retirement Plan. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations.

 

Information related to the Retirement Plan as of and for the years ended December 31, 2024 and 2023 is presented below (dollars in thousands):

 

   2024   2023 
Changes in plan assets:        
Fair value of plan assets, beginning  $18,485   $16,688 
Actual gains   1,711    2,376 
Benefits paid   (829)   (834)
Company contributions   800    255 
Participant contributions   
    
 
Fair value of plan assets, ending  $20,167   $18,485 
Less: projected accumulated benefit obligation  $17,530   $18,590 
Funded status, overfunded (underfunded)  $2,637   $(105)
           
Amounts recognized in the consolidated balance sheets:          
Other assets  $2,637   $
 
Other liabilities  $
   $(105)
Accumulated other comprehensive income  $(4,167)  $(2,231)
           
Assumptions used in computation of benefit obligations:          
Discount rate   5.50%   4.90%
Expected long-term return on plan assets   6.50%   6.50%
Rate of compensation increase   
    
 

 

   Years Ended December 31, 
   2024   2023   2022 
Components of net periodic benefit costs are as follows:            
Service cost  $267   $249   $404 
Interest cost   887    900    655 
Expected return on plan assets   (1,103)   (993)   (1,090)
Net periodic cost (benefit)  $51   $156   $(31)

The Company does not expect to make any contributions in the year ending December 31, 2025. Net periodic benefit for 2025 is estimated to be approximately $0.5 million.

 

The following table summarizes the expected benefit payments for the Company’s Retirement Plan for each of the next five fiscal years and in the aggregate for the five fiscal years thereafter (in thousands):

 

December 31:      
2025   $ 1,000  
2026     1,040  
2027     1,080  
2028     1,130  
2029     1,160  
2030-34     6,480  
    $ 11,890  

 

See Note 15 for discussion of the Retirement Plan’s fair value disclosures.

 

Historical and future expected returns of multiple asset classes were analyzed to develop a risk-free real rate of return and risk premiums for each asset class. The overall rate for each asset class was developed by combining a long-term inflation component, the risk-free real rate of return, and the associated risk premium. A weighted-average rate was developed based on those overall rates and the target asset allocation of the Retirement Plan.

 

The Company’s pension committee is responsible for overseeing the investment of pension plan assets. The pension committee is responsible for determining and monitoring the appropriate asset allocations and for selecting or replacing investment managers, trustees, and custodians. The Retirement Plan’s current investment target allocations are 50% equities and 50% debt. The pension committee periodically reviews the actual asset allocation in light of these targets and rebalances investments as necessary. The pension committee also evaluates the performance of investment managers as compared to the performance of specified benchmarks and peers and monitors the investment managers to ensure adherence to their stated investment style and to the Retirement Plan’s investment guidelines.

 

Postretirement Plan - The Company also sponsors a health care plan and life insurance plan (the “Postretirement Plan”) that provides postretirement medical benefits and life insurance to certain “grandfathered” unionized employees at its Alto Pekin production facilities. Employees hired after December 31, 2000, are not eligible to participate in the Postretirement Plan. The plan is contributory, with contributions required at the same rate as active employees. Benefit eligibility under the plan reduces at age 65 from a defined benefit to a defined dollar cap based upon years of service.

 

Information related to the Postretirement Plan as of December 31, 2024 and 2023 is presented below (dollars in thousands):

 

   2024   2023 
Amounts at the end of the year:        
Accumulated/projected benefit obligation  $3,783   $4,294 
Fair value of plan assets   
    
 
Funded status, underfunded  $(3,783)  $(4,294)
           
Amounts recognized in the consolidated balance sheets:          
Accrued liabilities  $(280)  $(320)
Other liabilities  $(3,503)  $(3,974)
Accumulated other comprehensive income  $(808)  $(250)
           
Discount rate used in computation of benefit obligations   5.30%   4.75%
   Years Ended December 31, 
   2024   2023   2022 
Components of net periodic benefit costs are as follows:            
Service cost  $19   $14   $26 
Interest cost   196    186    105 
Amortization of prior service cost   
    (53)   
 
Net periodic benefit cost  $215   $147   $131 
Amounts recognized in the plan for the year:               
Participant contributions  $35   $36   $43 
Benefits paid  $204   $201   $215 

 

The Company does not expect to recognize any amortization of net actuarial loss during the year ended December 31, 2025.

 

The following table summarizes the expected benefit payments for the Company’s Postretirement Plan for each of the next five fiscal years and in the aggregate for the five fiscal years thereafter (in thousands):

 

December 31:      
2025   $ 280  
2026     360  
2027     390  
2028     420  
2029     400  
2030-2034     1,780  
    $ 3,630  

 

For purposes of determining the cost and obligation for pre-Medicare postretirement medical benefits, a 8.50% annual rate of increase in the per capita cost of covered benefits (i.e., health care trend rate) was assumed for the Postretirement Plan in 2026, adjusted to a rate of 4.50% in 2035. Assumed health care cost trend rates have a significant effect on the amounts reported for health care plans.

v3.25.0.1
Income Taxes
12 Months Ended
Dec. 31, 2024
Income Taxes [Abstract]  
INCOME TAXES

11. INCOME TAXES.

 

The Company recorded a provision for income taxes as follows (in thousands):

 

   Years Ended December 31, 
   2024   2023   2022 
Current provision  $173   $97   $1,925 
Deferred provision            
Total  $173   $97   $1,925 

A reconciliation of the differences between the United States statutory federal income tax rate and the effective tax rate as provided in the consolidated statements of operations is as follows:

 

   Years Ended December 31, 
   2024   2023   2022 
Statutory rate   21.0%   21.0%   21.0%
State income taxes, net of federal benefit   5.5    4.6    5.8 
Change in valuation allowance   (29.3)   (23.4)   (33.9)
Stock-based compensation   (0.4)   (2.3)   3.1 
Non-deductible items   (0.1)   0.8    (1.6)
Other   3.0    (1.0)   0.6 
Effective rate   (0.3)%   (0.3)%   (5.0)%

 

Deferred income taxes are provided using the asset and liability method to reflect temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities using presently enacted tax rates and laws. The components of deferred income taxes included in the consolidated balance sheets were as follows (in thousands):

 

   December 31, 
   2024   2023 
Deferred tax assets:        
Net operating loss carryforwards  $64,901   $57,870 
Capital loss   26,692    26,518 
Disallowed interest   5,048    3,457 
R&D, Energy and AMT credits   3,742    3,742 
Derivatives   
    3,051 
Intangibles   2,981    1,201 
Pension liability   1,016    1,173 
Railcar contracts   1,090    818 
Stock-based compensation   803    696 
Allowance for credit losses and other assets   1,059    296 
Other   4,971    3,340 
Total gross deferred tax assets   112,303    102,162 
Less: valuation allowance   (110,687)   (93,506)
Total deferred tax assets, net of valuation allowance   1,616    8,656 
           
Deferred tax liabilities:          
Property and equipment   (703)   (7,720)
Derivatives   (574)   
 
Other   (575)   (1,172)
Total deferred tax liabilities   (1,852)   (8,892)
           
Net deferred tax liabilities, included in other liabilities  $(236)  $(236)

A portion of the Company’s net operating loss carryforwards are subject to provisions of the tax law that limit the use of losses incurred by a corporation prior to the date certain ownership changes occur. These limitations also apply to certain depreciation deductions associated with assets on hand at the time of the ownership change and otherwise allowable during the five-year period following the ownership change. As the five-year limitation period lapsed in 2019, these disallowed deductions are reflected in property and equipment in the schedule above but continue to be subject to the annual limitation that applies to the pre-change net operating losses. Due to the limitation on the use of net operating losses and depreciation deductions, a significant portion of these carryforwards will expire regardless of whether the Company generates future taxable income. After reducing these net operating loss carryforwards for the amount which will expire due to this limitation, the Company had remaining federal net operating loss carryforwards of approximately $227,673,000 and state net operating loss carryforwards of approximately $276,424,000 at December 31, 2024. These net operating loss carryforwards expire as follows (in thousands):

 

Tax Years  Federal   State 
2025–2029  $
   $30,603 
2030–2034   15,126    76,920 
2035–2039   83,771    112,608 
2040 and after*   128,776    56,293 
Total NOLs  $227,673   $276,424 
*Includes indefinite life federal net operating losses of $128.8 million generated after 2017.

 

Approximately $155,452,000 is available to utilize against federal taxable income for 2025.

 

To the extent amounts are not utilized in any year, they may be carried forward to the next year until expiration. These amounts may change if there are future additional limitations on their utilization.

 

Federal capital loss of $100,487,000 may be carried forward for 5 years and will expire in 2025. State capital loss of $95,469,000 may be carried forward for 5 years for most of the states in which the Company files returns and will expire in 2025.

 

In assessing whether the deferred tax assets are realizable, a more likely than not standard is applied. If it is determined that it is more likely than not that deferred tax assets will not be realized, a valuation allowance must be established against the deferred tax assets. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which the associated temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.

 

A valuation allowance was established in the amount of $110,687,000 and $93,506,000 as of December 31, 2024 and 2023, respectively, based on the Company’s assessment of the future realizability of certain deferred tax assets. The valuation allowance on deferred tax assets is related to future deductible temporary differences and net operating loss carryforwards for which the Company has concluded it is more likely than not that these items will not be realized in the ordinary course of operations.

For the year ended December 31, 2024, the Company recorded an increase in valuation allowance of $17,181,000. This was primarily related to additional net operating losses accumulated for the year. For the year ended December 31, 2023, the Company recorded an increase in valuation allowance of $5,557,000. This was primarily related to additional net operating losses accumulated for the year. For the year ended December 31, 2022, the Company recorded an increase in valuation allowance of $12,365,000. This was primarily related to additional net operating losses accumulated for the year.

 

Unrecognized Tax Benefits

 

A reconciliation of the beginning balance and the ending balance of gross unrecognized tax benefits, before interest and penalties, for the period presented is as follows (in thousands):

 

   December 31, 
   2024   2023 
Unrecognized tax benefits at beginning of year  $739   $739 
Increases related to current year tax positions   
    
 
Decreases related to current year tax positions   
    
 
Increases related to prior year tax positions   
    
 
Decreases related to prior year tax positions   
    
 
Decreases related to expiration of prior year tax positions   
    
 
Decreases related to settlements of prior year tax positions   
    
 
Unrecognized tax benefits at end of year  $739   $739 

 

The Company recorded unrecognized tax benefits for uncertain tax positions of approximately $739,000 as of December 31, 2024 and 2023, of which $739,000 would impact the effective tax rate, if recognized.

 

The Company recognizes interest and penalties related to income tax matters as a component of interest expense and other income, net, respectively. As of December 31, 2024, the Company accrued penalties of $74,000 and interest of $134,000 related to uncertain tax positions. The Company does not expect the unrecognized tax benefits to change significantly over the next 12 months.

The Company is subject to income tax in the United States federal jurisdiction and various state jurisdictions and has identified its federal tax return and tax returns in state jurisdictions below as “major” tax filings. These jurisdictions, along with the years still open to audit under the applicable statutes of limitation, are as follows:

 

Jurisdiction   Tax Years
Federal   2021 – 2023
Alabama   2021 – 2023
Arizona   2020 – 2023
Arkansas   2021 – 2023
California   2020 – 2023
Colorado   2020 – 2023
Connecticut   2021 – 2023
Georgia   2021 – 2023
Idaho   2021 – 2023
Illinois   2021 – 2023
Indiana   2021 – 2023
Iowa   2021 – 2023
Kansas   2021 – 2023
Louisiana   2021 – 2023
Michigan   2021 – 2023
Minnesota   2021 – 2023
Mississippi   2021 – 2023
Missouri   2021 – 2023
Nebraska   2021 – 2023
New Mexico   2021 – 2023
Oklahoma   2021 – 2023
Oregon   2021 – 2023
Pennsylvania   2021 – 2023
Rhode Island   2021 – 2023
South Carolina   2021 – 2023
Tennessee   2021 – 2023
Texas   2020 – 2023

 

However, because the Company had net operating losses and credits carried forward in several of the jurisdictions, including the United States federal and California jurisdictions, certain items attributable to closed tax years are still subject to adjustment by applicable taxing authorities through an adjustment to tax attributes carried forward to open years.

v3.25.0.1
Preferred Stock
12 Months Ended
Dec. 31, 2024
Preferred Stock [Abstract]  
PREFERRED STOCK

12. PREFERRED STOCK.

 

The Company has 6,734,835 undesignated shares of authorized and unissued preferred stock, which may be designated and issued in the future on the authority of the Company’s Board of Directors. As of December 31, 2024, the Company had the following designated classes of preferred stock:

 

Series A Preferred Stock – The Company has authorized 1,684,375 shares of Series A Cumulative Redeemable Convertible Preferred Stock (“Series A Preferred Stock”), with none outstanding at December 31, 2024 and 2023. Shares of Series A Preferred Stock that are converted into shares of the Company’s common stock revert to undesignated shares of authorized and unissued preferred stock.

Upon any issuance, the Series A Preferred Stock would rank senior in liquidation and dividend preferences to the Company’s common stock. Holders of Series A Preferred Stock would be entitled to quarterly cumulative dividends payable in arrears in cash in an amount equal to 5% per annum of the purchase price per share of the Series A Preferred Stock. The holders of the Series A Preferred Stock would have conversion rights initially equivalent to two shares of common stock for each share of Series A Preferred Stock, subject to customary antidilution adjustments. Certain specified issuances will not result in antidilution adjustments. The shares of Series A Preferred Stock would also be subject to forced conversion upon the occurrence of a transaction that would result in an internal rate of return to the holders of the Series A Preferred Stock of 25% or more. Accrued but unpaid dividends on the Series A Preferred Stock are to be paid in cash upon any conversion of the Series A Preferred Stock.

 

The holders of Series A Preferred Stock would have a liquidation preference over the holders of the Company’s common stock equivalent to the purchase price per share of the Series A Preferred Stock plus any accrued and unpaid dividends on the Series A Preferred Stock. A liquidation would be deemed to occur upon the happening of customary events, including transfer of all or substantially all of the Company’s capital stock or assets or a merger, consolidation, share exchange, reorganization or other transaction or series of related transactions, unless holders of 66 2/3% of the Series A Preferred Stock vote affirmatively in favor of or otherwise consent to such transaction.

 

Series B Preferred Stock – The Company has authorized 1,580,790 shares of Series B Cumulative Convertible Preferred Stock (“Series B Preferred Stock”), with 926,942 shares outstanding at December 31, 2024 and 2023. Shares of Series B Preferred Stock that are converted into shares of the Company’s common stock revert to undesignated shares of authorized and unissued preferred stock.

 

The Series B Preferred Stock ranks senior in liquidation and dividend preferences to the Company’s common stock. Holders of Series B Preferred Stock are entitled to quarterly cumulative dividends payable in arrears in cash in an amount equal to 7.00% per annum of the purchase price per share of the Series B Preferred Stock; however, subject to the provisions of the Letter Agreement described below, such dividends may, at the option of the Company, be paid in additional shares of Series B Preferred Stock based initially on the liquidation value of the Series B Preferred Stock. In addition to the quarterly cumulative dividends, holders of the Series B Preferred Stock are entitled to participate in any common stock dividends declared by the Company to its common stockholders. The holders of Series B Preferred Stock have a liquidation preference over the holders of the Company’s common stock initially equivalent to $19.50 per share of the Series B Preferred Stock plus any accrued and unpaid dividends on the Series B Preferred Stock. A liquidation will be deemed to occur upon the happening of customary events, including the transfer of all or substantially all of the capital stock or assets of the Company or a merger, consolidation, share exchange, reorganization or other transaction or series of related transactions (each, a “transaction”), unless holders of 66 2/3% of the Series B Preferred Stock vote affirmatively in favor of or otherwise consent that such transaction shall not be treated as a liquidation. The Company believes that such liquidation events are within its control and therefore has classified the Series B Preferred Stock in stockholders’ equity.

 

As of December 31, 2024, the Series B Preferred Stock was convertible into 980,712 shares of the Company’s common stock. The conversion ratio is subject to customary antidilution adjustments. In addition, antidilution adjustments are to occur in the event that the Company issues equity securities, including derivative securities convertible into equity securities (on an as-converted or as-exercised basis), at a price less than the conversion price then in effect. The shares of Series B Preferred Stock are also subject to forced conversion upon the occurrence of a transaction that would result in an internal rate of return to the holders of the Series B Preferred Stock of 25% or more. The forced conversion is to be based upon the conversion ratio as last adjusted. Accrued but unpaid dividends on the Series B Preferred Stock are to be paid in cash upon any conversion of the Series B Preferred Stock.

The holders of Series B Preferred Stock vote together as a single class with the holders of the Company’s common stock on all actions to be taken by the Company’s stockholders. Each share of Series B Preferred Stock entitles the holder to approximately 0.03 votes per share on all matters to be voted on by the stockholders of the Company. Notwithstanding the foregoing, the holders of Series B Preferred Stock are afforded numerous customary protective provisions with respect to certain actions that may only be approved by holders of a majority of the shares of Series B Preferred Stock, including, among other provisions, the right to approve any transaction that does not result in an internal rate of return of at least 25% to the holders of the Series B Preferred Stock.

 

In 2008, the Company entered into Letter Agreements with Lyles United LLC (“Lyles United”) and other purchasers under which the Company expressly waived its rights under the Certificate of Designations relating to the Series B Preferred Stock to make dividend payments in additional shares of Series B Preferred Stock in lieu of cash dividend payments without the prior written consent of Lyles United and the other purchasers.

 

Registration Rights Agreement – In connection with the sale of its Series B Preferred Stock, the Company entered into a registration rights agreement with Lyles United. The registration rights agreement is effective until the holders of the Series B Preferred Stock, and their affiliates, as a group, own less than 10% for each of the series issued, including common stock into which such Series B Preferred Stock has been converted. The registration rights agreement provides that holders of a majority of the Series B Preferred Stock, including common stock into which such Series B Preferred Stock has been converted, may demand and cause the Company to register on their behalf the shares of common stock issued, issuable or that may be issuable upon conversion of the Preferred Stock and as payment of dividends thereon, and upon exercise of the related warrants (collectively, the “Registrable Securities”). The Company is required to keep such registration statement effective until such time as all of the Registrable Securities are sold or until such holders may avail themselves of Rule 144 for sales of Registrable Securities without registration under the Securities Act of 1933, as amended. The holders are entitled to two demand registrations on Form S-1 and unlimited demand registrations on Form S-3; provided, however, that the Company is not obligated to effect more than one demand registration on Form S-3 in any calendar year. In addition to the demand registration rights afforded the holders under the registration rights agreement, the holders are entitled to unlimited “piggyback” registration rights. These rights entitle the holders who so elect to be included in registration statements to be filed by the Company with respect to other registrations of equity securities. The Company is responsible for all costs of registration, plus reasonable fees of one legal counsel for the holders, which fees are not to exceed $25,000 per registration. The registration rights agreement includes customary representations and warranties on the part of both the Company and the holders and other customary terms and conditions.

v3.25.0.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2024
Stock-based Compensation [Abstract]  
STOCK-BASED COMPENSATION

13. STOCK-BASED COMPENSATION.

 

On June 16, 2016, the Company’s shareholders approved the 2016 Stock Incentive Plan, which authorizes the issuance of incentive stock options and non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, direct stock issuances and other stock-based awards to the Company’s officers, directors or key employees or to consultants that do business with the Company initially for up to an aggregate of 1,150,000 shares of common stock. On June 14, 2018, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 3,650,000 shares. On November 7, 2019, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 5,650,000 shares. On November 18, 2020, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 7,400,000 shares. On June 23, 2022, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 8,900,000 shares. On June 22, 2023, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 11,400,000 shares. On June 20, 2024, the Company’s shareholders approved an increase to the aggregate number of shares authorized under the 2016 Stock Incentive Plan to 15,200,000 shares.

 

Restricted Stock – A summary of unvested restricted stock activity is as follows (shares in thousands):

 

   Number of
Shares
   Weighted-
Average
Grant Date
Fair Value
Per Share
 
Unvested at December 31, 2022   1,169   $5.95 
Issued   2,375   $1.87 
Vested   (547)  $5.61 
Canceled   (56)  $3.14 
Unvested at December 31, 2023   2,941   $2.77 
           
Issued   1,530   $1.91 
Vested   (1,597)  $3.08 
Canceled   (143)  $2.16 
Unvested at December 31, 2024   2,731   $2.14 

 

The fair value of the common stock at vesting aggregated $3,142,000, $929,000 and $6,900,000 for the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense related to employee and non-employee restricted stock and option grants recognized in the accompanying consolidated statements of operations, was as follows (in thousands):

 

   Years Ended December 31, 
   2024   2023   2022 
Employees  $3,960   $3,345   $2,689 
Non-employees   397    551    644 
Total stock-based compensation expense  $4,357   $3,896   $3,333 

 

Employee grants typically have a two or three-year vesting schedule, while non-employee grants have a one-year vesting schedule. At December 31, 2024, the total compensation expense related to unvested awards which had not been recognized was $3,678,000 and the associated weighted-average period over which the compensation expense attributable to those unvested awards will be recognized was approximately 0.67 years.

v3.25.0.1
Commitments and Contingencies
12 Months Ended
Dec. 31, 2024
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

14. COMMITMENTS AND CONTINGENCIES.

 

Commitments – The following is a description of significant commitments at December 31, 2024:

 

Sales Commitments – At December 31, 2024, the Company had entered into sales contracts with its major customers to sell certain quantities of alcohol and essential ingredients. The Company had open alcohol indexed-price contracts for 74,375,000 gallons as of December 31, 2024 and open fixed-price alcohol sales contracts totaling $166,794,000 as of December 31, 2024. The Company had open fixed-price sales contracts for essential ingredients totaling $5,952,000 and open indexed-price sales contracts of essential ingredients for 47,000 tons as of December 31, 2024. These sales contracts are scheduled for completion over the next twelve months.

 

Purchase Commitments – At December 31, 2024, the Company had indexed-price purchase contracts to purchase 23,028,000 gallons of alcohol and fixed-price purchase contracts to purchase $220,000 of alcohol from its suppliers. The Company had fixed-price purchase contracts to purchase $34,731,000 of corn from its suppliers as of December 31, 2024. The Company had indexed-price purchase contracts for 2,520,000 MMBTU of natural gas. The Company had future commitments for certain capital projects totaling $9,059,000. The Company also had a future commitment for $7,250,000 for the purchase of Kodiak Carbonic, LLC. See Note 16. These purchase commitments are scheduled to be satisfied through 2025.

 

Contingencies – The following is a description of significant contingencies at December 31, 2024:

 

Litigation The Company is subject to various claims and contingencies in the ordinary course of its business, including those related to litigation, business transactions, employee-related matters, and others. When the Company is aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, the Company will record a liability for the loss. If the loss is not probable or the amount of the loss cannot be reasonably estimated, the Company discloses the claim if the likelihood of a potential loss is reasonably possible, and the amount involved could be material. While the Company can provide no assurances, the Company does not expect that any of its pending legal proceedings will have a material financial impact on the Company’s operating results.

v3.25.0.1
Fair Value Measurements
12 Months Ended
Dec. 31, 2024
Fair Value Measurements [Abstract]  
FAIR VALUE MEASUREMENTS
15.FAIR VALUE MEASUREMENTS.

 

The fair value hierarchy prioritizes the inputs used in valuation techniques into three levels, as follows:

 

Level 1 – Observable inputs – unadjusted quoted prices in active markets for identical assets and liabilities;

 

Level 2 – Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and

 

Level 3 – Unobservable inputs – includes amounts derived from valuation models where one or more significant inputs are unobservable. For fair value measurements using significant unobservable inputs, a description of the inputs and the information used to develop the inputs is required along with a reconciliation of Level 3 values from the prior reporting period.

Pooled Separate Accounts – Pooled separate accounts invest primarily in domestic and international stocks, commercial paper or single mutual funds. The net asset value is used as a practical expedient to determine fair value for these accounts. Each pooled separate account provides for redemptions by the Retirement Plan at reported net asset values per share, with little to no advance notice requirement, therefore these funds are classified within Level 2 of the valuation hierarchy.

 

Derivative Instruments – The Company’s derivative instruments consist of commodity positions. The fair values of the commodity positions are based on quoted prices on the commodity exchanges and are designated as Level 1 inputs.

 

Long-Lived Assets – Long-lived assets consist of the Company’s estimated fair value associated with its Magic Valley facility. See Note 1 for additional information. The fair value of the long-lived assets are based on present value of estimated future cash flows and are designated as Level 3 inputs.

 

The following table summarizes recurring and nonrecurring fair value measurements by level at December 31, 2024 (in thousands):

 

                   Benefit Plan 
                  Percentage 
   Fair Value   Level 1   Level 2   Level 3   Allocation 
Assets:                    
Derivative financial instruments  $3,313   $3,313   $   $      
Long-lived assets – Magic Valley   19,397            19,397      
Defined benefit plan assets(1) (pooled separate accounts):                         
Large U.S. Equity(2)   6,962        6,962        34%
Small/Mid U.S. Equity(3)   3,636        3,636        18%
International Equity(4)   2,762        2,762        14%
Fixed Income(5)   6,807        6,807        34%
   $42,877   $3,313   $20,167   $19,397      
                          
Liabilities:                         
Derivative financial instruments  $1,177   $1,177   $   $      

The following table summarizes recurring and nonrecurring fair value measurements by level at December 31, 2023 (in thousands):

 

                   Benefit Plan 
   Fair               Percentage 
   Value   Level 1   Level 2   Level 3   Allocation 
Assets:                    
Derivative financial instruments  $2,412   $2,412   $
   $
      
Defined benefit plan assets(1) (pooled separate accounts):                         
Large U.S. Equity(2)   5,608    
    5,608    
    30%
Small/Mid U.S. Equity(3)   3,350    
    3,350    
    18%
International Equity(4)   2,682    
    2,682    
    15%
Fixed Income(5)   6,845    
    6,845    
    37%
   $20,897   $2,412   $18,485   $
      
                          
Liabilities:                         
Derivative financial instruments  $13,849   $13,849   $
   $
      
(1)See Note 10 for accounting discussion.

 

(2)This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

 

(3)This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

 

(4)This category includes investments in funds comprised of equity securities of foreign companies, including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

 

(5)This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
v3.25.0.1
Subsequent Events
12 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
16.SUBSEQUENT EVENTS.

 

On January 1, 2025, the Company’s wholly-owned subsidiary, Alto Carbonic, LLC, acquired 100% of the equity interests in Kodiak Carbonic, LLC, a beverage-grade liquid CO2 processor for $7.6 million in cash. The transaction also involved an improved, long-term sales contract with a third party for the sale of beverage-grade liquid CO2, which will improve the financial results of the production facility. Alto Carbonic’s facility is co-located at the Columbia ethanol facility. Based on its preliminary assessment, the Company expects to record at fair value $3.9 million in property and equipment and $3.7 million of intangible assets related to the long-term sales contract. The Company does not expect to record any goodwill with the transaction and plans to report the results of Alto Carbonic in the Company’s Western Production segment.

v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure      
Net Income (Loss) $ (58,984) $ (28,005) $ (41,597)
v3.25.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Rule 10b5-1 Arrangement Modified [Flag] false
Non-Rule 10b5-1 Arrangement Modified [Flag] false
v3.25.0.1
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]

We recognize the critical importance of maintaining the trust and confidence of our customers, business partners, employees and other stakeholders. We engage in active oversight of cybersecurity, a cornerstone of our comprehensive enterprise risk management (ERM) program. Our cybersecurity framework is rooted in the National Institute of Standards and Technology, or NIST, Cybersecurity Framework, or CSF, as well as the International Organization for Standardization (ISO/IEC 27001), reflecting our commitment to uphold the highest cybersecurity standards. We align our policies, standards and practices with these benchmarks and dynamically refine them to address evolving cybersecurity threats.

Risk Management and Strategy

We maintain a cybersecurity program aligned with NIST CSF standards designed to identify critical assets and vulnerabilities, protect them with appropriate safeguards, promptly detect cybersecurity events, respond effectively to mitigate their impact and recover from incidents to restore services. Our cybersecurity program is designed to safeguard the confidentiality, integrity and availability of information. Our cybersecurity risk management strategy includes:

Governance: The Audit Committee of our Board of Directors oversees our cybersecurity risk management. Our Chief Financial Officer and Director of Information Technology, along with key executives, have roles in governance and facilitating alignment across our organization.
Compliance and Standards: We design our cybersecurity program for compliance with industry-specific and other regulations (e.g., the General Data Protection Regulation (GDPR) and the California Consumer Privacy Act (CCPA)) demonstrating our commitment to both domestic and international information security standards.

Technical Safeguards

We deploy technical defenses against cybersecurity risks of attack and other incidents, including firewalls, intrusion detection and prevention systems and access controls. We refine these measures based on our ongoing assessments, including cybersecurity threat intelligence updates.

Incident Response and Recovery Planning: We maintain incident response and recovery frameworks, tested twice yearly through backup restorations to critical systems, to improve our preparedness to effectively manage and mitigate cybersecurity incidents.
Education and Awareness: Our personnel and members of our Board of Directors undergo mandatory periodic training on cybersecurity threats, with updated insights into effective defense mechanisms and our evolving cybersecurity policies and practices.
Use of Third Parties: We collaborate with external cybersecurity service providers, including auditors, consultants and governmental agencies, to refine our cybersecurity measures. These service providers carry out cybersecurity risk evaluations such as periodic assessments and vulnerability scans to pinpoint potential security flaws and suggest enhancements. In addition, we employ third-party technology and other solutions to enhance our protection against cybersecurity risks. These solutions include our use of a managed security service provider to support our in-house technology team, an endpoint detection and response, or EDR, system for ongoing surveillance, detection, and action against threats, as well as a security information and event management, or SIEM, system designed to automate the real time identification, investigation and prioritization of critical alerts.
Third-Party Risk Management: We use a comprehensive due diligence process to manage third-party risks, emphasizing continuous monitoring and to ensure our business partners’ cybersecurity practices meet our stringent standards.

As of the filing of this report, we do not believe that any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect, Alto Ingredients, Inc.

Cybersecurity Risk Management Processes Integrated [Text Block] Our cybersecurity program is designed to safeguard the confidentiality, integrity and availability of information.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]

As of the filing of this report, we do not believe that any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect, Alto Ingredients, Inc.

Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] We take a comprehensive and forward-looking approach to cybersecurity risk management under the oversight of our Audit Committee. Management, including our Chief Financial Officer and our Director of Information Technology, provide regular updates to ensure a strategic, unified response to cybersecurity challenges. Management is notified of, and monitors, cybersecurity incidents through our EDR and SIEM systems.
Cybersecurity Risk Role of Management [Text Block]

Risk Management and Strategy

We maintain a cybersecurity program aligned with NIST CSF standards designed to identify critical assets and vulnerabilities, protect them with appropriate safeguards, promptly detect cybersecurity events, respond effectively to mitigate their impact and recover from incidents to restore services. Our cybersecurity program is designed to safeguard the confidentiality, integrity and availability of information. Our cybersecurity risk management strategy includes:

Governance: The Audit Committee of our Board of Directors oversees our cybersecurity risk management. Our Chief Financial Officer and Director of Information Technology, along with key executives, have roles in governance and facilitating alignment across our organization.
Compliance and Standards: We design our cybersecurity program for compliance with industry-specific and other regulations (e.g., the General Data Protection Regulation (GDPR) and the California Consumer Privacy Act (CCPA)) demonstrating our commitment to both domestic and international information security standards.

Technical Safeguards

We deploy technical defenses against cybersecurity risks of attack and other incidents, including firewalls, intrusion detection and prevention systems and access controls. We refine these measures based on our ongoing assessments, including cybersecurity threat intelligence updates.

Incident Response and Recovery Planning: We maintain incident response and recovery frameworks, tested twice yearly through backup restorations to critical systems, to improve our preparedness to effectively manage and mitigate cybersecurity incidents.
Education and Awareness: Our personnel and members of our Board of Directors undergo mandatory periodic training on cybersecurity threats, with updated insights into effective defense mechanisms and our evolving cybersecurity policies and practices.
Use of Third Parties: We collaborate with external cybersecurity service providers, including auditors, consultants and governmental agencies, to refine our cybersecurity measures. These service providers carry out cybersecurity risk evaluations such as periodic assessments and vulnerability scans to pinpoint potential security flaws and suggest enhancements. In addition, we employ third-party technology and other solutions to enhance our protection against cybersecurity risks. These solutions include our use of a managed security service provider to support our in-house technology team, an endpoint detection and response, or EDR, system for ongoing surveillance, detection, and action against threats, as well as a security information and event management, or SIEM, system designed to automate the real time identification, investigation and prioritization of critical alerts.
Third-Party Risk Management: We use a comprehensive due diligence process to manage third-party risks, emphasizing continuous monitoring and to ensure our business partners’ cybersecurity practices meet our stringent standards.

As of the filing of this report, we do not believe that any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect, Alto Ingredients, Inc.

Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our Director of Information Technology has over 20 years of experience in information technology and five years of experience serving directly as a Chief Information Security Officer for other organizations.
Cybersecurity Risk Board of Directors Oversight [Text Block]

Governance

We take a comprehensive and forward-looking approach to cybersecurity risk management under the oversight of our Audit Committee. Management, including our Chief Financial Officer and our Director of Information Technology, provide regular updates to ensure a strategic, unified response to cybersecurity challenges. Management is notified of, and monitors, cybersecurity incidents through our EDR and SIEM systems.
Our Director of Information Technology has over 20 years of experience in information technology and five years of experience serving directly as a Chief Information Security Officer for other organizations.
Our networks and systems are continuously monitored by a combination of third-party service providers and an internal cybersecurity team. Management is promptly notified of cybersecurity incidents.
Our Audit Committee is promptly notified by our management of any material cybersecurity breach.
Our Board of Directors is briefed at least quarterly on the state of our cybersecurity program.
Our internal cybersecurity team collaborates with external cybersecurity service providers, including auditors, consultants and governmental agencies, to refine our cybersecurity measures. These service providers carry out cybersecurity risk evaluations such as periodic assessments and vulnerability scans to pinpoint potential security flaws and suggest enhancements.
v3.25.0.1
Accounting Policies, by Policy (Policies)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Organization and Business

Organization and Business – The consolidated financial statements include, for all periods presented, the accounts of Alto Ingredients, Inc., a Delaware corporation (“Alto Ingredients”), and its direct and indirect wholly-owned subsidiaries (collectively, the “Company”), including Kinergy Marketing LLC, an Oregon limited liability company (“Kinergy”), Alto Nutrients, LLC, a California limited liability company (“Alto Nutrients”), Alto Op Co., a Delaware corporation, Alto Pekin, LLC, a Delaware limited liability company (“Alto Pekin”) and Alto ICP, LLC, a Delaware limited liability company (“ICP”), and the Company’s production facilities in Oregon and Idaho.

As discussed in Note 2, on January 14, 2022, the Company acquired Eagle Alcohol Company LLC, a Missouri limited liability company (“Eagle Alcohol”). On that date, Eagle Alcohol became a wholly-owned subsidiary of the Company. Eagle Alcohol specializes in break bulk distribution of specialty alcohols.

As discussed in Note 16, On January 1, 2025, the Company’s wholly-owned subsidiary, Alto Carbonic, LLC (“Alto Carbonic”), acquired Kodiak Carbonic, LLC, a beverage-grade liquid CO2 processor for $7.6 million. Alto Carbonic is co-located at the Company’s Columbia ethanol facility. The Company plans to report the results of Alto Carbonic in the Company’s Western Production segment beginning January 1, 2025.

The Company produces and distributes renewable fuels, essential ingredients and specialty alcohols. The Company also markets fuel-grade ethanol produced by third parties. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and fuel-grade ethanol customers.

The Company has a combined alcohol production capacity of 350 million gallons per year and produces, on an annualized basis, over 1.4 million tons of essential ingredients, such as dried yeast, corn protein meal, corn protein feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company markets and distributes fuel-grade ethanol produced by third parties.

The Company focuses on Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels markets. Products for the Health, Home & Beauty market include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. Products for the Food & Beverage markets include grain neutral spirits used in alcoholic beverages and vinegar as well as corn germ used for corn oils. Products for Industry & Agriculture markets include alcohols and other products for paint applications and fertilizers. Products for Essential Ingredients markets include dried yeast, corn protein meal, corn protein feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. Products for Renewable Fuels markets include fuel-grade ethanol and distillers corn oil used as a feedstock for renewable diesel and biodiesel fuels.

The Company’s production facilities, other than its Magic Valley plant, were operating for all periods presented subject to scheduled and unscheduled downtimes to address facility repair and maintenance. In January 2024, the Company temporarily hot-idled its Magic Valley facility to minimize losses from negative regional crush margins and to expedite the installation of additional equipment to achieve the intended production rate, quality and consistency from the Company’s corn oil and high protein system at the facility. The Company restarted its Magic Valley facility in July 2024 and by October 2024, the facility consistently achieved average ethanol production rates at full capacity, the protein content yield from the plant reached 50% or greater, and the Company was able to expand its corn oil yields. Increases in regional corn basis and declining market prices for protein and corn oil resulted in overall margin compression, outweighing the economic benefits of these plant improvements. As a consequence, the Company cold-idled its Magic Valley facility on December 31, 2024 to minimize financial losses. The Company continues to provide terminal services at the plant and intends to resume operations at the facility when the economic environment in the region sustainably improves.

Basis of Presentation

Basis of Presentation – The consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated in consolidation.

Segments

Segments – A segment is a component of an enterprise whose operating results are regularly reviewed by the enterprise’s chief operating decision maker (“CODM”) to make decisions about resources to be allocated to the segment and assess its performance, and for which discrete financial information is available. The Company determines and discloses its segments in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Section 280, Segment Reporting, which defines how to determine segments. The Company has adopted the guidance issued under ASU 2023-07, Segment Reporting (Topic 280), which enhances disclosures about the Company’s segments. The Company’s CODM is the Company’s executive committee, which is led by the Company’s Chief Executive Officer (“CEO”) and includes its Chief Financial Officer, Chief Operating Officer, Chief Commercial Officer and Chief Legal Officer (“Executive Committee”). The Company manages and assesses the performance of its reportable segments by its gross profit (loss). As part of the Executive Committee’s review of segment-level performance, each member of the Executive Committee reviews the gross profit of the Company’s reportable segments and provides expertise and analysis from their respective areas which drive the evaluation of the performance of the Company’s reportable segments and allocation of resources to those segments. Even though the CEO has the authority to override the other members for strategic or other reasons, key decisions are made jointly by the Executive Committee.

The Company reports financial and operating performance in three reportable segments (1) Pekin production, which includes the entire campus in Pekin, Illinois (“Pekin Campus”), (2) marketing and distribution, which includes marketing and merchant trading for Company-produced specialty alcohols, fuel-grade ethanol and essential ingredients, and sales of fuel-grade ethanol sourced from third parties, and (3) Western production, which includes the Company’s two western production facilities and, beginning in 2025, its liquid CO2 plant on an aggregated basis (“Western production”).

Cash and Cash Equivalents

Cash and Cash Equivalents – The Company considers all highly-liquid investments with an original maturity of three months or less to be cash equivalents. The Company maintains its accounts at several financial institutions. These cash balances regularly exceed amounts insured by the Federal Deposit Insurance Corporation; however, the Company does not believe it is exposed to any significant credit risk on these balances.

Restricted Cash

Restricted Cash – The Company’s restricted cash comprises cash collateral balances held in derivative brokerage accounts.

Accounts Receivable and Allowance for Credit Losses

Accounts Receivable and Allowance for Credit Losses – Trade accounts receivable are presented at original invoice amount, net of the allowance for credit losses. The Company sells specialty alcohols to large consumer product companies, sells fuel-grade ethanol to gasoline refining and distribution companies, sells essential ingredients to animal feed customers, including distillers grains and other feed co-products to dairy operators and animal feedlots and corn oil to poultry and renewable diesel and biodiesel customers, in each case generally without requiring collateral. Due to a limited number of customers, the Company had significant concentrations of credit risk from sales as of December 31, 2024 and 2023, as described below.

The carrying amount of accounts receivable is reduced by a valuation allowance that reflects the Company’s best estimate of the amounts that will not be collected. The Company regularly reviews accounts receivable and based on assessments of current customer creditworthiness, estimates the portion, if any, of the customer balance that will not be collected.

Of the accounts receivable balance, approximately $44,750,000 and $51,315,000 at December 31, 2024 and 2023, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for credit losses was $23,000 and $85,000 as of December 31, 2024 and 2023, respectively. The Company recorded a bad debt recovery of $50,000, bad debt expense of $427,000 and a bad debt recovery of $217,000 for the years ended December 31, 2024, 2023 and 2022, respectively. The Company does not have any off-balance sheet credit exposure related to its customers.

Concentration Risks

Concentration Risks – Credit risk represents the accounting loss that would be recognized at the reporting date if counterparties failed completely to perform as contracted. Concentrations of credit risk, whether on- or off-balance sheet, that arise from financial instruments exist for groups of customers or counterparties when they have similar economic characteristics that would cause their ability to meet contractual obligations to be similarly affected by changes in economic or other conditions described below. Financial instruments that subject the Company to credit risk consist of cash balances maintained in excess of federal depository insurance limits and accounts receivable which have no collateral or security. The Company has not experienced any significant losses in such accounts.

The Company sells specialty alcohols to consumer product companies and fuel-grade ethanol to gasoline refining and distribution companies. The Company sold to customers representing 10% or more of the Company’s total net sales, as follows.

   Years Ended December 31, 
   2024   2023   2022 
Customer A   11%   9%   10%
Customer B   7%   7%   10%

The Company had accounts receivable due from these customers totaling $5,187,000 and $4,302,000, representing 9% and 7% of total accounts receivable, as of December 31, 2024 and 2023, respectively.

The Company purchases corn, its largest cost component in producing alcohols, from its suppliers. The Company purchased corn from suppliers representing 10% or more of the Company’s total corn purchases, as follows:

   Years Ended December 31, 
   2024   2023   2022 
Supplier A   16%   14%   11%
Supplier B   13%   12%   12%
Supplier C   %    %    15%

As of December 31, 2024, approximately 44% of the Company’s employees were covered by a collective bargaining agreement.

Inventories

Inventories – Inventories consisted primarily of bulk ethanol, specialty alcohols, corn, essential ingredients and unleaded fuel, and are valued at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventory is net of valuation adjustments of $2,050,000 and $2,201,000 as of December 31, 2024 and 2023, respectively. Of the inventory balance, approximately $35,495,000 and $41,041,000 at December 31, 2024 and 2023, respectively, were used as collateral under Kinergy’s operating line of credit. Inventory balances consisted of the following (in thousands):

   December 31, 
   2024   2023 
Finished goods  $31,120   $35,765 
Work in progress   4,203    5,063 
Raw materials   8,989    10,313 
Other   5,602    1,470 
Total  $49,914   $52,611 
Property and Equipment

Property and Equipment – Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the following estimated useful lives:

Buildings   40 years 
Facilities and plant equipment   10 – 25 years 
Other equipment, vehicles and furniture   5 – 10 years 

The cost of normal maintenance and repairs is charged to operations as incurred. Significant capital expenditures that increase the life of an asset are capitalized and depreciated over the estimated remaining useful life of the asset. The cost of property and equipment sold, or otherwise disposed of, and the related accumulated depreciation or amortization are removed from the accounts, and any resulting gains or losses are reflected in current operations.

Intangible Assets

Intangible Assets – The Company amortizes intangible assets with definite lives using the straight-line method over their estimated lives of 10-12 years. Additionally, the Company assesses indefinite-lived intangible assets for impairment annually, or more frequently if circumstances indicate impairment may have occurred. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. If the Company determines that an impairment charge is needed, the charge will be recorded as an asset impairment in the consolidated statements of operations.

Leases

Leases – The Company accounts for leases under ASC Section 842, Leases (“ASC 842), whereby lessees are required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: (1) a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted cash flow basis; and (2) a “right of use” asset, which is an asset that represents the lessee’s right to use the specified asset for the lease term. See Note 9 for further information.

Derivative Instruments and Hedging Activities

Derivative Instruments and Hedging Activities – Derivative transactions, which can include exchange-traded futures contracts, options and futures positions on the New York Mercantile Exchange or the Chicago Mercantile Exchange, are recorded on the balance sheet as assets and liabilities based on the derivative’s fair value. Changes in the fair value of derivative contracts are recognized currently in income unless specific hedge accounting criteria are met. If derivatives meet those criteria, and hedge accounting is elected, effective gains and losses are deferred in accumulated other comprehensive income (loss) and later recorded together with the hedged item in consolidated income (loss). For derivatives designated as a cash flow hedge, the Company formally documents the hedge and assesses the effectiveness with associated transactions. The Company has designated and documented contracts for the physical delivery of commodity products to and from counterparties as normal purchases and normal sales.

Revenue Recognition

Revenue Recognition – The Company recognizes revenue under ASC Section 606, Revenue from Contracts with Customers (“ASC 606”). The provisions of ASC 606 include a five-step process by which an entity will determine revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which an entity expects to be entitled in exchange for those goods or services. ASC 606 requires the Company to apply the following steps: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, the Company satisfies the performance obligation.

The Company recognizes revenue primarily from sales of alcohols and essential ingredients.

The Company has five production facilities from which it produces and sells alcohols to its customers through Kinergy. Kinergy enters into back-to-back sales contracts with its customers under exclusive intercompany sales agreements with each of the Company’s five production facilities. Kinergy also acts as a principal when it purchases third party fuel-grade ethanol which it resells to its customers. Finally, for the year ended December 31, 2022, Kinergy had exclusive sales agreements with certain third-party owned fuel-grade ethanol production facilities under which it sold the facilities’ fuel-grade ethanol for a fee plus the costs to deliver the ethanol to Kinergy’s customers. These sales were referred to as third-party agent sales. Revenue from these third-party agent sales was recorded on a net basis, with Kinergy recognizing its predetermined fees and any associated delivery costs. Kinergy has terminated these contracts, and as a result, did not have any related sales for the year ended December 31, 2024 and 2023. The Company’s balances of accounts receivable, net of allowance for credit losses, were $58,217,000, $58,729,000 and $68,655,000, as of December 31, 2024, 2023 and 2022, respectively.

The Company has five production facilities from which it produces and sells essential ingredients to its customers through Alto Nutrients. Alto Nutrients enters into sales contracts with essential ingredient customers under exclusive intercompany sales agreements with each of the Company’s five production facilities.

The Company recognizes revenue from sales of alcohols and essential ingredients at the point in time when the customer obtains control of the products, which typically occurs upon delivery depending on the terms of the underlying contracts. In some instances, the Company enters into contracts with customers that contain multiple performance obligations to deliver volumes of alcohols or essential ingredients over a contractual period of less than 12 months. The Company allocates the transaction price to each performance obligation identified in the contract based on relative standalone selling prices and recognizes the related revenue as control of each individual product is transferred to the customer in satisfaction of the corresponding performance obligations.

When the Company is the agent, the supplier controls the products before they are transferred to the customer because the supplier is primarily responsible for fulfilling the promise to provide the product, has inventory risk before the product has been transferred to a customer and has discretion in establishing the price for the product. When the Company is the principal, the Company controls the products before they are transferred to the customer because the Company is primarily responsible for fulfilling the promise to provide the products, has inventory risk before the product has been transferred to a customer and has discretion in establishing the price for the product.

See the tables in Note 4 for the Company’s revenue by type of contracts.

Shipping and Handling Costs

Shipping and Handling Costs – The Company accounts for shipping and handling costs relating to contracts with customers as costs to fulfill its promise to transfer its products. Accordingly, the costs are classified as a component of cost of goods sold in the accompanying consolidated statements of operations.

Selling Costs

Selling Costs – Selling costs associated with the Company’s product sales are classified as a component of selling, general and administrative expenses in the accompanying consolidated statements of operations.

Stock-Based Compensation

Stock-Based Compensation – The Company accounts for the cost of employee services received in exchange for the award of equity instruments based on the fair value of the award, determined on the date of grant. The expense is recognized over the period during which an employee is required to provide services in exchange for the award. The Company accounts for forfeitures as they occur. The Company recognizes stock-based compensation expense as a component of either cost of goods sold or selling, general and administrative expenses in the consolidated statements of operations.

Goodwill

Goodwill – Goodwill represents the excess of cost of an acquired entity over the net of the amounts assigned to net assets acquired and liabilities assumed. Annually, or more frequently, if indications of impairment arise, the Company performs a review for impairment. This review includes the determination of each reporting unit’s fair value using market multiples and discounted cash flow modeling. The estimates of future cash flows are judgments based on management’s experience and knowledge of the Company’s operations and the industries in which the Company operates. These estimates can be significantly affected by future changes in market conditions, the economic environment, including inflation, and capital spending decisions of the Company’s customers. Any assessed impairments will be permanent and expensed in the period in which the impairment is determined. If the Company determines through its assessment process that any of its goodwill requires impairment charges, the charges will be recorded in asset impairment expenses in the consolidated statements of operations.

The Company performed its annual review of impairment of goodwill and recognized an asset impairment loss of $6.0 million for the year ended December 31, 2023. No impairment losses for goodwill were recognized for the year ended December 31, 2024 and 2022.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets – The Company assesses the impairment of long-lived assets, including property and equipment, internally developed software and purchased intangibles subject to amortization, when events or changes in circumstances indicate that the fair value of assets could be less than their net book value. In such event, the Company assesses long-lived assets for impairment by first determining the forecasted, undiscounted cash flows the asset group is expected to generate plus the net proceeds expected from the sale of the asset group. If this amount is less than the carrying value of the asset, the Company will then determine the fair value of the asset group. When the estimated fair value of the asset group is less than its carrying value, the Company recognizes an impairment expense equal to the difference between the asset group’s carrying value and estimated fair value. Forecasts of future cash flows are judgments based on the Company’s experience and knowledge of its operations and the industries in which it operates. These forecasts could be significantly affected by future changes in market conditions, the economic environment, including inflation, and purchasing decisions of the Company’s customers. The Company’s assessment resulted in an asset impairment of $24,790,000 primarily from the cold-idling of the Company’s Magic Valley facility due to increased regional corn basis and overall margin compression and the Company’s changes to its Eagle Alcohol business, for the year ended December 31, 2024. The Company’s assessment resulted in an asset impairment of $574,000 related to amendments to certain of the Company’s lease agreements, for the year ended December 31, 2023. The Company’s impairment analysis performed during the year ended December 31, 2022 did not result in an impairment charge.

Deferred Financing Costs

Deferred Financing Costs – Deferred financing costs are costs incurred to obtain debt financing, including all related fees, and are amortized as interest expense over the term of the related financing using the straight-line method, which approximates the effective interest rate method. Amortization of deferred financing costs, included in interest expense, net, in the accompanying consolidated statements of operations, was approximately $1,016,000, $1,048,000 and $177,000 for the years ended December 31, 2024, 2023 and 2022, respectively. Unamortized deferred financing costs were approximately $3,684,000 and $4,700,000 as of December 31, 2024 and 2023, respectively, and are recorded as a reduction of long-term debt in the consolidated balance sheets.

Provision for Income Taxes

Provision for Income Taxes – Income taxes are accounted for under the asset and liability approach, where deferred tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities and are measured using enacted tax rates and laws that are expected to be in effect when the differences reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized.

The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining whether it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. An uncertain tax position is considered effectively settled on completion of an examination by a taxing authority if certain other conditions are satisfied. Should the Company incur interest and penalties relating to tax uncertainties, such amounts would be classified as a component of interest expense, net, and other income (expense), net, respectively. Deferred tax assets and liabilities are classified as noncurrent in the Company’s consolidated balance sheets.

The Company files a consolidated federal income tax return. This return includes all wholly owned subsidiaries as well as the Company’s pro-rata share of taxable income from pass-through entities in which the Company owns less than 100%. State tax returns are filed on a consolidated, combined or separate basis depending on the applicable laws relating to the Company and its subsidiaries. The Company does not have any foreign operations.

Loss Per Share

Loss Per Share – Basic loss per share is computed on the basis of the weighted-average number of shares of common stock outstanding during the period. Preferred dividends are deducted from net loss attributed to Alto Ingredients, Inc. and are considered in the calculation of loss attributable to common stockholders in computing basic loss per share. Common stock equivalents to preferred stock are considered participating securities and are also included in this calculation when dilutive.

The following tables compute basic and diluted loss per share (in thousands, except per share data):

   Year Ended December 31, 2024 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(58,984)          
Less: Preferred stock dividends   (1,269)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(60,253)   73,482   $(0.82)
   Year Ended December 31, 2023 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(28,005)          
Less: Preferred stock dividends   (1,265)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(29,270)   73,339   $(0.40)
   Year Ended December 31, 2022 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(41,597)          
Less: Preferred stock dividends   (1,265)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(42,862)   71,944   $(0.60)

There were an aggregate of 981,000, 981,000 and 964,000 potentially dilutive shares from convertible securities outstanding for the years ended December 31, 2024, 2023 and 2022, respectively. These convertible securities were not considered in calculating diluted loss per common share for the years ended December 31, 2024, 2023 and 2022 as their effect would be anti-dilutive. In addition, there were an aggregate of 3,188,000 weighted-average anti-dilutive shares from outstanding out-of-the-money warrants for the year ended December 31, 2022.

Financial Instruments

Financial Instruments – The carrying values of cash and cash equivalents, restricted cash, accounts receivable, derivative instruments, accounts payable and accrued liabilities are reasonable estimates of their fair values because of the short maturity of these items. The Company believes the carrying value of its long-term debt instruments are not considered materially different than fair value.

Business Combinations

Business Combinations – Business acquisitions are accounted for in accordance with ASC Section 805, Business Combinations. ASC 805 requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable tangible and intangible assets acquired and liabilities assumed and recognize and measure goodwill or a gain from the purchase. Assets acquired and liabilities assumed are recorded at their fair values and the excess of the purchase price over the amounts assigned is recorded as goodwill. Adjustments to fair value assessments are recorded to goodwill over the measurement period (not longer than twelve months).

Income from Cash Grant

Income from Cash Grant – For the years ended December 31, 2023 and 2022, the Company received $2,812,000 and $22,652,000, respectively, in cash from the USDA’s Biofuel Producer Program. The Company did not receive any cash from this program for the year ended December 31, 2024. The program was created as part of the CARES Act of 2020, which allocated $700,000,000 to support biofuel producers who experienced market losses due to the pandemic. The Company is not required to repay the grants. Since these funds are provided to subsidize historical losses of the Company, and are not required to be repaid, the Company accounted for the proceeds by analogy to International Accounting Standards 20, Accounting for Government Grants and Disclosure of Government Assistance, and reported the amount as income from cash grant in the accompanying consolidated statements of operations.

Employment-related Benefits

Employment-related Benefits – Employment-related benefits associated with pensions and postretirement health care are expensed based on actuarial analysis. The recognition of expense is affected by estimates made by management, such as discount rates used to value certain liabilities, investment rates of return on plan assets, increases in future wage amounts and future health care costs. Discount rates are determined based on a spot yield curve that includes bonds with maturities that match the expected timing of benefit payments under the plan.

Share Repurchase Program

Share Repurchase Program – On September 12, 2022, the Company announced a share repurchase program under which it may repurchase up to $50,000,000 of its common stock with an initial purchase authorization of $10,000,000. The Company’s lender has further limited the Company’s purchase authorization to $5,000,000. Amounts in excess of the purchase authorization of $5,000,000 will require additional lender consent and amounts in excess of the initial purchase authorization of $10,000,000 will require additional board and preferred stockholder authorization. The share repurchase program does not have an expiration date, does not require the repurchase of any particular amount of shares, and may be implemented, modified, suspended or discontinued in whole or in part at any time and without further notice. As repurchases are made, the Company will retire the shares, resulting in a reduction of issued and outstanding shares. For the years ended December 31, 2023 and 2022, the Company repurchased an aggregate of 1,685,000 shares and 351,000 shares for $3,674,000 and $1,325,000 in cash, respectively. No shares were repurchased during the year ended December 31, 2024.

Nonvoting Common Stock

Nonvoting Common Stock – In 2015, the Company issued nonvoting common stock convertible at a holder’s election into voting common stock. As of December 31, 2024, an aggregate of 3,539,236 shares of nonvoting common stock had been converted into an equal number of shares of the Company’s voting common stock. As of December 31, 2024, there were 896 shares of nonvoting common stock outstanding.

Estimates and Assumptions

Estimates and Assumptions – The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining net realizable value of inventory, long-lived asset impairments, goodwill impairment, valuation allowances on deferred income taxes and the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.

Recent Accounting Pronouncements

Recent Accounting Pronouncements – In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40), which provides for more detailed information about the types of expenses aggregated in common expense captions in the statement of operations. ASU 2024-03 is effective for the Company for the year ended December 31, 2027, with early adoption permitted. The Company is currently evaluating the impact of this ASU.

Subsequent Events

Subsequent Events – Management evaluates, as of each reporting period, events or transactions that occur after the balance sheet date through the date that the financial statements are issued for either disclosure or adjustment to the consolidated financial results. See Note 16.

v3.25.0.1
Organization and Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Organization and Significant Accounting Policies [Abstract]  
Schedule of Concentrations of Credit Risk

The Company sells specialty alcohols to consumer product companies and fuel-grade ethanol to gasoline refining and distribution companies. The Company sold to customers representing 10% or more of the Company’s total net sales, as follows.

 

   Years Ended December 31, 
   2024   2023   2022 
Customer A   11%   9%   10%
Customer B   7%   7%   10%

The Company purchases corn, its largest cost component in producing alcohols, from its suppliers. The Company purchased corn from suppliers representing 10% or more of the Company’s total corn purchases, as follows:

 

   Years Ended December 31, 
   2024   2023   2022 
Supplier A   16%   14%   11%
Supplier B   13%   12%   12%
Supplier C   %    %    15%
Schedule of Inventory Inventory balances consisted of the following (in thousands):
   December 31, 
   2024   2023 
Finished goods  $31,120   $35,765 
Work in progress   4,203    5,063 
Raw materials   8,989    10,313 
Other   5,602    1,470 
Total  $49,914   $52,611 
Schedule of Depreciation Is Computed Using the Straight-Line Method Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the following estimated useful lives:
Buildings   40 years 
Facilities and plant equipment   10 – 25 years 
Other equipment, vehicles and furniture   5 – 10 years 
Schedule of Basic and Diluted Earnings Per Share

The following tables compute basic and diluted loss per share (in thousands, except per share data):

 

   Year Ended December 31, 2024 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(58,984)          
Less: Preferred stock dividends   (1,269)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(60,253)   73,482   $(0.82)

 

   Year Ended December 31, 2023 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(28,005)          
Less: Preferred stock dividends   (1,265)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(29,270)   73,339   $(0.40)

 

   Year Ended December 31, 2022 
   Loss
Numerator
   Shares Denominator   Per-Share Amount 
Consolidated net loss  $(41,597)          
Less: Preferred stock dividends   (1,265)          
Basic and diluted loss per share:               
Loss attributable to common stockholders  $(42,862)   71,944   $(0.60)
v3.25.0.1
Segments (Tables)
12 Months Ended
Dec. 31, 2024
Segments [Abstract]  
Schedule of Financial Data for Operating Segments

The following tables set forth certain financial data for the Company’s operating segments (in thousands):

 

   Years Ended December 31, 
Net Sales  2024   2023   2022 
Pekin Campus production, recorded as gross:            
Alcohol sales  $415,710   $502,217   $521,273 
Essential ingredient sales   169,308    217,702    225,871 
Intersegment sales   1,243    1,427    1,212 
Total Pekin Campus sales   586,261    721,346    748,356 
                
Marketing and distribution:               
Alcohol sales, gross  $216,295   $262,587   $227,626 
Alcohol sales, net   229    365    1,225 
Intersegment sales   10,833    11,654    12,459 
Total marketing and distribution sales   227,357    274,606    241,310 
                
Western Production, recorded as gross:               
Alcohol sales  $115,389   $166,971   $253,605 
Essential ingredient sales   36,953    57,264    90,209 
Intersegment sales   (122)   134    22 
Total Western production sales   152,220    224,369    343,836 
                
Corporate and other   11,374    15,834    15,812 
Intersegment eliminations   (11,954)   (13,215)   (13,693)
Net sales as reported  $965,258   $1,222,940   $1,335,621 
                
Cost of goods sold:            
Pekin Campus production  $563,033   $710,088   $772,755 
Marketing and distribution   213,023    259,234    229,288 
Western production   172,209    230,445    353,775 
Corporate and other   12,285    12,122    12,167 
Intersegment eliminations   (5,014)   (4,602)   (4,814)
Cost of goods sold as reported  $955,536   $1,207,287   $1,363,171 
             
Gross profit (loss):            
Pekin Campus production  $23,228   $11,258   $(24,399)
Marketing and distribution   14,334    15,372    12,022 
Western production   (19,989)   (6,076)   (9,939)
Corporate and other   (911)   3,712    3,645 
Intersegment eliminations   (6,940)   (8,613)   (8,879)
   $9,722   $15,653   $(27,550)
Income (loss) before provision for income taxes:               
Pekin Campus production  $6,308   $(1,560)  $(27,376)
Marketing and distribution   5,261    7,644    3,748 
Western production   (51,086)   (13,506)   (7,209)
Corporate and other   (19,294)   (20,486)   (8,835)
   $(58,811)  $(27,908)  $(39,672)
Asset impairments:               
Western production  $21,389   $
   $
 
Corporate and other   3,401    6,544    
 
   $24,790   $6,544   $
 
Depreciation and amortization expense:               
Pekin Campus production  $21,017   $19,789   $19,136 
Western production   2,409    2,381    5,085 
Corporate and other   982    910    874 
   $24,408   $23,080   $25,095 
Interest expense, net of capitalized interest:            
Pekin Campus production  $1,765   $(207)  $(381)
Marketing and distribution   389    822    1,658 
Western production   2,829    1,164    (339)
Corporate and other   2,661    5,646    889 
   $7,644   $7,425   $1,827 
Schedule of Total Assets by Operating Segment

The following table sets forth the Company’s total assets by operating segment (in thousands): 

 

   December 31, 
   2024   2023 
Total assets:        
Pekin Campus production  $223,934    251,048 
Marketing and distribution   102,895    101,196 
Western production   44,992    57,533 
Corporate and other   29,617    44,464 
   $401,438   $454,241 
v3.25.0.1
Property and Equipment (Tables)
12 Months Ended
Dec. 31, 2024
Property and Equipment [Abstract]  
Schedule of Property and Equipment

Property and equipment consisted of the following (in thousands):

 

   December 31, 
   2024   2023 
Facilities and plant equipment  $420,456   $405,010 
Land   3,594    3,687 
Other equipment, vehicles and furniture   20,636    9,719 
Construction in progress   11,154    50,505 
    455,840    468,921 
Accumulated depreciation   (241,098)   (220,173)
   $214,742   $248,748 
v3.25.0.1
Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2024
Intangible Assets [Abstract]  
Schedule of Intangible Assets Including Goodwill

Intangible assets, including goodwill, consisted of the following (in thousands):

 

       December 31, 2024   December 31, 2023 
   Useful
Life
(Years)
   Gross   Accumulated
Amortization/
Impairment
   Net Book
Value
   Gross   Accumulated
Amortization/
Impairment
   Net Book
Value
 
Non-Amortizing:                            
Goodwill       $5,970   $(5,970)  $
   $5,970   $(5,970)  $
 
Kinergy tradename        2,678    
    2,678    2,678    
    2,678 
Amortizing:                                   
Customer relationships   12    6,556    (5,021)   1,535    6,556    (1,074)   5,482 
Eagle Alcohol tradename   10    420    (124)   296    420    (82)   338 
Total goodwill and intangible assets       $15,624   $(11,115)  $4,509   $15,624   $(7,126)  $8,498 
Schedule of Expected Amortization Expense Relating to Amortizable Intangible Assets

The expected amortization expense relating to amortizable intangible assets in each of the five years after December 31, 2024 are (in thousands):

 

Years Ended December 31,  Amount 
2025  $213 
2026   213 
2027   213 
2028   213 
2029   213 
Thereafter   766 
Total  $1,831 
v3.25.0.1
Derivatives (Tables)
12 Months Ended
Dec. 31, 2024
Derivatives [Abstract]  
Schedule of Derivatives Not Designated as Hedging Instruments The classification and amounts of the Company’s derivatives not designated as hedging instruments, and related cash collateral balances, are as follows (in thousands):
   As of December 31, 2024
   Assets  Liabilities
Type of Instrument  Balance Sheet Location  Fair  Value   Balance Sheet Location  Fair Value 
               
Cash collateral balance  Restricted cash  $742         
Commodity contracts  Derivative instruments  $3,313   Derivative instruments  $1,177 

 

   As of December 31, 2024
   Assets  Liabilities
Type of Instrument  Balance Sheet Location  Fair Value   Balance Sheet Location  Fair Value 
               
Cash collateral balance  Restricted cash  $15,466         
Commodity contracts  Derivative instruments  $2,412   Derivative instruments  $13,849 
Schedule of Recognized Gains (Losses) For Its Derivatives Not Designated as Hedging Instruments

The classification and amounts of the Company’s recognized gains (losses) for its derivatives not designated as hedging instruments are as follows (in thousands):

 

      Realized Gains (Losses) 
      For the Years Ended December 31, 
Type of Instrument  Statements of Operations Location  2024   2023   2022 
                
Commodity contracts  Cost of goods sold  $(2,529)  $1,647   $23,280 
      $(2,529)  $1,647   $23,280 

 

      Unrealized Gains (Losses) 
      For the Years Ended December 31, 
Type of Instrument  Statements of Operations Location  2024   2023   2022 
                
Commodity contracts  Cost of goods sold  $13,574   $(9,678)  $(4,017)
      $13,574   $(9,678)  $(4,017)
v3.25.0.1
Debt (Tables)
12 Months Ended
Dec. 31, 2024
Debt [Abstract]  
Schedule of Long-Term Borrowings

Long-term borrowings are summarized as follows (in thousands):

 

   December 31,
2024
   December 31,
2023
 
Kinergy line of credit  $39,677   $30,690 
Orion term loan   60,000    60,000 
    99,677    90,690 
Less unamortized debt discount   (3,089)   (3,893)
Less unamortized debt financing costs   (3,684)   (4,700)
Less current portion   
    
 
Long-term debt  $92,904   $82,097 
Schedule of Long-term Debt Matures The Company’s long-term debt matures as follows (in thousands):
December 31:    
2027  $39,677 
2028   60,000 
   $99,677 
v3.25.0.1
Leases (Tables)
12 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Schedule of Leases

Leases consist of the following (in thousands):

 

   Classification  December 31, 
Assets     2024   2023 
Operating  Right of use operating lease assets, net  $20,553   $22,597 
Liabilites             
Operating - Current  Current portion, operating leases  $4,851   $4,333 
Operating - Noncurrent  Operating leases, net of current portion  $16,913   $19,029 
Schedule of Components of Lease Costs

The Components of lease costs were as follows (in thousands):

 

   Years Ended December 31, 
   2024   2023   2022 
             
Fixed lease cost  $5,989   $5,722   $5,224 
Variable lease cost   529    871    124 
Net lease cost  $6,518   $6,593   $5,348 
Schedule of Operating Lease Liabilities

The following table summarizes the remaining maturities of the Company’s operating lease liabilities, assuming all land lease extensions are taken, as of December 31, 2024 (in thousands):

 

Year Ended:   Equipment     Land Related  
2025   $ 5,334     $ 1,060  
2026     4,761       1,037  
2027     4,152       1,011  
2028     3,368       1,024  
2029     1,992       660  
2030-76     119       3,881  
Less interest     (3,299 )     (3,336 )
    $ 16,427     $ 5,337  
v3.25.0.1
Pension Plans (Tables)
12 Months Ended
Dec. 31, 2024
Pension Plans [Abstract]  
Schedule of Information Related to the Retirement Plan

Information related to the Retirement Plan as of and for the years ended December 31, 2024 and 2023 is presented below (dollars in thousands):

 

   2024   2023 
Changes in plan assets:        
Fair value of plan assets, beginning  $18,485   $16,688 
Actual gains   1,711    2,376 
Benefits paid   (829)   (834)
Company contributions   800    255 
Participant contributions   
    
 
Fair value of plan assets, ending  $20,167   $18,485 
Less: projected accumulated benefit obligation  $17,530   $18,590 
Funded status, overfunded (underfunded)  $2,637   $(105)
           
Amounts recognized in the consolidated balance sheets:          
Other assets  $2,637   $
 
Other liabilities  $
   $(105)
Accumulated other comprehensive income  $(4,167)  $(2,231)
           
Assumptions used in computation of benefit obligations:          
Discount rate   5.50%   4.90%
Expected long-term return on plan assets   6.50%   6.50%
Rate of compensation increase   
    
 
Schedule of Components of Net Periodic Benefit Costs
   Years Ended December 31, 
   2024   2023   2022 
Components of net periodic benefit costs are as follows:            
Service cost  $267   $249   $404 
Interest cost   887    900    655 
Expected return on plan assets   (1,103)   (993)   (1,090)
Net periodic cost (benefit)  $51   $156   $(31)
Schedule of Expected Benefit Payments

The following table summarizes the expected benefit payments for the Company’s Retirement Plan for each of the next five fiscal years and in the aggregate for the five fiscal years thereafter (in thousands):

 

December 31:      
2025   $ 1,000  
2026     1,040  
2027     1,080  
2028     1,130  
2029     1,160  
2030-34     6,480  
    $ 11,890  
Schedule of Information Related to the Postretirement Plan

Information related to the Postretirement Plan as of December 31, 2024 and 2023 is presented below (dollars in thousands):

 

   2024   2023 
Amounts at the end of the year:        
Accumulated/projected benefit obligation  $3,783   $4,294 
Fair value of plan assets   
    
 
Funded status, underfunded  $(3,783)  $(4,294)
           
Amounts recognized in the consolidated balance sheets:          
Accrued liabilities  $(280)  $(320)
Other liabilities  $(3,503)  $(3,974)
Accumulated other comprehensive income  $(808)  $(250)
           
Discount rate used in computation of benefit obligations   5.30%   4.75%
Schedule of Net Periodic Benefit Costs
   Years Ended December 31, 
   2024   2023   2022 
Components of net periodic benefit costs are as follows:            
Service cost  $19   $14   $26 
Interest cost   196    186    105 
Amortization of prior service cost   
    (53)   
 
Net periodic benefit cost  $215   $147   $131 
Amounts recognized in the plan for the year:               
Participant contributions  $35   $36   $43 
Benefits paid  $204   $201   $215 
Schedule of Expected Benefit Payments

The following table summarizes the expected benefit payments for the Company’s Postretirement Plan for each of the next five fiscal years and in the aggregate for the five fiscal years thereafter (in thousands):

 

December 31:      
2025   $ 280  
2026     360  
2027     390  
2028     420  
2029     400  
2030-2034     1,780  
    $ 3,630  
v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Taxes [Abstract]  
Schedule of Provision for Income Taxes

The Company recorded a provision for income taxes as follows (in thousands):

 

   Years Ended December 31, 
   2024   2023   2022 
Current provision  $173   $97   $1,925 
Deferred provision            
Total  $173   $97   $1,925 
Schedule of Reconciliation of Effective Tax Rate

A reconciliation of the differences between the United States statutory federal income tax rate and the effective tax rate as provided in the consolidated statements of operations is as follows:

 

   Years Ended December 31, 
   2024   2023   2022 
Statutory rate   21.0%   21.0%   21.0%
State income taxes, net of federal benefit   5.5    4.6    5.8 
Change in valuation allowance   (29.3)   (23.4)   (33.9)
Stock-based compensation   (0.4)   (2.3)   3.1 
Non-deductible items   (0.1)   0.8    (1.6)
Other   3.0    (1.0)   0.6 
Effective rate   (0.3)%   (0.3)%   (5.0)%
Schedule of Components of Deferred Income Taxes

Deferred income taxes are provided using the asset and liability method to reflect temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities using presently enacted tax rates and laws. The components of deferred income taxes included in the consolidated balance sheets were as follows (in thousands):

 

   December 31, 
   2024   2023 
Deferred tax assets:        
Net operating loss carryforwards  $64,901   $57,870 
Capital loss   26,692    26,518 
Disallowed interest   5,048    3,457 
R&D, Energy and AMT credits   3,742    3,742 
Derivatives   
    3,051 
Intangibles   2,981    1,201 
Pension liability   1,016    1,173 
Railcar contracts   1,090    818 
Stock-based compensation   803    696 
Allowance for credit losses and other assets   1,059    296 
Other   4,971    3,340 
Total gross deferred tax assets   112,303    102,162 
Less: valuation allowance   (110,687)   (93,506)
Total deferred tax assets, net of valuation allowance   1,616    8,656 
           
Deferred tax liabilities:          
Property and equipment   (703)   (7,720)
Derivatives   (574)   
 
Other   (575)   (1,172)
Total deferred tax liabilities   (1,852)   (8,892)
           
Net deferred tax liabilities, included in other liabilities  $(236)  $(236)
Schedule of Net Operating Loss Carryforwards These net operating loss carryforwards expire as follows (in thousands):
Tax Years  Federal   State 
2025–2029  $
   $30,603 
2030–2034   15,126    76,920 
2035–2039   83,771    112,608 
2040 and after*   128,776    56,293 
Total NOLs  $227,673   $276,424 
*Includes indefinite life federal net operating losses of $128.8 million generated after 2017.
Schedule of Balance of Gross Unrecognized Tax Benefits, Before Interest and Penalties

A reconciliation of the beginning balance and the ending balance of gross unrecognized tax benefits, before interest and penalties, for the period presented is as follows (in thousands):

 

   December 31, 
   2024   2023 
Unrecognized tax benefits at beginning of year  $739   $739 
Increases related to current year tax positions   
    
 
Decreases related to current year tax positions   
    
 
Increases related to prior year tax positions   
    
 
Decreases related to prior year tax positions   
    
 
Decreases related to expiration of prior year tax positions   
    
 
Decreases related to settlements of prior year tax positions   
    
 
Unrecognized tax benefits at end of year  $739   $739 
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions

The Company is subject to income tax in the United States federal jurisdiction and various state jurisdictions and has identified its federal tax return and tax returns in state jurisdictions below as “major” tax filings. These jurisdictions, along with the years still open to audit under the applicable statutes of limitation, are as follows:

 

Jurisdiction   Tax Years
Federal   2021 – 2023
Alabama   2021 – 2023
Arizona   2020 – 2023
Arkansas   2021 – 2023
California   2020 – 2023
Colorado   2020 – 2023
Connecticut   2021 – 2023
Georgia   2021 – 2023
Idaho   2021 – 2023
Illinois   2021 – 2023
Indiana   2021 – 2023
Iowa   2021 – 2023
Kansas   2021 – 2023
Louisiana   2021 – 2023
Michigan   2021 – 2023
Minnesota   2021 – 2023
Mississippi   2021 – 2023
Missouri   2021 – 2023
Nebraska   2021 – 2023
New Mexico   2021 – 2023
Oklahoma   2021 – 2023
Oregon   2021 – 2023
Pennsylvania   2021 – 2023
Rhode Island   2021 – 2023
South Carolina   2021 – 2023
Tennessee   2021 – 2023
Texas   2020 – 2023
v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Stock-based Compensation [Abstract]  
Schedule of Unvested Restricted Stock Activity

Restricted Stock – A summary of unvested restricted stock activity is as follows (shares in thousands):

 

   Number of
Shares
   Weighted-
Average
Grant Date
Fair Value
Per Share
 
Unvested at December 31, 2022   1,169   $5.95 
Issued   2,375   $1.87 
Vested   (547)  $5.61 
Canceled   (56)  $3.14 
Unvested at December 31, 2023   2,941   $2.77 
           
Issued   1,530   $1.91 
Vested   (1,597)  $3.08 
Canceled   (143)  $2.16 
Unvested at December 31, 2024   2,731   $2.14 
Schedule of Stock-Based Compensation Expense

The fair value of the common stock at vesting aggregated $3,142,000, $929,000 and $6,900,000 for the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense related to employee and non-employee restricted stock and option grants recognized in the accompanying consolidated statements of operations, was as follows (in thousands):

 

   Years Ended December 31, 
   2024   2023   2022 
Employees  $3,960   $3,345   $2,689 
Non-employees   397    551    644 
Total stock-based compensation expense  $4,357   $3,896   $3,333 
v3.25.0.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Measurements [Abstract]  
Schedule of Recurring and Nonrecurring Fair Value Measurements

The following table summarizes recurring and nonrecurring fair value measurements by level at December 31, 2024 (in thousands):

 

                   Benefit Plan 
                  Percentage 
   Fair Value   Level 1   Level 2   Level 3   Allocation 
Assets:                    
Derivative financial instruments  $3,313   $3,313   $   $      
Long-lived assets – Magic Valley   19,397            19,397      
Defined benefit plan assets(1) (pooled separate accounts):                         
Large U.S. Equity(2)   6,962        6,962        34%
Small/Mid U.S. Equity(3)   3,636        3,636        18%
International Equity(4)   2,762        2,762        14%
Fixed Income(5)   6,807        6,807        34%
   $42,877   $3,313   $20,167   $19,397      
                          
Liabilities:                         
Derivative financial instruments  $1,177   $1,177   $   $      

The following table summarizes recurring and nonrecurring fair value measurements by level at December 31, 2023 (in thousands):

 

                   Benefit Plan 
   Fair               Percentage 
   Value   Level 1   Level 2   Level 3   Allocation 
Assets:                    
Derivative financial instruments  $2,412   $2,412   $
   $
      
Defined benefit plan assets(1) (pooled separate accounts):                         
Large U.S. Equity(2)   5,608    
    5,608    
    30%
Small/Mid U.S. Equity(3)   3,350    
    3,350    
    18%
International Equity(4)   2,682    
    2,682    
    15%
Fixed Income(5)   6,845    
    6,845    
    37%
   $20,897   $2,412   $18,485   $
      
                          
Liabilities:                         
Derivative financial instruments  $13,849   $13,849   $
   $
      
(1)See Note 10 for accounting discussion.

 

(2)This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

 

(3)This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

 

(4)This category includes investments in funds comprised of equity securities of foreign companies, including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

 

(5)This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
v3.25.0.1
Organization and Significant Accounting Policies (Details)
gal in Millions, T in Millions
12 Months Ended
Jan. 01, 2025
USD ($)
Sep. 12, 2022
USD ($)
Dec. 31, 2024
USD ($)
T
shares
gal
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Organization and Significant Accounting Policies [Line Items]          
Production capacity (in US Gallons) | gal     350    
Essential ingredient product capacity (in US Tons) | T     1.4    
Percentage of average ethanol production     50.00%    
Accounts receivable balance     $ 44,750,000 $ 51,315,000  
Allowance for credit losses     23,000 85,000  
Bad debt (recovery) expense     (50,000) 427,000 $ (217,000)
Accounts receivable total amount     5,187,000 4,302,000  
Inventory net of valuation adjustments     2,050,000 2,201,000  
Inventory amount     49,914,000 52,611,000  
Accounts receivable, net of allowance for credit losses     58,217,000 58,729,000 68,655,000
Impairment of goodwill     6,000,000
Asset impairments     24,790,000 574,000  
Amortization of deferred financing costs     1,016,000 1,048,000 $ 177,000
Unamortized financing cost     $ 3,684,000 $ 4,700,000  
Conserve capital, percentage     50.00%    
Potentially dilutive shares (in Shares) | shares     981,000 981,000 964,000
Weighted-average antidilutive shares (in Shares) | shares       3,188,000  
Income from cash grant     $ 2,812,000 $ 22,652,000
Allocated market losses     $ 700,000,000    
Authorized value   $ 50,000,000      
Initial purchase authorization   10,000,000      
Purchase authorization   5,000,000      
Excess purchase authorization   5,000,000      
Purchase additional amount   $ 10,000,000      
Repurchased an aggregate shares (in Shares) | shares       1,685,000 351,000
Cash       $ 3,674,000 $ 1,325,000
Shares of nonvoting common stock (in Shares) | shares     76,565,072 75,703,100  
Inventories [Member]          
Organization and Significant Accounting Policies [Line Items]          
Inventory amount     $ 35,495,000 $ 41,041,000  
Equity Method Investment [Member]          
Organization and Significant Accounting Policies [Line Items]          
Ownership percentage     100.00%    
Minimum [Member]          
Organization and Significant Accounting Policies [Line Items]          
Estimated lives     10 years    
Maximum [Member]          
Organization and Significant Accounting Policies [Line Items]          
Estimated lives     12 years    
Suppliers [Member] | Supplier Concentration Risk [Member] | Collective Bargaining Agreement [Member]          
Organization and Significant Accounting Policies [Line Items]          
Concentration risk percentage     44.00%    
Subsequent Event [Member]          
Organization and Significant Accounting Policies [Line Items]          
Wholly-owned subsidiary $ 7,600,000        
Cash $ 7,600,000        
Other Customer [Member] | Customer Concentration Risk [Member] | Accounts Receivable [Member]          
Organization and Significant Accounting Policies [Line Items]          
Concentration risk percentage     9.00% 7.00%  
Nonvoting Common Stock [Member]          
Organization and Significant Accounting Policies [Line Items]          
Shares of nonvoting common stock (in Shares) | shares     896 896  
Shares of nonvoting common stock outstanding (in Shares) | shares     896    
Nonvoting Common Stock [Member] | Common Stock [Member]          
Organization and Significant Accounting Policies [Line Items]          
Shares of nonvoting common stock (in Shares) | shares     3,539,236    
v3.25.0.1
Organization and Significant Accounting Policies - Schedule of Concentrations of Credit Risk (Details) - Customer Concentration Risk [Member]
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Total corn purchases [Member] | Supplier A [Member]      
Schedule of Sold to Customers Representing Company’s Total Net Sales [Line Items]      
Concentration risks percentage 16.00% 14.00% 11.00%
Total corn purchases [Member] | Supplier B [Member]      
Schedule of Sold to Customers Representing Company’s Total Net Sales [Line Items]      
Concentration risks percentage 13.00% 12.00% 12.00%
Total corn purchases [Member] | Supplier C [Member]      
Schedule of Sold to Customers Representing Company’s Total Net Sales [Line Items]      
Concentration risks percentage 15.00%
Customer A [Member] | Total net sales [Member]      
Schedule of Sold to Customers Representing Company’s Total Net Sales [Line Items]      
Concentration risks percentage 11.00% 9.00% 10.00%
Customer B [Member] | Total net sales [Member]      
Schedule of Sold to Customers Representing Company’s Total Net Sales [Line Items]      
Concentration risks percentage 7.00% 7.00% 10.00%
v3.25.0.1
Organization and Significant Accounting Policies - Schedule of Inventory (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Schedule of Inventories [Abstract]    
Finished goods $ 31,120 $ 35,765
Work in progress 4,203 5,063
Raw materials 8,989 10,313
Other 5,602 1,470
Total $ 49,914 $ 52,611
v3.25.0.1
Organization and Significant Accounting Policies - Schedule of Depreciation Is Computed Using the Straight-Line Method (Details)
Dec. 31, 2024
Buildings [Member]  
Schedule of Depreciation Is Computed Using the Straight-Line Method [Line Items]  
Property and equipment estimated useful lives 40 years
Minimum [Member] | Facilities and plant equipment [Member]  
Schedule of Depreciation Is Computed Using the Straight-Line Method [Line Items]  
Property and equipment estimated useful lives 10 years
Minimum [Member] | Other equipment, vehicles and furniture [Member]  
Schedule of Depreciation Is Computed Using the Straight-Line Method [Line Items]  
Property and equipment estimated useful lives 5 years
Maximum [Member] | Facilities and plant equipment [Member]  
Schedule of Depreciation Is Computed Using the Straight-Line Method [Line Items]  
Property and equipment estimated useful lives 25 years
Maximum [Member] | Other equipment, vehicles and furniture [Member]  
Schedule of Depreciation Is Computed Using the Straight-Line Method [Line Items]  
Property and equipment estimated useful lives 10 years
v3.25.0.1
Organization and Significant Accounting Policies - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of Basic and Diluted Earnings Per Share [Abstract]      
Consolidated net loss, Loss Numerator $ (58,984) $ (28,005) $ (41,597)
Less: Preferred stock dividends, Loss Numerator (1,269) (1,265) (1,265)
Basic and diluted loss per share:      
Loss attributable to common stockholders, Basic, Loss Numerator $ (60,253) $ (29,270) $ (42,862)
Loss attributable to common stockholders, Basic, Shares Denominator (in Shares) 73,482,000 73,339,000 71,944,000
Loss attributable to common stockholders, Basic, Per-Share Amount (in Dollars per share) $ (0.82) $ (0.4) $ (0.6)
Loss attributable to common stockholders, Diluted, Loss Numerator $ (60,253) $ (29,270) $ (42,862)
Loss attributable to common stockholders, Diluted, Shares Denominator (in Shares) 73,482,000 73,339,000 71,944,000
Loss attributable to common stockholders, Diluted, Per-Share Amount (in Dollars per share) $ (0.82) $ (0.4) $ (0.6)
v3.25.0.1
Acquisition of Eagle Alcohol (Details) - Acquisition of Eagle Alcohol [Member] - USD ($)
$ in Millions
Jan. 14, 2022
Dec. 31, 2024
Dec. 31, 2023
Acquisition of Eagle Alcohol [Line Items]      
Membership interests 100.00%    
Membership interest, description The purchase price was $14.0 million in cash plus an estimated net working capital adjustment of $1.3 million in cash. The selling members of Eagle Alcohol were eligible to receive up to an additional $14.0 million of contingent consideration, payable through a combination of $9.0 million in cash over the succeeding three years and an aggregate of $5.0 million in the Company’s common stock on the fourth- and fifth-year anniversaries of the closing date, subject to the satisfaction of certain conditions.    
Other current liabilities   $ 7.7 $ 2.8
Customer relationships intangible asset   6.5  
Trade name intangible asset   0.4  
Goodwill   $ 6.0  
v3.25.0.1
Intercompany Agreements (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Affiliate Management Agreement [Member]      
Intercompany Agreements [Line Items]      
Revenue $ 18,000,000    
Alto Ingredients, Inc [Member]      
Intercompany Agreements [Line Items]      
Revenue   $ 13,200,000 $ 12,403,000
Ethanol Marketing Agreements [Member]      
Intercompany Agreements [Line Items]      
Revenue $ 5,407,000 5,431,000 5,746,000
Marketable agreement description Under the terms of the marketing agreements, within ten days after delivering alcohol to Kinergy, an amount is paid to Kinergy equal to (i) the estimated purchase price payable by the third-party purchaser of the alcohol, minus (ii) the estimated amount of transportation costs to be incurred, minus (iii) the estimated incentive fee payable to Kinergy, which equals 1% of the aggregate third-party purchase price, provided that the marketing fee shall not be less than $0.015 per gallon and not more than $0.0225 per gallon.    
Corn Procurement and Handling Agreements [Member]      
Intercompany Agreements [Line Items]      
Revenue $ 2,910,000 3,007,000 3,207,000
Receives fee per bushel (in Dollars per share) $ 0.03    
Essential Ingredients Marketing Agreements [Member]      
Intercompany Agreements [Line Items]      
Revenue $ 2,516,000 $ 3,216,500 $ 3,505,000
Marketable agreement description Under the terms of the marketing agreements, within ten days after a facility delivers essential ingredients to Alto Nutrients, the production facility is paid an amount equal to (i) the estimated purchase price payable by the third-party purchaser of the essential ingredients, minus (ii) the estimated amount of transportation costs to be incurred, minus (iii) the estimated amount of fees and taxes payable to governmental authorities in connection with the tonnage of the essential ingredients produced or marketed, minus (iv) the estimated incentive fee payable to the Company, which equals (a) 5% of the aggregate third-party purchase price for wet corn protein feed, wet distillers grains, corn condensed distillers solubles and distillers grains with solubles, or (b) 1% of the aggregate third-party purchase price for corn protein meal, dry corn protein feed, dry distillers grains, corn germ and corn oil. Each marketing agreement had an initial term of one year and has successive one year renewal periods at the option of the production facility.    
v3.25.0.1
Segments (Details)
12 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Segments [Line Items]      
Operating segments 3    
Pekin Campus Production Segment [Member]      
Segments [Line Items]      
Management fees $ 7,200,000 $ 5,280,000 $ 5,046,000
Marketing and Distribution Segment [Member]      
Segments [Line Items]      
Management fees 5,400,000 3,960,000 3,840,000
Western Production Segment [Member]      
Segments [Line Items]      
Management fees 3,600,000 2,640,000 2,400,000
Capital expenditures 4,300,000 11,800,000 12,300,000
Pekin Campus Segment [Member]      
Segments [Line Items]      
Capital expenditures $ 6,800,000 $ 17,700,000 $ 25,700,000
v3.25.0.1
Segments - Schedule of Financial Data for Operating Segments (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pekin Campus production, recorded as gross:      
Net Sales $ 965,258 $ 1,222,940 $ 1,335,621
Cost of goods sold:      
Cost of goods sold 955,536 1,207,287 1,363,171
Gross profit (loss):      
Gross profit (loss) 9,722 15,653 (27,550)
Income (loss) before provision for income taxes:      
Income (loss) before provision for income taxes (58,811) (27,908) (39,672)
Asset impairments:      
Asset impairments 24,790 6,544
Depreciation and amortization expense:      
Depreciation and amortization expense 24,408 23,080 25,095
Interest expense, net of capitalized interest:      
Interest expense, net of capitalized interest 7,644 7,425 1,827
Pekin Campus [Member]      
Cost of goods sold:      
Cost of goods sold 563,033 710,088 772,755
Gross profit (loss):      
Gross profit (loss) 23,228 11,258 (24,399)
Income (loss) before provision for income taxes:      
Income (loss) before provision for income taxes 6,308 (1,560) (27,376)
Depreciation and amortization expense:      
Depreciation and amortization expense 21,017 19,789 19,136
Interest expense, net of capitalized interest:      
Interest expense, net of capitalized interest 1,765 (207) (381)
Pekin Campus [Member] | Alcohol Sales [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 415,710 502,217 521,273
Pekin Campus [Member] | Essential ingredient sales [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 169,308 217,702 225,871
Pekin Campus [Member] | Intersegment sales [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 1,243 1,427 1,212
Total Pekin Campus Sales [Member] | Intersegment sales [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 586,261 721,346 748,356
Marketing and distribution [Member]      
Cost of goods sold:      
Cost of goods sold 213,023 259,234 229,288
Gross profit (loss):      
Gross profit (loss) 14,334 15,372 12,022
Income (loss) before provision for income taxes:      
Income (loss) before provision for income taxes 5,261 7,644 3,748
Interest expense, net of capitalized interest:      
Interest expense, net of capitalized interest 389 822 1,658
Marketing and distribution [Member] | Intersegment sales [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 10,833 11,654 12,459
Marketing and distribution [Member] | Alcohol sales, gross [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 216,295 262,587 227,626
Marketing and distribution [Member] | Alcohol sales, net [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 229 365 1,225
Total Marketing and Distribution Sales [Member] | Intersegment sales [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 227,357 274,606 241,310
Western production [Member]      
Cost of goods sold:      
Cost of goods sold 172,209 230,445 353,775
Income (loss) before provision for income taxes:      
Income (loss) before provision for income taxes (51,086) (13,506) (7,209)
Depreciation and amortization expense:      
Depreciation and amortization expense 2,409 2,381 5,085
Interest expense, net of capitalized interest:      
Interest expense, net of capitalized interest 2,829 1,164 (339)
Western production [Member] | Essential ingredient sales [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 36,953 57,264 90,209
Western production [Member] | Intersegment sales [Member]      
Pekin Campus production, recorded as gross:      
Net Sales (122) 134 22
Western production [Member] | Intersegment sales [Member] | Total Western production sales [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 152,220 224,369 343,836
Western production [Member] | Alcohol sales [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 115,389 166,971 253,605
Corporate and other [Member]      
Pekin Campus production, recorded as gross:      
Net Sales 11,374 15,834 15,812
Cost of goods sold:      
Cost of goods sold 12,285 12,122 12,167
Gross profit (loss):      
Gross profit (loss) (911) 3,712 3,645
Income (loss) before provision for income taxes:      
Income (loss) before provision for income taxes (19,294) (20,486) (8,835)
Asset impairments:      
Asset impairments 3,401 6,544
Depreciation and amortization expense:      
Depreciation and amortization expense 982 910 874
Interest expense, net of capitalized interest:      
Interest expense, net of capitalized interest 2,661 5,646 889
Intersegment eliminations [Member]      
Pekin Campus production, recorded as gross:      
Net Sales (11,954) (13,215) (13,693)
Cost of goods sold:      
Cost of goods sold (5,014) (4,602) (4,814)
Gross profit (loss):      
Gross profit (loss) (6,940) (8,613) (8,879)
Western production [Member]      
Gross profit (loss):      
Gross profit (loss) (19,989) (6,076) (9,939)
Asset impairments:      
Asset impairments $ 21,389
v3.25.0.1
Segments - Schedule of Total Assets by Operating Segment (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Total assets:    
Total assets by operating segment $ 401,438 $ 454,241
Pekin Campus [Member]    
Total assets:    
Total assets by operating segment 223,934 251,048
Marketing and distribution [Member]    
Total assets:    
Total assets by operating segment 102,895 101,196
Western production [Member]    
Total assets:    
Total assets by operating segment 44,992 57,533
Corporate and Other [Member]    
Total assets:    
Total assets by operating segment $ 29,617 $ 44,464
v3.25.0.1
Property and Equipment (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Property And Equipment [Line Items]      
Depreciation expense $ 23,820,000 $ 22,492,000 $ 24,528,000
Capitalized interest 2,517,000 $ 2,454,000 $ 720,000
Asset impairment $ 19,000,000    
v3.25.0.1
Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Schedule of Property and Equipment [Abstract]    
Facilities and plant equipment $ 420,456 $ 405,010
Land 3,594 3,687
Other equipment, vehicles and furniture 20,636 9,719
Construction in progress 11,154 50,505
Total of property and equipment gross 455,840 468,921
Accumulated depreciation (241,098) (220,173)
Total property and equipment $ 214,742 $ 248,748
v3.25.0.1
Intangible Assets (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Intangible Assets [Line Items]      
Goodwill $ 5,970,000    
Goodwill and asset impairments   $ 5,970,000  
Asset impairments 24,790,000 6,544,000
Amortization expense of intangible assets 588,000 $ 588,000 $ 567,000
Kinergy Tradename [Member]      
Intangible Assets [Line Items]      
Recorded amount 2,678,000    
Customer Relationships [Member]      
Intangible Assets [Line Items]      
Recorded amount 6,556,000    
Asset impairments 3,401,000    
Eagle Alcohol Tradename [Member]      
Intangible Assets [Line Items]      
Recorded amount $ 420,000    
Customer Relationships and Tradename [Member]      
Intangible Assets [Line Items]      
Weighted-average unamortized life 8 years 8 months 12 days    
v3.25.0.1
Intangible Assets - Schedule of Intangible Assets Including Goodwill (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Schedule of Intangible Assets Including Goodwill [Line Items]    
Gross $ 15,624 $ 15,624
Accumulated Amortization/Impairment (11,115) (7,126)
Net Book Value 4,509 8,498
Goodwill [Member]    
Schedule of Intangible Assets Including Goodwill [Line Items]    
Gross 5,970 5,970
Accumulated Amortization/Impairment (5,970) (5,970)
Net Book Value
Kinergy tradename [Member]    
Schedule of Intangible Assets Including Goodwill [Line Items]    
Gross 2,678 2,678
Accumulated Amortization/Impairment
Net Book Value $ 2,678 2,678
Customer relationships [Member]    
Schedule of Intangible Assets Including Goodwill [Line Items]    
Useful Life (Years) 12 years  
Gross $ 6,556 6,556
Accumulated Amortization/Impairment (5,021) (1,074)
Net Book Value $ 1,535 5,482
Eagle Alcohol tradename [Member]    
Schedule of Intangible Assets Including Goodwill [Line Items]    
Useful Life (Years) 10 years  
Gross $ 420 420
Accumulated Amortization/Impairment (124) (82)
Net Book Value $ 296 $ 338
v3.25.0.1
Intangible Assets - Schedule of Expected Amortization Expense Relating to Amortizable Intangible Assets (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Schedule of Expected Amortization Expense Relating to Amortizable Intangible Assets [Abstract]  
2025 $ 213
2026 213
2027 213
2028 213
2029 213
Thereafter 766
Total $ 1,831
v3.25.0.1
Derivatives (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Derivatives [Abstract]      
Recognized net gains and losses $ 11,045,000 $ 8,031,000 $ 19,263,000
v3.25.0.1
Derivatives - Schedule of Derivatives Not Designated as Hedging Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Cash collateral balance [Member]    
Schedule of Derivatives Not Designated as Hedging Instruments [Line Items]    
Restricted cash $ 742 $ 15,466
Commodity contracts [Member]    
Schedule of Derivatives Not Designated as Hedging Instruments [Line Items]    
Derivative instruments, Assets 3,313 2,412
Derivative instruments, Liabilities $ 1,177 $ 13,849
v3.25.0.1
Derivatives - Schedule of Recognized Gains (Losses) For Its Derivatives Not Designated as Hedging Instruments (Details) - Cost of goods sold [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Realized Gains (Losses) [Member]      
Schedule of Realized and Unrealized Gains and Losses for its Derivatives not Designated as Hedging Instruments [Line Items]      
Realized gain (loss) on derivatives $ (2,529) $ 1,647 $ 23,280
Realized Gains (Losses) [Member] | Commodity contracts [Member]      
Schedule of Realized and Unrealized Gains and Losses for its Derivatives not Designated as Hedging Instruments [Line Items]      
Realized gain (loss) on derivatives (2,529) 1,647 23,280
Unrealized Gains (Losses) [Member]      
Schedule of Realized and Unrealized Gains and Losses for its Derivatives not Designated as Hedging Instruments [Line Items]      
Unrealized gain (loss) on derivatives 13,574 (9,678) (4,017)
Unrealized Gains (Losses) [Member] | Commodity contracts [Member]      
Schedule of Realized and Unrealized Gains and Losses for its Derivatives not Designated as Hedging Instruments [Line Items]      
Unrealized gain (loss) on derivatives $ 13,574 $ (9,678) $ (4,017)
v3.25.0.1
Debt (Details) - USD ($)
12 Months Ended
Jan. 01, 2025
Nov. 23, 2022
Dec. 31, 2024
Nov. 07, 2027
Debt [Line Items]        
Interest rates     6.06%  
Initial funding (in Dollars)   $ 60,000,000    
Percentage of excess cash flow     75.00%  
Fixed-charge coverage ratio (in Dollars per share)     $ 1.1  
Unused borrowing availability under line of credit (in Dollars)     $ 125,000,000  
Advance from Lenders (in Dollars)     100,000,000  
Advance from Lenders additional (in Dollars)     $ 25,000,000  
Share issue to the lenders (in Shares)   1,282,051    
Principal amount outstanding (in Dollars)   $ 60,000,000    
Loan proceeds (in Dollars)   $ 3,912,000    
Loan increased percentage 10.75%      
Kinergy line of credit [Member]        
Debt [Line Items]        
Margin interest rate     1.50%  
Unused borrowing (in Dollars)     $ 23,100,000  
Orion term loan [Member]        
Debt [Line Items]        
Loan fixed rate percentage     10.00%  
Kinergy [Member]        
Debt [Line Items]        
Initial funding (in Dollars)     $ 1,500,000  
Alto Nutrients [Member]        
Debt [Line Items]        
Initial funding (in Dollars)     $ 500,000  
Orion term loan [Member]        
Debt [Line Items]        
Share issue to the lenders (in Shares)     1,282,051  
Additional share issue to the lenders (in Dollars)     $ 320,513  
Minimum [Member]        
Debt [Line Items]        
Interest rates     1.25%  
Percentage of unused line fee     0.25%  
Maximum [Member]        
Debt [Line Items]        
Interest rates     1.75%  
Percentage of unused line fee     0.375%  
Forecast [Member] | Kinergy line of credit [Member]        
Debt [Line Items]        
Line of credit (in Dollars)       $ 100,000,000
If the leverage ratio is greater than or equal to 3.0x [Member]        
Debt [Line Items]        
Percentage of excess cash flow amount     100.00%  
If the leverage ratio is less than 3.0x and greater than or equal to 1.5x        
Debt [Line Items]        
Percentage of excess cash flow amount     50.00%  
If the leverage ratio is less than 1.5x [Member]        
Debt [Line Items]        
Percentage of excess cash flow amount     25.00%  
v3.25.0.1
Debt - Schedule of Long-Term Borrowings (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Total debt $ 99,677 $ 90,690
Less unamortized debt discount (3,089) (3,893)
Less unamortized debt financing costs (3,684) (4,700)
Less current portion
Long-term debt 92,904 82,097
Kinergy line of credit [Member]    
Debt Instrument [Line Items]    
Total debt 39,677 30,690
Orion term loan [Member]    
Debt Instrument [Line Items]    
Total debt $ 60,000 $ 60,000
v3.25.0.1
Debt - Schedule of Long-term Debt Matures (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Schedule of Long-term Debt Matures [Abstract]    
2027 $ 39,677  
2028 60,000  
Total debt $ 99,677 $ 90,690
v3.25.0.1
Leases (Details)
Dec. 31, 2024
Dec. 31, 2023
Leases [Line Items]    
Weighted-average discount rate 7.78% 7.78%
Equipment [Member]    
Leases [Line Items]    
Weighted-average remaining lease terms 4 years 1 month 20 days 4 years 8 months 23 days
Land [Member]    
Leases [Line Items]    
Weighted-average remaining lease terms 16 years 5 months 1 day 15 years 4 months 28 days
Minimum [Member]    
Leases [Line Items]    
Remaining lease terms 1 year  
Maximum [Member]    
Leases [Line Items]    
Remaining lease terms 51 years  
v3.25.0.1
Leases - Schedule of Leases (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Disclosure Text Block Abstract    
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Operating Lease, Right-of-Use Asset Operating Lease, Right-of-Use Asset
Operating Lease, Right-of-Use Asset $ 20,553 $ 22,597
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current Operating Lease, Liability, Current
Operating Lease, Liability, Current $ 4,851 $ 4,333
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent Operating Lease, Liability, Noncurrent
Operating Lease, Liability, Noncurrent $ 16,913 $ 19,029
v3.25.0.1
Leases - Schedule of Components of Lease Costs (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of Components of Lease Costs [Abstract]      
Fixed lease cost $ 5,989 $ 5,722 $ 5,224
Variable lease cost 529 871 124
Net lease cost $ 6,518 $ 6,593 $ 5,348
v3.25.0.1
Leases - Schedule of Operating Lease Liabilities (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Equipment [Member]  
Schedule of Operating Lease Liabilities [Line Items]  
2025 $ 5,334
2026 4,761
2027 4,152
2028 3,368
2029 1,992
2030-76 119
Less interest (3,299)
Operating lease liabilities 16,427
Land Related [Member]  
Schedule of Operating Lease Liabilities [Line Items]  
2025 1,060
2026 1,037
2027 1,011
2028 1,024
2029 660
2030-76 3,881
Less interest (3,336)
Operating lease liabilities $ 5,337
v3.25.0.1
Pension Plans (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Postretirement Plan [Member]        
Pension Plans [Line Items]        
Net periodic benefit (in Dollars)   $ 204 $ 201 $ 215
Adjusted rate   4.50%    
Pre-Medicare Postretirement [Member]        
Pension Plans [Line Items]        
Annual rate   8.50%    
Defined Benefit Plan, Equity Securities [Member]        
Pension Plans [Line Items]        
Equity retirement plan rate   50.00%    
Defined Benefit Plan, Debt Security [Member]        
Pension Plans [Line Items]        
Equity retirement plan rate   50.00%    
Forecast [Member]        
Pension Plans [Line Items]        
Net periodic benefit (in Dollars) $ 500      
v3.25.0.1
Pension Plans - Schedule of Information Related to the Retirement Plan (Details) - Retirement Plan [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Changes in plan assets:    
Fair value of plan assets, beginning $ 18,485 $ 16,688
Actual gains 1,711 2,376
Benefits paid (829) (834)
Company contributions 800 255
Participant contributions
Fair value of plan assets, ending 20,167 18,485
Less: projected accumulated benefit obligation 17,530 18,590
Funded status, overfunded (underfunded) 2,637 (105)
Amounts recognized in the consolidated balance sheets:    
Other assets 2,637
Other liabilities (105)
Accumulated other comprehensive income $ (4,167) $ (2,231)
Assumptions used in computation of benefit obligations:    
Discount rate 5.50% 4.90%
Expected long-term return on plan assets 6.50% 6.50%
Rate of compensation increase
v3.25.0.1
Pension Plans - Schedule of Components of Net Periodic Benefit Costs (Details) - Retirement Plan [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Components of net periodic benefit costs are as follows:      
Service cost $ 267 $ 249 $ 404
Interest cost 887 900 655
Expected return on plan assets (1,103) (993) (1,090)
Net periodic cost (benefit) $ 51 $ 156 $ (31)
v3.25.0.1
Pension Plans - Schedule of Expected Benefit Payments (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Schedule of Expected Benefit Payments [Abstract]  
2025 $ 1,000
2026 1,040
2027 1,080
2028 1,130
2029 1,160
2030-34 6,480
Total expected benefit payments $ 11,890
v3.25.0.1
Pension Plans - Schedule of Information Related to the Postretirement Plan (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Amounts at the end of the year:    
Accumulated/projected benefit obligation $ 3,783 $ 4,294
Fair value of plan assets
Funded status, underfunded (3,783) (4,294)
Amounts recognized in the consolidated balance sheets:    
Accrued liabilities (280) (320)
Other liabilities (3,503) (3,974)
Accumulated other comprehensive income $ (808) $ (250)
Discount rate used in computation of benefit obligations 5.30% 4.75%
v3.25.0.1
Pension Plans - Schedule of Net Periodic Benefit Costs (Details) - Postretirement Plan [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Components of net periodic benefit costs are as follows:      
Service cost $ 19 $ 14 $ 26
Interest cost 196 186 105
Amortization of prior service cost (53)
Net periodic benefit cost 215 147 131
Amounts recognized in the plan for the year:      
Participant contributions 35 36 43
Benefits paid $ 204 $ 201 $ 215
v3.25.0.1
Pension Plans - Schedule of Expected Benefit Payments (Details) - Postretirement Plan [Member]
$ in Thousands
Dec. 31, 2024
USD ($)
Schedule of Expected Benefit Payments [Line Items]  
2025 $ 280
2026 360
2027 390
2028 420
2029 400
2030-2034 1,780
Total expected benefit payments $ 3,630
v3.25.0.1
Income Taxes (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Taxes [Line Items]      
Federal net operating losses $ 128,800,000    
Federal taxable income 155,452,000    
Valuation allowance 110,687,000 $ 93,506,000  
Increase in valuation allowance 17,181,000 5,557,000 $ 12,365,000
Uncertain tax positions 739,000 739,000  
Effective tax 739,000    
Accrued penalties 74,000    
Accrued interest 134,000    
Assessment [Member]      
Income Taxes [Line Items]      
Valuation allowance 110,687,000 $ 93,506,000  
Domestic Tax Authority [Member]      
Income Taxes [Line Items]      
Net operating loss 227,673,000    
State and Local Jurisdiction [Member]      
Income Taxes [Line Items]      
Net operating loss 276,424,000    
Tax Year 2025 [Member]      
Income Taxes [Line Items]      
Federal capital loss $ 100,487,000    
Expire Term 5 years    
State capital loss $ 95,469,000    
Expire Term 5 years    
v3.25.0.1
Income Taxes - Schedule of Provision for Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of Provision for Income Taxes [Abstract]      
Current provision $ 173 $ 97 $ 1,925
Deferred provision
Total $ 173 $ 97 $ 1,925
v3.25.0.1
Income Taxes - Schedule of Reconciliation of Effective Tax Rate (Details)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of Reconciliation of Effective Tax Rate [Abstract]      
Statutory rate 21.00% 21.00% 21.00%
State income taxes, net of federal benefit 5.50% 4.60% 5.80%
Change in valuation allowance (29.30%) (23.40%) (33.90%)
Stock-based compensation (0.40%) (2.30%) 3.10%
Non-deductible items (0.10%) 0.80% (1.60%)
Other 3.00% (1.00%) 0.60%
Effective rate (0.30%) (0.30%) (5.00%)
v3.25.0.1
Income Taxes - Schedule of Components of Deferred Income Taxes (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Deferred tax assets:    
Net operating loss carryforwards $ 64,901 $ 57,870
Capital loss 26,692 26,518
Disallowed interest 5,048 3,457
R&D, Energy and AMT credits 3,742 3,742
Derivatives 3,051
Intangibles 2,981 1,201
Pension liability 1,016 1,173
Railcar contracts 1,090 818
Stock-based compensation 803 696
Allowance for credit losses and other assets 1,059 296
Other 4,971 3,340
Total gross deferred tax assets 112,303 102,162
Less: valuation allowance (110,687) (93,506)
Total deferred tax assets, net of valuation allowance 1,616 8,656
Deferred tax liabilities:    
Property and equipment (703) (7,720)
Derivatives (574)
Other (575) (1,172)
Total deferred tax liabilities (1,852) (8,892)
Net deferred tax liabilities, included in other liabilities $ (236) $ (236)
v3.25.0.1
Income Taxes - Schedule of Net Operating Loss Carryforwards (Details)
Dec. 31, 2024
USD ($)
Federal [Member]  
Schedule of Net Operating Loss Carryforwards [Line Items]  
Net Operating Loss Carryforward $ 227,673,000
State [Member]  
Schedule of Net Operating Loss Carryforwards [Line Items]  
Net Operating Loss Carryforward 276,424,000
2025–2029 [Member] | Federal [Member]  
Schedule of Net Operating Loss Carryforwards [Line Items]  
Net Operating Loss Carryforward
2025–2029 [Member] | State [Member]  
Schedule of Net Operating Loss Carryforwards [Line Items]  
Net Operating Loss Carryforward 30,603,000
2030–2034 [Member] | Federal [Member]  
Schedule of Net Operating Loss Carryforwards [Line Items]  
Net Operating Loss Carryforward 15,126,000
2030–2034 [Member] | State [Member]  
Schedule of Net Operating Loss Carryforwards [Line Items]  
Net Operating Loss Carryforward 76,920,000
2035–2039 [Member] | Federal [Member]  
Schedule of Net Operating Loss Carryforwards [Line Items]  
Net Operating Loss Carryforward 83,771,000
2035–2039 [Member] | State [Member]  
Schedule of Net Operating Loss Carryforwards [Line Items]  
Net Operating Loss Carryforward 112,608,000
2040 and after [Member] | Federal [Member]  
Schedule of Net Operating Loss Carryforwards [Line Items]  
Net Operating Loss Carryforward 128,776,000 [1]
2040 and after [Member] | State [Member]  
Schedule of Net Operating Loss Carryforwards [Line Items]  
Net Operating Loss Carryforward $ 56,293,000 [1]
[1] Includes indefinite life federal net operating losses of $128.8 million generated after 2017.
v3.25.0.1
Income Taxes - Schedule of Balance of Gross Unrecognized Tax Benefits, Before Interest and Penalties (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Schedule of Balance of Gross Unrecognized Tax Benefits Before Interest and Penalties [Abstract]    
Unrecognized tax benefits at beginning of year $ 739 $ 739
Increases related to current year tax positions
Decreases related to current year tax positions
Increases related to prior year tax positions
Decreases related to prior year tax positions
Decreases related to expiration of prior year tax positions
Decreases related to settlements of prior year tax positions
Unrecognized tax benefits at end of year $ 739 $ 739
v3.25.0.1
Income Taxes - Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions (Details)
12 Months Ended
Dec. 31, 2024
Federal [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Alabama [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Arizona [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2020 – 2023
Arkansas [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
California [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2020 – 2023
Colorado [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2020 – 2023
Connecticut [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Georgia [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Idaho [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Illinois [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Indiana [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Iowa [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Kansas [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Louisiana [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Michigan [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Minnesota [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Mississippi [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Missouri [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Nebraska [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
New Mexico [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Oklahoma [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Oregon [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Pennsylvania [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Rhode Island [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
South Carolina [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Tennessee [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2021 – 2023
Texas [Member]  
Schedule of Income Tax in the United States Jurisdiction and Various State Jurisdictions [Line Items]  
Tax years still open to audit 2020 – 2023
v3.25.0.1
Preferred Stock (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Preferred Stock [Line Items]    
Shares authorized 10,000,000 10,000,000
Internal rate of return 25.00%  
Expenses of preferred stock (in Dollars) $ 25,000  
Board of Directors Chairman [Member]    
Preferred Stock [Line Items]    
Undesignated shares of authorized and unissued preferred stock 6,734,835  
Series A Preferred Stock [Member]    
Preferred Stock [Line Items]    
Shares authorized 1,684,375 1,684,375
Preferred stock, shares outstanding
Dividend rate percentage 5.00%  
Series B Preferred Stock [Member]    
Preferred Stock [Line Items]    
Shares authorized 1,580,790 1,580,790
Preferred stock, shares outstanding 926,942 926,942
Dividend rate percentage 7.00%  
Liquidation preference, per share (in Dollars per share) $ 19.5  
Convertible shares 980,712  
Votes per share (in Dollars per share) $ 0.03  
v3.25.0.1
Stock-Based Compensation (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Jun. 20, 2024
Jun. 22, 2023
Jun. 23, 2022
Nov. 18, 2020
Nov. 07, 2019
Jun. 14, 2018
Jun. 16, 2016
Stock Based Compensation [Line Items]                    
Shares of common stock                   1,150,000
Fair value of the common stock at vesting aggregated (in Dollars) $ 3,142,000 $ 929,000 $ 6,900,000              
Unvested awards not been recognized amount (in Dollars) $ 3,678,000                  
Compensation expense attributable to unvested term 8 months 1 day                  
2016 Stock Incentive Plan [Member]                    
Stock Based Compensation [Line Items]                    
Aggregate number of shares authorized       15,200,000 11,400,000 8,900,000 7,400,000 5,650,000 3,650,000  
v3.25.0.1
Stock-Based Compensation - Schedule of Unvested Restricted Stock Activity (Details) - Restricted Stock [Member] - $ / shares
shares in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Schedule of Unvested Restricted Stock Activity [Line Items]    
Number of Shares Unvested, Ending 2,941 1,169
Weighted- Average Grant Date Fair Value Per Share Unvested, Ending $ 2.77 $ 5.95
Number of Shares Issued 1,530 2,375
Weighted- Average Grant Date Fair Value Per Share Issued $ 1.91 $ 1.87
Number of Shares Vested (1,597) (547)
Weighted- Average Grant Date Fair Value Per Share Vested $ 3.08 $ 5.61
Number of Shares Canceled (143) (56)
Weighted- Average Grant Date Fair Value Per Share Canceled $ 2.16 $ 3.14
Number of Shares Unvested, Ending 2,731 2,941
Weighted- Average Grant Date Fair Value Per Share Unvested, Ending $ 2.14 $ 2.77
v3.25.0.1
Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Schedule of Stock-Based Compensation Expense [Line Items]      
Total stock-based compensation expense $ 4,357 $ 3,896 $ 3,333
Employees [Member]      
Schedule of Stock-Based Compensation Expense [Line Items]      
Total stock-based compensation expense 3,960 3,345 2,689
Non-employees [Member]      
Schedule of Stock-Based Compensation Expense [Line Items]      
Total stock-based compensation expense $ 397 $ 551 $ 644
v3.25.0.1
Commitments and Contingencies (Details)
12 Months Ended
Dec. 31, 2024
USD ($)
dth
gal
T
Commitments and Contingencies [Line Items]  
Sales contracts valued $ 5,952,000
Indexed price sales contracts (in US Tons) | T 47,000
Future commitments for capital projects $ 9,059,000
Alcohol Sales Contracts [Member]  
Commitments and Contingencies [Line Items]  
Sales contracts valued $ 166,794,000
Sales Commitments [Member]  
Commitments and Contingencies [Line Items]  
Indexed-price sales (in US Gallons) | gal 74,375,000
Purchase Commitments [Member] | Alcohol From Suppliers [Member]  
Commitments and Contingencies [Line Items]  
Indexed-price sales (in US Gallons) | gal 23,028,000
Fixed-price purchase contracts value $ 220,000
Purchase Commitments [Member] | Corn From Suppliers [Member]  
Commitments and Contingencies [Line Items]  
Fixed-price purchase contracts value $ 34,731,000
Purchase Commitments [Member] | Natural Gas [Member]  
Commitments and Contingencies [Line Items]  
Indexed-price purchase contracts (in Dekatherms) | dth 2,520,000
Kodiak Carbonic, LLC [Member]  
Commitments and Contingencies [Line Items]  
Future commitments for capital projects $ 7,250,000
v3.25.0.1
Fair Value Measurements - Schedule of Recurring and Nonrecurring Fair Value Measurements (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Assets:    
Derivative financial instruments , Assets $ 3,313 $ 2,412
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets 42,877
Liabilities:    
Derivative financial instruments , Liabilities 1,177 13,849
Level 1 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets 3,313 20,897
Level 2 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets 20,167 2,412
Level 3 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets 19,397 18,485
Derivative Financial Instruments, Liabilities [Member]    
Liabilities:    
Derivative financial instruments , Liabilities 1,177
Derivative Financial Instruments, Liabilities [Member] | Level 1 [Member]    
Liabilities:    
Derivative financial instruments , Liabilities 1,177 13,849
Derivative Financial Instruments, Liabilities [Member] | Level 2 [Member]    
Liabilities:    
Derivative financial instruments , Liabilities 13,849
Derivative Financial Instruments, Liabilities [Member] | Level 3 [Member]    
Liabilities:    
Derivative financial instruments , Liabilities
Large U.S. Equity [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[2] $ 6,962
Benefit plan percentage allocation [1],[2] 34.00% 30.00%
Large U.S. Equity [Member] | Level 1 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[2] $ 5,608
Large U.S. Equity [Member] | Level 2 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[2] 6,962
Large U.S. Equity [Member] | Level 3 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[2] 5,608
Small/Mid U.S. Equity [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[3] $ 3,636
Benefit plan percentage allocation [1],[3] 18.00% 18.00%
Small/Mid U.S. Equity [Member] | Level 1 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[3] $ 3,350
Small/Mid U.S. Equity [Member] | Level 2 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[3] 3,636
Small/Mid U.S. Equity [Member] | Level 3 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[3] 3,350
International Equity [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[4] $ 2,762
Benefit plan percentage allocation [1],[4] 14.00% 15.00%
International Equity [Member] | Level 1 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[4] $ 2,682
International Equity [Member] | Level 2 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[4] 2,762
International Equity [Member] | Level 3 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[4] 2,682
Fixed Income [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[5] $ 6,807
Benefit plan percentage allocation [1],[5] 34.00% 37.00%
Fixed Income [Member] | Level 1 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[5] $ 6,845
Fixed Income [Member] | Level 2 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[5] 6,807
Fixed Income [Member] | Level 3 [Member]    
Defined benefit plan assets(1) (pooled separate accounts):    
Defined benefit plan assets [1],[5] 6,845
Derivative Financial Instruments, Assets [Member]    
Assets:    
Derivative financial instruments , Assets 3,313
Derivative Financial Instruments, Assets [Member] | Level 1 [Member]    
Assets:    
Derivative financial instruments , Assets 3,313 2,412
Derivative Financial Instruments, Assets [Member] | Level 2 [Member]    
Assets:    
Derivative financial instruments , Assets 2,412
Derivative Financial Instruments, Assets [Member] | Level 3 [Member]    
Assets:    
Derivative financial instruments , Assets
Long-lived assets – Magic Valley [Member]    
Assets:    
Derivative financial instruments , Assets 19,397  
Long-lived assets – Magic Valley [Member] | Level 1 [Member]    
Assets:    
Derivative financial instruments , Assets  
Long-lived assets – Magic Valley [Member] | Level 2 [Member]    
Assets:    
Derivative financial instruments , Assets  
Long-lived assets – Magic Valley [Member] | Level 3 [Member]    
Assets:    
Derivative financial instruments , Assets $ 19,397  
[1] See Note 10 for accounting discussion.
[2] This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
[3] This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
[4] This category includes investments in funds comprised of equity securities of foreign companies, including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
[5] This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
v3.25.0.1
Subsequent Events (Details) - Subsequent Event [Member]
$ in Millions
Jan. 01, 2025
USD ($)
Subsequent Events [Line Items]  
Cash $ 7.6
Fair value property and equipment 3.9
Intangible assets $ 3.7
Kodiak Carbonic, LLC [Member]  
Subsequent Events [Line Items]  
Acquired of the equity interests 100.00%

Grafico Azioni Alto Ingredients (NASDAQ:ALTO)
Storico
Da Mar 2025 a Apr 2025 Clicca qui per i Grafici di Alto Ingredients
Grafico Azioni Alto Ingredients (NASDAQ:ALTO)
Storico
Da Apr 2024 a Apr 2025 Clicca qui per i Grafici di Alto Ingredients